#begin document (1885825); part 000
1885825	0	1	CARD15	NN	-	-	-	-	-	-	-	(1
1885825	0	2	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	3	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	4	Is	VBZ	-	-	-	-	-	-	-	-
1885825	0	5	Required	VBN	-	-	-	-	-	-	-	-
1885825	0	6	for	IN	-	-	-	-	-	-	-	-
1885825	0	7	Peyer	NNP	-	-	-	-	-	-	-	(2|(3
1885825	0	8	's	POS	-	-	-	-	-	-	-	-
1885825	0	9	Patches	NNS	-	-	-	-	-	-	-	2)
1885825	0	10	Homeostasis	NN	-	-	-	-	-	-	-	3)
1885825	0	11	in	IN	-	-	-	-	-	-	-	-
1885825	0	12	Mice	NNS	-	-	-	-	-	-	-	(4)

1885825	0	1	Abstract	NN	-	-	-	-	-	-	-	-

1885825	0	1	Background	NN	-	-	-	-	-	-	-	-

1885825	0	1	CARD15	NN	-	-	-	-	-	-	-	(1|(5
1885825	0	2	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	3	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	4	mutations	NNS	-	-	-	-	-	-	-	5)
1885825	0	5	are	VBP	-	-	-	-	-	-	-	-
1885825	0	6	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	7	with	IN	-	-	-	-	-	-	-	-
1885825	0	8	susceptibility	NN	-	-	-	-	-	-	-	-
1885825	0	9	to	IN	-	-	-	-	-	-	-	-
1885825	0	10	Crohn	NNP	-	-	-	-	-	-	-	(6|(7
1885825	0	11	's	POS	-	-	-	-	-	-	-	-
1885825	0	12	Disease	NN	-	-	-	-	-	-	-	6)
1885825	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	14	CD	NN	-	-	-	-	-	-	-	-
1885825	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	16	and	CC	-	-	-	-	-	-	-	-
1885825	0	17	Graft	NN	-	-	-	-	-	-	-	(8
1885825	0	18	Versus	CC	-	-	-	-	-	-	-	-
1885825	0	19	Host	NN	-	-	-	-	-	-	-	-
1885825	0	20	Disease	NN	-	-	-	-	-	-	-	8)
1885825	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	22	GVHD	NN	-	-	-	-	-	-	-	-
1885825	0	23	)	-RRB-	-	-	-	-	-	-	-	7)
1885825	0	24	.	.	-	-	-	-	-	-	-	-

1885825	0	1	CD	NN	-	-	-	-	-	-	-	(7|(6)
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	GVHD	NN	-	-	-	-	-	-	-	(8)|7)
1885825	0	4	are	VBP	-	-	-	-	-	-	-	-
1885825	0	5	suspected	VBN	-	-	-	-	-	-	-	-
1885825	0	6	to	TO	-	-	-	-	-	-	-	-
1885825	0	7	be	VB	-	-	-	-	-	-	-	-
1885825	0	8	related	VBN	-	-	-	-	-	-	-	-
1885825	0	9	with	IN	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	-
1885825	0	11	dysfunction	NN	-	-	-	-	-	-	-	-
1885825	0	12	of	IN	-	-	-	-	-	-	-	-
1885825	0	13	Peyer	NNP	-	-	-	-	-	-	-	(2|(9
1885825	0	14	's	POS	-	-	-	-	-	-	-	-
1885825	0	15	patches	NNS	-	-	-	-	-	-	-	2)
1885825	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	17	PP	NN	-	-	-	-	-	-	-	-
1885825	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	isolated	VBN	-	-	-	-	-	-	-	(10
1885825	0	21	lymphoid	JJ	-	-	-	-	-	-	-	-
1885825	0	22	follicles	NNS	-	-	-	-	-	-	-	10)
1885825	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	24	LFs	NNS	-	-	-	-	-	-	-	9)
1885825	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Using	VBG	-	-	-	-	-	-	-	-
1885825	0	2	a	DT	-	-	-	-	-	-	-	-
1885825	0	3	new	JJ	-	-	-	-	-	-	-	-
1885825	0	4	mouse	NN	-	-	-	-	-	-	-	(4)
1885825	0	5	model	NN	-	-	-	-	-	-	-	-
1885825	0	6	invalidated	VBN	-	-	-	-	-	-	-	-
1885825	0	7	for	IN	-	-	-	-	-	-	-	-
1885825	0	8	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	9	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	10	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	11	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	12	KO	NN	-	-	-	-	-	-	-	(12)
1885825	0	13	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	14	,	,	-	-	-	-	-	-	-	-
1885825	0	15	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	16	thus	RB	-	-	-	-	-	-	-	-
1885825	0	17	analysed	VBD	-	-	-	-	-	-	-	-
1885825	0	18	the	DT	-	-	-	-	-	-	-	-
1885825	0	19	impact	NN	-	-	-	-	-	-	-	-
1885825	0	20	of	IN	-	-	-	-	-	-	-	-
1885825	0	21	the	DT	-	-	-	-	-	-	-	(11
1885825	0	22	gene	NN	-	-	-	-	-	-	-	11)
1885825	0	23	in	IN	-	-	-	-	-	-	-	-
1885825	0	24	these	DT	-	-	-	-	-	-	-	(9
1885825	0	25	lymphoid	JJ	-	-	-	-	-	-	-	-
1885825	0	26	formations	NNS	-	-	-	-	-	-	-	9)
1885825	0	27	together	RB	-	-	-	-	-	-	-	-
1885825	0	28	with	IN	-	-	-	-	-	-	-	-
1885825	0	29	the	DT	-	-	-	-	-	-	-	-
1885825	0	30	development	NN	-	-	-	-	-	-	-	-
1885825	0	31	of	IN	-	-	-	-	-	-	-	-
1885825	0	32	experimental	JJ	-	-	-	-	-	-	-	(14
1885825	0	33	colitis	NN	-	-	-	-	-	-	-	14)
1885825	0	34	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Methodology	NN	-	-	-	-	-	-	-	-
1885825	0	2	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	3	Principal	JJ	-	-	-	-	-	-	-	-
1885825	0	4	Findings	NNS	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	weeks	NNS	-	-	-	-	-	-	-	(15|(17|(16c)|(18b)
1885825	0	3	4	CD	-	-	-	-	-	-	-	15)
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	12	CD	-	-	-	-	-	-	-	(16c)
1885825	0	6	and	CC	-	-	-	-	-	-	-	-
1885825	0	7	52	CD	-	-	-	-	-	-	-	(18b)|17)
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	(19
1885825	0	10	numbers	NNS	-	-	-	-	-	-	-	-
1885825	0	11	of	IN	-	-	-	-	-	-	-	-
1885825	0	12	PPs	NNS	-	-	-	-	-	-	-	(2)|19)
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	LFs	NNS	-	-	-	-	-	-	-	(20)
1885825	0	15	were	VBD	-	-	-	-	-	-	-	-
1885825	0	16	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	17	in	IN	-	-	-	-	-	-	-	-
1885825	0	18	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	19	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	20	while	IN	-	-	-	-	-	-	-	-
1885825	0	21	no	DT	-	-	-	-	-	-	-	-
1885825	0	22	difference	NN	-	-	-	-	-	-	-	-
1885825	0	23	was	VBD	-	-	-	-	-	-	-	-
1885825	0	24	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	25	at	IN	-	-	-	-	-	-	-	-
1885825	0	26	birth	NN	-	-	-	-	-	-	-	(21)
1885825	0	27	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	weeks	NNS	-	-	-	-	-	-	-	(15|(22|(16a)
1885825	0	3	4	CD	-	-	-	-	-	-	-	15)
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	12	CD	-	-	-	-	-	-	-	(16a)|22)
1885825	0	6	,	,	-	-	-	-	-	-	-	-
1885825	0	7	the	DT	-	-	-	-	-	-	-	-
1885825	0	8	size	NN	-	-	-	-	-	-	-	(23a)
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	cellular	JJ	-	-	-	-	-	-	-	(24
1885825	0	11	composition	NN	-	-	-	-	-	-	-	-
1885825	0	12	of	IN	-	-	-	-	-	-	-	(23a
1885825	0	13	PPs	NNS	-	-	-	-	-	-	-	(2)|24)|23a)
1885825	0	14	were	VBD	-	-	-	-	-	-	-	-
1885825	0	15	analysed	VBN	-	-	-	-	-	-	-	-
1885825	0	16	by	IN	-	-	-	-	-	-	-	-
1885825	0	17	flow	NN	-	-	-	-	-	-	-	(25
1885825	0	18	cytometry	NN	-	-	-	-	-	-	-	25)
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	immunohistochemistry	NN	-	-	-	-	-	-	-	(26)
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	PPs	NNS	-	-	-	-	-	-	-	(27
1885825	0	2	of	IN	-	-	-	-	-	-	-	-
1885825	0	3	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	4	mice	NNS	-	-	-	-	-	-	-	27)|12)
1885825	0	5	were	VBD	-	-	-	-	-	-	-	-
1885825	0	6	larger	JJR	-	-	-	-	-	-	-	-
1885825	0	7	with	IN	-	-	-	-	-	-	-	-
1885825	0	8	an	DT	-	-	-	-	-	-	-	-
1885825	0	9	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	10	proportion	NN	-	-	-	-	-	-	-	-
1885825	0	11	of	IN	-	-	-	-	-	-	-	-
1885825	0	12	M	NN	-	-	-	-	-	-	-	(28|(29
1885825	0	13	cells	NNS	-	-	-	-	-	-	-	28)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	CD4	NN	-	-	-	-	-	-	-	(30
1885825	0	16	+	SYM	-	-	-	-	-	-	-	-
1885825	0	17	T	NN	-	-	-	-	-	-	-	-
1885825	0	18	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	19	cells	NNS	-	-	-	-	-	-	-	30)|29)
1885825	0	20	.	.	-	-	-	-	-	-	-	-

1885825	0	1	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	2	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	3	were	VBD	-	-	-	-	-	-	-	-
1885825	0	4	also	RB	-	-	-	-	-	-	-	-
1885825	0	5	characterised	VBN	-	-	-	-	-	-	-	-
1885825	0	6	by	IN	-	-	-	-	-	-	-	-
1885825	0	7	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	8	concentrations	NNS	-	-	-	-	-	-	-	-
1885825	0	9	of	IN	-	-	-	-	-	-	-	-
1885825	0	10	TNFα	NN	-	-	-	-	-	-	-	(32|(31)
1885825	0	11	,	,	-	-	-	-	-	-	-	-
1885825	0	12	IFNγ	NN	-	-	-	-	-	-	-	(33)
1885825	0	13	,	,	-	-	-	-	-	-	-	-
1885825	0	14	IL12	NN	-	-	-	-	-	-	-	(34)
1885825	0	15	and	CC	-	-	-	-	-	-	-	-
1885825	0	16	IL4	NN	-	-	-	-	-	-	-	(35)|32)
1885825	0	17	measured	VBN	-	-	-	-	-	-	-	-
1885825	0	18	by	IN	-	-	-	-	-	-	-	-
1885825	0	19	ELISA	NNP	-	-	-	-	-	-	-	(36)
1885825	0	20	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	contrast	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	little	JJ	-	-	-	-	-	-	-	-
1885825	0	5	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	6	were	VBD	-	-	-	-	-	-	-	-
1885825	0	7	found	VBN	-	-	-	-	-	-	-	-
1885825	0	8	in	IN	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	(37
1885825	0	10	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	11	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	12	free	JJ	-	-	-	-	-	-	-	-
1885825	0	13	ileum	NN	-	-	-	-	-	-	-	37)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	the	DT	-	-	-	-	-	-	-	(38
1885825	0	16	spleen	NN	-	-	-	-	-	-	-	-
1885825	0	17	of	IN	-	-	-	-	-	-	-	-
1885825	0	18	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	19	mice	NNS	-	-	-	-	-	-	-	38)|12)
1885825	0	20	.	.	-	-	-	-	-	-	-	-

1885825	0	1	By	IN	-	-	-	-	-	-	-	-
1885825	0	2	Ussing	VBG	-	-	-	-	-	-	-	(39|(40
1885825	0	3	chamber	NN	-	-	-	-	-	-	-	39)
1885825	0	4	experiments	NNS	-	-	-	-	-	-	-	40)
1885825	0	5	,	,	-	-	-	-	-	-	-	-
1885825	0	6	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	7	found	VBD	-	-	-	-	-	-	-	-
1885825	0	8	that	IN	-	-	-	-	-	-	-	-
1885825	0	9	this	DT	-	-	-	-	-	-	-	(12
1885825	0	10	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	11	phenotype	NN	-	-	-	-	-	-	-	12)
1885825	0	12	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	13	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	14	with	IN	-	-	-	-	-	-	-	-
1885825	0	15	an	DT	-	-	-	-	-	-	-	-
1885825	0	16	increased	NN	-	-	-	-	-	-	-	-
1885825	0	17	of	IN	-	-	-	-	-	-	-	-
1885825	0	18	both	CC	-	-	-	-	-	-	-	-
1885825	0	19	paracellular	JJ	-	-	-	-	-	-	-	(41
1885825	0	20	permeability	NN	-	-	-	-	-	-	-	41)
1885825	0	21	and	CC	-	-	-	-	-	-	-	-
1885825	0	22	yeast	NN	-	-	-	-	-	-	-	(42a)
1885825	0	23	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	24	bacterial	JJ	-	-	-	-	-	-	-	(43
1885825	0	25	translocation	NN	-	-	-	-	-	-	-	(42a)|43)
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	4	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	5	were	VBD	-	-	-	-	-	-	-	-
1885825	0	6	more	RBR	-	-	-	-	-	-	-	-
1885825	0	7	susceptible	JJ	-	-	-	-	-	-	-	-
1885825	0	8	to	IN	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	(44
1885825	0	10	colitis	NN	-	-	-	-	-	-	-	-
1885825	0	11	induced	VBN	-	-	-	-	-	-	-	-
1885825	0	12	by	IN	-	-	-	-	-	-	-	-
1885825	0	13	TNBS	NN	-	-	-	-	-	-	-	(45)|44)
1885825	0	14	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Conclusions	NNS	-	-	-	-	-	-	-	-

1885825	0	1	Card15	NN	-	-	-	-	-	-	-	(11|(46|(47
1885825	0	2	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	3	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	4	deficiency	NN	-	-	-	-	-	-	-	46)
1885825	0	5	induces	VBZ	-	-	-	-	-	-	-	-
1885825	0	6	an	DT	-	-	-	-	-	-	-	-
1885825	0	7	abnormal	JJ	-	-	-	-	-	-	-	-
1885825	0	8	development	NN	-	-	-	-	-	-	-	-
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	function	NN	-	-	-	-	-	-	-	(48
1885825	0	11	of	IN	-	-	-	-	-	-	-	-
1885825	0	12	the	DT	-	-	-	-	-	-	-	(2
1885825	0	13	PPs	NNS	-	-	-	-	-	-	-	48)|2)
1885825	0	14	characterised	VBN	-	-	-	-	-	-	-	-
1885825	0	15	by	IN	-	-	-	-	-	-	-	-
1885825	0	16	an	DT	-	-	-	-	-	-	-	-
1885825	0	17	exaggerated	VBN	-	-	-	-	-	-	-	-
1885825	0	18	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	19	response	NN	-	-	-	-	-	-	-	-
1885825	0	20	and	CC	-	-	-	-	-	-	-	-
1885825	0	21	an	DT	-	-	-	-	-	-	-	(49
1885825	0	22	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	23	permeability	NN	-	-	-	-	-	-	-	49)|47)
1885825	0	24	.	.	-	-	-	-	-	-	-	-

1885825	0	1	These	DT	-	-	-	-	-	-	-	(47
1885825	0	2	observations	NNS	-	-	-	-	-	-	-	47)
1885825	0	3	provide	VBP	-	-	-	-	-	-	-	-
1885825	0	4	a	DT	-	-	-	-	-	-	-	-
1885825	0	5	comprehensive	JJ	-	-	-	-	-	-	-	-
1885825	0	6	link	NN	-	-	-	-	-	-	-	-
1885825	0	7	between	IN	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	(46
1885825	0	9	molecular	JJ	-	-	-	-	-	-	-	-
1885825	0	10	defect	NN	-	-	-	-	-	-	-	46)
1885825	0	11	and	CC	-	-	-	-	-	-	-	-
1885825	0	12	the	DT	-	-	-	-	-	-	-	-
1885825	0	13	Human	JJ	-	-	-	-	-	-	-	-
1885825	0	14	CARD15	NN	-	-	-	-	-	-	-	-
1885825	0	15	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	NOD2	NN	-	-	-	-	-	-	-	-
1885825	0	17	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	18	disorders	NNS	-	-	-	-	-	-	-	-
1885825	0	19	:	:	-	-	-	-	-	-	-	-
1885825	0	20	CD	NN	-	-	-	-	-	-	-	(7|(6)
1885825	0	21	and	CC	-	-	-	-	-	-	-	-
1885825	0	22	GVHD	NN	-	-	-	-	-	-	-	(8)|7)
1885825	0	23	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Introduction	NN	-	-	-	-	-	-	-	-

1885825	0	1	Caspase	NN	-	-	-	-	-	-	-	(1
1885825	0	2	Recruitment	NN	-	-	-	-	-	-	-	-
1885825	0	3	Domain	NN	-	-	-	-	-	-	-	-
1885825	0	4	15	CD	-	-	-	-	-	-	-	-
1885825	0	5	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	6	CARD15	NN	-	-	-	-	-	-	-	-
1885825	0	7	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	8	also	RB	-	-	-	-	-	-	-	-
1885825	0	9	known	VBN	-	-	-	-	-	-	-	-
1885825	0	10	as	IN	-	-	-	-	-	-	-	-
1885825	0	11	Nucleotide	NN	-	-	-	-	-	-	-	-
1885825	0	12	oligomerisation	NN	-	-	-	-	-	-	-	-
1885825	0	13	domain	NN	-	-	-	-	-	-	-	-
1885825	0	14	2	CD	-	-	-	-	-	-	-	-
1885825	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	16	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	17	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	18	has	VBZ	-	-	-	-	-	-	-	-
1885825	0	19	been	VBN	-	-	-	-	-	-	-	-
1885825	0	20	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	21	with	IN	-	-	-	-	-	-	-	-
1885825	0	22	Crohn	NNP	-	-	-	-	-	-	-	(6|(7
1885825	0	23	's	POS	-	-	-	-	-	-	-	-
1885825	0	24	Disease	NN	-	-	-	-	-	-	-	6)
1885825	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	26	CD	NN	-	-	-	-	-	-	-	-
1885825	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	28	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	29	1	CD	-	-	-	-	-	-	-	(50)
1885825	0	30	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	31	,	,	-	-	-	-	-	-	-	-
1885825	0	32	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	33	2	CD	-	-	-	-	-	-	-	(51)
1885825	0	34	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	35	and	CC	-	-	-	-	-	-	-	-
1885825	0	36	graft	NN	-	-	-	-	-	-	-	(8
1885825	0	37	versus	CC	-	-	-	-	-	-	-	-
1885825	0	38	host	NN	-	-	-	-	-	-	-	-
1885825	0	39	disease	NN	-	-	-	-	-	-	-	8)
1885825	0	40	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	41	GVHD	NN	-	-	-	-	-	-	-	7)
1885825	0	42	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	43	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	44	3	CD	-	-	-	-	-	-	-	(52)
1885825	0	45	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	46	,	,	-	-	-	-	-	-	-	-
1885825	0	47	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	48	4	CD	-	-	-	-	-	-	-	(53)
1885825	0	49	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	50	.	.	-	-	-	-	-	-	-	-

1885825	0	1	NOD2	NN	-	-	-	-	-	-	-	(1)
1885825	0	2	belongs	VBZ	-	-	-	-	-	-	-	-
1885825	0	3	to	IN	-	-	-	-	-	-	-	-
1885825	0	4	a	DT	-	-	-	-	-	-	-	-
1885825	0	5	family	NN	-	-	-	-	-	-	-	-
1885825	0	6	of	IN	-	-	-	-	-	-	-	-
1885825	0	7	genes	NNS	-	-	-	-	-	-	-	-
1885825	0	8	involved	VBN	-	-	-	-	-	-	-	-
1885825	0	9	in	IN	-	-	-	-	-	-	-	-
1885825	0	10	innate	JJ	-	-	-	-	-	-	-	(54
1885825	0	11	immunity	NN	-	-	-	-	-	-	-	54)
1885825	0	12	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	13	5	CD	-	-	-	-	-	-	-	(55)
1885825	0	14	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	It	PRP	-	-	-	-	-	-	-	(1)
1885825	0	2	can	MD	-	-	-	-	-	-	-	-
1885825	0	3	be	VB	-	-	-	-	-	-	-	-
1885825	0	4	activated	VBN	-	-	-	-	-	-	-	-
1885825	0	5	by	IN	-	-	-	-	-	-	-	-
1885825	0	6	muropeptides	NNS	-	-	-	-	-	-	-	(56
1885825	0	7	which	WDT	-	-	-	-	-	-	-	-
1885825	0	8	are	VBP	-	-	-	-	-	-	-	-
1885825	0	9	components	NNS	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	the	DT	-	-	-	-	-	-	-	-
1885825	0	12	bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	13	cell	NN	-	-	-	-	-	-	-	-
1885825	0	14	wall	NN	-	-	-	-	-	-	-	56)
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	When	WRB	-	-	-	-	-	-	-	-
1885825	0	2	activated	VBN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	NOD2	NN	-	-	-	-	-	-	-	(1)
1885825	0	5	interacts	VBZ	-	-	-	-	-	-	-	-
1885825	0	6	with	IN	-	-	-	-	-	-	-	-
1885825	0	7	Rick	NN	-	-	-	-	-	-	-	-
1885825	0	8	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	Rip2	NN	-	-	-	-	-	-	-	-
1885825	0	10	which	WDT	-	-	-	-	-	-	-	-
1885825	0	11	in	IN	-	-	-	-	-	-	-	-
1885825	0	12	turn	JJ	-	-	-	-	-	-	-	-
1885825	0	13	activates	VBZ	-	-	-	-	-	-	-	-
1885825	0	14	the	DT	-	-	-	-	-	-	-	(57
1885825	0	15	NF	NN	-	-	-	-	-	-	-	-
1885825	0	16	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	kB	NN	-	-	-	-	-	-	-	-
1885825	0	18	pathway	NN	-	-	-	-	-	-	-	57)
1885825	0	19	,	,	-	-	-	-	-	-	-	-
1885825	0	20	resulting	VBG	-	-	-	-	-	-	-	-
1885825	0	21	in	IN	-	-	-	-	-	-	-	-
1885825	0	22	the	DT	-	-	-	-	-	-	-	-
1885825	0	23	production	NN	-	-	-	-	-	-	-	-
1885825	0	24	of	IN	-	-	-	-	-	-	-	-
1885825	0	25	pro-inflammatory	JJ	-	-	-	-	-	-	-	(58
1885825	0	26	cytokines	NNS	-	-	-	-	-	-	-	58)
1885825	0	27	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Half	NN	-	-	-	-	-	-	-	-
1885825	0	2	of	IN	-	-	-	-	-	-	-	-
1885825	0	3	CD	NN	-	-	-	-	-	-	-	(59|(6)
1885825	0	4	patients	NNS	-	-	-	-	-	-	-	59)
1885825	0	5	have	VBP	-	-	-	-	-	-	-	-
1885825	0	6	one	CD	-	-	-	-	-	-	-	-
1885825	0	7	or	CC	-	-	-	-	-	-	-	-
1885825	0	8	more	JJR	-	-	-	-	-	-	-	-
1885825	0	9	NOD2	NN	-	-	-	-	-	-	-	(1)
1885825	0	10	mutations	NNS	-	-	-	-	-	-	-	-
1885825	0	11	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	12	6	CD	-	-	-	-	-	-	-	-
1885825	0	13	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	14	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Some	DT	-	-	-	-	-	-	-	-
1885825	0	2	of	IN	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	-
1885825	0	4	CD	NN	-	-	-	-	-	-	-	-
1885825	0	5	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	6	mutations	NNS	-	-	-	-	-	-	-	-
1885825	0	7	were	VBD	-	-	-	-	-	-	-	-
1885825	0	8	found	VBN	-	-	-	-	-	-	-	-
1885825	0	9	unresponsive	JJ	-	-	-	-	-	-	-	-
1885825	0	10	to	IN	-	-	-	-	-	-	-	-
1885825	0	11	muropeptides	NNS	-	-	-	-	-	-	-	(56)
1885825	0	12	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	13	5	CD	-	-	-	-	-	-	-	(55)
1885825	0	14	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	By	IN	-	-	-	-	-	-	-	-
1885825	0	2	consequence	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	CD	NN	-	-	-	-	-	-	-	(6)
1885825	0	5	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	6	usually	RB	-	-	-	-	-	-	-	-
1885825	0	7	considered	VBN	-	-	-	-	-	-	-	-
1885825	0	8	as	IN	-	-	-	-	-	-	-	-
1885825	0	9	an	DT	-	-	-	-	-	-	-	-
1885825	0	10	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	11	deficiency	NN	-	-	-	-	-	-	-	-
1885825	0	12	toward	IN	-	-	-	-	-	-	-	-
1885825	0	13	bacteria	NNS	-	-	-	-	-	-	-	-
1885825	0	14	present	JJ	-	-	-	-	-	-	-	-
1885825	0	15	in	IN	-	-	-	-	-	-	-	-
1885825	0	16	the	DT	-	-	-	-	-	-	-	(60
1885825	0	17	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	18	lumen	NN	-	-	-	-	-	-	-	60)
1885825	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	20	7	CD	-	-	-	-	-	-	-	(62)
1885825	0	21	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	However	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	-
1885825	0	4	exact	JJ	-	-	-	-	-	-	-	-
1885825	0	5	mechanism	NN	-	-	-	-	-	-	-	-
1885825	0	6	by	IN	-	-	-	-	-	-	-	-
1885825	0	7	which	WDT	-	-	-	-	-	-	-	-
1885825	0	8	NOD2	NN	-	-	-	-	-	-	-	(5|(1)
1885825	0	9	mutations	NNS	-	-	-	-	-	-	-	5)
1885825	0	10	are	VBP	-	-	-	-	-	-	-	-
1885825	0	11	able	JJ	-	-	-	-	-	-	-	-
1885825	0	12	to	TO	-	-	-	-	-	-	-	-
1885825	0	13	induce	VB	-	-	-	-	-	-	-	-
1885825	0	14	CD	NN	-	-	-	-	-	-	-	(63|(6)
1885825	0	15	lesions	NNS	-	-	-	-	-	-	-	63)
1885825	0	16	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	17	still	RB	-	-	-	-	-	-	-	-
1885825	0	18	subject	JJ	-	-	-	-	-	-	-	-
1885825	0	19	to	IN	-	-	-	-	-	-	-	-
1885825	0	20	debate	NN	-	-	-	-	-	-	-	-
1885825	0	21	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	22	7	CD	-	-	-	-	-	-	-	(62)
1885825	0	23	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	24	–	SYM	-	-	-	-	-	-	-	-
1885825	0	25	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	26	10	CD	-	-	-	-	-	-	-	-
1885825	0	27	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	28	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Holler	NNP	-	-	-	-	-	-	-	-
1885825	0	2	et	FW	-	-	-	-	-	-	-	-
1885825	0	3	al.	FW	-	-	-	-	-	-	-	-
1885825	0	4	reported	VBD	-	-	-	-	-	-	-	-
1885825	0	5	that	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	-
1885825	0	7	three	CD	-	-	-	-	-	-	-	-
1885825	0	8	major	JJ	-	-	-	-	-	-	-	-
1885825	0	9	mutations	NNS	-	-	-	-	-	-	-	-
1885825	0	10	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	11	with	IN	-	-	-	-	-	-	-	-
1885825	0	12	CD	NN	-	-	-	-	-	-	-	(6)
1885825	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	14	R702W	NN	-	-	-	-	-	-	-	-
1885825	0	15	,	,	-	-	-	-	-	-	-	-
1885825	0	16	G908R	NN	-	-	-	-	-	-	-	-
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	1007fs	NN	-	-	-	-	-	-	-	-
1885825	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	20	are	VBP	-	-	-	-	-	-	-	-
1885825	0	21	also	RB	-	-	-	-	-	-	-	-
1885825	0	22	associated	JJ	-	-	-	-	-	-	-	-
1885825	0	23	with	IN	-	-	-	-	-	-	-	-
1885825	0	24	severe	JJ	-	-	-	-	-	-	-	-
1885825	0	25	acute	JJ	-	-	-	-	-	-	-	-
1885825	0	26	GVHD	NN	-	-	-	-	-	-	-	-
1885825	0	27	and	CC	-	-	-	-	-	-	-	-
1885825	0	28	bone	NN	-	-	-	-	-	-	-	(64
1885825	0	29	marrow	NN	-	-	-	-	-	-	-	-
1885825	0	30	transplantation	NN	-	-	-	-	-	-	-	64)
1885825	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	32	BMT	NN	-	-	-	-	-	-	-	-
1885825	0	33	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	34	related	VBN	-	-	-	-	-	-	-	-
1885825	0	35	mortality	NN	-	-	-	-	-	-	-	-
1885825	0	36	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	37	3	CD	-	-	-	-	-	-	-	(52)
1885825	0	38	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	39	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Mutations	NNS	-	-	-	-	-	-	-	-
1885825	0	2	in	IN	-	-	-	-	-	-	-	-
1885825	0	3	both	CC	-	-	-	-	-	-	-	-
1885825	0	4	donor	NN	-	-	-	-	-	-	-	-
1885825	0	5	and	CC	-	-	-	-	-	-	-	-
1885825	0	6	recipient	NN	-	-	-	-	-	-	-	-
1885825	0	7	were	VBD	-	-	-	-	-	-	-	-
1885825	0	8	found	VBN	-	-	-	-	-	-	-	-
1885825	0	9	deleterious	JJ	-	-	-	-	-	-	-	-
1885825	0	10	,	,	-	-	-	-	-	-	-	-
1885825	0	11	suggesting	VBG	-	-	-	-	-	-	-	-
1885825	0	12	a	DT	-	-	-	-	-	-	-	-
1885825	0	13	role	NN	-	-	-	-	-	-	-	-
1885825	0	14	of	IN	-	-	-	-	-	-	-	-
1885825	0	15	epithelial	JJ	-	-	-	-	-	-	-	(65a)
1885825	0	16	and	CC	-	-	-	-	-	-	-	-
1885825	0	17	circulating	VBG	-	-	-	-	-	-	-	-
1885825	0	18	cells	NNS	-	-	-	-	-	-	-	(65a)
1885825	0	19	in	IN	-	-	-	-	-	-	-	-
1885825	0	20	disease	NN	-	-	-	-	-	-	-	(66
1885825	0	21	mechanisms	NNS	-	-	-	-	-	-	-	66)
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Despite	IN	-	-	-	-	-	-	-	-
1885825	0	2	some	DT	-	-	-	-	-	-	-	-
1885825	0	3	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	4	in	IN	-	-	-	-	-	-	-	-
1885825	0	5	their	PRP$	-	-	-	-	-	-	-	(67)
1885825	0	6	conclusions	NNS	-	-	-	-	-	-	-	-
1885825	0	7	,	,	-	-	-	-	-	-	-	-
1885825	0	8	other	JJ	-	-	-	-	-	-	-	(67
1885825	0	9	groups	NNS	-	-	-	-	-	-	-	67)
1885825	0	10	recently	RB	-	-	-	-	-	-	-	-
1885825	0	11	confirmed	VBD	-	-	-	-	-	-	-	-
1885825	0	12	the	DT	-	-	-	-	-	-	-	-
1885825	0	13	association	NN	-	-	-	-	-	-	-	-
1885825	0	14	between	IN	-	-	-	-	-	-	-	-
1885825	0	15	NOD2	NN	-	-	-	-	-	-	-	(1)
1885825	0	16	and	CC	-	-	-	-	-	-	-	-
1885825	0	17	BMT	NN	-	-	-	-	-	-	-	(64)
1885825	0	18	complications	NNS	-	-	-	-	-	-	-	-
1885825	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	20	4	CD	-	-	-	-	-	-	-	(53)
1885825	0	21	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	,	,	-	-	-	-	-	-	-	-
1885825	0	23	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	24	11	CD	-	-	-	-	-	-	-	-
1885825	0	25	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	CD	NN	-	-	-	-	-	-	-	(6)
1885825	0	2	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	3	a	DT	-	-	-	-	-	-	-	-
1885825	0	4	chronic	JJ	-	-	-	-	-	-	-	-
1885825	0	5	relapsing	VBG	-	-	-	-	-	-	-	-
1885825	0	6	inflammatory	JJ	-	-	-	-	-	-	-	-
1885825	0	7	bowel	NN	-	-	-	-	-	-	-	-
1885825	0	8	disease	NN	-	-	-	-	-	-	-	-
1885825	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	10	IBD	NN	-	-	-	-	-	-	-	-
1885825	0	11	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	12	with	IN	-	-	-	-	-	-	-	-
1885825	0	13	mucosal	JJ	-	-	-	-	-	-	-	-
1885825	0	14	ulcerations	NNS	-	-	-	-	-	-	-	-
1885825	0	15	of	IN	-	-	-	-	-	-	-	-
1885825	0	16	the	DT	-	-	-	-	-	-	-	-
1885825	0	17	digestive	JJ	-	-	-	-	-	-	-	-
1885825	0	18	tract	NN	-	-	-	-	-	-	-	-
1885825	0	19	.	.	-	-	-	-	-	-	-	-

1885825	0	1	CD	NN	-	-	-	-	-	-	-	(63|(6)
1885825	0	2	lesions	NNS	-	-	-	-	-	-	-	63)
1885825	0	3	are	VBP	-	-	-	-	-	-	-	-
1885825	0	4	characterised	VBN	-	-	-	-	-	-	-	-
1885825	0	5	by	IN	-	-	-	-	-	-	-	-
1885825	0	6	a	DT	-	-	-	-	-	-	-	-
1885825	0	7	T	NN	-	-	-	-	-	-	-	(68
1885825	0	8	helper	NN	-	-	-	-	-	-	-	-
1885825	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	10	Th	NN	-	-	-	-	-	-	-	-
1885825	0	11	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	12	1	CD	-	-	-	-	-	-	-	68)
1885825	0	13	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	14	response	NN	-	-	-	-	-	-	-	-
1885825	0	15	and	CC	-	-	-	-	-	-	-	-
1885825	0	16	several	JJ	-	-	-	-	-	-	-	-
1885825	0	17	authors	NNS	-	-	-	-	-	-	-	-
1885825	0	18	have	VBP	-	-	-	-	-	-	-	-
1885825	0	19	shown	VBN	-	-	-	-	-	-	-	-
1885825	0	20	that	IN	-	-	-	-	-	-	-	-
1885825	0	21	they	PRP	-	-	-	-	-	-	-	(63)
1885825	0	22	are	VBP	-	-	-	-	-	-	-	-
1885825	0	23	related	VBN	-	-	-	-	-	-	-	-
1885825	0	24	with	IN	-	-	-	-	-	-	-	-
1885825	0	25	gut	NN	-	-	-	-	-	-	-	(69|(61)
1885825	0	26	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	27	lymphoid	JJ	-	-	-	-	-	-	-	-
1885825	0	28	tissue	NN	-	-	-	-	-	-	-	69)
1885825	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	30	GALT	NN	-	-	-	-	-	-	-	-
1885825	0	31	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	32	,	,	-	-	-	-	-	-	-	-
1885825	0	33	known	VBN	-	-	-	-	-	-	-	-
1885825	0	34	as	IN	-	-	-	-	-	-	-	-
1885825	0	35	lymphoid	JJ	-	-	-	-	-	-	-	(20
1885825	0	36	follicles	NNS	-	-	-	-	-	-	-	20)
1885825	0	37	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	38	LFs	NNS	-	-	-	-	-	-	-	-
1885825	0	39	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	40	.	.	-	-	-	-	-	-	-	-

1885825	0	1	LFs	NNS	-	-	-	-	-	-	-	(20)
1885825	0	2	are	VBP	-	-	-	-	-	-	-	-
1885825	0	3	mainly	RB	-	-	-	-	-	-	-	-
1885825	0	4	encountered	VBN	-	-	-	-	-	-	-	-
1885825	0	5	in	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(70
1885825	0	7	colon	NN	-	-	-	-	-	-	-	70)
1885825	0	8	where	WRB	-	-	-	-	-	-	-	-
1885825	0	9	they	PRP	-	-	-	-	-	-	-	(20)
1885825	0	10	are	VBP	-	-	-	-	-	-	-	-
1885825	0	11	isolated	VBN	-	-	-	-	-	-	-	-
1885825	0	12	and	CC	-	-	-	-	-	-	-	-
1885825	0	13	in	IN	-	-	-	-	-	-	-	-
1885825	0	14	small	JJ	-	-	-	-	-	-	-	-
1885825	0	15	bowel	NN	-	-	-	-	-	-	-	-
1885825	0	16	where	WRB	-	-	-	-	-	-	-	-
1885825	0	17	they	PRP	-	-	-	-	-	-	-	(20)
1885825	0	18	are	VBP	-	-	-	-	-	-	-	-
1885825	0	19	grouped	VBN	-	-	-	-	-	-	-	-
1885825	0	20	forming	VBG	-	-	-	-	-	-	-	-
1885825	0	21	Peyer	NNP	-	-	-	-	-	-	-	(2
1885825	0	22	's	POS	-	-	-	-	-	-	-	-
1885825	0	23	patches	NNS	-	-	-	-	-	-	-	2)
1885825	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	25	PP	NNS	-	-	-	-	-	-	-	-
1885825	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	27	which	WDT	-	-	-	-	-	-	-	-
1885825	0	28	are	VBP	-	-	-	-	-	-	-	-
1885825	0	29	known	VBN	-	-	-	-	-	-	-	-
1885825	0	30	to	TO	-	-	-	-	-	-	-	-
1885825	0	31	be	VB	-	-	-	-	-	-	-	-
1885825	0	32	pivotal	JJ	-	-	-	-	-	-	-	-
1885825	0	33	sites	NNS	-	-	-	-	-	-	-	-
1885825	0	34	for	IN	-	-	-	-	-	-	-	-
1885825	0	35	the	DT	-	-	-	-	-	-	-	-
1885825	0	36	host	NN	-	-	-	-	-	-	-	(71)
1885825	0	37	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	38	response	NN	-	-	-	-	-	-	-	-
1885825	0	39	and	CC	-	-	-	-	-	-	-	-
1885825	0	40	for	IN	-	-	-	-	-	-	-	-
1885825	0	41	the	DT	-	-	-	-	-	-	-	-
1885825	0	42	entry	NN	-	-	-	-	-	-	-	-
1885825	0	43	of	IN	-	-	-	-	-	-	-	-
1885825	0	44	enteropathogen	NN	-	-	-	-	-	-	-	(72
1885825	0	45	bacteria	NNS	-	-	-	-	-	-	-	72)
1885825	0	46	.	.	-	-	-	-	-	-	-	-

1885825	0	1	CD	NN	-	-	-	-	-	-	-	(63|(6)
1885825	0	2	lesions	NNS	-	-	-	-	-	-	-	63)
1885825	0	3	are	VBP	-	-	-	-	-	-	-	-
1885825	0	4	most	RBS	-	-	-	-	-	-	-	-
1885825	0	5	often	RB	-	-	-	-	-	-	-	-
1885825	0	6	localized	VBN	-	-	-	-	-	-	-	-
1885825	0	7	in	IN	-	-	-	-	-	-	-	-
1885825	0	8	colon	NN	-	-	-	-	-	-	-	(70)
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	distal	JJ	-	-	-	-	-	-	-	-
1885825	0	11	ileum	NN	-	-	-	-	-	-	-	-
1885825	0	12	,	,	-	-	-	-	-	-	-	-
1885825	0	13	where	WRB	-	-	-	-	-	-	-	-
1885825	0	14	the	DT	-	-	-	-	-	-	-	(20
1885825	0	15	LFs	NNS	-	-	-	-	-	-	-	20)
1885825	0	16	are	VBP	-	-	-	-	-	-	-	-
1885825	0	17	the	DT	-	-	-	-	-	-	-	-
1885825	0	18	most	RBS	-	-	-	-	-	-	-	-
1885825	0	19	abundant	JJ	-	-	-	-	-	-	-	-
1885825	0	20	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	21	12	CD	-	-	-	-	-	-	-	-
1885825	0	22	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	23	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Fujimura	NNP	-	-	-	-	-	-	-	-
1885825	0	2	et	FW	-	-	-	-	-	-	-	-
1885825	0	3	al.	FW	-	-	-	-	-	-	-	-
1885825	0	4	found	VBD	-	-	-	-	-	-	-	-
1885825	0	5	that	IN	-	-	-	-	-	-	-	-
1885825	0	6	aphtoïd	NN	-	-	-	-	-	-	-	(73
1885825	0	7	ulcerations	NNS	-	-	-	-	-	-	-	-
1885825	0	8	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	9	which	WDT	-	-	-	-	-	-	-	-
1885825	0	10	are	VBP	-	-	-	-	-	-	-	-
1885825	0	11	often	RB	-	-	-	-	-	-	-	-
1885825	0	12	considered	VBN	-	-	-	-	-	-	-	-
1885825	0	13	as	IN	-	-	-	-	-	-	-	-
1885825	0	14	the	DT	-	-	-	-	-	-	-	-
1885825	0	15	earliest	JJS	-	-	-	-	-	-	-	-
1885825	0	16	CD	NN	-	-	-	-	-	-	-	(6)
1885825	0	17	lesions	NNS	-	-	-	-	-	-	-	-
1885825	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	19	are	VBP	-	-	-	-	-	-	-	-
1885825	0	20	centred	VBN	-	-	-	-	-	-	-	-
1885825	0	21	by	IN	-	-	-	-	-	-	-	-
1885825	0	22	LFs	NNS	-	-	-	-	-	-	-	(20)|73)
1885825	0	23	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	24	13	CD	-	-	-	-	-	-	-	-
1885825	0	25	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	addition	NN	-	-	-	-	-	-	-	-
1885825	0	3	to	IN	-	-	-	-	-	-	-	-
1885825	0	4	this	DT	-	-	-	-	-	-	-	(73
1885825	0	5	spatial	JJ	-	-	-	-	-	-	-	-
1885825	0	6	relationship	NN	-	-	-	-	-	-	-	73)
1885825	0	7	,	,	-	-	-	-	-	-	-	-
1885825	0	8	a	DT	-	-	-	-	-	-	-	-
1885825	0	9	temporal	JJ	-	-	-	-	-	-	-	-
1885825	0	10	link	NN	-	-	-	-	-	-	-	-
1885825	0	11	between	IN	-	-	-	-	-	-	-	-
1885825	0	12	CD	NN	-	-	-	-	-	-	-	(6)|(74a)
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	PP	NN	-	-	-	-	-	-	-	(75|(2)
1885825	0	15	development	NN	-	-	-	-	-	-	-	(74a)|75)
1885825	0	16	has	VBZ	-	-	-	-	-	-	-	-
1885825	0	17	also	RB	-	-	-	-	-	-	-	-
1885825	0	18	been	VBN	-	-	-	-	-	-	-	-
1885825	0	19	suggested	VBN	-	-	-	-	-	-	-	-
1885825	0	20	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	21	14	CD	-	-	-	-	-	-	-	-
1885825	0	22	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	23	.	.	-	-	-	-	-	-	-	-

1885825	0	1	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	2	develop	VBP	-	-	-	-	-	-	-	-
1885825	0	3	from	IN	-	-	-	-	-	-	-	-
1885825	0	4	birth	NN	-	-	-	-	-	-	-	(21)
1885825	0	5	to	IN	-	-	-	-	-	-	-	-
1885825	0	6	10	CD	-	-	-	-	-	-	-	-
1885825	0	7	–	SYM	-	-	-	-	-	-	-	-
1885825	0	8	15	CD	-	-	-	-	-	-	-	-
1885825	0	9	years	NNS	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	life	NN	-	-	-	-	-	-	-	-
1885825	0	12	and	CC	-	-	-	-	-	-	-	-
1885825	0	13	then	RB	-	-	-	-	-	-	-	-
1885825	0	14	undergo	VBP	-	-	-	-	-	-	-	-
1885825	0	15	involution	NN	-	-	-	-	-	-	-	-
1885825	0	16	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	age	NN	-	-	-	-	-	-	-	-
1885825	0	3	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	4	dependent	JJ	-	-	-	-	-	-	-	-
1885825	0	5	incidence	NN	-	-	-	-	-	-	-	-
1885825	0	6	curve	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	CD	NN	-	-	-	-	-	-	-	(6)
1885825	0	9	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	10	roughly	RB	-	-	-	-	-	-	-	-
1885825	0	11	parallel	JJ	-	-	-	-	-	-	-	-
1885825	0	12	to	IN	-	-	-	-	-	-	-	-
1885825	0	13	the	DT	-	-	-	-	-	-	-	(19
1885825	0	14	number	NN	-	-	-	-	-	-	-	-
1885825	0	15	of	IN	-	-	-	-	-	-	-	-
1885825	0	16	PP	NN	-	-	-	-	-	-	-	(2)|19)
1885825	0	17	with	IN	-	-	-	-	-	-	-	-
1885825	0	18	a	DT	-	-	-	-	-	-	-	-
1885825	0	19	delay	NN	-	-	-	-	-	-	-	-
1885825	0	20	of	IN	-	-	-	-	-	-	-	-
1885825	0	21	about	IN	-	-	-	-	-	-	-	-
1885825	0	22	10	CD	-	-	-	-	-	-	-	-
1885825	0	23	years	NNS	-	-	-	-	-	-	-	-
1885825	0	24	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	ileal	JJ	-	-	-	-	-	-	-	-
1885825	0	4	lesions	NNS	-	-	-	-	-	-	-	-
1885825	0	5	are	VBP	-	-	-	-	-	-	-	-
1885825	0	6	uncommon	JJ	-	-	-	-	-	-	-	-
1885825	0	7	in	IN	-	-	-	-	-	-	-	-
1885825	0	8	young	JJ	-	-	-	-	-	-	-	-
1885825	0	9	children	NNS	-	-	-	-	-	-	-	-
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	seniors	NNS	-	-	-	-	-	-	-	-
1885825	0	12	where	WRB	-	-	-	-	-	-	-	-
1885825	0	13	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	14	are	VBP	-	-	-	-	-	-	-	-
1885825	0	15	rare	JJ	-	-	-	-	-	-	-	-
1885825	0	16	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	17	15	CD	-	-	-	-	-	-	-	-
1885825	0	18	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	19	,	,	-	-	-	-	-	-	-	-
1885825	0	20	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	21	16	CD	-	-	-	-	-	-	-	-
1885825	0	22	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	23	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	role	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	GALT	NN	-	-	-	-	-	-	-	(69)
1885825	0	5	in	IN	-	-	-	-	-	-	-	-
1885825	0	6	GVHD	NN	-	-	-	-	-	-	-	(8)
1885825	0	7	has	VBZ	-	-	-	-	-	-	-	-
1885825	0	8	been	VBN	-	-	-	-	-	-	-	-
1885825	0	9	suspected	VBN	-	-	-	-	-	-	-	-
1885825	0	10	on	IN	-	-	-	-	-	-	-	-
1885825	0	11	both	CC	-	-	-	-	-	-	-	-
1885825	0	12	experimental	JJ	-	-	-	-	-	-	-	-
1885825	0	13	models	NNS	-	-	-	-	-	-	-	-
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	clinical	JJ	-	-	-	-	-	-	-	-
1885825	0	16	observations	NNS	-	-	-	-	-	-	-	-
1885825	0	17	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Animal	NN	-	-	-	-	-	-	-	(76)
1885825	0	2	studies	NNS	-	-	-	-	-	-	-	-
1885825	0	3	showed	VBD	-	-	-	-	-	-	-	-
1885825	0	4	that	IN	-	-	-	-	-	-	-	-
1885825	0	5	death	NN	-	-	-	-	-	-	-	-
1885825	0	6	after	IN	-	-	-	-	-	-	-	-
1885825	0	7	BMT	NN	-	-	-	-	-	-	-	(64)
1885825	0	8	was	VBD	-	-	-	-	-	-	-	-
1885825	0	9	prevented	VBN	-	-	-	-	-	-	-	-
1885825	0	10	by	IN	-	-	-	-	-	-	-	-
1885825	0	11	gut	NN	-	-	-	-	-	-	-	(77|(61)
1885825	0	12	decontamination	NN	-	-	-	-	-	-	-	77)
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	that	IN	-	-	-	-	-	-	-	-
1885825	0	15	prevention	NN	-	-	-	-	-	-	-	-
1885825	0	16	of	IN	-	-	-	-	-	-	-	-
1885825	0	17	mucosal	JJ	-	-	-	-	-	-	-	(78
1885825	0	18	damage	NN	-	-	-	-	-	-	-	78)
1885825	0	19	also	RB	-	-	-	-	-	-	-	-
1885825	0	20	prevents	VBZ	-	-	-	-	-	-	-	-
1885825	0	21	lethal	JJ	-	-	-	-	-	-	-	-
1885825	0	22	GVHD	NN	-	-	-	-	-	-	-	-
1885825	0	23	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	24	17	CD	-	-	-	-	-	-	-	-
1885825	0	25	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	clinical	JJ	-	-	-	-	-	-	-	-
1885825	0	3	practice	NN	-	-	-	-	-	-	-	-
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	gut	NN	-	-	-	-	-	-	-	(77|(61)
1885825	0	6	decontamination	NN	-	-	-	-	-	-	-	77)
1885825	0	7	reduces	VBZ	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	-
1885825	0	9	frequency	NN	-	-	-	-	-	-	-	-
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	severity	NN	-	-	-	-	-	-	-	-
1885825	0	12	of	IN	-	-	-	-	-	-	-	-
1885825	0	13	GVHD	NN	-	-	-	-	-	-	-	(8)
1885825	0	14	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	Murai	NNP	-	-	-	-	-	-	-	-
1885825	0	4	et	FW	-	-	-	-	-	-	-	-
1885825	0	5	al.	FW	-	-	-	-	-	-	-	-
1885825	0	6	recently	RB	-	-	-	-	-	-	-	-
1885825	0	7	showed	VBD	-	-	-	-	-	-	-	-
1885825	0	8	that	IN	-	-	-	-	-	-	-	-
1885825	0	9	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	10	deficient	JJ	-	-	-	-	-	-	-	-
1885825	0	11	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	12	are	VBP	-	-	-	-	-	-	-	-
1885825	0	13	resistant	JJ	-	-	-	-	-	-	-	-
1885825	0	14	to	IN	-	-	-	-	-	-	-	-
1885825	0	15	GVHD	NN	-	-	-	-	-	-	-	(8)
1885825	0	16	,	,	-	-	-	-	-	-	-	-
1885825	0	17	arguing	VBG	-	-	-	-	-	-	-	-
1885825	0	18	for	IN	-	-	-	-	-	-	-	-
1885825	0	19	a	DT	-	-	-	-	-	-	-	-
1885825	0	20	crucial	JJ	-	-	-	-	-	-	-	-
1885825	0	21	role	NN	-	-	-	-	-	-	-	-
1885825	0	22	of	IN	-	-	-	-	-	-	-	-
1885825	0	23	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	24	in	IN	-	-	-	-	-	-	-	-
1885825	0	25	GVHD	NN	-	-	-	-	-	-	-	(8)
1885825	0	26	,	,	-	-	-	-	-	-	-	-
1885825	0	27	at	RB	-	-	-	-	-	-	-	-
1885825	0	28	least	RBS	-	-	-	-	-	-	-	-
1885825	0	29	in	IN	-	-	-	-	-	-	-	-
1885825	0	30	models	NNS	-	-	-	-	-	-	-	-
1885825	0	31	that	WDT	-	-	-	-	-	-	-	-
1885825	0	32	do	VBP	-	-	-	-	-	-	-	-
1885825	0	33	not	RB	-	-	-	-	-	-	-	-
1885825	0	34	use	VB	-	-	-	-	-	-	-	-
1885825	0	35	conditioning	NN	-	-	-	-	-	-	-	-
1885825	0	36	of	IN	-	-	-	-	-	-	-	-
1885825	0	37	the	DT	-	-	-	-	-	-	-	(71
1885825	0	38	host	NN	-	-	-	-	-	-	-	71)
1885825	0	39	prior	JJ	-	-	-	-	-	-	-	-
1885825	0	40	to	IN	-	-	-	-	-	-	-	-
1885825	0	41	adoptive	JJ	-	-	-	-	-	-	-	-
1885825	0	42	transfer	NN	-	-	-	-	-	-	-	-
1885825	0	43	of	IN	-	-	-	-	-	-	-	-
1885825	0	44	the	DT	-	-	-	-	-	-	-	-
1885825	0	45	allogeneic	JJ	-	-	-	-	-	-	-	-
1885825	0	46	donor	NN	-	-	-	-	-	-	-	-
1885825	0	47	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	48	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	49	18	CD	-	-	-	-	-	-	-	(79)
1885825	0	50	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	51	,	,	-	-	-	-	-	-	-	-
1885825	0	52	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	53	19	CD	-	-	-	-	-	-	-	-
1885825	0	54	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	55	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Considering	VBG	-	-	-	-	-	-	-	-
1885825	0	2	all	PDT	-	-	-	-	-	-	-	-
1885825	0	3	these	DT	-	-	-	-	-	-	-	-
1885825	0	4	elements	NNS	-	-	-	-	-	-	-	-
1885825	0	5	,	,	-	-	-	-	-	-	-	-
1885825	0	6	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	7	hypothesized	VBD	-	-	-	-	-	-	-	-
1885825	0	8	that	IN	-	-	-	-	-	-	-	-
1885825	0	9	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	10	may	MD	-	-	-	-	-	-	-	-
1885825	0	11	play	VB	-	-	-	-	-	-	-	-
1885825	0	12	a	DT	-	-	-	-	-	-	-	-
1885825	0	13	role	NN	-	-	-	-	-	-	-	-
1885825	0	14	in	IN	-	-	-	-	-	-	-	-
1885825	0	15	the	DT	-	-	-	-	-	-	-	-
1885825	0	16	structure	NN	-	-	-	-	-	-	-	-
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	function	NN	-	-	-	-	-	-	-	-
1885825	0	19	of	IN	-	-	-	-	-	-	-	-
1885825	0	20	the	DT	-	-	-	-	-	-	-	(69
1885825	0	21	GALT	NN	-	-	-	-	-	-	-	69)
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Consequently	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	4	used	VBD	-	-	-	-	-	-	-	-
1885825	0	5	a	DT	-	-	-	-	-	-	-	(12
1885825	0	6	new	JJ	-	-	-	-	-	-	-	-
1885825	0	7	mouse	NN	-	-	-	-	-	-	-	(4)
1885825	0	8	model	NN	-	-	-	-	-	-	-	-
1885825	0	9	deficient	JJ	-	-	-	-	-	-	-	-
1885825	0	10	for	IN	-	-	-	-	-	-	-	-
1885825	0	11	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	12	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	13	Nod2	NN	-	-	-	-	-	-	-	12)|11)
1885825	0	14	i	LS	-	-	-	-	-	-	-	-
1885825	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	16	to	TO	-	-	-	-	-	-	-	-
1885825	0	17	evaluate	VB	-	-	-	-	-	-	-	-
1885825	0	18	the	DT	-	-	-	-	-	-	-	-
1885825	0	19	involvement	NN	-	-	-	-	-	-	-	-
1885825	0	20	of	IN	-	-	-	-	-	-	-	-
1885825	0	21	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	22	on	IN	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	(19
1885825	0	24	number	NN	-	-	-	-	-	-	-	19)
1885825	0	25	and	CC	-	-	-	-	-	-	-	-
1885825	0	26	PPs	NNS	-	-	-	-	-	-	-	(23|(2)
1885825	0	27	size	NN	-	-	-	-	-	-	-	23)
1885825	0	28	;	:	-	-	-	-	-	-	-	-
1885825	0	29	ii	LS	-	-	-	-	-	-	-	-
1885825	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	31	to	TO	-	-	-	-	-	-	-	-
1885825	0	32	assess	VB	-	-	-	-	-	-	-	-
1885825	0	33	whether	IN	-	-	-	-	-	-	-	-
1885825	0	34	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	35	modified	VBN	-	-	-	-	-	-	-	-
1885825	0	36	cellular	JJ	-	-	-	-	-	-	-	(24a
1885825	0	37	composition	NN	-	-	-	-	-	-	-	24a)
1885825	0	38	and	CC	-	-	-	-	-	-	-	-
1885825	0	39	cytokine	NN	-	-	-	-	-	-	-	(80
1885825	0	40	expression	NN	-	-	-	-	-	-	-	-
1885825	0	41	of	IN	-	-	-	-	-	-	-	(24a
1885825	0	42	PPs	NNS	-	-	-	-	-	-	-	(2)|80)|24a)
1885825	0	43	;	:	-	-	-	-	-	-	-	-
1885825	0	44	and	CC	-	-	-	-	-	-	-	-
1885825	0	45	iii	LS	-	-	-	-	-	-	-	-
1885825	0	46	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	47	to	TO	-	-	-	-	-	-	-	-
1885825	0	48	determine	VB	-	-	-	-	-	-	-	-
1885825	0	49	whether	IN	-	-	-	-	-	-	-	-
1885825	0	50	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	51	may	MD	-	-	-	-	-	-	-	-
1885825	0	52	alter	VB	-	-	-	-	-	-	-	-
1885825	0	53	paracellular	JJ	-	-	-	-	-	-	-	-
1885825	0	54	permeability	NN	-	-	-	-	-	-	-	-
1885825	0	55	and	CC	-	-	-	-	-	-	-	-
1885825	0	56	bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	57	translocation	NN	-	-	-	-	-	-	-	-
1885825	0	58	of	IN	-	-	-	-	-	-	-	-
1885825	0	59	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	60	in	IN	-	-	-	-	-	-	-	-
1885825	0	61	adult	JJ	-	-	-	-	-	-	-	(81
1885825	0	62	mice	NNS	-	-	-	-	-	-	-	81)
1885825	0	63	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	4	also	RB	-	-	-	-	-	-	-	-
1885825	0	5	examined	VBD	-	-	-	-	-	-	-	-
1885825	0	6	if	IN	-	-	-	-	-	-	-	-
1885825	0	7	Card15	NN	-	-	-	-	-	-	-	(11|(46
1885825	0	8	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	10	deficiency	NN	-	-	-	-	-	-	-	46)
1885825	0	11	affects	VBZ	-	-	-	-	-	-	-	-
1885825	0	12	the	DT	-	-	-	-	-	-	-	-
1885825	0	13	colonic	JJ	-	-	-	-	-	-	-	-
1885825	0	14	response	NN	-	-	-	-	-	-	-	-
1885825	0	15	to	IN	-	-	-	-	-	-	-	-
1885825	0	16	2	CD	-	-	-	-	-	-	-	-
1885825	0	17	,	,	-	-	-	-	-	-	-	-
1885825	0	18	4	CD	-	-	-	-	-	-	-	-
1885825	0	19	,	,	-	-	-	-	-	-	-	-
1885825	0	20	6	CD	-	-	-	-	-	-	-	-
1885825	0	21	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	22	trinitrobenzene	NN	-	-	-	-	-	-	-	(45
1885825	0	23	sulphonic	JJ	-	-	-	-	-	-	-	-
1885825	0	24	acid	NN	-	-	-	-	-	-	-	45)
1885825	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	26	TNBS	NN	-	-	-	-	-	-	-	-
1885825	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	28	,	,	-	-	-	-	-	-	-	-
1885825	0	29	a	DT	-	-	-	-	-	-	-	-
1885825	0	30	classic	JJ	-	-	-	-	-	-	-	-
1885825	0	31	experimental	JJ	-	-	-	-	-	-	-	-
1885825	0	32	model	NN	-	-	-	-	-	-	-	-
1885825	0	33	of	IN	-	-	-	-	-	-	-	-
1885825	0	34	colitis	NN	-	-	-	-	-	-	-	(82)
1885825	0	35	in	IN	-	-	-	-	-	-	-	-
1885825	0	36	mouse	NN	-	-	-	-	-	-	-	(4)
1885825	0	37	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Results	NNS	-	-	-	-	-	-	-	-

1885825	0	1	Body	NNP	-	-	-	-	-	-	-	(83
1885825	0	2	weight	NN	-	-	-	-	-	-	-	83)
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	intestinal	JJ	-	-	-	-	-	-	-	(84
1885825	0	5	length	NN	-	-	-	-	-	-	-	84)
1885825	0	6	and	CC	-	-	-	-	-	-	-	-
1885825	0	7	intestinal	JJ	-	-	-	-	-	-	-	(85
1885825	0	8	weight	NN	-	-	-	-	-	-	-	85)
1885825	0	9	were	VBD	-	-	-	-	-	-	-	-
1885825	0	10	similar	JJ	-	-	-	-	-	-	-	-
1885825	0	11	in	IN	-	-	-	-	-	-	-	-
1885825	0	12	KO	NN	-	-	-	-	-	-	-	(86|(12q)
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	15	mice	NNS	-	-	-	-	-	-	-	(12q)|87)|86)
1885825	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	17	supplementary	JJ	-	-	-	-	-	-	-	-
1885825	0	18	information	NN	-	-	-	-	-	-	-	-
1885825	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	20	SI	NN	-	-	-	-	-	-	-	-
1885825	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	Table	NN	-	-	-	-	-	-	-	(88
1885825	0	23	S1	NN	-	-	-	-	-	-	-	88)
1885825	0	24	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	25	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Macroscopically	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	no	DT	-	-	-	-	-	-	-	-
1885825	0	4	inflammation	NN	-	-	-	-	-	-	-	-
1885825	0	5	was	VBD	-	-	-	-	-	-	-	-
1885825	0	6	visible	JJ	-	-	-	-	-	-	-	-
1885825	0	7	in	IN	-	-	-	-	-	-	-	-
1885825	0	8	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	10	according	VBG	-	-	-	-	-	-	-	-
1885825	0	11	to	IN	-	-	-	-	-	-	-	-
1885825	0	12	Wallace	NNP	-	-	-	-	-	-	-	-
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	Ameho	NNP	-	-	-	-	-	-	-	-
1885825	0	15	criteria	NNS	-	-	-	-	-	-	-	-
1885825	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	17	data	NNS	-	-	-	-	-	-	-	-
1885825	0	18	not	RB	-	-	-	-	-	-	-	-
1885825	0	19	shown	VBN	-	-	-	-	-	-	-	-
1885825	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	2	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	3	exhibited	VBD	-	-	-	-	-	-	-	-
1885825	0	4	an	DT	-	-	-	-	-	-	-	-
1885825	0	5	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	6	number	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	9	in	IN	-	-	-	-	-	-	-	-
1885825	0	10	comparison	NN	-	-	-	-	-	-	-	-
1885825	0	11	with	IN	-	-	-	-	-	-	-	-
1885825	0	12	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	13	mice	NNS	-	-	-	-	-	-	-	87)
1885825	0	14	at	IN	-	-	-	-	-	-	-	-
1885825	0	15	weeks	NNS	-	-	-	-	-	-	-	(15|(17|(16e)|(18e)
1885825	0	16	4	CD	-	-	-	-	-	-	-	15)
1885825	0	17	,	,	-	-	-	-	-	-	-	-
1885825	0	18	12	CD	-	-	-	-	-	-	-	(16e)
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	52	CD	-	-	-	-	-	-	-	(18e
1885825	0	21	after	IN	-	-	-	-	-	-	-	-
1885825	0	22	birth	NN	-	-	-	-	-	-	-	(21)|18e)|17)
1885825	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	24	Fig	NN	-	-	-	-	-	-	-	(89
1885825	0	25	1	CD	-	-	-	-	-	-	-	-
1885825	0	26	A	NN	-	-	-	-	-	-	-	89)
1885825	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	28	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	weeks	NNS	-	-	-	-	-	-	-	(16|(18c)
1885825	0	3	12	CD	-	-	-	-	-	-	-	16)
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	52	CD	-	-	-	-	-	-	-	(18c)
1885825	0	6	,	,	-	-	-	-	-	-	-	-
1885825	0	7	the	DT	-	-	-	-	-	-	-	(90
1885825	0	8	number	NN	-	-	-	-	-	-	-	-
1885825	0	9	of	IN	-	-	-	-	-	-	-	-
1885825	0	10	isolated	VBN	-	-	-	-	-	-	-	(10
1885825	0	11	LFs	NNS	-	-	-	-	-	-	-	90)|10)
1885825	0	12	per	IN	-	-	-	-	-	-	-	-
1885825	0	13	small	JJ	-	-	-	-	-	-	-	(91
1885825	0	14	intestine	NN	-	-	-	-	-	-	-	91)
1885825	0	15	was	VBD	-	-	-	-	-	-	-	-
1885825	0	16	also	RB	-	-	-	-	-	-	-	-
1885825	0	17	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	18	in	IN	-	-	-	-	-	-	-	-
1885825	0	19	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	20	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	21	than	IN	-	-	-	-	-	-	-	-
1885825	0	22	in	IN	-	-	-	-	-	-	-	-
1885825	0	23	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	24	mice	NNS	-	-	-	-	-	-	-	87)
1885825	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	26	Fig	NN	-	-	-	-	-	-	-	-
1885825	0	27	1	CD	-	-	-	-	-	-	-	-
1885825	0	28	B	NN	-	-	-	-	-	-	-	-
1885825	0	29	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	30	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	contrast	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	the	DT	-	-	-	-	-	-	-	-
1885825	0	5	number	NN	-	-	-	-	-	-	-	-
1885825	0	6	of	IN	-	-	-	-	-	-	-	-
1885825	0	7	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	8	at	IN	-	-	-	-	-	-	-	-
1885825	0	9	birth	NN	-	-	-	-	-	-	-	(21)
1885825	0	10	was	VBD	-	-	-	-	-	-	-	-
1885825	0	11	similar	JJ	-	-	-	-	-	-	-	-
1885825	0	12	between	IN	-	-	-	-	-	-	-	-
1885825	0	13	KO	NN	-	-	-	-	-	-	-	(86|(12x)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	16	mice	NNS	-	-	-	-	-	-	-	(12x)|87)|86)
1885825	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	18	6.2	CD	-	-	-	-	-	-	-	-
1885825	0	19	±	SYM	-	-	-	-	-	-	-	-
1885825	0	20	0.5	CD	-	-	-	-	-	-	-	-
1885825	0	21	vs.	CC	-	-	-	-	-	-	-	-
1885825	0	22	6.0	CD	-	-	-	-	-	-	-	-
1885825	0	23	±	SYM	-	-	-	-	-	-	-	-
1885825	0	24	0.4	CD	-	-	-	-	-	-	-	-
1885825	0	25	;	:	-	-	-	-	-	-	-	-
1885825	0	26	P	NN	-	-	-	-	-	-	-	(93|(92)
1885825	0	27	>	SYM	-	-	-	-	-	-	-	-
1885825	0	28	0.05	CD	-	-	-	-	-	-	-	93)
1885825	0	29	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	30	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	31	Fig	NN	-	-	-	-	-	-	-	(89
1885825	0	32	1	CD	-	-	-	-	-	-	-	-
1885825	0	33	A	NN	-	-	-	-	-	-	-	89)
1885825	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	35	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Macroscopically	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(94
1885825	0	4	size	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	7	formations	NNS	-	-	-	-	-	-	-	-
1885825	0	8	appeared	VBD	-	-	-	-	-	-	-	-
1885825	0	9	to	TO	-	-	-	-	-	-	-	-
1885825	0	10	be	VB	-	-	-	-	-	-	-	-
1885825	0	11	larger	JJR	-	-	-	-	-	-	-	-
1885825	0	12	in	IN	-	-	-	-	-	-	-	-
1885825	0	13	adult	JJ	-	-	-	-	-	-	-	(95
1885825	0	14	KO	NN	-	-	-	-	-	-	-	-
1885825	0	15	mice	NNS	-	-	-	-	-	-	-	95)|94)
1885825	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	17	data	NNS	-	-	-	-	-	-	-	-
1885825	0	18	not	RB	-	-	-	-	-	-	-	-
1885825	0	19	shown	VBN	-	-	-	-	-	-	-	-
1885825	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	To	TO	-	-	-	-	-	-	-	-
1885825	0	2	quantify	VB	-	-	-	-	-	-	-	-
1885825	0	3	this	DT	-	-	-	-	-	-	-	(94
1885825	0	4	difference	NN	-	-	-	-	-	-	-	94)
1885825	0	5	,	,	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(96
1885825	0	7	three	CD	-	-	-	-	-	-	-	-
1885825	0	8	biggest	JJS	-	-	-	-	-	-	-	-
1885825	0	9	PPs	NNS	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	each	DT	-	-	-	-	-	-	-	-
1885825	0	12	mouse	NN	-	-	-	-	-	-	-	96)
1885825	0	13	were	VBD	-	-	-	-	-	-	-	-
1885825	0	14	pooled	VBN	-	-	-	-	-	-	-	-
1885825	0	15	and	CC	-	-	-	-	-	-	-	-
1885825	0	16	their	PRP$	-	-	-	-	-	-	-	(96)
1885825	0	17	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	18	were	VBD	-	-	-	-	-	-	-	-
1885825	0	19	counted	VBN	-	-	-	-	-	-	-	-
1885825	0	20	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	weeks	NNS	-	-	-	-	-	-	-	(15|(17|(16h)|(18f)
1885825	0	3	4	CD	-	-	-	-	-	-	-	15)
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	12	CD	-	-	-	-	-	-	-	(16h)
1885825	0	6	and	CC	-	-	-	-	-	-	-	-
1885825	0	7	52	CD	-	-	-	-	-	-	-	(18f)|17)
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	10	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	11	exhibited	VBD	-	-	-	-	-	-	-	-
1885825	0	12	a	DT	-	-	-	-	-	-	-	-
1885825	0	13	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	14	cell	NN	-	-	-	-	-	-	-	-
1885825	0	15	number	NN	-	-	-	-	-	-	-	-
1885825	0	16	per	IN	-	-	-	-	-	-	-	-
1885825	0	17	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	19	fig	NN	-	-	-	-	-	-	-	-
1885825	0	20	1	CD	-	-	-	-	-	-	-	-
1885825	0	21	C	NN	-	-	-	-	-	-	-	-
1885825	0	22	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	23	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	contrast	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	cell	NN	-	-	-	-	-	-	-	-
1885825	0	5	counts	NNS	-	-	-	-	-	-	-	-
1885825	0	6	were	VBD	-	-	-	-	-	-	-	-
1885825	0	7	comparable	JJ	-	-	-	-	-	-	-	-
1885825	0	8	in	IN	-	-	-	-	-	-	-	-
1885825	0	9	spleens	NNS	-	-	-	-	-	-	-	(38b|(97
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	KO	NN	-	-	-	-	-	-	-	(86|(12u)|38b)
1885825	0	12	and	CC	-	-	-	-	-	-	-	-
1885825	0	13	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	14	mice	NNS	-	-	-	-	-	-	-	(12u)|(38b)|97)|87)|86)
1885825	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	16	Fig	NN	-	-	-	-	-	-	-	-
1885825	0	17	1	CD	-	-	-	-	-	-	-	-
1885825	0	18	D	NN	-	-	-	-	-	-	-	-
1885825	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	20	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Microscopic	JJ	-	-	-	-	-	-	-	-
1885825	0	2	analyses	NNS	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	5	formations	NNS	-	-	-	-	-	-	-	-
1885825	0	6	from	IN	-	-	-	-	-	-	-	-
1885825	0	7	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	8	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	9	revealed	VBD	-	-	-	-	-	-	-	-
1885825	0	10	no	DT	-	-	-	-	-	-	-	-
1885825	0	11	gross	JJ	-	-	-	-	-	-	-	-
1885825	0	12	abnormalities	NNS	-	-	-	-	-	-	-	-
1885825	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	14	Fig	NN	-	-	-	-	-	-	-	(98
1885825	0	15	1	CD	-	-	-	-	-	-	-	-
1885825	0	16	E	NN	-	-	-	-	-	-	-	98)
1885825	0	17	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	as	IN	-	-	-	-	-	-	-	-
1885825	0	4	NOD2	NN	-	-	-	-	-	-	-	(1)
1885825	0	5	modulates	VBZ	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(57
1885825	0	7	NF	NN	-	-	-	-	-	-	-	-
1885825	0	8	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	κappaB	NN	-	-	-	-	-	-	-	-
1885825	0	10	pathway	NN	-	-	-	-	-	-	-	57)
1885825	0	11	and	CC	-	-	-	-	-	-	-	-
1885825	0	12	putatively	RB	-	-	-	-	-	-	-	-
1885825	0	13	the	DT	-	-	-	-	-	-	-	(99
1885825	0	14	apoptosis	NN	-	-	-	-	-	-	-	99)
1885825	0	15	,	,	-	-	-	-	-	-	-	-
1885825	0	16	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	17	investigated	VBD	-	-	-	-	-	-	-	-
1885825	0	18	the	DT	-	-	-	-	-	-	-	-
1885825	0	19	number	NN	-	-	-	-	-	-	-	-
1885825	0	20	of	IN	-	-	-	-	-	-	-	-
1885825	0	21	apoptotic	JJ	-	-	-	-	-	-	-	-
1885825	0	22	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	23	inside	IN	-	-	-	-	-	-	-	-
1885825	0	24	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	25	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Immunohistochemistry	NN	-	-	-	-	-	-	-	(26)
1885825	0	2	experiments	NNS	-	-	-	-	-	-	-	-
1885825	0	3	did	VBD	-	-	-	-	-	-	-	-
1885825	0	4	not	RB	-	-	-	-	-	-	-	-
1885825	0	5	show	VB	-	-	-	-	-	-	-	-
1885825	0	6	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	7	between	IN	-	-	-	-	-	-	-	-
1885825	0	8	KO	NN	-	-	-	-	-	-	-	(86|(12v)
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	11	mice	NNS	-	-	-	-	-	-	-	(12v)|87)|86)
1885825	0	12	for	IN	-	-	-	-	-	-	-	-
1885825	0	13	the	DT	-	-	-	-	-	-	-	-
1885825	0	14	number	NN	-	-	-	-	-	-	-	-
1885825	0	15	of	IN	-	-	-	-	-	-	-	-
1885825	0	16	caspase	NN	-	-	-	-	-	-	-	-
1885825	0	17	3	CD	-	-	-	-	-	-	-	-
1885825	0	18	positive	JJ	-	-	-	-	-	-	-	-
1885825	0	19	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	20	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	21	1.01	CD	-	-	-	-	-	-	-	-
1885825	0	22	±	SYM	-	-	-	-	-	-	-	-
1885825	0	23	0.11	CD	-	-	-	-	-	-	-	-
1885825	0	24	vs.	CC	-	-	-	-	-	-	-	-
1885825	0	25	1.32	CD	-	-	-	-	-	-	-	-
1885825	0	26	±	SYM	-	-	-	-	-	-	-	-
1885825	0	27	0.10	CD	-	-	-	-	-	-	-	-
1885825	0	28	;	:	-	-	-	-	-	-	-	-
1885825	0	29	P	NN	-	-	-	-	-	-	-	(93|(92)
1885825	0	30	>	SYM	-	-	-	-	-	-	-	-
1885825	0	31	0.05	CD	-	-	-	-	-	-	-	93)
1885825	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	33	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	34	Fig	NN	-	-	-	-	-	-	-	(98
1885825	0	35	1	CD	-	-	-	-	-	-	-	-
1885825	0	36	E	NN	-	-	-	-	-	-	-	98)
1885825	0	37	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	38	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	order	NN	-	-	-	-	-	-	-	-
1885825	0	3	to	TO	-	-	-	-	-	-	-	-
1885825	0	4	better	RBR	-	-	-	-	-	-	-	-
1885825	0	5	characterise	VB	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	-
1885825	0	7	phenotype	NN	-	-	-	-	-	-	-	-
1885825	0	8	of	IN	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	-
1885825	0	10	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	11	present	JJ	-	-	-	-	-	-	-	-
1885825	0	12	in	IN	-	-	-	-	-	-	-	-
1885825	0	13	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	14	,	,	-	-	-	-	-	-	-	-
1885825	0	15	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	16	performed	VBD	-	-	-	-	-	-	-	-
1885825	0	17	flow	NN	-	-	-	-	-	-	-	(25
1885825	0	18	cytometry	NN	-	-	-	-	-	-	-	25)
1885825	0	19	experiments	NNS	-	-	-	-	-	-	-	-
1885825	0	20	using	VBG	-	-	-	-	-	-	-	-
1885825	0	21	the	DT	-	-	-	-	-	-	-	-
1885825	0	22	B220	NN	-	-	-	-	-	-	-	(102|(100)|(101b)
1885825	0	23	,	,	-	-	-	-	-	-	-	-
1885825	0	24	CD3	NN	-	-	-	-	-	-	-	(103)|(104a)
1885825	0	25	and	CC	-	-	-	-	-	-	-	-
1885825	0	26	CD11c	NN	-	-	-	-	-	-	-	(105|(105)
1885825	0	27	antibodies	NNS	-	-	-	-	-	-	-	(101b)|(104a)|105)|102)
1885825	0	28	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	week	NN	-	-	-	-	-	-	-	(16
1885825	0	3	12	CD	-	-	-	-	-	-	-	16)
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	no	DT	-	-	-	-	-	-	-	-
1885825	0	6	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	7	were	VBD	-	-	-	-	-	-	-	-
1885825	0	8	seen	VBN	-	-	-	-	-	-	-	-
1885825	0	9	regarding	VBG	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	-
1885825	0	11	relative	JJ	-	-	-	-	-	-	-	-
1885825	0	12	proportions	NNS	-	-	-	-	-	-	-	-
1885825	0	13	of	IN	-	-	-	-	-	-	-	-
1885825	0	14	B220	NN	-	-	-	-	-	-	-	-
1885825	0	15	+	SYM	-	-	-	-	-	-	-	-
1885825	0	16	B	NN	-	-	-	-	-	-	-	-
1885825	0	17	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	18	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	19	,	,	-	-	-	-	-	-	-	-
1885825	0	20	CD3	NN	-	-	-	-	-	-	-	(106
1885825	0	21	+	SYM	-	-	-	-	-	-	-	-
1885825	0	22	T	NN	-	-	-	-	-	-	-	-
1885825	0	23	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	24	cells	NNS	-	-	-	-	-	-	-	106)
1885825	0	25	and	CC	-	-	-	-	-	-	-	-
1885825	0	26	CD11c	NN	-	-	-	-	-	-	-	-
1885825	0	27	+	SYM	-	-	-	-	-	-	-	-
1885825	0	28	dendritic	JJ	-	-	-	-	-	-	-	-
1885825	0	29	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	30	between	IN	-	-	-	-	-	-	-	-
1885825	0	31	KO	NN	-	-	-	-	-	-	-	(86|(12j)
1885825	0	32	and	CC	-	-	-	-	-	-	-	-
1885825	0	33	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	34	mice	NNS	-	-	-	-	-	-	-	(12j)|87)|86)
1885825	0	35	either	CC	-	-	-	-	-	-	-	-
1885825	0	36	for	IN	-	-	-	-	-	-	-	-
1885825	0	37	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	38	or	CC	-	-	-	-	-	-	-	-
1885825	0	39	spleens	NNS	-	-	-	-	-	-	-	(107)
1885825	0	40	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	41	Fig	NN	-	-	-	-	-	-	-	(108
1885825	0	42	2	CD	-	-	-	-	-	-	-	-
1885825	0	43	A	NN	-	-	-	-	-	-	-	-
1885825	0	44	–	SYM	-	-	-	-	-	-	-	-
1885825	0	45	B	NN	-	-	-	-	-	-	-	108)
1885825	0	46	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	47	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Because	IN	-	-	-	-	-	-	-	-
1885825	0	2	some	DT	-	-	-	-	-	-	-	-
1885825	0	3	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	4	present	JJ	-	-	-	-	-	-	-	-
1885825	0	5	in	IN	-	-	-	-	-	-	-	-
1885825	0	6	a	DT	-	-	-	-	-	-	-	-
1885825	0	7	limited	VBN	-	-	-	-	-	-	-	-
1885825	0	8	number	NN	-	-	-	-	-	-	-	-
1885825	0	9	may	MD	-	-	-	-	-	-	-	-
1885825	0	10	be	VB	-	-	-	-	-	-	-	-
1885825	0	11	functionally	RB	-	-	-	-	-	-	-	-
1885825	0	12	important	JJ	-	-	-	-	-	-	-	-
1885825	0	13	,	,	-	-	-	-	-	-	-	-
1885825	0	14	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	15	also	RB	-	-	-	-	-	-	-	-
1885825	0	16	investigated	VBD	-	-	-	-	-	-	-	-
1885825	0	17	the	DT	-	-	-	-	-	-	-	-
1885825	0	18	relative	JJ	-	-	-	-	-	-	-	-
1885825	0	19	proportion	NN	-	-	-	-	-	-	-	-
1885825	0	20	of	IN	-	-	-	-	-	-	-	-
1885825	0	21	Ly	NN	-	-	-	-	-	-	-	-
1885825	0	22	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	23	6G	NN	-	-	-	-	-	-	-	-
1885825	0	24	+	SYM	-	-	-	-	-	-	-	-
1885825	0	25	polymorphonuclear	JJ	-	-	-	-	-	-	-	(109
1885825	0	26	neutrophils	NNS	-	-	-	-	-	-	-	109)
1885825	0	27	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	28	PMN	NN	-	-	-	-	-	-	-	-
1885825	0	29	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	30	present	JJ	-	-	-	-	-	-	-	-
1885825	0	31	in	IN	-	-	-	-	-	-	-	-
1885825	0	32	the	DT	-	-	-	-	-	-	-	(2
1885825	0	33	PPs	NNS	-	-	-	-	-	-	-	2)
1885825	0	34	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	35	Fig	NN	-	-	-	-	-	-	-	(110
1885825	0	36	2	CD	-	-	-	-	-	-	-	-
1885825	0	37	C	NN	-	-	-	-	-	-	-	110)
1885825	0	38	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	39	and	CC	-	-	-	-	-	-	-	-
1885825	0	40	the	DT	-	-	-	-	-	-	-	-
1885825	0	41	number	NN	-	-	-	-	-	-	-	-
1885825	0	42	of	IN	-	-	-	-	-	-	-	-
1885825	0	43	M	NN	-	-	-	-	-	-	-	(28
1885825	0	44	cells	NNS	-	-	-	-	-	-	-	28)
1885825	0	45	located	VBN	-	-	-	-	-	-	-	-
1885825	0	46	inside	IN	-	-	-	-	-	-	-	-
1885825	0	47	the	DT	-	-	-	-	-	-	-	(111
1885825	0	48	follicle	NN	-	-	-	-	-	-	-	-
1885825	0	49	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	50	epithelium	NN	-	-	-	-	-	-	-	111)
1885825	0	51	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	52	FAE	NN	-	-	-	-	-	-	-	-
1885825	0	53	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	54	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	55	Fig	NN	-	-	-	-	-	-	-	(112
1885825	0	56	2	CD	-	-	-	-	-	-	-	-
1885825	0	57	D	NN	-	-	-	-	-	-	-	112)
1885825	0	58	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	59	.	.	-	-	-	-	-	-	-	-

1885825	0	1	No	DT	-	-	-	-	-	-	-	-
1885825	0	2	difference	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	PMN	NN	-	-	-	-	-	-	-	(109)
1885825	0	5	relative	JJ	-	-	-	-	-	-	-	-
1885825	0	6	proportion	NN	-	-	-	-	-	-	-	-
1885825	0	7	was	VBD	-	-	-	-	-	-	-	-
1885825	0	8	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	9	in	IN	-	-	-	-	-	-	-	-
1885825	0	10	PPs	NNS	-	-	-	-	-	-	-	(113|(2)
1885825	0	11	of	IN	-	-	-	-	-	-	-	-
1885825	0	12	KO	NN	-	-	-	-	-	-	-	(86|(12o)
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	15	mice	NNS	-	-	-	-	-	-	-	(12o)|87)|86)|113)
1885825	0	16	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	17	Fig	NN	-	-	-	-	-	-	-	(110
1885825	0	18	2	CD	-	-	-	-	-	-	-	-
1885825	0	19	C	NN	-	-	-	-	-	-	-	110)
1885825	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	the	DT	-	-	-	-	-	-	-	-
1885825	0	3	opposite	JJ	-	-	-	-	-	-	-	-
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	M	NN	-	-	-	-	-	-	-	(28
1885825	0	6	cell	NN	-	-	-	-	-	-	-	28)
1885825	0	7	number	NN	-	-	-	-	-	-	-	-
1885825	0	8	was	VBD	-	-	-	-	-	-	-	-
1885825	0	9	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	10	in	IN	-	-	-	-	-	-	-	-
1885825	0	11	the	DT	-	-	-	-	-	-	-	(111
1885825	0	12	FAE	NN	-	-	-	-	-	-	-	111)
1885825	0	13	of	IN	-	-	-	-	-	-	-	-
1885825	0	14	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	15	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	16	in	IN	-	-	-	-	-	-	-	-
1885825	0	17	comparison	NN	-	-	-	-	-	-	-	-
1885825	0	18	with	IN	-	-	-	-	-	-	-	-
1885825	0	19	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	20	mice	NNS	-	-	-	-	-	-	-	87)
1885825	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	22	Fig	NN	-	-	-	-	-	-	-	(112
1885825	0	23	2	CD	-	-	-	-	-	-	-	-
1885825	0	24	D	NN	-	-	-	-	-	-	-	112)
1885825	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	As	IN	-	-	-	-	-	-	-	-
1885825	0	2	T	NN	-	-	-	-	-	-	-	(114
1885825	0	3	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	4	cells	NNS	-	-	-	-	-	-	-	114)
1885825	0	5	are	VBP	-	-	-	-	-	-	-	-
1885825	0	6	known	VBN	-	-	-	-	-	-	-	-
1885825	0	7	to	TO	-	-	-	-	-	-	-	-
1885825	0	8	play	VB	-	-	-	-	-	-	-	-
1885825	0	9	a	DT	-	-	-	-	-	-	-	-
1885825	0	10	pivotal	JJ	-	-	-	-	-	-	-	-
1885825	0	11	role	NN	-	-	-	-	-	-	-	-
1885825	0	12	in	IN	-	-	-	-	-	-	-	-
1885825	0	13	CD	NN	-	-	-	-	-	-	-	(6)
1885825	0	14	,	,	-	-	-	-	-	-	-	-
1885825	0	15	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	16	further	RB	-	-	-	-	-	-	-	-
1885825	0	17	analyzed	VBD	-	-	-	-	-	-	-	-
1885825	0	18	the	DT	-	-	-	-	-	-	-	(106
1885825	0	19	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	20	+	SYM	-	-	-	-	-	-	-	-
1885825	0	21	T	NN	-	-	-	-	-	-	-	-
1885825	0	22	cells	NNS	-	-	-	-	-	-	-	106)
1885825	0	23	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	week	NN	-	-	-	-	-	-	-	(16
1885825	0	3	12	CD	-	-	-	-	-	-	-	16)
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	6	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	7	exhibited	VBD	-	-	-	-	-	-	-	-
1885825	0	8	an	DT	-	-	-	-	-	-	-	-
1885825	0	9	increase	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	CD4	NN	-	-	-	-	-	-	-	(30
1885825	0	12	+	SYM	-	-	-	-	-	-	-	-
1885825	0	13	T	NN	-	-	-	-	-	-	-	-
1885825	0	14	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	15	cell	NN	-	-	-	-	-	-	-	30)
1885825	0	16	relative	JJ	-	-	-	-	-	-	-	-
1885825	0	17	proportion	NN	-	-	-	-	-	-	-	-
1885825	0	18	within	IN	-	-	-	-	-	-	-	-
1885825	0	19	their	PRP$	-	-	-	-	-	-	-	(115|(12)
1885825	0	20	PPs	NNS	-	-	-	-	-	-	-	115)
1885825	0	21	,	,	-	-	-	-	-	-	-	-
1885825	0	22	whereas	IN	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	-
1885825	0	24	proportion	NN	-	-	-	-	-	-	-	-
1885825	0	25	of	IN	-	-	-	-	-	-	-	-
1885825	0	26	CD8	NN	-	-	-	-	-	-	-	(116
1885825	0	27	+	SYM	-	-	-	-	-	-	-	-
1885825	0	28	T	NN	-	-	-	-	-	-	-	-
1885825	0	29	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	30	cells	NNS	-	-	-	-	-	-	-	116)
1885825	0	31	remained	VBD	-	-	-	-	-	-	-	-
1885825	0	32	constant	JJ	-	-	-	-	-	-	-	-
1885825	0	33	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	34	Fig	NN	-	-	-	-	-	-	-	(117
1885825	0	35	3	CD	-	-	-	-	-	-	-	-
1885825	0	36	A	NN	-	-	-	-	-	-	-	117)
1885825	0	37	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	38	.	.	-	-	-	-	-	-	-	-

1885825	0	1	As	IN	-	-	-	-	-	-	-	-
1885825	0	2	a	DT	-	-	-	-	-	-	-	-
1885825	0	3	mirror	NN	-	-	-	-	-	-	-	-
1885825	0	4	image	NN	-	-	-	-	-	-	-	-
1885825	0	5	,	,	-	-	-	-	-	-	-	-
1885825	0	6	PPs	NNS	-	-	-	-	-	-	-	(115
1885825	0	7	from	IN	-	-	-	-	-	-	-	-
1885825	0	8	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	12)|115)
1885825	0	10	exhibited	VBD	-	-	-	-	-	-	-	-
1885825	0	11	significantly	RB	-	-	-	-	-	-	-	-
1885825	0	12	fewer	JJR	-	-	-	-	-	-	-	-
1885825	0	13	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	14	+	SYM	-	-	-	-	-	-	-	-
1885825	0	15	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	16	−	SYM	-	-	-	-	-	-	-	-
1885825	0	17	CD8	NN	-	-	-	-	-	-	-	-
1885825	0	18	−	SYM	-	-	-	-	-	-	-	-
1885825	0	19	T	NN	-	-	-	-	-	-	-	-
1885825	0	20	-	SYM	-	-	-	-	-	-	-	-
1885825	0	21	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	23	Fig	NN	-	-	-	-	-	-	-	(117
1885825	0	24	3	CD	-	-	-	-	-	-	-	-
1885825	0	25	A	NN	-	-	-	-	-	-	-	117)
1885825	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	27	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	contrast	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	no	DT	-	-	-	-	-	-	-	-
1885825	0	5	comparable	JJ	-	-	-	-	-	-	-	-
1885825	0	6	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	7	were	VBD	-	-	-	-	-	-	-	-
1885825	0	8	seen	VBN	-	-	-	-	-	-	-	-
1885825	0	9	in	IN	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	(107
1885825	0	11	spleens	NNS	-	-	-	-	-	-	-	107)
1885825	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	13	Fig	NN	-	-	-	-	-	-	-	-
1885825	0	14	3	CD	-	-	-	-	-	-	-	-
1885825	0	15	B	NN	-	-	-	-	-	-	-	-
1885825	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	17	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Similar	JJ	-	-	-	-	-	-	-	-
1885825	0	2	data	NNS	-	-	-	-	-	-	-	-
1885825	0	3	were	VBD	-	-	-	-	-	-	-	-
1885825	0	4	obtained	VBN	-	-	-	-	-	-	-	-
1885825	0	5	at	IN	-	-	-	-	-	-	-	-
1885825	0	6	week	NN	-	-	-	-	-	-	-	(15
1885825	0	7	4	CD	-	-	-	-	-	-	-	15)
1885825	0	8	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	9	SI	NN	-	-	-	-	-	-	-	-
1885825	0	10	Fig	NN	-	-	-	-	-	-	-	-
1885825	0	11	S1	NN	-	-	-	-	-	-	-	-
1885825	0	12	A	NN	-	-	-	-	-	-	-	-
1885825	0	13	–	SYM	-	-	-	-	-	-	-	-
1885825	0	14	B	NN	-	-	-	-	-	-	-	-
1885825	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	16	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	4	investigated	VBD	-	-	-	-	-	-	-	-
1885825	0	5	the	DT	-	-	-	-	-	-	-	-
1885825	0	6	phenotype	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	CD4	NN	-	-	-	-	-	-	-	(30
1885825	0	9	+	SYM	-	-	-	-	-	-	-	-
1885825	0	10	T	NN	-	-	-	-	-	-	-	-
1885825	0	11	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	12	cells	NNS	-	-	-	-	-	-	-	30)
1885825	0	13	present	JJ	-	-	-	-	-	-	-	-
1885825	0	14	in	IN	-	-	-	-	-	-	-	-
1885825	0	15	the	DT	-	-	-	-	-	-	-	(2
1885825	0	16	PPs	NNS	-	-	-	-	-	-	-	2)
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	spleens	NNS	-	-	-	-	-	-	-	(107)
1885825	0	19	by	IN	-	-	-	-	-	-	-	-
1885825	0	20	examining	VBG	-	-	-	-	-	-	-	-
1885825	0	21	the	DT	-	-	-	-	-	-	-	-
1885825	0	22	relative	JJ	-	-	-	-	-	-	-	-
1885825	0	23	proportions	NNS	-	-	-	-	-	-	-	-
1885825	0	24	of	IN	-	-	-	-	-	-	-	-
1885825	0	25	naive	JJ	-	-	-	-	-	-	-	(118
1885825	0	26	CD25	NN	-	-	-	-	-	-	-	-
1885825	0	27	−	SYM	-	-	-	-	-	-	-	-
1885825	0	28	CD45Rb	NN	-	-	-	-	-	-	-	-
1885825	0	29	+	SYM	-	-	-	-	-	-	-	118)
1885825	0	30	,	,	-	-	-	-	-	-	-	-
1885825	0	31	regulatory	JJ	-	-	-	-	-	-	-	(119
1885825	0	32	CD25	NN	-	-	-	-	-	-	-	-
1885825	0	33	+	SYM	-	-	-	-	-	-	-	-
1885825	0	34	CD45Rb	NN	-	-	-	-	-	-	-	-
1885825	0	35	−	SYM	-	-	-	-	-	-	-	119)
1885825	0	36	and	CC	-	-	-	-	-	-	-	-
1885825	0	37	memory	NN	-	-	-	-	-	-	-	(120
1885825	0	38	CD25	NN	-	-	-	-	-	-	-	-
1885825	0	39	−	SYM	-	-	-	-	-	-	-	-
1885825	0	40	CD45Rb	NN	-	-	-	-	-	-	-	-
1885825	0	41	−	SYM	-	-	-	-	-	-	-	-
1885825	0	42	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	43	+	SYM	-	-	-	-	-	-	-	-
1885825	0	44	T	NN	-	-	-	-	-	-	-	-
1885825	0	45	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	46	cells	NNS	-	-	-	-	-	-	-	120)
1885825	0	47	.	.	-	-	-	-	-	-	-	-

1885825	0	1	KO	NN	-	-	-	-	-	-	-	(86|(12g)
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	4	mice	NNS	-	-	-	-	-	-	-	(12g)|87)|86)
1885825	0	5	had	VBD	-	-	-	-	-	-	-	-
1885825	0	6	a	DT	-	-	-	-	-	-	-	-
1885825	0	7	similar	JJ	-	-	-	-	-	-	-	-
1885825	0	8	relative	JJ	-	-	-	-	-	-	-	-
1885825	0	9	proportion	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	naive	JJ	-	-	-	-	-	-	-	(121|(118)|(122a)
1885825	0	12	,	,	-	-	-	-	-	-	-	-
1885825	0	13	regulatory	JJ	-	-	-	-	-	-	-	(119)|(123b)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	memory	NN	-	-	-	-	-	-	-	(120|(124
1885825	0	16	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	17	+	SYM	-	-	-	-	-	-	-	-
1885825	0	18	T	NN	-	-	-	-	-	-	-	(122a|(123b
1885825	0	19	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	20	cells	NNS	-	-	-	-	-	-	-	120)
1885825	0	21	in	IN	-	-	-	-	-	-	-	-
1885825	0	22	PPs	NNS	-	-	-	-	-	-	-	(2)|124)|123b)|122a)|121)
1885825	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	24	SI	NN	-	-	-	-	-	-	-	-
1885825	0	25	Fig	NN	-	-	-	-	-	-	-	-
1885825	0	26	S2	NN	-	-	-	-	-	-	-	-
1885825	0	27	A	NN	-	-	-	-	-	-	-	-
1885825	0	28	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	29	and	CC	-	-	-	-	-	-	-	-
1885825	0	30	spleen	NN	-	-	-	-	-	-	-	(107)
1885825	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	32	SI	NN	-	-	-	-	-	-	-	-
1885825	0	33	Fig	NN	-	-	-	-	-	-	-	-
1885825	0	34	S2	NN	-	-	-	-	-	-	-	-
1885825	0	35	B	NN	-	-	-	-	-	-	-	-
1885825	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	37	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Flow	NN	-	-	-	-	-	-	-	(125|(25
1885825	0	2	cytometry	NN	-	-	-	-	-	-	-	25)
1885825	0	3	analyses	NNS	-	-	-	-	-	-	-	125)
1885825	0	4	also	RB	-	-	-	-	-	-	-	-
1885825	0	5	failed	VBD	-	-	-	-	-	-	-	-
1885825	0	6	to	TO	-	-	-	-	-	-	-	-
1885825	0	7	reveal	VB	-	-	-	-	-	-	-	-
1885825	0	8	a	DT	-	-	-	-	-	-	-	-
1885825	0	9	difference	NN	-	-	-	-	-	-	-	-
1885825	0	10	between	IN	-	-	-	-	-	-	-	-
1885825	0	11	KO	NN	-	-	-	-	-	-	-	(86|(12l)
1885825	0	12	and	CC	-	-	-	-	-	-	-	-
1885825	0	13	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	14	mice	NNS	-	-	-	-	-	-	-	(12l)|87)|86)
1885825	0	15	when	WRB	-	-	-	-	-	-	-	-
1885825	0	16	investigating	VBG	-	-	-	-	-	-	-	-
1885825	0	17	the	DT	-	-	-	-	-	-	-	-
1885825	0	18	annexin	NN	-	-	-	-	-	-	-	-
1885825	0	19	V	CD	-	-	-	-	-	-	-	-
1885825	0	20	positive	JJ	-	-	-	-	-	-	-	-
1885825	0	21	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	22	+	SYM	-	-	-	-	-	-	-	-
1885825	0	23	and	CC	-	-	-	-	-	-	-	-
1885825	0	24	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	25	+	SYM	-	-	-	-	-	-	-	-
1885825	0	26	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	27	+	SYM	-	-	-	-	-	-	-	-
1885825	0	28	T	NN	-	-	-	-	-	-	-	-
1885825	0	29	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	30	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	31	extracted	VBN	-	-	-	-	-	-	-	-
1885825	0	32	from	IN	-	-	-	-	-	-	-	-
1885825	0	33	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	34	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	35	SI	NN	-	-	-	-	-	-	-	-
1885825	0	36	Fig	NN	-	-	-	-	-	-	-	-
1885825	0	37	S2	NN	-	-	-	-	-	-	-	-
1885825	0	38	C	NN	-	-	-	-	-	-	-	-
1885825	0	39	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	40	suggesting	VBG	-	-	-	-	-	-	-	-
1885825	0	41	that	IN	-	-	-	-	-	-	-	-
1885825	0	42	the	DT	-	-	-	-	-	-	-	-
1885825	0	43	excess	NN	-	-	-	-	-	-	-	-
1885825	0	44	of	IN	-	-	-	-	-	-	-	-
1885825	0	45	CD4	NN	-	-	-	-	-	-	-	(30
1885825	0	46	+	SYM	-	-	-	-	-	-	-	-
1885825	0	47	T	NN	-	-	-	-	-	-	-	-
1885825	0	48	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	49	cells	NNS	-	-	-	-	-	-	-	30)
1885825	0	50	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	51	in	IN	-	-	-	-	-	-	-	-
1885825	0	52	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	53	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	54	does	VBZ	-	-	-	-	-	-	-	-
1885825	0	55	not	RB	-	-	-	-	-	-	-	-
1885825	0	56	result	VB	-	-	-	-	-	-	-	-
1885825	0	57	from	IN	-	-	-	-	-	-	-	-
1885825	0	58	a	DT	-	-	-	-	-	-	-	-
1885825	0	59	defect	NN	-	-	-	-	-	-	-	-
1885825	0	60	of	IN	-	-	-	-	-	-	-	-
1885825	0	61	apoptosis	NN	-	-	-	-	-	-	-	(99)
1885825	0	62	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Considering	VBG	-	-	-	-	-	-	-	-
1885825	0	2	the	DT	-	-	-	-	-	-	-	-
1885825	0	3	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	4	of	IN	-	-	-	-	-	-	-	-
1885825	0	5	PP	NN	-	-	-	-	-	-	-	(19|(2)
1885825	0	6	cell	NN	-	-	-	-	-	-	-	-
1885825	0	7	number	NN	-	-	-	-	-	-	-	19)
1885825	0	8	and	CC	-	-	-	-	-	-	-	-
1885825	0	9	cellular	JJ	-	-	-	-	-	-	-	(24
1885825	0	10	composition	NN	-	-	-	-	-	-	-	24)
1885825	0	11	,	,	-	-	-	-	-	-	-	-
1885825	0	12	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	13	further	RB	-	-	-	-	-	-	-	-
1885825	0	14	evaluated	VBD	-	-	-	-	-	-	-	-
1885825	0	15	whether	IN	-	-	-	-	-	-	-	-
1885825	0	16	PPs	NNS	-	-	-	-	-	-	-	(113|(115a
1885825	0	17	from	IN	-	-	-	-	-	-	-	-
1885825	0	18	KO	NN	-	-	-	-	-	-	-	(86|(12k)|115a)
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	21	mice	NNS	-	-	-	-	-	-	-	(115a)|(12k)|87)|86)|113)
1885825	0	22	might	MD	-	-	-	-	-	-	-	-
1885825	0	23	exhibit	VB	-	-	-	-	-	-	-	-
1885825	0	24	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	25	regarding	VBG	-	-	-	-	-	-	-	-
1885825	0	26	their	PRP$	-	-	-	-	-	-	-	(113)
1885825	0	27	cytokine	NN	-	-	-	-	-	-	-	-
1885825	0	28	profile	NN	-	-	-	-	-	-	-	-
1885825	0	29	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Thus	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	-
1885825	0	4	expression	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	IL	NN	-	-	-	-	-	-	-	(126|(127
1885825	0	7	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	8	1β	NN	-	-	-	-	-	-	-	126)
1885825	0	9	,	,	-	-	-	-	-	-	-	-
1885825	0	10	IFNγ	NN	-	-	-	-	-	-	-	(33)
1885825	0	11	,	,	-	-	-	-	-	-	-	-
1885825	0	12	TNFα	NN	-	-	-	-	-	-	-	(31)
1885825	0	13	,	,	-	-	-	-	-	-	-	-
1885825	0	14	IL	NN	-	-	-	-	-	-	-	(34
1885825	0	15	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	12	CD	-	-	-	-	-	-	-	34)
1885825	0	17	,	,	-	-	-	-	-	-	-	-
1885825	0	18	and	CC	-	-	-	-	-	-	-	-
1885825	0	19	IL	NN	-	-	-	-	-	-	-	(35
1885825	0	20	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	21	4	CD	-	-	-	-	-	-	-	35)|127)
1885825	0	22	in	IN	-	-	-	-	-	-	-	-
1885825	0	23	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	24	,	,	-	-	-	-	-	-	-	-
1885825	0	25	PP	NN	-	-	-	-	-	-	-	(37|(2)
1885825	0	26	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	27	free	JJ	-	-	-	-	-	-	-	-
1885825	0	28	ileum	NN	-	-	-	-	-	-	-	37)
1885825	0	29	and	CC	-	-	-	-	-	-	-	-
1885825	0	30	spleen	NN	-	-	-	-	-	-	-	(107)
1885825	0	31	were	VBD	-	-	-	-	-	-	-	-
1885825	0	32	determined	VBN	-	-	-	-	-	-	-	-
1885825	0	33	by	IN	-	-	-	-	-	-	-	-
1885825	0	34	ELISA	NNP	-	-	-	-	-	-	-	(36)
1885825	0	35	,	,	-	-	-	-	-	-	-	-
1885825	0	36	at	IN	-	-	-	-	-	-	-	-
1885825	0	37	weeks	NNS	-	-	-	-	-	-	-	(15|(22|(16b)
1885825	0	38	4	CD	-	-	-	-	-	-	-	15)
1885825	0	39	and	CC	-	-	-	-	-	-	-	-
1885825	0	40	12	CD	-	-	-	-	-	-	-	(16b)|22)
1885825	0	41	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Levels	NNS	-	-	-	-	-	-	-	(128a|(129b
1885825	0	2	of	IN	-	-	-	-	-	-	-	129b)|128a)
1885825	0	3	IFNγ	NN	-	-	-	-	-	-	-	(32|(33)
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	TNFα	NN	-	-	-	-	-	-	-	(128a)|(31)
1885825	0	6	,	,	-	-	-	-	-	-	-	-
1885825	0	7	IL	NN	-	-	-	-	-	-	-	(129b|(34
1885825	0	8	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	12	CD	-	-	-	-	-	-	-	34)|129b)
1885825	0	10	,	,	-	-	-	-	-	-	-	-
1885825	0	11	and	CC	-	-	-	-	-	-	-	-
1885825	0	12	IL	NN	-	-	-	-	-	-	-	(35
1885825	0	13	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	14	4	CD	-	-	-	-	-	-	-	35)|32)
1885825	0	15	were	VBD	-	-	-	-	-	-	-	-
1885825	0	16	significantly	RB	-	-	-	-	-	-	-	-
1885825	0	17	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	18	in	IN	-	-	-	-	-	-	-	-
1885825	0	19	PPs	NNS	-	-	-	-	-	-	-	(27|(2)
1885825	0	20	of	IN	-	-	-	-	-	-	-	-
1885825	0	21	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	22	mice	NNS	-	-	-	-	-	-	-	27)|12)
1885825	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	24	Fig	NN	-	-	-	-	-	-	-	(130
1885825	0	25	4	CD	-	-	-	-	-	-	-	130)
1885825	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	27	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	contrast	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	less	RBR	-	-	-	-	-	-	-	-
1885825	0	5	marked	JJ	-	-	-	-	-	-	-	-
1885825	0	6	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	7	were	VBD	-	-	-	-	-	-	-	-
1885825	0	8	seen	VBN	-	-	-	-	-	-	-	-
1885825	0	9	between	IN	-	-	-	-	-	-	-	-
1885825	0	10	KO	NN	-	-	-	-	-	-	-	(86|(12t)
1885825	0	11	and	CC	-	-	-	-	-	-	-	-
1885825	0	12	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	13	mice	NNS	-	-	-	-	-	-	-	(12t)|87)|86)
1885825	0	14	in	IN	-	-	-	-	-	-	-	-
1885825	0	15	PP	NN	-	-	-	-	-	-	-	(37|(2)
1885825	0	16	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	free	JJ	-	-	-	-	-	-	-	-
1885825	0	18	ileum	NN	-	-	-	-	-	-	-	37)
1885825	0	19	where	WRB	-	-	-	-	-	-	-	-
1885825	0	20	TNFα	NN	-	-	-	-	-	-	-	(31)
1885825	0	21	and	CC	-	-	-	-	-	-	-	-
1885825	0	22	IFNγ	NN	-	-	-	-	-	-	-	(33)
1885825	0	23	were	VBD	-	-	-	-	-	-	-	-
1885825	0	24	the	DT	-	-	-	-	-	-	-	-
1885825	0	25	only	JJ	-	-	-	-	-	-	-	-
1885825	0	26	cytokines	NNS	-	-	-	-	-	-	-	-
1885825	0	27	differentially	RB	-	-	-	-	-	-	-	-
1885825	0	28	expressed	VBN	-	-	-	-	-	-	-	-
1885825	0	29	at	IN	-	-	-	-	-	-	-	-
1885825	0	30	week	NN	-	-	-	-	-	-	-	(15
1885825	0	31	4	CD	-	-	-	-	-	-	-	15)
1885825	0	32	but	CC	-	-	-	-	-	-	-	-
1885825	0	33	not	RB	-	-	-	-	-	-	-	-
1885825	0	34	in	IN	-	-	-	-	-	-	-	-
1885825	0	35	adult	JJ	-	-	-	-	-	-	-	(81
1885825	0	36	mice	NNS	-	-	-	-	-	-	-	81)
1885825	0	37	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	38	Fig	NN	-	-	-	-	-	-	-	(130
1885825	0	39	4	CD	-	-	-	-	-	-	-	130)
1885825	0	40	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	41	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	no	DT	-	-	-	-	-	-	-	-
1885825	0	4	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	5	were	VBD	-	-	-	-	-	-	-	-
1885825	0	6	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	7	in	IN	-	-	-	-	-	-	-	-
1885825	0	8	spleens	NNS	-	-	-	-	-	-	-	(38a|(97|(107)
1885825	0	9	from	IN	-	-	-	-	-	-	-	-
1885825	0	10	KO	NN	-	-	-	-	-	-	-	(86|(12m)|38a)
1885825	0	11	and	CC	-	-	-	-	-	-	-	-
1885825	0	12	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	13	mice	NNS	-	-	-	-	-	-	-	(12m)|(38a)|97)|87)|86)
1885825	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	15	Fig	NN	-	-	-	-	-	-	-	(130
1885825	0	16	4	CD	-	-	-	-	-	-	-	130)
1885825	0	17	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Cell	NN	-	-	-	-	-	-	-	(131|(132
1885825	0	2	composition	NN	-	-	-	-	-	-	-	131)
1885825	0	3	and	CC	-	-	-	-	-	-	-	-
1885825	0	4	cytokine	NN	-	-	-	-	-	-	-	(133
1885825	0	5	production	NN	-	-	-	-	-	-	-	133)|132)
1885825	0	6	may	MD	-	-	-	-	-	-	-	-
1885825	0	7	affect	VB	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	(48
1885825	0	9	function	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	PPs	NNS	-	-	-	-	-	-	-	(2)|48)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	We	PRP	-	-	-	-	-	-	-	(13)
1885825	0	2	thus	RB	-	-	-	-	-	-	-	-
1885825	0	3	used	VBD	-	-	-	-	-	-	-	-
1885825	0	4	Ussing	NNP	-	-	-	-	-	-	-	(39
1885825	0	5	chambers	NNS	-	-	-	-	-	-	-	39)
1885825	0	6	for	IN	-	-	-	-	-	-	-	-
1885825	0	7	determining	VBG	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	(134|(41
1885825	0	9	paracellular	JJ	-	-	-	-	-	-	-	-
1885825	0	10	permeability	NN	-	-	-	-	-	-	-	41)
1885825	0	11	through	IN	-	-	-	-	-	-	-	-
1885825	0	12	PP	NNS	-	-	-	-	-	-	-	(135|(2)
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	PP	NNS	-	-	-	-	-	-	-	(37|(2)
1885825	0	15	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	free	JJ	-	-	-	-	-	-	-	-
1885825	0	17	ileum	NN	-	-	-	-	-	-	-	37)|135)|134)
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	PPs	NNS	-	-	-	-	-	-	-	(136|(27c)
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	4	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	5	free	JJ	-	-	-	-	-	-	-	-
1885825	0	6	ileum	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	(27c
1885825	0	8	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	27c)|12)
1885825	0	10	exhibited	VBD	-	-	-	-	-	-	-	-
1885825	0	11	a	DT	-	-	-	-	-	-	-	-
1885825	0	12	significant	JJ	-	-	-	-	-	-	-	-
1885825	0	13	increase	NN	-	-	-	-	-	-	-	-
1885825	0	14	in	IN	-	-	-	-	-	-	-	-
1885825	0	15	paracellular	JJ	-	-	-	-	-	-	-	(41
1885825	0	16	permeability	NN	-	-	-	-	-	-	-	41)
1885825	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	18	Fig	NN	-	-	-	-	-	-	-	(137
1885825	0	19	5	CD	-	-	-	-	-	-	-	-
1885825	0	20	A	NN	-	-	-	-	-	-	-	137)
1885825	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	while	IN	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	-
1885825	0	24	electrical	JJ	-	-	-	-	-	-	-	-
1885825	0	25	resistances	NNS	-	-	-	-	-	-	-	-
1885825	0	26	were	VBD	-	-	-	-	-	-	-	-
1885825	0	27	comparable	JJ	-	-	-	-	-	-	-	136)
1885825	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	29	data	NNS	-	-	-	-	-	-	-	-
1885825	0	30	not	RB	-	-	-	-	-	-	-	-
1885825	0	31	shown	VBN	-	-	-	-	-	-	-	-
1885825	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	33	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	parallel	NN	-	-	-	-	-	-	-	-
1885825	0	3	to	IN	-	-	-	-	-	-	-	-
1885825	0	4	this	DT	-	-	-	-	-	-	-	(136
1885825	0	5	change	NN	-	-	-	-	-	-	-	136)
1885825	0	6	,	,	-	-	-	-	-	-	-	-
1885825	0	7	mRNA	NN	-	-	-	-	-	-	-	(138
1885825	0	8	expression	NN	-	-	-	-	-	-	-	-
1885825	0	9	levels	NNS	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	TJ	NN	-	-	-	-	-	-	-	(139
1885825	0	12	proteins	NN	-	-	-	-	-	-	-	139)|138)
1885825	0	13	were	VBD	-	-	-	-	-	-	-	-
1885825	0	14	affected	VBN	-	-	-	-	-	-	-	-
1885825	0	15	in	IN	-	-	-	-	-	-	-	-
1885825	0	16	PP	NNS	-	-	-	-	-	-	-	(27|(2)
1885825	0	17	of	IN	-	-	-	-	-	-	-	-
1885825	0	18	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	19	mice	NNS	-	-	-	-	-	-	-	27)|12)
1885825	0	20	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Indeed	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	expression	NN	-	-	-	-	-	-	-	-
1885825	0	4	of	IN	-	-	-	-	-	-	-	-
1885825	0	5	mRNAs	NNS	-	-	-	-	-	-	-	-
1885825	0	6	encoding	VBG	-	-	-	-	-	-	-	-
1885825	0	7	ZO	NN	-	-	-	-	-	-	-	(140|(141
1885825	0	8	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	2	CD	-	-	-	-	-	-	-	140)
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	ZO	NN	-	-	-	-	-	-	-	(142
1885825	0	12	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	13	1	CD	-	-	-	-	-	-	-	142)|141)
1885825	0	14	were	VBD	-	-	-	-	-	-	-	-
1885825	0	15	decreased	VBN	-	-	-	-	-	-	-	-
1885825	0	16	by	IN	-	-	-	-	-	-	-	-
1885825	0	17	45	CD	-	-	-	-	-	-	-	-
1885825	0	18	%	NN	-	-	-	-	-	-	-	-
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	36	CD	-	-	-	-	-	-	-	-
1885825	0	21	%	NN	-	-	-	-	-	-	-	-
1885825	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	23	P	NN	-	-	-	-	-	-	-	(143|(92)
1885825	0	24	<	SYM	-	-	-	-	-	-	-	-
1885825	0	25	0.01	CD	-	-	-	-	-	-	-	143)
1885825	0	26	and	CC	-	-	-	-	-	-	-	-
1885825	0	27	P	NN	-	-	-	-	-	-	-	(92)
1885825	0	28	<	SYM	-	-	-	-	-	-	-	-
1885825	0	29	0.06	CD	-	-	-	-	-	-	-	-
1885825	0	30	respectively	RB	-	-	-	-	-	-	-	-
1885825	0	31	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	32	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	33	Fig	NN	-	-	-	-	-	-	-	(144
1885825	0	34	5	CD	-	-	-	-	-	-	-	-
1885825	0	35	B	NN	-	-	-	-	-	-	-	144)
1885825	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	37	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	contrast	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	Occludin	NN	-	-	-	-	-	-	-	(145)
1885825	0	5	expression	NN	-	-	-	-	-	-	-	-
1885825	0	6	was	VBD	-	-	-	-	-	-	-	-
1885825	0	7	unchanged	JJ	-	-	-	-	-	-	-	-
1885825	0	8	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	9	Fig	NN	-	-	-	-	-	-	-	(144
1885825	0	10	5	CD	-	-	-	-	-	-	-	-
1885825	0	11	B	NN	-	-	-	-	-	-	-	144)
1885825	0	12	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	13	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Because	IN	-	-	-	-	-	-	-	-
1885825	0	2	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	3	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	4	involved	VBN	-	-	-	-	-	-	-	-
1885825	0	5	in	IN	-	-	-	-	-	-	-	-
1885825	0	6	innate	JJ	-	-	-	-	-	-	-	(54
1885825	0	7	immunity	NN	-	-	-	-	-	-	-	54)
1885825	0	8	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	9	hypothesised	VBD	-	-	-	-	-	-	-	-
1885825	0	10	that	IN	-	-	-	-	-	-	-	-
1885825	0	11	Card15	NN	-	-	-	-	-	-	-	(11|(46
1885825	0	12	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	13	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	14	deficiency	NN	-	-	-	-	-	-	-	46)
1885825	0	15	may	MD	-	-	-	-	-	-	-	-
1885825	0	16	affect	VB	-	-	-	-	-	-	-	-
1885825	0	17	the	DT	-	-	-	-	-	-	-	(146
1885825	0	18	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	19	microflora	NNS	-	-	-	-	-	-	-	146)
1885825	0	20	.	.	-	-	-	-	-	-	-	-

1885825	0	1	We	PRP	-	-	-	-	-	-	-	(13)
1885825	0	2	thus	RB	-	-	-	-	-	-	-	-
1885825	0	3	counted	VBD	-	-	-	-	-	-	-	-
1885825	0	4	the	DT	-	-	-	-	-	-	-	-
1885825	0	5	numbers	NNS	-	-	-	-	-	-	-	-
1885825	0	6	of	IN	-	-	-	-	-	-	-	-
1885825	0	7	bacteria	NNS	-	-	-	-	-	-	-	-
1885825	0	8	classified	VBN	-	-	-	-	-	-	-	-
1885825	0	9	as	IN	-	-	-	-	-	-	-	-
1885825	0	10	Enterobacteriaceae	NNP	-	-	-	-	-	-	-	-
1885825	0	11	,	,	-	-	-	-	-	-	-	-
1885825	0	12	Pseudomonas	NNP	-	-	-	-	-	-	-	(147)
1885825	0	13	,	,	-	-	-	-	-	-	-	-
1885825	0	14	Staphylococcus	NNP	-	-	-	-	-	-	-	(148)
1885825	0	15	,	,	-	-	-	-	-	-	-	-
1885825	0	16	Streptococcus	NNP	-	-	-	-	-	-	-	-
1885825	0	17	,	,	-	-	-	-	-	-	-	-
1885825	0	18	Enterococcus	NNP	-	-	-	-	-	-	-	-
1885825	0	19	or	CC	-	-	-	-	-	-	-	-
1885825	0	20	Lactobacillus	NNP	-	-	-	-	-	-	-	-
1885825	0	21	in	IN	-	-	-	-	-	-	-	-
1885825	0	22	the	DT	-	-	-	-	-	-	-	(149|(150
1885825	0	23	ileum	NN	-	-	-	-	-	-	-	149)
1885825	0	24	of	IN	-	-	-	-	-	-	-	-
1885825	0	25	KO	NN	-	-	-	-	-	-	-	(86|(12h)
1885825	0	26	and	CC	-	-	-	-	-	-	-	-
1885825	0	27	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	28	mice	NNS	-	-	-	-	-	-	-	(12h)|87)|86)|150)
1885825	0	29	.	.	-	-	-	-	-	-	-	-

1885825	0	1	However	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	4	did	VBD	-	-	-	-	-	-	-	-
1885825	0	5	not	RB	-	-	-	-	-	-	-	-
1885825	0	6	observed	VB	-	-	-	-	-	-	-	-
1885825	0	7	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	8	between	IN	-	-	-	-	-	-	-	-
1885825	0	9	groups	NNS	-	-	-	-	-	-	-	-
1885825	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	11	SI	NN	-	-	-	-	-	-	-	(151
1885825	0	12	Table	NN	-	-	-	-	-	-	-	-
1885825	0	13	S2	NN	-	-	-	-	-	-	-	151)
1885825	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Ussing	NNP	-	-	-	-	-	-	-	(39|(40
1885825	0	2	chamber	NN	-	-	-	-	-	-	-	39)
1885825	0	3	experiments	NNS	-	-	-	-	-	-	-	40)
1885825	0	4	were	VBD	-	-	-	-	-	-	-	-
1885825	0	5	also	RB	-	-	-	-	-	-	-	-
1885825	0	6	performed	VBN	-	-	-	-	-	-	-	-
1885825	0	7	to	TO	-	-	-	-	-	-	-	-
1885825	0	8	investigate	VB	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	-
1885825	0	10	bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	11	passage	NN	-	-	-	-	-	-	-	-
1885825	0	12	through	IN	-	-	-	-	-	-	-	-
1885825	0	13	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	14	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	(152
1885825	0	2	passage	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	a	DT	-	-	-	-	-	-	-	-
1885825	0	5	chemically	RB	-	-	-	-	-	-	-	-
1885825	0	6	killed	VBN	-	-	-	-	-	-	-	-
1885825	0	7	Escherichia	FW	-	-	-	-	-	-	-	-
1885825	0	8	coli	FW	-	-	-	-	-	-	-	-
1885825	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	10	K	NN	-	-	-	-	-	-	-	(153
1885825	0	11	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	12	12	CD	-	-	-	-	-	-	-	153)
1885825	0	13	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	14	was	VBD	-	-	-	-	-	-	-	-
1885825	0	15	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	16	in	IN	-	-	-	-	-	-	-	-
1885825	0	17	PP	NN	-	-	-	-	-	-	-	(27|(2)
1885825	0	18	of	IN	-	-	-	-	-	-	-	-
1885825	0	19	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	20	mice	NNS	-	-	-	-	-	-	-	27)|152)|12)
1885825	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	22	P	NN	-	-	-	-	-	-	-	(143|(92)
1885825	0	23	<	SYM	-	-	-	-	-	-	-	-
1885825	0	24	0.01	CD	-	-	-	-	-	-	-	143)
1885825	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	26	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	27	Fig	NN	-	-	-	-	-	-	-	(154
1885825	0	28	5	CD	-	-	-	-	-	-	-	-
1885825	0	29	C	NN	-	-	-	-	-	-	-	154)
1885825	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	31	.	.	-	-	-	-	-	-	-	-

1885825	0	1	This	DT	-	-	-	-	-	-	-	(152
1885825	0	2	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	3	translocation	NN	-	-	-	-	-	-	-	152)
1885825	0	4	was	VBD	-	-	-	-	-	-	-	-
1885825	0	5	also	RB	-	-	-	-	-	-	-	-
1885825	0	6	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	7	using	VBG	-	-	-	-	-	-	-	-
1885825	0	8	living	VBG	-	-	-	-	-	-	-	(155
1885825	0	9	non	AFX	-	-	-	-	-	-	-	-
1885825	0	10	pathogenic	JJ	-	-	-	-	-	-	-	-
1885825	0	11	Escherichia	NNP	-	-	-	-	-	-	-	(156
1885825	0	12	coli	NNP	-	-	-	-	-	-	-	156)
1885825	0	13	strain	NN	-	-	-	-	-	-	-	-
1885825	0	14	J53	NN	-	-	-	-	-	-	-	155)
1885825	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	16	Fig	NN	-	-	-	-	-	-	-	(157
1885825	0	17	5	CD	-	-	-	-	-	-	-	-
1885825	0	18	D	NN	-	-	-	-	-	-	-	157)
1885825	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	20	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	contrast	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	translocation	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	Escherichia	NNP	-	-	-	-	-	-	-	(156
1885825	0	7	coli	NNP	-	-	-	-	-	-	-	156)
1885825	0	8	across	IN	-	-	-	-	-	-	-	-
1885825	0	9	free	JJ	-	-	-	-	-	-	-	(37
1885825	0	10	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	12	ileum	NN	-	-	-	-	-	-	-	37)
1885825	0	13	mucosa	NN	-	-	-	-	-	-	-	-
1885825	0	14	was	VBD	-	-	-	-	-	-	-	-
1885825	0	15	very	RB	-	-	-	-	-	-	-	-
1885825	0	16	low	JJ	-	-	-	-	-	-	-	-
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	not	RB	-	-	-	-	-	-	-	-
1885825	0	19	significantly	RB	-	-	-	-	-	-	-	-
1885825	0	20	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	22	P	NN	-	-	-	-	-	-	-	(93|(92)
1885825	0	23	>	SYM	-	-	-	-	-	-	-	-
1885825	0	24	0.05	CD	-	-	-	-	-	-	-	93)
1885825	0	25	,	,	-	-	-	-	-	-	-	-
1885825	0	26	fig	NN	-	-	-	-	-	-	-	(154
1885825	0	27	5	CD	-	-	-	-	-	-	-	-
1885825	0	28	C	NN	-	-	-	-	-	-	-	154)
1885825	0	29	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	30	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	translocation	NN	-	-	-	-	-	-	-	-
1885825	0	3	through	IN	-	-	-	-	-	-	-	-
1885825	0	4	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	a	DT	-	-	-	-	-	-	-	-
1885825	0	7	chemically	RB	-	-	-	-	-	-	-	-
1885825	0	8	killed	VBN	-	-	-	-	-	-	-	-
1885825	0	9	Staphylococcus	NNP	-	-	-	-	-	-	-	-
1885825	0	10	Aureus	NNP	-	-	-	-	-	-	-	-
1885825	0	11	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	12	Wood	NN	-	-	-	-	-	-	-	(158
1885825	0	13	strain	NN	-	-	-	-	-	-	-	-
1885825	0	14	without	IN	-	-	-	-	-	-	-	-
1885825	0	15	proteinA	NN	-	-	-	-	-	-	-	158)
1885825	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	Saccharomyces	NNP	-	-	-	-	-	-	-	(159
1885825	0	19	cerevisiae	NNP	-	-	-	-	-	-	-	159)
1885825	0	20	was	VBD	-	-	-	-	-	-	-	-
1885825	0	21	also	RB	-	-	-	-	-	-	-	-
1885825	0	22	higher	JJR	-	-	-	-	-	-	-	(160
1885825	0	23	in	IN	-	-	-	-	-	-	-	-
1885825	0	24	KO	NN	-	-	-	-	-	-	-	(12)
1885825	0	25	than	IN	-	-	-	-	-	-	-	-
1885825	0	26	in	IN	-	-	-	-	-	-	-	-
1885825	0	27	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	28	mice	NNS	-	-	-	-	-	-	-	87)|160)
1885825	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	30	Fig	NN	-	-	-	-	-	-	-	-
1885825	0	31	5	CD	-	-	-	-	-	-	-	-
1885825	0	32	E	NN	-	-	-	-	-	-	-	-
1885825	0	33	and	CC	-	-	-	-	-	-	-	-
1885825	0	34	F	NN	-	-	-	-	-	-	-	-
1885825	0	35	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	37	.	.	-	-	-	-	-	-	-	-

1885825	0	1	TNBS	NN	-	-	-	-	-	-	-	(44|(45)
1885825	0	2	colitis	NN	-	-	-	-	-	-	-	44)
1885825	0	3	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	4	a	DT	-	-	-	-	-	-	-	(161
1885825	0	5	well	RB	-	-	-	-	-	-	-	-
1885825	0	6	studied	VBN	-	-	-	-	-	-	-	-
1885825	0	7	model	NN	-	-	-	-	-	-	-	-
1885825	0	8	of	IN	-	-	-	-	-	-	-	-
1885825	0	9	acute	JJ	-	-	-	-	-	-	-	-
1885825	0	10	colitis	NN	-	-	-	-	-	-	-	-
1885825	0	11	in	IN	-	-	-	-	-	-	-	-
1885825	0	12	mice	NNS	-	-	-	-	-	-	-	(4)|161)
1885825	0	13	but	CC	-	-	-	-	-	-	-	-
1885825	0	14	no	DT	-	-	-	-	-	-	-	-
1885825	0	15	data	NNS	-	-	-	-	-	-	-	-
1885825	0	16	are	VBP	-	-	-	-	-	-	-	-
1885825	0	17	currently	RB	-	-	-	-	-	-	-	-
1885825	0	18	available	JJ	-	-	-	-	-	-	-	-
1885825	0	19	in	IN	-	-	-	-	-	-	-	-
1885825	0	20	the	DT	-	-	-	-	-	-	-	-
1885825	0	21	literature	NN	-	-	-	-	-	-	-	-
1885825	0	22	on	IN	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	-
1885825	0	24	effect	NN	-	-	-	-	-	-	-	-
1885825	0	25	of	IN	-	-	-	-	-	-	-	-
1885825	0	26	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	27	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	28	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	29	in	IN	-	-	-	-	-	-	-	-
1885825	0	30	this	DT	-	-	-	-	-	-	-	(161
1885825	0	31	experimental	JJ	-	-	-	-	-	-	-	-
1885825	0	32	model	NN	-	-	-	-	-	-	-	161)
1885825	0	33	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Three	CD	-	-	-	-	-	-	-	-
1885825	0	2	days	NNS	-	-	-	-	-	-	-	-
1885825	0	3	after	IN	-	-	-	-	-	-	-	-
1885825	0	4	intracolonic	JJ	-	-	-	-	-	-	-	-
1885825	0	5	instillation	NN	-	-	-	-	-	-	-	-
1885825	0	6	of	IN	-	-	-	-	-	-	-	-
1885825	0	7	TNBS	NN	-	-	-	-	-	-	-	(45)
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	(162
1885825	0	10	body	NN	-	-	-	-	-	-	-	(83
1885825	0	11	weight	NN	-	-	-	-	-	-	-	83)
1885825	0	12	loss	NN	-	-	-	-	-	-	-	-
1885825	0	13	was	VBD	-	-	-	-	-	-	-	-
1885825	0	14	higher	JJR	-	-	-	-	-	-	-	(160
1885825	0	15	in	IN	-	-	-	-	-	-	-	-
1885825	0	16	KO	NN	-	-	-	-	-	-	-	(12)
1885825	0	17	than	IN	-	-	-	-	-	-	-	-
1885825	0	18	in	IN	-	-	-	-	-	-	-	-
1885825	0	19	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	20	mice	NNS	-	-	-	-	-	-	-	87)|162)|160)
1885825	0	21	but	CC	-	-	-	-	-	-	-	-
1885825	0	22	this	DT	-	-	-	-	-	-	-	(162
1885825	0	23	difference	NN	-	-	-	-	-	-	-	162)
1885825	0	24	did	VBD	-	-	-	-	-	-	-	-
1885825	0	25	not	RB	-	-	-	-	-	-	-	-
1885825	0	26	reach	VB	-	-	-	-	-	-	-	-
1885825	0	27	significance	NN	-	-	-	-	-	-	-	-
1885825	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	29	Fig	NN	-	-	-	-	-	-	-	(163
1885825	0	30	6	CD	-	-	-	-	-	-	-	-
1885825	0	31	A	NN	-	-	-	-	-	-	-	163)
1885825	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	33	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Nevertheless	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(164
1885825	0	4	colonic	JJ	-	-	-	-	-	-	-	-
1885825	0	5	mucosal	JJ	-	-	-	-	-	-	-	(78
1885825	0	6	damage	NN	-	-	-	-	-	-	-	78)
1885825	0	7	score	NN	-	-	-	-	-	-	-	164)
1885825	0	8	was	VBD	-	-	-	-	-	-	-	-
1885825	0	9	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	10	in	IN	-	-	-	-	-	-	-	-
1885825	0	11	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	12	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	14	Fig	NN	-	-	-	-	-	-	-	(165
1885825	0	15	6	CD	-	-	-	-	-	-	-	-
1885825	0	16	B	NN	-	-	-	-	-	-	-	165)
1885825	0	17	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	18	as	RB	-	-	-	-	-	-	-	-
1885825	0	19	well	RB	-	-	-	-	-	-	-	-
1885825	0	20	as	IN	-	-	-	-	-	-	-	-
1885825	0	21	mucosal	JJ	-	-	-	-	-	-	-	-
1885825	0	22	concentrations	NNS	-	-	-	-	-	-	-	-
1885825	0	23	of	IN	-	-	-	-	-	-	-	-
1885825	0	24	IL	NN	-	-	-	-	-	-	-	(126
1885825	0	25	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	26	1β	NN	-	-	-	-	-	-	-	126)
1885825	0	27	,	,	-	-	-	-	-	-	-	-
1885825	0	28	TNF	NN	-	-	-	-	-	-	-	-
1885825	0	29	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	30	α	NN	-	-	-	-	-	-	-	-
1885825	0	31	and	CC	-	-	-	-	-	-	-	-
1885825	0	32	IL	NN	-	-	-	-	-	-	-	(34
1885825	0	33	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	34	12	CD	-	-	-	-	-	-	-	34)
1885825	0	35	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	36	Fig	NN	-	-	-	-	-	-	-	(166
1885825	0	37	6	CD	-	-	-	-	-	-	-	-
1885825	0	38	C	NN	-	-	-	-	-	-	-	166)
1885825	0	39	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	40	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Discussion	NN	-	-	-	-	-	-	-	-

1885825	0	1	Since	IN	-	-	-	-	-	-	-	-
1885825	0	2	the	DT	-	-	-	-	-	-	-	-
1885825	0	3	discovery	NN	-	-	-	-	-	-	-	-
1885825	0	4	of	IN	-	-	-	-	-	-	-	-
1885825	0	5	an	DT	-	-	-	-	-	-	-	-
1885825	0	6	association	NN	-	-	-	-	-	-	-	-
1885825	0	7	between	IN	-	-	-	-	-	-	-	-
1885825	0	8	CARD15	NN	-	-	-	-	-	-	-	(1|(5
1885825	0	9	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	10	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	11	mutations	NNS	-	-	-	-	-	-	-	5)
1885825	0	12	and	CC	-	-	-	-	-	-	-	-
1885825	0	13	both	CC	-	-	-	-	-	-	-	-
1885825	0	14	CD	NN	-	-	-	-	-	-	-	(6)
1885825	0	15	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	16	1	CD	-	-	-	-	-	-	-	(50)
1885825	0	17	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	18	,	,	-	-	-	-	-	-	-	-
1885825	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	20	2	CD	-	-	-	-	-	-	-	(51)
1885825	0	21	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	and	CC	-	-	-	-	-	-	-	-
1885825	0	23	GVH	NN	-	-	-	-	-	-	-	(8)
1885825	0	24	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	25	3	CD	-	-	-	-	-	-	-	(52)
1885825	0	26	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	27	,	,	-	-	-	-	-	-	-	-
1885825	0	28	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	29	4	CD	-	-	-	-	-	-	-	(53)
1885825	0	30	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	31	,	,	-	-	-	-	-	-	-	-
1885825	0	32	the	DT	-	-	-	-	-	-	-	-
1885825	0	33	pathophysiological	JJ	-	-	-	-	-	-	-	-
1885825	0	34	functions	NNS	-	-	-	-	-	-	-	-
1885825	0	35	of	IN	-	-	-	-	-	-	-	-
1885825	0	36	CARD15	NN	-	-	-	-	-	-	-	(1
1885825	0	37	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	38	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	39	involved	VBN	-	-	-	-	-	-	-	-
1885825	0	40	in	IN	-	-	-	-	-	-	-	-
1885825	0	41	CD	NN	-	-	-	-	-	-	-	(7|(6)|(74b)
1885825	0	42	and	CC	-	-	-	-	-	-	-	-
1885825	0	43	GVHD	NN	-	-	-	-	-	-	-	(8)|7)
1885825	0	44	development	NN	-	-	-	-	-	-	-	(74b)
1885825	0	45	are	VBP	-	-	-	-	-	-	-	-
1885825	0	46	poorly	RB	-	-	-	-	-	-	-	-
1885825	0	47	understood	VBN	-	-	-	-	-	-	-	-
1885825	0	48	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	49	9	CD	-	-	-	-	-	-	-	-
1885825	0	50	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	51	.	.	-	-	-	-	-	-	-	-

1885825	0	1	However	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	because	IN	-	-	-	-	-	-	-	-
1885825	0	4	an	DT	-	-	-	-	-	-	-	-
1885825	0	5	association	NN	-	-	-	-	-	-	-	-
1885825	0	6	between	IN	-	-	-	-	-	-	-	-
1885825	0	7	GALT	NN	-	-	-	-	-	-	-	(69)
1885825	0	8	dysfonctions	NNS	-	-	-	-	-	-	-	-
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	GVHD	NN	-	-	-	-	-	-	-	(8)
1885825	0	11	,	,	-	-	-	-	-	-	-	-
1885825	0	12	as	RB	-	-	-	-	-	-	-	-
1885825	0	13	well	RB	-	-	-	-	-	-	-	-
1885825	0	14	as	IN	-	-	-	-	-	-	-	-
1885825	0	15	spatial	JJ	-	-	-	-	-	-	-	-
1885825	0	16	and	CC	-	-	-	-	-	-	-	-
1885825	0	17	temporal	JJ	-	-	-	-	-	-	-	-
1885825	0	18	links	NNS	-	-	-	-	-	-	-	-
1885825	0	19	between	IN	-	-	-	-	-	-	-	-
1885825	0	20	CD	NN	-	-	-	-	-	-	-	(63|(6)
1885825	0	21	lesions	NNS	-	-	-	-	-	-	-	63)
1885825	0	22	and	CC	-	-	-	-	-	-	-	-
1885825	0	23	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	24	have	VBP	-	-	-	-	-	-	-	-
1885825	0	25	been	VBN	-	-	-	-	-	-	-	-
1885825	0	26	suggested	VBN	-	-	-	-	-	-	-	-
1885825	0	27	by	IN	-	-	-	-	-	-	-	-
1885825	0	28	several	JJ	-	-	-	-	-	-	-	-
1885825	0	29	authors	NNS	-	-	-	-	-	-	-	-
1885825	0	30	,	,	-	-	-	-	-	-	-	-
1885825	0	31	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	32	used	VBD	-	-	-	-	-	-	-	-
1885825	0	33	a	DT	-	-	-	-	-	-	-	-
1885825	0	34	new	JJ	-	-	-	-	-	-	-	-
1885825	0	35	model	NN	-	-	-	-	-	-	-	-
1885825	0	36	of	IN	-	-	-	-	-	-	-	-
1885825	0	37	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	38	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	39	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	40	deficient	JJ	-	-	-	-	-	-	-	-
1885825	0	41	mouse	NN	-	-	-	-	-	-	-	-
1885825	0	42	,	,	-	-	-	-	-	-	-	-
1885825	0	43	to	TO	-	-	-	-	-	-	-	-
1885825	0	44	explore	VB	-	-	-	-	-	-	-	-
1885825	0	45	the	DT	-	-	-	-	-	-	-	-
1885825	0	46	impact	NN	-	-	-	-	-	-	-	-
1885825	0	47	of	IN	-	-	-	-	-	-	-	-
1885825	0	48	CARD15	NN	-	-	-	-	-	-	-	(1
1885825	0	49	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	50	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	51	in	IN	-	-	-	-	-	-	-	-
1885825	0	52	PP	NN	-	-	-	-	-	-	-	(75|(2)|(48a)
1885825	0	53	development	NN	-	-	-	-	-	-	-	75)
1885825	0	54	and	CC	-	-	-	-	-	-	-	-
1885825	0	55	function	NN	-	-	-	-	-	-	-	(48a)
1885825	0	56	.	.	-	-	-	-	-	-	-	-

1885825	0	1	We	PRP	-	-	-	-	-	-	-	(13)
1885825	0	2	observed	VBD	-	-	-	-	-	-	-	-
1885825	0	3	that	IN	-	-	-	-	-	-	-	-
1885825	0	4	adult	JJ	-	-	-	-	-	-	-	(167|(95
1885825	0	5	KO	NN	-	-	-	-	-	-	-	-
1885825	0	6	mice	NNS	-	-	-	-	-	-	-	95)
1885825	0	7	exhibit	VBP	-	-	-	-	-	-	-	-
1885825	0	8	an	DT	-	-	-	-	-	-	-	-
1885825	0	9	excess	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	12	and	CC	-	-	-	-	-	-	-	-
1885825	0	13	isolated	VBN	-	-	-	-	-	-	-	(10
1885825	0	14	LFs	NNS	-	-	-	-	-	-	-	10)
1885825	0	15	in	IN	-	-	-	-	-	-	-	-
1885825	0	16	the	DT	-	-	-	-	-	-	-	(61
1885825	0	17	gut	NN	-	-	-	-	-	-	-	61)
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	PP	NNS	-	-	-	-	-	-	-	(168
1885825	0	2	from	IN	-	-	-	-	-	-	-	-
1885825	0	3	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	4	mice	NNS	-	-	-	-	-	-	-	168)|12)
1885825	0	5	are	VBP	-	-	-	-	-	-	-	-
1885825	0	6	characterized	VBN	-	-	-	-	-	-	-	-
1885825	0	7	by	IN	-	-	-	-	-	-	-	-
1885825	0	8	an	DT	-	-	-	-	-	-	-	-
1885825	0	9	excess	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	M	NN	-	-	-	-	-	-	-	(28|(29
1885825	0	12	cells	NNS	-	-	-	-	-	-	-	28)
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	CD4	NN	-	-	-	-	-	-	-	(30
1885825	0	15	+	SYM	-	-	-	-	-	-	-	-
1885825	0	16	T	NN	-	-	-	-	-	-	-	-
1885825	0	17	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	18	cells	NNS	-	-	-	-	-	-	-	30)|29)
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	a	DT	-	-	-	-	-	-	-	-
1885825	0	21	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	22	expression	NN	-	-	-	-	-	-	-	-
1885825	0	23	of	IN	-	-	-	-	-	-	-	-
1885825	0	24	Th1	NN	-	-	-	-	-	-	-	(68)
1885825	0	25	and	CC	-	-	-	-	-	-	-	-
1885825	0	26	Th2	NN	-	-	-	-	-	-	-	(169
1885825	0	27	cytokines	NNS	-	-	-	-	-	-	-	169)|167)
1885825	0	28	.	.	-	-	-	-	-	-	-	-

1885825	0	1	These	DT	-	-	-	-	-	-	-	(167
1885825	0	2	differences	NNS	-	-	-	-	-	-	-	167)
1885825	0	3	are	VBP	-	-	-	-	-	-	-	-
1885825	0	4	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	5	with	IN	-	-	-	-	-	-	-	-
1885825	0	6	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	7	paracellular	JJ	-	-	-	-	-	-	-	-
1885825	0	8	permeability	NN	-	-	-	-	-	-	-	-
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	11	and	CC	-	-	-	-	-	-	-	-
1885825	0	12	yeast	NN	-	-	-	-	-	-	-	-
1885825	0	13	passage	NN	-	-	-	-	-	-	-	-
1885825	0	14	through	IN	-	-	-	-	-	-	-	-
1885825	0	15	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	16	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	4	observed	VBD	-	-	-	-	-	-	-	-
1885825	0	5	that	IN	-	-	-	-	-	-	-	-
1885825	0	6	Card15	NN	-	-	-	-	-	-	-	(11|(170
1885825	0	7	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	8	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	9	deficient	JJ	-	-	-	-	-	-	-	-
1885825	0	10	mice	NNS	-	-	-	-	-	-	-	170)
1885825	0	11	are	VBP	-	-	-	-	-	-	-	-
1885825	0	12	more	RBR	-	-	-	-	-	-	-	-
1885825	0	13	susceptible	JJ	-	-	-	-	-	-	-	-
1885825	0	14	to	IN	-	-	-	-	-	-	-	-
1885825	0	15	TNBS	NN	-	-	-	-	-	-	-	(44|(45)
1885825	0	16	induced	VBN	-	-	-	-	-	-	-	-
1885825	0	17	colitis	NN	-	-	-	-	-	-	-	44)
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	As	IN	-	-	-	-	-	-	-	-
1885825	0	2	a	DT	-	-	-	-	-	-	-	-
1885825	0	3	whole	NN	-	-	-	-	-	-	-	-
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	the	DT	-	-	-	-	-	-	-	(12
1885825	0	6	here	RB	-	-	-	-	-	-	-	-
1885825	0	7	reported	VBN	-	-	-	-	-	-	-	-
1885825	0	8	phenotype	NN	-	-	-	-	-	-	-	-
1885825	0	9	of	IN	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	(12
1885825	0	11	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	12	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	13	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	14	KO	NN	-	-	-	-	-	-	-	-
1885825	0	15	mouse	NN	-	-	-	-	-	-	-	12)|12)
1885825	0	16	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	17	reminiscent	JJ	-	-	-	-	-	-	-	-
1885825	0	18	to	IN	-	-	-	-	-	-	-	-
1885825	0	19	the	DT	-	-	-	-	-	-	-	-
1885825	0	20	observations	NNS	-	-	-	-	-	-	-	-
1885825	0	21	made	VBN	-	-	-	-	-	-	-	-
1885825	0	22	in	IN	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	-
1885825	0	24	Human	JJ	-	-	-	-	-	-	-	-
1885825	0	25	diseases	NNS	-	-	-	-	-	-	-	-
1885825	0	26	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	27	with	IN	-	-	-	-	-	-	-	-
1885825	0	28	CARD15	NN	-	-	-	-	-	-	-	(1|(5
1885825	0	29	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	30	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	31	mutations	NNS	-	-	-	-	-	-	-	5)
1885825	0	32	:	:	-	-	-	-	-	-	-	-
1885825	0	33	CD	NN	-	-	-	-	-	-	-	(7|(6)
1885825	0	34	and	CC	-	-	-	-	-	-	-	-
1885825	0	35	GVHD	NN	-	-	-	-	-	-	-	(8)|7)
1885825	0	36	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Our	PRP$	-	-	-	-	-	-	-	(171|(13)
1885825	0	2	data	NNS	-	-	-	-	-	-	-	171)
1885825	0	3	demonstrate	VBP	-	-	-	-	-	-	-	-
1885825	0	4	first	RB	-	-	-	-	-	-	-	-
1885825	0	5	that	IN	-	-	-	-	-	-	-	-
1885825	0	6	Card15	NN	-	-	-	-	-	-	-	(11|(170|(172
1885825	0	7	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	8	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	9	deficient	JJ	-	-	-	-	-	-	-	-
1885825	0	10	mice	NNS	-	-	-	-	-	-	-	170)
1885825	0	11	have	VBP	-	-	-	-	-	-	-	-
1885825	0	12	an	DT	-	-	-	-	-	-	-	-
1885825	0	13	elevated	VBN	-	-	-	-	-	-	-	-
1885825	0	14	number	NN	-	-	-	-	-	-	-	-
1885825	0	15	of	IN	-	-	-	-	-	-	-	-
1885825	0	16	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	isolated	VBN	-	-	-	-	-	-	-	(10
1885825	0	19	LFs	NNS	-	-	-	-	-	-	-	10)
1885825	0	20	after	IN	-	-	-	-	-	-	-	-
1885825	0	21	birth	NN	-	-	-	-	-	-	-	(21)|172)
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	As	IN	-	-	-	-	-	-	-	-
1885825	0	2	intestinal	JJ	-	-	-	-	-	-	-	(85|(84a)
1885825	0	3	weight	NN	-	-	-	-	-	-	-	85)
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	length	NN	-	-	-	-	-	-	-	(84a)
1885825	0	6	are	VBP	-	-	-	-	-	-	-	-
1885825	0	7	similar	JJ	-	-	-	-	-	-	-	-
1885825	0	8	between	IN	-	-	-	-	-	-	-	-
1885825	0	9	KO	NN	-	-	-	-	-	-	-	(86|(12n)
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	12	mice	NNS	-	-	-	-	-	-	-	(12n)|87)|86)
1885825	0	13	,	,	-	-	-	-	-	-	-	-
1885825	0	14	this	DT	-	-	-	-	-	-	-	(172
1885825	0	15	finding	NN	-	-	-	-	-	-	-	172)
1885825	0	16	does	VBZ	-	-	-	-	-	-	-	-
1885825	0	17	not	RB	-	-	-	-	-	-	-	-
1885825	0	18	seem	VB	-	-	-	-	-	-	-	-
1885825	0	19	to	TO	-	-	-	-	-	-	-	-
1885825	0	20	be	VB	-	-	-	-	-	-	-	-
1885825	0	21	secondary	JJ	-	-	-	-	-	-	-	-
1885825	0	22	to	IN	-	-	-	-	-	-	-	-
1885825	0	23	an	DT	-	-	-	-	-	-	-	-
1885825	0	24	intestinal	JJ	-	-	-	-	-	-	-	-
1885825	0	25	overgrowth	NN	-	-	-	-	-	-	-	-
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	addition	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	5	from	IN	-	-	-	-	-	-	-	-
1885825	0	6	deficient	JJ	-	-	-	-	-	-	-	(170
1885825	0	7	mice	NNS	-	-	-	-	-	-	-	170)
1885825	0	8	are	VBP	-	-	-	-	-	-	-	-
1885825	0	9	larger	JJR	-	-	-	-	-	-	-	-
1885825	0	10	,	,	-	-	-	-	-	-	-	-
1885825	0	11	as	IN	-	-	-	-	-	-	-	-
1885825	0	12	indicated	VBN	-	-	-	-	-	-	-	-
1885825	0	13	by	IN	-	-	-	-	-	-	-	-
1885825	0	14	the	DT	-	-	-	-	-	-	-	-
1885825	0	15	macroscopic	JJ	-	-	-	-	-	-	-	-
1885825	0	16	examination	NN	-	-	-	-	-	-	-	-
1885825	0	17	of	IN	-	-	-	-	-	-	-	-
1885825	0	18	the	DT	-	-	-	-	-	-	-	(173
1885825	0	19	intestines	NNS	-	-	-	-	-	-	-	173)
1885825	0	20	and	CC	-	-	-	-	-	-	-	-
1885825	0	21	by	IN	-	-	-	-	-	-	-	-
1885825	0	22	the	DT	-	-	-	-	-	-	-	-
1885825	0	23	count	NN	-	-	-	-	-	-	-	-
1885825	0	24	of	IN	-	-	-	-	-	-	-	-
1885825	0	25	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	26	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	27	.	.	-	-	-	-	-	-	-	-

1885825	0	1	As	IN	-	-	-	-	-	-	-	-
1885825	0	2	a	DT	-	-	-	-	-	-	-	-
1885825	0	3	result	NN	-	-	-	-	-	-	-	-
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	6	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	7	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	8	modulates	VBZ	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	-
1885825	0	10	development	NN	-	-	-	-	-	-	-	(174
1885825	0	11	of	IN	-	-	-	-	-	-	-	-
1885825	0	12	the	DT	-	-	-	-	-	-	-	(69
1885825	0	13	GALT	NN	-	-	-	-	-	-	-	69)|174)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	Card15	NN	-	-	-	-	-	-	-	(11|(46
1885825	0	16	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	18	deficiency	NN	-	-	-	-	-	-	-	46)
1885825	0	19	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	20	characterised	VBN	-	-	-	-	-	-	-	-
1885825	0	21	by	IN	-	-	-	-	-	-	-	-
1885825	0	22	an	DT	-	-	-	-	-	-	-	(175
1885825	0	23	overgrowth	NN	-	-	-	-	-	-	-	-
1885825	0	24	of	IN	-	-	-	-	-	-	-	-
1885825	0	25	the	DT	-	-	-	-	-	-	-	(176
1885825	0	26	lymphoïd	NN	-	-	-	-	-	-	-	-
1885825	0	27	tissue	NN	-	-	-	-	-	-	-	-
1885825	0	28	present	JJ	-	-	-	-	-	-	-	-
1885825	0	29	in	IN	-	-	-	-	-	-	-	-
1885825	0	30	the	DT	-	-	-	-	-	-	-	(61
1885825	0	31	gut	NN	-	-	-	-	-	-	-	61)|176)|175)
1885825	0	32	.	.	-	-	-	-	-	-	-	-

1885825	0	1	This	DT	-	-	-	-	-	-	-	(175
1885825	0	2	over	RB	-	-	-	-	-	-	-	-
1885825	0	3	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	4	development	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(176
1885825	0	7	lymphoïd	JJ	-	-	-	-	-	-	-	-
1885825	0	8	tissue	NN	-	-	-	-	-	-	-	176)|175)
1885825	0	9	seems	VBZ	-	-	-	-	-	-	-	-
1885825	0	10	to	TO	-	-	-	-	-	-	-	-
1885825	0	11	be	VB	-	-	-	-	-	-	-	-
1885825	0	12	specific	JJ	-	-	-	-	-	-	-	-
1885825	0	13	to	IN	-	-	-	-	-	-	-	-
1885825	0	14	the	DT	-	-	-	-	-	-	-	-
1885825	0	15	GI	NN	-	-	-	-	-	-	-	-
1885825	0	16	tract	NN	-	-	-	-	-	-	-	-
1885825	0	17	as	IN	-	-	-	-	-	-	-	-
1885825	0	18	non	AFX	-	-	-	-	-	-	-	-
1885825	0	19	significant	JJ	-	-	-	-	-	-	-	-
1885825	0	20	change	NN	-	-	-	-	-	-	-	-
1885825	0	21	were	VBD	-	-	-	-	-	-	-	-
1885825	0	22	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	23	in	IN	-	-	-	-	-	-	-	-
1885825	0	24	a	DT	-	-	-	-	-	-	-	-
1885825	0	25	systemic	JJ	-	-	-	-	-	-	-	-
1885825	0	26	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	27	organe	NN	-	-	-	-	-	-	-	-
1885825	0	28	like	IN	-	-	-	-	-	-	-	-
1885825	0	29	spleen	NN	-	-	-	-	-	-	-	(107)
1885825	0	30	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	lack	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	difference	NN	-	-	-	-	-	-	-	-
1885825	0	5	in	IN	-	-	-	-	-	-	-	-
1885825	0	6	PP	NNS	-	-	-	-	-	-	-	(19|(2)
1885825	0	7	number	NN	-	-	-	-	-	-	-	19)
1885825	0	8	between	IN	-	-	-	-	-	-	-	-
1885825	0	9	WT	NN	-	-	-	-	-	-	-	(86|(87h)
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	12	mice	NNS	-	-	-	-	-	-	-	(87h)|86)|12)
1885825	0	13	at	IN	-	-	-	-	-	-	-	-
1885825	0	14	birth	NN	-	-	-	-	-	-	-	(21)
1885825	0	15	indicates	VBZ	-	-	-	-	-	-	-	-
1885825	0	16	that	IN	-	-	-	-	-	-	-	-
1885825	0	17	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	18	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	19	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	20	plays	VBZ	-	-	-	-	-	-	-	-
1885825	0	21	its	PRP$	-	-	-	-	-	-	-	(11)
1885825	0	22	role	NN	-	-	-	-	-	-	-	-
1885825	0	23	during	IN	-	-	-	-	-	-	-	-
1885825	0	24	post	AFX	-	-	-	-	-	-	-	(177
1885825	0	25	natal	JJ	-	-	-	-	-	-	-	-
1885825	0	26	development	NN	-	-	-	-	-	-	-	-
1885825	0	27	of	IN	-	-	-	-	-	-	-	-
1885825	0	28	the	DT	-	-	-	-	-	-	-	(69
1885825	0	29	GALT	NN	-	-	-	-	-	-	-	69)|177)
1885825	0	30	.	.	-	-	-	-	-	-	-	-

1885825	0	1	While	IN	-	-	-	-	-	-	-	-
1885825	0	2	lymphotoxin	NN	-	-	-	-	-	-	-	-
1885825	0	3	and	CC	-	-	-	-	-	-	-	-
1885825	0	4	IL	NN	-	-	-	-	-	-	-	-
1885825	0	5	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	6	7	CD	-	-	-	-	-	-	-	-
1885825	0	7	signalling	NN	-	-	-	-	-	-	-	-
1885825	0	8	are	VBP	-	-	-	-	-	-	-	-
1885825	0	9	essential	JJ	-	-	-	-	-	-	-	-
1885825	0	10	for	IN	-	-	-	-	-	-	-	-
1885825	0	11	the	DT	-	-	-	-	-	-	-	-
1885825	0	12	organogenesis	NN	-	-	-	-	-	-	-	-
1885825	0	13	of	IN	-	-	-	-	-	-	-	-
1885825	0	14	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	15	during	IN	-	-	-	-	-	-	-	-
1885825	0	16	the	DT	-	-	-	-	-	-	-	-
1885825	0	17	embryonic	JJ	-	-	-	-	-	-	-	-
1885825	0	18	stage	NN	-	-	-	-	-	-	-	-
1885825	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	20	20	CD	-	-	-	-	-	-	-	-
1885825	0	21	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	–	SYM	-	-	-	-	-	-	-	-
1885825	0	23	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	24	22	CD	-	-	-	-	-	-	-	-
1885825	0	25	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	26	,	,	-	-	-	-	-	-	-	-
1885825	0	27	it	PRP	-	-	-	-	-	-	-	-
1885825	0	28	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	29	widely	RB	-	-	-	-	-	-	-	-
1885825	0	30	believed	VBN	-	-	-	-	-	-	-	-
1885825	0	31	that	IN	-	-	-	-	-	-	-	-
1885825	0	32	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	33	commensal	JJ	-	-	-	-	-	-	-	-
1885825	0	34	bacteria	NNS	-	-	-	-	-	-	-	-
1885825	0	35	are	VBP	-	-	-	-	-	-	-	-
1885825	0	36	critical	JJ	-	-	-	-	-	-	-	-
1885825	0	37	for	IN	-	-	-	-	-	-	-	-
1885825	0	38	the	DT	-	-	-	-	-	-	-	-
1885825	0	39	postnatal	JJ	-	-	-	-	-	-	-	-
1885825	0	40	development	NN	-	-	-	-	-	-	-	-
1885825	0	41	of	IN	-	-	-	-	-	-	-	-
1885825	0	42	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	43	mucosal	JJ	-	-	-	-	-	-	-	-
1885825	0	44	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	45	system	NN	-	-	-	-	-	-	-	-
1885825	0	46	,	,	-	-	-	-	-	-	-	-
1885825	0	47	as	IN	-	-	-	-	-	-	-	-
1885825	0	48	demonstrated	VBN	-	-	-	-	-	-	-	-
1885825	0	49	by	IN	-	-	-	-	-	-	-	-
1885825	0	50	studies	NNS	-	-	-	-	-	-	-	-
1885825	0	51	on	IN	-	-	-	-	-	-	-	-
1885825	0	52	germ	NN	-	-	-	-	-	-	-	(178
1885825	0	53	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	54	free	JJ	-	-	-	-	-	-	-	-
1885825	0	55	animals	NNS	-	-	-	-	-	-	-	178)
1885825	0	56	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	57	23	CD	-	-	-	-	-	-	-	(179)
1885825	0	58	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	59	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Such	JJ	-	-	-	-	-	-	-	(178
1885825	0	2	animals	NNS	-	-	-	-	-	-	-	178)
1885825	0	3	have	VBP	-	-	-	-	-	-	-	-
1885825	0	4	an	DT	-	-	-	-	-	-	-	-
1885825	0	5	underdeveloped	VBN	-	-	-	-	-	-	-	-
1885825	0	6	GALT	NN	-	-	-	-	-	-	-	-
1885825	0	7	and	CC	-	-	-	-	-	-	-	-
1885825	0	8	are	VBP	-	-	-	-	-	-	-	-
1885825	0	9	resistant	JJ	-	-	-	-	-	-	-	-
1885825	0	10	to	IN	-	-	-	-	-	-	-	-
1885825	0	11	experimental	JJ	-	-	-	-	-	-	-	(14
1885825	0	12	colitis	NN	-	-	-	-	-	-	-	14)
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	to	IN	-	-	-	-	-	-	-	-
1885825	0	15	severe	JJ	-	-	-	-	-	-	-	-
1885825	0	16	GVHD	NN	-	-	-	-	-	-	-	-
1885825	0	17	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	18	18	CD	-	-	-	-	-	-	-	(79)
1885825	0	19	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	20	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Thereby	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	pattern	NN	-	-	-	-	-	-	-	-
1885825	0	4	recognition	NN	-	-	-	-	-	-	-	-
1885825	0	5	receptors	NNS	-	-	-	-	-	-	-	-
1885825	0	6	,	,	-	-	-	-	-	-	-	-
1885825	0	7	including	VBG	-	-	-	-	-	-	-	-
1885825	0	8	TLRs	NNS	-	-	-	-	-	-	-	(180)
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	NOD	NN	-	-	-	-	-	-	-	-
1885825	0	11	molecules	NNS	-	-	-	-	-	-	-	-
1885825	0	12	,	,	-	-	-	-	-	-	-	-
1885825	0	13	can	MD	-	-	-	-	-	-	-	-
1885825	0	14	be	VB	-	-	-	-	-	-	-	-
1885825	0	15	seen	VBN	-	-	-	-	-	-	-	-
1885825	0	16	as	IN	-	-	-	-	-	-	-	-
1885825	0	17	good	JJ	-	-	-	-	-	-	-	-
1885825	0	18	candidates	NNS	-	-	-	-	-	-	-	-
1885825	0	19	by	IN	-	-	-	-	-	-	-	-
1885825	0	20	which	WDT	-	-	-	-	-	-	-	-
1885825	0	21	the	DT	-	-	-	-	-	-	-	-
1885825	0	22	resident	JJ	-	-	-	-	-	-	-	-
1885825	0	23	flora	NN	-	-	-	-	-	-	-	-
1885825	0	24	stimulates	VBZ	-	-	-	-	-	-	-	-
1885825	0	25	the	DT	-	-	-	-	-	-	-	(174
1885825	0	26	development	NN	-	-	-	-	-	-	-	-
1885825	0	27	of	IN	-	-	-	-	-	-	-	-
1885825	0	28	GALT	NN	-	-	-	-	-	-	-	(69)|174)
1885825	0	29	.	.	-	-	-	-	-	-	-	-

1885825	0	1	However	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	TLRs	NNS	-	-	-	-	-	-	-	(180)
1885825	0	4	play	VBP	-	-	-	-	-	-	-	-
1885825	0	5	only	RB	-	-	-	-	-	-	-	-
1885825	0	6	a	DT	-	-	-	-	-	-	-	-
1885825	0	7	limited	VBN	-	-	-	-	-	-	-	-
1885825	0	8	role	NN	-	-	-	-	-	-	-	-
1885825	0	9	in	IN	-	-	-	-	-	-	-	-
1885825	0	10	PP	NN	-	-	-	-	-	-	-	(75|(2)
1885825	0	11	development	NN	-	-	-	-	-	-	-	75)
1885825	0	12	at	IN	-	-	-	-	-	-	-	-
1885825	0	13	early	JJ	-	-	-	-	-	-	-	-
1885825	0	14	postnatal	JJ	-	-	-	-	-	-	-	-
1885825	0	15	stage	NN	-	-	-	-	-	-	-	-
1885825	0	16	in	IN	-	-	-	-	-	-	-	-
1885825	0	17	mice	NNS	-	-	-	-	-	-	-	(4)
1885825	0	18	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	19	24	CD	-	-	-	-	-	-	-	-
1885825	0	20	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	the	DT	-	-	-	-	-	-	-	-
1885825	0	3	opposite	JJ	-	-	-	-	-	-	-	-
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	our	PRP$	-	-	-	-	-	-	-	(171|(13)
1885825	0	6	data	NNS	-	-	-	-	-	-	-	171)
1885825	0	7	suggest	VBP	-	-	-	-	-	-	-	-
1885825	0	8	that	IN	-	-	-	-	-	-	-	-
1885825	0	9	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	10	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	12	plays	VBZ	-	-	-	-	-	-	-	-
1885825	0	13	a	DT	-	-	-	-	-	-	-	-
1885825	0	14	pivotal	JJ	-	-	-	-	-	-	-	-
1885825	0	15	role	NN	-	-	-	-	-	-	-	-
1885825	0	16	in	IN	-	-	-	-	-	-	-	-
1885825	0	17	the	DT	-	-	-	-	-	-	-	(177
1885825	0	18	postnatal	JJ	-	-	-	-	-	-	-	-
1885825	0	19	development	NN	-	-	-	-	-	-	-	-
1885825	0	20	of	IN	-	-	-	-	-	-	-	-
1885825	0	21	GALT	NN	-	-	-	-	-	-	-	(69)|177)
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Because	IN	-	-	-	-	-	-	-	-
1885825	0	2	gut	NN	-	-	-	-	-	-	-	(181|(61)
1885825	0	3	flora	NN	-	-	-	-	-	-	-	181)
1885825	0	4	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	5	important	JJ	-	-	-	-	-	-	-	-
1885825	0	6	in	IN	-	-	-	-	-	-	-	-
1885825	0	7	PP	NNS	-	-	-	-	-	-	-	(75|(2)
1885825	0	8	development	NN	-	-	-	-	-	-	-	75)
1885825	0	9	,	,	-	-	-	-	-	-	-	-
1885825	0	10	it	PRP	-	-	-	-	-	-	-	-
1885825	0	11	can	MD	-	-	-	-	-	-	-	-
1885825	0	12	be	VB	-	-	-	-	-	-	-	-
1885825	0	13	questioned	VBN	-	-	-	-	-	-	-	(182)
1885825	0	14	if	IN	-	-	-	-	-	-	-	-
1885825	0	15	Card15	NN	-	-	-	-	-	-	-	(11|(46
1885825	0	16	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	18	deficiency	NN	-	-	-	-	-	-	-	46)
1885825	0	19	affects	VBZ	-	-	-	-	-	-	-	-
1885825	0	20	gut	NN	-	-	-	-	-	-	-	(181|(61)
1885825	0	21	flora	NN	-	-	-	-	-	-	-	181)
1885825	0	22	composition	NN	-	-	-	-	-	-	-	-
1885825	0	23	of	IN	-	-	-	-	-	-	-	-
1885825	0	24	the	DT	-	-	-	-	-	-	-	(71
1885825	0	25	host	NN	-	-	-	-	-	-	-	71)
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	order	NN	-	-	-	-	-	-	-	-
1885825	0	3	to	TO	-	-	-	-	-	-	-	-
1885825	0	4	answer	VB	-	-	-	-	-	-	-	-
1885825	0	5	this	DT	-	-	-	-	-	-	-	(182
1885825	0	6	question	NN	-	-	-	-	-	-	-	182)
1885825	0	7	,	,	-	-	-	-	-	-	-	-
1885825	0	8	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	9	counted	VBD	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	-
1885825	0	11	bacteria	NNS	-	-	-	-	-	-	-	-
1885825	0	12	most	RBS	-	-	-	-	-	-	-	-
1885825	0	13	represented	VBN	-	-	-	-	-	-	-	-
1885825	0	14	in	IN	-	-	-	-	-	-	-	-
1885825	0	15	the	DT	-	-	-	-	-	-	-	(149
1885825	0	16	ileum	NN	-	-	-	-	-	-	-	149)
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	able	JJ	-	-	-	-	-	-	-	-
1885825	0	19	to	TO	-	-	-	-	-	-	-	-
1885825	0	20	cultivate	VB	-	-	-	-	-	-	-	-
1885825	0	21	in	IN	-	-	-	-	-	-	-	-
1885825	0	22	standard	JJ	-	-	-	-	-	-	-	-
1885825	0	23	conditions	NNS	-	-	-	-	-	-	-	-
1885825	0	24	.	.	-	-	-	-	-	-	-	-

1885825	0	1	We	PRP	-	-	-	-	-	-	-	(13)
1885825	0	2	failed	VBD	-	-	-	-	-	-	-	-
1885825	0	3	to	TO	-	-	-	-	-	-	-	-
1885825	0	4	demonstrate	VB	-	-	-	-	-	-	-	-
1885825	0	5	differences	NNS	-	-	-	-	-	-	-	-
1885825	0	6	between	IN	-	-	-	-	-	-	-	-
1885825	0	7	KO	NN	-	-	-	-	-	-	-	(86|(12d)
1885825	0	8	and	CC	-	-	-	-	-	-	-	-
1885825	0	9	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	10	mice	NNS	-	-	-	-	-	-	-	(12d)|87)|86)
1885825	0	11	suggesting	VBG	-	-	-	-	-	-	-	-
1885825	0	12	that	IN	-	-	-	-	-	-	-	-
1885825	0	13	Card15	NN	-	-	-	-	-	-	-	(11|(46
1885825	0	14	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	15	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	16	deficiency	NN	-	-	-	-	-	-	-	46)
1885825	0	17	does	VBZ	-	-	-	-	-	-	-	-
1885825	0	18	not	RB	-	-	-	-	-	-	-	-
1885825	0	19	induce	VB	-	-	-	-	-	-	-	-
1885825	0	20	gross	JJ	-	-	-	-	-	-	-	-
1885825	0	21	abnormalities	NNS	-	-	-	-	-	-	-	-
1885825	0	22	of	IN	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	(146
1885825	0	24	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	25	microflora	NNS	-	-	-	-	-	-	-	146)
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	However	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	more	RBR	-	-	-	-	-	-	-	-
1885825	0	4	discrete	JJ	-	-	-	-	-	-	-	-
1885825	0	5	alterations	NNS	-	-	-	-	-	-	-	-
1885825	0	6	can	MD	-	-	-	-	-	-	-	-
1885825	0	7	not	RB	-	-	-	-	-	-	-	-
1885825	0	8	be	VB	-	-	-	-	-	-	-	-
1885825	0	9	discarded	VBN	-	-	-	-	-	-	-	-
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	additional	JJ	-	-	-	-	-	-	-	-
1885825	0	12	experiments	NNS	-	-	-	-	-	-	-	-
1885825	0	13	using	VBG	-	-	-	-	-	-	-	-
1885825	0	14	germ	NN	-	-	-	-	-	-	-	(178
1885825	0	15	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	free	JJ	-	-	-	-	-	-	-	-
1885825	0	17	animals	NNS	-	-	-	-	-	-	-	178)
1885825	0	18	and	CC	-	-	-	-	-	-	-	-
1885825	0	19	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	20	or	CC	-	-	-	-	-	-	-	-
1885825	0	21	molecular	JJ	-	-	-	-	-	-	-	-
1885825	0	22	methods	NNS	-	-	-	-	-	-	-	-
1885825	0	23	for	IN	-	-	-	-	-	-	-	-
1885825	0	24	bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	25	detection	NN	-	-	-	-	-	-	-	-
1885825	0	26	are	VBP	-	-	-	-	-	-	-	-
1885825	0	27	required	VBN	-	-	-	-	-	-	-	-
1885825	0	28	to	TO	-	-	-	-	-	-	-	-
1885825	0	29	further	RB	-	-	-	-	-	-	-	-
1885825	0	30	explore	VB	-	-	-	-	-	-	-	-
1885825	0	31	the	DT	-	-	-	-	-	-	-	-
1885825	0	32	relationship	NN	-	-	-	-	-	-	-	-
1885825	0	33	between	IN	-	-	-	-	-	-	-	-
1885825	0	34	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	35	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	36	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	37	and	CC	-	-	-	-	-	-	-	-
1885825	0	38	the	DT	-	-	-	-	-	-	-	-
1885825	0	39	normal	JJ	-	-	-	-	-	-	-	-
1885825	0	40	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	41	flora	NNS	-	-	-	-	-	-	-	-
1885825	0	42	.	.	-	-	-	-	-	-	-	-

1885825	0	1	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	2	have	VBP	-	-	-	-	-	-	-	-
1885825	0	3	B	NN	-	-	-	-	-	-	-	(183
1885825	0	4	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	5	cell	NN	-	-	-	-	-	-	-	183)
1885825	0	6	follicles	NNS	-	-	-	-	-	-	-	-
1885825	0	7	and	CC	-	-	-	-	-	-	-	-
1885825	0	8	germinal	JJ	-	-	-	-	-	-	-	-
1885825	0	9	centres	NNS	-	-	-	-	-	-	-	-
1885825	0	10	surrounded	VBN	-	-	-	-	-	-	-	-
1885825	0	11	by	IN	-	-	-	-	-	-	-	-
1885825	0	12	areas	NNS	-	-	-	-	-	-	-	-
1885825	0	13	that	WDT	-	-	-	-	-	-	-	-
1885825	0	14	contain	VBP	-	-	-	-	-	-	-	-
1885825	0	15	predominantly	RB	-	-	-	-	-	-	-	-
1885825	0	16	T	NN	-	-	-	-	-	-	-	(114
1885825	0	17	cells	NNS	-	-	-	-	-	-	-	114)
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	(184
1885825	0	2	analysis	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	the	DT	-	-	-	-	-	-	-	-
1885825	0	5	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	6	from	IN	-	-	-	-	-	-	-	-
1885825	0	7	Card15	NN	-	-	-	-	-	-	-	(11|(170
1885825	0	8	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	10	deficient	JJ	-	-	-	-	-	-	-	-
1885825	0	11	mice	NNS	-	-	-	-	-	-	-	170)
1885825	0	12	failed	VBD	-	-	-	-	-	-	-	-
1885825	0	13	to	TO	-	-	-	-	-	-	-	-
1885825	0	14	reveal	VB	-	-	-	-	-	-	-	-
1885825	0	15	gross	JJ	-	-	-	-	-	-	-	-
1885825	0	16	abnormalities	NNS	-	-	-	-	-	-	-	-
1885825	0	17	in	IN	-	-	-	-	-	-	-	-
1885825	0	18	terms	NNS	-	-	-	-	-	-	-	-
1885825	0	19	of	IN	-	-	-	-	-	-	-	-
1885825	0	20	microachitecture	NN	-	-	-	-	-	-	-	-
1885825	0	21	,	,	-	-	-	-	-	-	-	-
1885825	0	22	apoptosis	NN	-	-	-	-	-	-	-	(99)
1885825	0	23	or	CC	-	-	-	-	-	-	-	-
1885825	0	24	cell	NN	-	-	-	-	-	-	-	(131
1885825	0	25	composition	NN	-	-	-	-	-	-	-	184)|131)
1885825	0	26	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	27	at	RB	-	-	-	-	-	-	-	-
1885825	0	28	least	RBS	-	-	-	-	-	-	-	-
1885825	0	29	for	IN	-	-	-	-	-	-	-	-
1885825	0	30	the	DT	-	-	-	-	-	-	-	-
1885825	0	31	three	CD	-	-	-	-	-	-	-	-
1885825	0	32	main	JJ	-	-	-	-	-	-	-	-
1885825	0	33	cell	NN	-	-	-	-	-	-	-	-
1885825	0	34	lineages	NNS	-	-	-	-	-	-	-	-
1885825	0	35	present	JJ	-	-	-	-	-	-	-	-
1885825	0	36	in	IN	-	-	-	-	-	-	-	-
1885825	0	37	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	38	,	,	-	-	-	-	-	-	-	-
1885825	0	39	namely	RB	-	-	-	-	-	-	-	-
1885825	0	40	B	NN	-	-	-	-	-	-	-	(183|(185
1885825	0	41	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	42	cells	NNS	-	-	-	-	-	-	-	183)
1885825	0	43	,	,	-	-	-	-	-	-	-	-
1885825	0	44	T	NN	-	-	-	-	-	-	-	(114
1885825	0	45	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	46	cells	NNS	-	-	-	-	-	-	-	114)
1885825	0	47	and	CC	-	-	-	-	-	-	-	-
1885825	0	48	dendritic	JJ	-	-	-	-	-	-	-	(186
1885825	0	49	cells	NNS	-	-	-	-	-	-	-	186)|185)
1885825	0	50	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	51	.	.	-	-	-	-	-	-	-	-

1885825	0	1	This	DT	-	-	-	-	-	-	-	(184
1885825	0	2	observation	NN	-	-	-	-	-	-	-	184)
1885825	0	3	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	4	in	IN	-	-	-	-	-	-	-	-
1885825	0	5	accordance	NN	-	-	-	-	-	-	-	-
1885825	0	6	with	IN	-	-	-	-	-	-	-	-
1885825	0	7	the	DT	-	-	-	-	-	-	-	-
1885825	0	8	previous	JJ	-	-	-	-	-	-	-	-
1885825	0	9	descriptions	NNS	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	other	JJ	-	-	-	-	-	-	-	-
1885825	0	12	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	13	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	14	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	15	KO	NN	-	-	-	-	-	-	-	-
1885825	0	16	models	NNS	-	-	-	-	-	-	-	-
1885825	0	17	of	IN	-	-	-	-	-	-	-	-
1885825	0	18	mice	NNS	-	-	-	-	-	-	-	(4)
1885825	0	19	which	WDT	-	-	-	-	-	-	-	-
1885825	0	20	failed	VBD	-	-	-	-	-	-	-	-
1885825	0	21	to	TO	-	-	-	-	-	-	-	-
1885825	0	22	reveal	VB	-	-	-	-	-	-	-	-
1885825	0	23	gross	JJ	-	-	-	-	-	-	-	-
1885825	0	24	intestinal	JJ	-	-	-	-	-	-	-	-
1885825	0	25	abnormalities	NNS	-	-	-	-	-	-	-	-
1885825	0	26	under	IN	-	-	-	-	-	-	-	-
1885825	0	27	basal	JJ	-	-	-	-	-	-	-	(187
1885825	0	28	conditions	NNS	-	-	-	-	-	-	-	187)
1885825	0	29	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	30	7	CD	-	-	-	-	-	-	-	(62)
1885825	0	31	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	32	,	,	-	-	-	-	-	-	-	-
1885825	0	33	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	34	25	CD	-	-	-	-	-	-	-	-
1885825	0	35	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	36	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Interestingly	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(12
1885825	0	4	phenotype	NN	-	-	-	-	-	-	-	-
1885825	0	5	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	6	in	IN	-	-	-	-	-	-	-	-
1885825	0	7	the	DT	-	-	-	-	-	-	-	-
1885825	0	8	deficient	JJ	-	-	-	-	-	-	-	-
1885825	0	9	mouse	NN	-	-	-	-	-	-	-	12)
1885825	0	10	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	11	reminiscent	JJ	-	-	-	-	-	-	-	-
1885825	0	12	with	IN	-	-	-	-	-	-	-	-
1885825	0	13	the	DT	-	-	-	-	-	-	-	-
1885825	0	14	Human	JJ	-	-	-	-	-	-	-	-
1885825	0	15	CD	NN	-	-	-	-	-	-	-	(6)
1885825	0	16	condition	NN	-	-	-	-	-	-	-	-
1885825	0	17	where	WRB	-	-	-	-	-	-	-	-
1885825	0	18	large	JJ	-	-	-	-	-	-	-	-
1885825	0	19	lymphoid	JJ	-	-	-	-	-	-	-	-
1885825	0	20	aggregates	NNS	-	-	-	-	-	-	-	-
1885825	0	21	with	IN	-	-	-	-	-	-	-	-
1885825	0	22	normal	JJ	-	-	-	-	-	-	-	-
1885825	0	23	microarchitecture	NN	-	-	-	-	-	-	-	-
1885825	0	24	and	CC	-	-	-	-	-	-	-	-
1885825	0	25	cell	NN	-	-	-	-	-	-	-	(131
1885825	0	26	composition	NN	-	-	-	-	-	-	-	131)
1885825	0	27	have	VBP	-	-	-	-	-	-	-	-
1885825	0	28	been	VBN	-	-	-	-	-	-	-	-
1885825	0	29	reported	VBN	-	-	-	-	-	-	-	-
1885825	0	30	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	31	26	CD	-	-	-	-	-	-	-	-
1885825	0	32	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	33	.	.	-	-	-	-	-	-	-	-

1885825	0	1	LFs	NNS	-	-	-	-	-	-	-	(20)
1885825	0	2	are	VBP	-	-	-	-	-	-	-	-
1885825	0	3	covered	VBN	-	-	-	-	-	-	-	-
1885825	0	4	by	IN	-	-	-	-	-	-	-	-
1885825	0	5	a	DT	-	-	-	-	-	-	-	(188
1885825	0	6	specialised	VBN	-	-	-	-	-	-	-	-
1885825	0	7	epithelium	NN	-	-	-	-	-	-	-	-
1885825	0	8	including	VBG	-	-	-	-	-	-	-	-
1885825	0	9	M	NN	-	-	-	-	-	-	-	(28
1885825	0	10	cells	NNS	-	-	-	-	-	-	-	28)|188)
1885825	0	11	.	.	-	-	-	-	-	-	-	-

1885825	0	1	These	DT	-	-	-	-	-	-	-	(188
1885825	0	2	cells	NNS	-	-	-	-	-	-	-	188)
1885825	0	3	are	VBP	-	-	-	-	-	-	-	-
1885825	0	4	able	JJ	-	-	-	-	-	-	-	-
1885825	0	5	to	TO	-	-	-	-	-	-	-	-
1885825	0	6	transfer	VB	-	-	-	-	-	-	-	-
1885825	0	7	bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	8	and	CC	-	-	-	-	-	-	-	-
1885825	0	9	food	NN	-	-	-	-	-	-	-	-
1885825	0	10	antigens	NNS	-	-	-	-	-	-	-	-
1885825	0	11	from	IN	-	-	-	-	-	-	-	-
1885825	0	12	the	DT	-	-	-	-	-	-	-	(60
1885825	0	13	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	14	lumen	NN	-	-	-	-	-	-	-	60)
1885825	0	15	to	IN	-	-	-	-	-	-	-	-
1885825	0	16	antigen	NN	-	-	-	-	-	-	-	-
1885825	0	17	presenting	VBG	-	-	-	-	-	-	-	-
1885825	0	18	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	19	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	20	23	CD	-	-	-	-	-	-	-	(179)
1885825	0	21	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	They	PRP	-	-	-	-	-	-	-	(188)
1885825	0	2	have	VBP	-	-	-	-	-	-	-	-
1885825	0	3	thus	RB	-	-	-	-	-	-	-	-
1885825	0	4	a	DT	-	-	-	-	-	-	-	-
1885825	0	5	pivotal	JJ	-	-	-	-	-	-	-	-
1885825	0	6	role	NN	-	-	-	-	-	-	-	-
1885825	0	7	in	IN	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	(48
1885825	0	9	function	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	PP	NNS	-	-	-	-	-	-	-	(2)|48)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	M	NN	-	-	-	-	-	-	-	(28
1885825	0	2	cells	NNS	-	-	-	-	-	-	-	28)
1885825	0	3	were	VBD	-	-	-	-	-	-	-	-
1885825	0	4	found	VBN	-	-	-	-	-	-	-	-
1885825	0	5	more	RBR	-	-	-	-	-	-	-	-
1885825	0	6	numerous	JJ	-	-	-	-	-	-	-	-
1885825	0	7	in	IN	-	-	-	-	-	-	-	-
1885825	0	8	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	10	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	addition	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	PP	NNS	-	-	-	-	-	-	-	(189|(27
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	7	mice	NNS	-	-	-	-	-	-	-	27)|12)
1885825	0	8	exhibited	VBD	-	-	-	-	-	-	-	-
1885825	0	9	a	DT	-	-	-	-	-	-	-	-
1885825	0	10	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	11	proportion	NN	-	-	-	-	-	-	-	-
1885825	0	12	of	IN	-	-	-	-	-	-	-	-
1885825	0	13	CD4	NN	-	-	-	-	-	-	-	(30
1885825	0	14	+	SYM	-	-	-	-	-	-	-	-
1885825	0	15	T	NN	-	-	-	-	-	-	-	-
1885825	0	16	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	cells	NNS	-	-	-	-	-	-	-	30)|189)
1885825	0	18	and	CC	-	-	-	-	-	-	-	-
1885825	0	19	a	DT	-	-	-	-	-	-	-	-
1885825	0	20	decreased	VBN	-	-	-	-	-	-	-	-
1885825	0	21	percentage	NN	-	-	-	-	-	-	-	-
1885825	0	22	of	IN	-	-	-	-	-	-	-	-
1885825	0	23	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	24	+	SYM	-	-	-	-	-	-	-	-
1885825	0	25	CD8	NN	-	-	-	-	-	-	-	-
1885825	0	26	−	SYM	-	-	-	-	-	-	-	-
1885825	0	27	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	28	−	SYM	-	-	-	-	-	-	-	-
1885825	0	29	T	NN	-	-	-	-	-	-	-	-
1885825	0	30	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	31	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	32	.	.	-	-	-	-	-	-	-	-

1885825	0	1	As	IN	-	-	-	-	-	-	-	-
1885825	0	2	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	3	may	MD	-	-	-	-	-	-	-	-
1885825	0	4	modulate	VB	-	-	-	-	-	-	-	-
1885825	0	5	the	DT	-	-	-	-	-	-	-	(99
1885825	0	6	apoptosis	NN	-	-	-	-	-	-	-	99)
1885825	0	7	,	,	-	-	-	-	-	-	-	-
1885825	0	8	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	9	have	VBP	-	-	-	-	-	-	-	-
1885825	0	10	hypothesized	VBN	-	-	-	-	-	-	-	-
1885825	0	11	that	IN	-	-	-	-	-	-	-	-
1885825	0	12	this	DT	-	-	-	-	-	-	-	(189
1885825	0	13	increase	NN	-	-	-	-	-	-	-	-
1885825	0	14	of	IN	-	-	-	-	-	-	-	-
1885825	0	15	CD4	NN	-	-	-	-	-	-	-	(30
1885825	0	16	+	SYM	-	-	-	-	-	-	-	-
1885825	0	17	T	NN	-	-	-	-	-	-	-	-
1885825	0	18	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	19	cell	NN	-	-	-	-	-	-	-	30)
1885825	0	20	number	NN	-	-	-	-	-	-	-	189)
1885825	0	21	may	MD	-	-	-	-	-	-	-	-
1885825	0	22	result	VB	-	-	-	-	-	-	-	-
1885825	0	23	from	IN	-	-	-	-	-	-	-	-
1885825	0	24	an	DT	-	-	-	-	-	-	-	-
1885825	0	25	apoptosis	NN	-	-	-	-	-	-	-	(99)
1885825	0	26	defect	NN	-	-	-	-	-	-	-	-
1885825	0	27	in	IN	-	-	-	-	-	-	-	-
1885825	0	28	the	DT	-	-	-	-	-	-	-	(190
1885825	0	29	lymphoid	JJ	-	-	-	-	-	-	-	-
1885825	0	30	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	31	of	IN	-	-	-	-	-	-	-	-
1885825	0	32	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	33	mice	NNS	-	-	-	-	-	-	-	190)|12)
1885825	0	34	.	.	-	-	-	-	-	-	-	-

1885825	0	1	However	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	flow	NN	-	-	-	-	-	-	-	(125|(25
1885825	0	4	cytometry	NN	-	-	-	-	-	-	-	25)
1885825	0	5	analyses	NNS	-	-	-	-	-	-	-	125)
1885825	0	6	revealed	VBD	-	-	-	-	-	-	-	-
1885825	0	7	that	IN	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	-
1885825	0	9	relative	JJ	-	-	-	-	-	-	-	-
1885825	0	10	proportion	NN	-	-	-	-	-	-	-	-
1885825	0	11	of	IN	-	-	-	-	-	-	-	-
1885825	0	12	apoptotic	JJ	-	-	-	-	-	-	-	-
1885825	0	13	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	14	+	SYM	-	-	-	-	-	-	-	-
1885825	0	15	T	NN	-	-	-	-	-	-	-	-
1885825	0	16	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	18	from	IN	-	-	-	-	-	-	-	-
1885825	0	19	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	20	was	VBD	-	-	-	-	-	-	-	-
1885825	0	21	similar	JJ	-	-	-	-	-	-	-	-
1885825	0	22	between	IN	-	-	-	-	-	-	-	-
1885825	0	23	KO	NN	-	-	-	-	-	-	-	(86|(12p)
1885825	0	24	and	CC	-	-	-	-	-	-	-	-
1885825	0	25	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	26	mice	NNS	-	-	-	-	-	-	-	(12p)|87)|86)
1885825	0	27	.	.	-	-	-	-	-	-	-	-

1885825	0	1	As	IN	-	-	-	-	-	-	-	-
1885825	0	2	a	DT	-	-	-	-	-	-	-	-
1885825	0	3	result	NN	-	-	-	-	-	-	-	-
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	our	PRP$	-	-	-	-	-	-	-	(13)
1885825	0	6	experiments	NNS	-	-	-	-	-	-	-	-
1885825	0	7	do	VBP	-	-	-	-	-	-	-	-
1885825	0	8	not	RB	-	-	-	-	-	-	-	-
1885825	0	9	support	VB	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	-
1885825	0	11	opinion	NN	-	-	-	-	-	-	-	-
1885825	0	12	that	IN	-	-	-	-	-	-	-	-
1885825	0	13	Card15	NN	-	-	-	-	-	-	-	(11|(46
1885825	0	14	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	15	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	16	deficiency	NN	-	-	-	-	-	-	-	46)
1885825	0	17	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	18	characterised	VBN	-	-	-	-	-	-	-	-
1885825	0	19	by	IN	-	-	-	-	-	-	-	-
1885825	0	20	a	DT	-	-	-	-	-	-	-	-
1885825	0	21	general	JJ	-	-	-	-	-	-	-	-
1885825	0	22	apoptosis	NN	-	-	-	-	-	-	-	(99)
1885825	0	23	defect	NN	-	-	-	-	-	-	-	-
1885825	0	24	in	IN	-	-	-	-	-	-	-	-
1885825	0	25	the	DT	-	-	-	-	-	-	-	(190
1885825	0	26	lymphoid	JJ	-	-	-	-	-	-	-	-
1885825	0	27	tissue	NN	-	-	-	-	-	-	-	-
1885825	0	28	of	IN	-	-	-	-	-	-	-	-
1885825	0	29	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	30	mice	NNS	-	-	-	-	-	-	-	190)|12)
1885825	0	31	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(191
1885825	0	4	altered	VBN	-	-	-	-	-	-	-	-
1885825	0	5	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	6	cell	NN	-	-	-	-	-	-	-	-
1885825	0	7	composition	NN	-	-	-	-	-	-	-	-
1885825	0	8	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	9	concomitant	JJ	-	-	-	-	-	-	-	-
1885825	0	10	with	IN	-	-	-	-	-	-	-	-
1885825	0	11	an	DT	-	-	-	-	-	-	-	-
1885825	0	12	increase	NN	-	-	-	-	-	-	-	-
1885825	0	13	of	IN	-	-	-	-	-	-	-	-
1885825	0	14	pro-inflammatory	JJ	-	-	-	-	-	-	-	(68
1885825	0	15	Th1	NN	-	-	-	-	-	-	-	68)
1885825	0	16	but	CC	-	-	-	-	-	-	-	-
1885825	0	17	also	RB	-	-	-	-	-	-	-	-
1885825	0	18	anti-inflammatory	JJ	-	-	-	-	-	-	-	-
1885825	0	19	Th2	NN	-	-	-	-	-	-	-	(169
1885825	0	20	cytokine	NN	-	-	-	-	-	-	-	169)
1885825	0	21	expression	NN	-	-	-	-	-	-	-	191)
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Altogether	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	these	DT	-	-	-	-	-	-	-	(191
1885825	0	4	results	NNS	-	-	-	-	-	-	-	191)
1885825	0	5	indicate	VBP	-	-	-	-	-	-	-	-
1885825	0	6	that	IN	-	-	-	-	-	-	-	-
1885825	0	7	under	IN	-	-	-	-	-	-	-	-
1885825	0	8	basal	JJ	-	-	-	-	-	-	-	(187
1885825	0	9	condition	NN	-	-	-	-	-	-	-	187)
1885825	0	10	,	,	-	-	-	-	-	-	-	-
1885825	0	11	PPs	NNS	-	-	-	-	-	-	-	(27
1885825	0	12	of	IN	-	-	-	-	-	-	-	-
1885825	0	13	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	14	mice	NNS	-	-	-	-	-	-	-	27)|12)
1885825	0	15	are	VBP	-	-	-	-	-	-	-	-
1885825	0	16	characterised	VBN	-	-	-	-	-	-	-	-
1885825	0	17	by	IN	-	-	-	-	-	-	-	-
1885825	0	18	an	DT	-	-	-	-	-	-	-	-
1885825	0	19	exaggerated	VBN	-	-	-	-	-	-	-	-
1885825	0	20	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	21	response	NN	-	-	-	-	-	-	-	-
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Cell	NN	-	-	-	-	-	-	-	(131|(132
1885825	0	2	composition	NN	-	-	-	-	-	-	-	131)
1885825	0	3	and	CC	-	-	-	-	-	-	-	-
1885825	0	4	cytokine	NN	-	-	-	-	-	-	-	(133
1885825	0	5	production	NN	-	-	-	-	-	-	-	133)|132)
1885825	0	6	may	MD	-	-	-	-	-	-	-	-
1885825	0	7	affect	VB	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	(48
1885825	0	9	function	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	PP	NNS	-	-	-	-	-	-	-	(2)|48)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	We	PRP	-	-	-	-	-	-	-	(13)
1885825	0	2	thus	RB	-	-	-	-	-	-	-	-
1885825	0	3	used	VBD	-	-	-	-	-	-	-	-
1885825	0	4	Ussing	NNP	-	-	-	-	-	-	-	(39
1885825	0	5	chambers	NNS	-	-	-	-	-	-	-	39)
1885825	0	6	for	IN	-	-	-	-	-	-	-	-
1885825	0	7	determining	VBG	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	(134
1885825	0	9	paracellular	JJ	-	-	-	-	-	-	-	-
1885825	0	10	permeability	NN	-	-	-	-	-	-	-	-
1885825	0	11	through	IN	-	-	-	-	-	-	-	-
1885825	0	12	PP	NNS	-	-	-	-	-	-	-	(135|(2)
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	PP	NNS	-	-	-	-	-	-	-	(37|(2)
1885825	0	15	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	free	JJ	-	-	-	-	-	-	-	-
1885825	0	17	ileum	NN	-	-	-	-	-	-	-	37)|135)|134)
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	KO	NN	-	-	-	-	-	-	-	(12|(192
1885825	0	2	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	3	exhibited	VBD	-	-	-	-	-	-	-	-
1885825	0	4	a	DT	-	-	-	-	-	-	-	-
1885825	0	5	significant	JJ	-	-	-	-	-	-	-	-
1885825	0	6	increase	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	paracellular	JJ	-	-	-	-	-	-	-	(41
1885825	0	9	permeability	NN	-	-	-	-	-	-	-	41)|192)
1885825	0	10	.	.	-	-	-	-	-	-	-	-

1885825	0	1	This	DT	-	-	-	-	-	-	-	(192
1885825	0	2	result	NN	-	-	-	-	-	-	-	192)
1885825	0	3	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	4	in	IN	-	-	-	-	-	-	-	-
1885825	0	5	accordance	NN	-	-	-	-	-	-	-	-
1885825	0	6	with	IN	-	-	-	-	-	-	-	-
1885825	0	7	the	DT	-	-	-	-	-	-	-	-
1885825	0	8	altered	VBN	-	-	-	-	-	-	-	-
1885825	0	9	intestinal	JJ	-	-	-	-	-	-	-	-
1885825	0	10	permeability	NN	-	-	-	-	-	-	-	-
1885825	0	11	reported	VBN	-	-	-	-	-	-	-	-
1885825	0	12	in	IN	-	-	-	-	-	-	-	-
1885825	0	13	CD	NN	-	-	-	-	-	-	-	(59|(6)
1885825	0	14	patients	NNS	-	-	-	-	-	-	-	59)
1885825	0	15	and	CC	-	-	-	-	-	-	-	-
1885825	0	16	their	PRP$	-	-	-	-	-	-	-	(59)
1885825	0	17	healthy	JJ	-	-	-	-	-	-	-	-
1885825	0	18	relatives	NNS	-	-	-	-	-	-	-	-
1885825	0	19	,	,	-	-	-	-	-	-	-	-
1885825	0	20	especially	RB	-	-	-	-	-	-	-	-
1885825	0	21	in	IN	-	-	-	-	-	-	-	-
1885825	0	22	case	NN	-	-	-	-	-	-	-	-
1885825	0	23	of	IN	-	-	-	-	-	-	-	-
1885825	0	24	CARD15	NN	-	-	-	-	-	-	-	(1|(5
1885825	0	25	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	26	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	27	mutations	NNS	-	-	-	-	-	-	-	5)
1885825	0	28	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	29	27	CD	-	-	-	-	-	-	-	-
1885825	0	30	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	31	–	SYM	-	-	-	-	-	-	-	-
1885825	0	32	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	33	30	CD	-	-	-	-	-	-	-	-
1885825	0	34	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	35	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Pro	AFX	-	-	-	-	-	-	-	(58
1885825	0	2	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	3	and	CC	-	-	-	-	-	-	-	-
1885825	0	4	anti-inflammatory	JJ	-	-	-	-	-	-	-	-
1885825	0	5	cytokines	NNS	-	-	-	-	-	-	-	58)
1885825	0	6	are	VBP	-	-	-	-	-	-	-	-
1885825	0	7	known	VBN	-	-	-	-	-	-	-	-
1885825	0	8	to	TO	-	-	-	-	-	-	-	-
1885825	0	9	modulate	VB	-	-	-	-	-	-	-	-
1885825	0	10	intestinal	JJ	-	-	-	-	-	-	-	-
1885825	0	11	paracellular	JJ	-	-	-	-	-	-	-	-
1885825	0	12	permeability	NN	-	-	-	-	-	-	-	-
1885825	0	13	.	.	-	-	-	-	-	-	-	-

1885825	0	1	IFNγ	NN	-	-	-	-	-	-	-	(33)
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	TNFα	NN	-	-	-	-	-	-	-	(31)
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	IL	NN	-	-	-	-	-	-	-	(35
1885825	0	6	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	7	4	CD	-	-	-	-	-	-	-	35)
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	act	VBP	-	-	-	-	-	-	-	-
1885825	0	10	on	IN	-	-	-	-	-	-	-	-
1885825	0	11	membrane	NN	-	-	-	-	-	-	-	-
1885825	0	12	receptors	NNS	-	-	-	-	-	-	-	-
1885825	0	13	of	IN	-	-	-	-	-	-	-	-
1885825	0	14	epithelial	JJ	-	-	-	-	-	-	-	(65
1885825	0	15	cells	NNS	-	-	-	-	-	-	-	65)
1885825	0	16	to	TO	-	-	-	-	-	-	-	-
1885825	0	17	increase	VB	-	-	-	-	-	-	-	-
1885825	0	18	tight	JJ	-	-	-	-	-	-	-	-
1885825	0	19	junction	NN	-	-	-	-	-	-	-	-
1885825	0	20	permeability	NN	-	-	-	-	-	-	-	-
1885825	0	21	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	22	31	CD	-	-	-	-	-	-	-	(193)
1885825	0	23	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	24	–	SYM	-	-	-	-	-	-	-	-
1885825	0	25	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	26	34	CD	-	-	-	-	-	-	-	-
1885825	0	27	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	28	.	.	-	-	-	-	-	-	-	-

1885825	0	1	For	IN	-	-	-	-	-	-	-	-
1885825	0	2	example	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	on	IN	-	-	-	-	-	-	-	-
1885825	0	5	T84	NN	-	-	-	-	-	-	-	-
1885825	0	6	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	7	IFNγ	NN	-	-	-	-	-	-	-	(33)
1885825	0	8	decreased	VBD	-	-	-	-	-	-	-	-
1885825	0	9	levels	NNS	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	ZO	NN	-	-	-	-	-	-	-	(142
1885825	0	12	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	13	1	CD	-	-	-	-	-	-	-	142)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	altered	VBD	-	-	-	-	-	-	-	-
1885825	0	16	apical	JJ	-	-	-	-	-	-	-	-
1885825	0	17	actin	NN	-	-	-	-	-	-	-	-
1885825	0	18	organisation	NN	-	-	-	-	-	-	-	-
1885825	0	19	,	,	-	-	-	-	-	-	-	-
1885825	0	20	which	WDT	-	-	-	-	-	-	-	-
1885825	0	21	leads	VBZ	-	-	-	-	-	-	-	-
1885825	0	22	to	IN	-	-	-	-	-	-	-	-
1885825	0	23	disorganisation	NN	-	-	-	-	-	-	-	-
1885825	0	24	of	IN	-	-	-	-	-	-	-	-
1885825	0	25	TJ	NN	-	-	-	-	-	-	-	(139)
1885825	0	26	and	CC	-	-	-	-	-	-	-	-
1885825	0	27	increased	VBN	-	-	-	-	-	-	-	(49
1885825	0	28	permeability	NN	-	-	-	-	-	-	-	49)
1885825	0	29	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	30	35	CD	-	-	-	-	-	-	-	-
1885825	0	31	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	32	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Similarly	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	PP	NNS	-	-	-	-	-	-	-	(168
1885825	0	4	from	IN	-	-	-	-	-	-	-	-
1885825	0	5	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	6	mice	NNS	-	-	-	-	-	-	-	168)|12)
1885825	0	7	exhibited	VBD	-	-	-	-	-	-	-	-
1885825	0	8	a	DT	-	-	-	-	-	-	-	-
1885825	0	9	decrease	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	ZO	NN	-	-	-	-	-	-	-	(141|(142|(194
1885825	0	12	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	13	1	CD	-	-	-	-	-	-	-	142)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	ZO	NN	-	-	-	-	-	-	-	(140
1885825	0	16	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	2	CD	-	-	-	-	-	-	-	141)|140)
1885825	0	18	mRNA	NN	-	-	-	-	-	-	-	-
1885825	0	19	expression	NN	-	-	-	-	-	-	-	194)
1885825	0	20	in	IN	-	-	-	-	-	-	-	-
1885825	0	21	comparison	NN	-	-	-	-	-	-	-	-
1885825	0	22	with	IN	-	-	-	-	-	-	-	-
1885825	0	23	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	24	mice	NNS	-	-	-	-	-	-	-	87)
1885825	0	25	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Consequently	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	-
1885825	0	4	excessive	JJ	-	-	-	-	-	-	-	-
1885825	0	5	concentration	NN	-	-	-	-	-	-	-	-
1885825	0	6	of	IN	-	-	-	-	-	-	-	-
1885825	0	7	IFNγ	NN	-	-	-	-	-	-	-	(33)
1885825	0	8	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	9	in	IN	-	-	-	-	-	-	-	-
1885825	0	10	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	11	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	12	may	MD	-	-	-	-	-	-	-	-
1885825	0	13	down	RB	-	-	-	-	-	-	-	-
1885825	0	14	regulate	VB	-	-	-	-	-	-	-	-
1885825	0	15	the	DT	-	-	-	-	-	-	-	-
1885825	0	16	transcription	NN	-	-	-	-	-	-	-	-
1885825	0	17	of	IN	-	-	-	-	-	-	-	-
1885825	0	18	ZO	NN	-	-	-	-	-	-	-	(141|(142|(194
1885825	0	19	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	20	1	CD	-	-	-	-	-	-	-	142)
1885825	0	21	and	CC	-	-	-	-	-	-	-	-
1885825	0	22	ZO	NN	-	-	-	-	-	-	-	(140
1885825	0	23	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	24	2	CD	-	-	-	-	-	-	-	141)|140)
1885825	0	25	mRNA	NN	-	-	-	-	-	-	-	-
1885825	0	26	expression	NN	-	-	-	-	-	-	-	194)
1885825	0	27	and	CC	-	-	-	-	-	-	-	-
1885825	0	28	contribute	VBP	-	-	-	-	-	-	-	-
1885825	0	29	to	IN	-	-	-	-	-	-	-	-
1885825	0	30	the	DT	-	-	-	-	-	-	-	-
1885825	0	31	increase	VBN	-	-	-	-	-	-	-	-
1885825	0	32	paracellular	JJ	-	-	-	-	-	-	-	-
1885825	0	33	permeability	NN	-	-	-	-	-	-	-	-
1885825	0	34	in	IN	-	-	-	-	-	-	-	-
1885825	0	35	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	36	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	37	.	.	-	-	-	-	-	-	-	-

1885825	0	1	It	PRP	-	-	-	-	-	-	-	-
1885825	0	2	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	3	to	TO	-	-	-	-	-	-	-	-
1885825	0	4	note	VB	-	-	-	-	-	-	-	-
1885825	0	5	that	IN	-	-	-	-	-	-	-	-
1885825	0	6	this	DT	-	-	-	-	-	-	-	(12
1885825	0	7	phenotype	NN	-	-	-	-	-	-	-	12)
1885825	0	8	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	9	reminiscent	JJ	-	-	-	-	-	-	-	-
1885825	0	10	to	IN	-	-	-	-	-	-	-	-
1885825	0	11	the	DT	-	-	-	-	-	-	-	(7
1885825	0	12	CARD15	NN	-	-	-	-	-	-	-	-
1885825	0	13	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	14	NOD2	NN	-	-	-	-	-	-	-	-
1885825	0	15	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	16	Human	JJ	-	-	-	-	-	-	-	-
1885825	0	17	disorders	NNS	-	-	-	-	-	-	-	7)
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Indeed	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	in	IN	-	-	-	-	-	-	-	-
1885825	0	4	CD	NN	-	-	-	-	-	-	-	(59|(6)
1885825	0	5	patients	NNS	-	-	-	-	-	-	-	59)
1885825	0	6	,	,	-	-	-	-	-	-	-	-
1885825	0	7	increased	VBN	-	-	-	-	-	-	-	(49
1885825	0	8	permeability	NN	-	-	-	-	-	-	-	49)
1885825	0	9	has	VBZ	-	-	-	-	-	-	-	-
1885825	0	10	been	VBN	-	-	-	-	-	-	-	-
1885825	0	11	reported	VBN	-	-	-	-	-	-	-	-
1885825	0	12	to	TO	-	-	-	-	-	-	-	-
1885825	0	13	be	VB	-	-	-	-	-	-	-	-
1885825	0	14	mediated	VBN	-	-	-	-	-	-	-	-
1885825	0	15	by	IN	-	-	-	-	-	-	-	-
1885825	0	16	TNFα	NN	-	-	-	-	-	-	-	(31)
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	to	TO	-	-	-	-	-	-	-	-
1885825	0	19	precede	VB	-	-	-	-	-	-	-	-
1885825	0	20	the	DT	-	-	-	-	-	-	-	-
1885825	0	21	clinical	JJ	-	-	-	-	-	-	-	-
1885825	0	22	relapse	NN	-	-	-	-	-	-	-	-
1885825	0	23	while	IN	-	-	-	-	-	-	-	-
1885825	0	24	GVHD	NN	-	-	-	-	-	-	-	(8)
1885825	0	25	has	VBZ	-	-	-	-	-	-	-	-
1885825	0	26	been	VBN	-	-	-	-	-	-	-	-
1885825	0	27	treated	VBN	-	-	-	-	-	-	-	-
1885825	0	28	by	IN	-	-	-	-	-	-	-	-
1885825	0	29	anti-TNF	JJ	-	-	-	-	-	-	-	-
1885825	0	30	antibodies	NNS	-	-	-	-	-	-	-	-
1885825	0	31	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	32	36	CD	-	-	-	-	-	-	-	-
1885825	0	33	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	34	,	,	-	-	-	-	-	-	-	-
1885825	0	35	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	36	37	CD	-	-	-	-	-	-	-	-
1885825	0	37	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	38	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Because	IN	-	-	-	-	-	-	-	-
1885825	0	2	of	IN	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	-
1885825	0	4	changes	NNS	-	-	-	-	-	-	-	-
1885825	0	5	in	IN	-	-	-	-	-	-	-	-
1885825	0	6	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	7	permeability	NN	-	-	-	-	-	-	-	-
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	10	finally	RB	-	-	-	-	-	-	-	-
1885825	0	11	studied	VBD	-	-	-	-	-	-	-	-
1885825	0	12	the	DT	-	-	-	-	-	-	-	-
1885825	0	13	role	NN	-	-	-	-	-	-	-	-
1885825	0	14	of	IN	-	-	-	-	-	-	-	-
1885825	0	15	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	16	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	18	in	IN	-	-	-	-	-	-	-	-
1885825	0	19	bacterial	JJ	-	-	-	-	-	-	-	(43
1885825	0	20	translocation	NN	-	-	-	-	-	-	-	43)
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	2	passage	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	Staphylococcus	NNP	-	-	-	-	-	-	-	(148
1885825	0	5	aureus	NNP	-	-	-	-	-	-	-	148)
1885825	0	6	and	CC	-	-	-	-	-	-	-	-
1885825	0	7	Escherichia	NNP	-	-	-	-	-	-	-	(156
1885825	0	8	coli	NNP	-	-	-	-	-	-	-	156)
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	yeast	NN	-	-	-	-	-	-	-	-
1885825	0	11	ingress	NN	-	-	-	-	-	-	-	-
1885825	0	12	of	IN	-	-	-	-	-	-	-	-
1885825	0	13	Saccharomyces	NNP	-	-	-	-	-	-	-	(159
1885825	0	14	cerevisiae	NNP	-	-	-	-	-	-	-	159)
1885825	0	15	were	VBD	-	-	-	-	-	-	-	-
1885825	0	16	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	17	through	IN	-	-	-	-	-	-	-	-
1885825	0	18	PP	NNS	-	-	-	-	-	-	-	(27
1885825	0	19	of	IN	-	-	-	-	-	-	-	-
1885825	0	20	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	21	mice	NNS	-	-	-	-	-	-	-	27)|12)
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	It	PRP	-	-	-	-	-	-	-	-
1885825	0	2	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	3	widely	RB	-	-	-	-	-	-	-	-
1885825	0	4	accepted	VBN	-	-	-	-	-	-	-	-
1885825	0	5	that	IN	-	-	-	-	-	-	-	-
1885825	0	6	CD	NN	-	-	-	-	-	-	-	(195|(6)
1885825	0	7	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	8	related	VBN	-	-	-	-	-	-	-	-
1885825	0	9	with	IN	-	-	-	-	-	-	-	-
1885825	0	10	an	DT	-	-	-	-	-	-	-	-
1885825	0	11	excessive	JJ	-	-	-	-	-	-	-	-
1885825	0	12	bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	13	translocation	NN	-	-	-	-	-	-	-	-
1885825	0	14	through	IN	-	-	-	-	-	-	-	-
1885825	0	15	the	DT	-	-	-	-	-	-	-	-
1885825	0	16	intestinal	JJ	-	-	-	-	-	-	-	-
1885825	0	17	epithelium	NN	-	-	-	-	-	-	-	195)
1885825	0	18	even	RB	-	-	-	-	-	-	-	-
1885825	0	19	if	IN	-	-	-	-	-	-	-	-
1885825	0	20	this	DT	-	-	-	-	-	-	-	(195
1885825	0	21	hypothesis	NN	-	-	-	-	-	-	-	195)
1885825	0	22	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	23	not	RB	-	-	-	-	-	-	-	-
1885825	0	24	perfectly	RB	-	-	-	-	-	-	-	-
1885825	0	25	documented	VBN	-	-	-	-	-	-	-	-
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	present	JJ	-	-	-	-	-	-	-	-
1885825	0	3	data	NNS	-	-	-	-	-	-	-	-
1885825	0	4	further	RB	-	-	-	-	-	-	-	-
1885825	0	5	support	VBP	-	-	-	-	-	-	-	-
1885825	0	6	this	DT	-	-	-	-	-	-	-	(195
1885825	0	7	opinion	NN	-	-	-	-	-	-	-	195)
1885825	0	8	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	addition	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	this	DT	-	-	-	-	-	-	-	(195
1885825	0	5	excess	NN	-	-	-	-	-	-	-	-
1885825	0	6	of	IN	-	-	-	-	-	-	-	-
1885825	0	7	yeast	NN	-	-	-	-	-	-	-	(42b)
1885825	0	8	and	CC	-	-	-	-	-	-	-	-
1885825	0	9	bacteria	NNS	-	-	-	-	-	-	-	(43
1885825	0	10	translocation	NN	-	-	-	-	-	-	-	(42b)|43)|195)
1885825	0	11	through	IN	-	-	-	-	-	-	-	-
1885825	0	12	PP	NN	-	-	-	-	-	-	-	(27
1885825	0	13	of	IN	-	-	-	-	-	-	-	-
1885825	0	14	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	15	mice	NNS	-	-	-	-	-	-	-	27)|12)
1885825	0	16	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	17	in	IN	-	-	-	-	-	-	-	-
1885825	0	18	agreement	NN	-	-	-	-	-	-	-	-
1885825	0	19	with	IN	-	-	-	-	-	-	-	-
1885825	0	20	recent	JJ	-	-	-	-	-	-	-	-
1885825	0	21	reports	NNS	-	-	-	-	-	-	-	-
1885825	0	22	showing	VBG	-	-	-	-	-	-	-	-
1885825	0	23	that	IN	-	-	-	-	-	-	-	-
1885825	0	24	mutated	VBN	-	-	-	-	-	-	-	(196
1885825	0	25	CD	NN	-	-	-	-	-	-	-	(6)
1885825	0	26	patients	NNS	-	-	-	-	-	-	-	196)
1885825	0	27	and	CC	-	-	-	-	-	-	-	-
1885825	0	28	their	PRP$	-	-	-	-	-	-	-	(196)
1885825	0	29	unaffected	JJ	-	-	-	-	-	-	-	-
1885825	0	30	relatives	NNS	-	-	-	-	-	-	-	-
1885825	0	31	develop	VBP	-	-	-	-	-	-	-	-
1885825	0	32	more	RBR	-	-	-	-	-	-	-	-
1885825	0	33	frequently	RB	-	-	-	-	-	-	-	-
1885825	0	34	antibodies	NNS	-	-	-	-	-	-	-	-
1885825	0	35	to	IN	-	-	-	-	-	-	-	-
1885825	0	36	Saccharomyces	NNP	-	-	-	-	-	-	-	(159
1885825	0	37	cerevisiae	NNP	-	-	-	-	-	-	-	159)
1885825	0	38	,	,	-	-	-	-	-	-	-	-
1885825	0	39	Pseudomonas	NNP	-	-	-	-	-	-	-	(147)
1885825	0	40	fluorescens	NNP	-	-	-	-	-	-	-	-
1885825	0	41	–	HYPH	-	-	-	-	-	-	-	-
1885825	0	42	related	VBN	-	-	-	-	-	-	-	-
1885825	0	43	protein	NN	-	-	-	-	-	-	-	-
1885825	0	44	,	,	-	-	-	-	-	-	-	-
1885825	0	45	Escherichia	NNP	-	-	-	-	-	-	-	(156
1885825	0	46	coli	NNP	-	-	-	-	-	-	-	156)
1885825	0	47	outer	JJ	-	-	-	-	-	-	-	-
1885825	0	48	membrane	NN	-	-	-	-	-	-	-	-
1885825	0	49	porin	NN	-	-	-	-	-	-	-	-
1885825	0	50	C	NN	-	-	-	-	-	-	-	-
1885825	0	51	and	CC	-	-	-	-	-	-	-	-
1885825	0	52	CBir1	NN	-	-	-	-	-	-	-	-
1885825	0	53	flagellin	NN	-	-	-	-	-	-	-	-
1885825	0	54	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	55	38	CD	-	-	-	-	-	-	-	-
1885825	0	56	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	57	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	excessive	JJ	-	-	-	-	-	-	-	-
1885825	0	3	bacteria	NNS	-	-	-	-	-	-	-	-
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	yeast	NN	-	-	-	-	-	-	-	-
1885825	0	6	passage	NN	-	-	-	-	-	-	-	-
1885825	0	7	reported	VBN	-	-	-	-	-	-	-	-
1885825	0	8	here	RB	-	-	-	-	-	-	-	-
1885825	0	9	may	MD	-	-	-	-	-	-	-	-
1885825	0	10	participate	VB	-	-	-	-	-	-	-	-
1885825	0	11	in	IN	-	-	-	-	-	-	-	-
1885825	0	12	the	DT	-	-	-	-	-	-	-	-
1885825	0	13	enhancement	NN	-	-	-	-	-	-	-	-
1885825	0	14	of	IN	-	-	-	-	-	-	-	-
1885825	0	15	adaptive	JJ	-	-	-	-	-	-	-	-
1885825	0	16	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	17	responses	NNS	-	-	-	-	-	-	-	-
1885825	0	18	to	IN	-	-	-	-	-	-	-	-
1885825	0	19	microbial	JJ	-	-	-	-	-	-	-	-
1885825	0	20	antigens	NNS	-	-	-	-	-	-	-	-
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	(197
1885825	0	2	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	3	number	NN	-	-	-	-	-	-	-	-
1885825	0	4	of	IN	-	-	-	-	-	-	-	-
1885825	0	5	M	NN	-	-	-	-	-	-	-	(28
1885825	0	6	cells	NNS	-	-	-	-	-	-	-	28)
1885825	0	7	can	MD	-	-	-	-	-	-	-	-
1885825	0	8	contribute	VB	-	-	-	-	-	-	-	-
1885825	0	9	to	IN	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	-
1885825	0	11	high	JJ	-	-	-	-	-	-	-	-
1885825	0	12	translocation	NN	-	-	-	-	-	-	-	-
1885825	0	13	rate	NN	-	-	-	-	-	-	-	-
1885825	0	14	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	15	in	IN	-	-	-	-	-	-	-	-
1885825	0	16	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	17	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	However	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	because	IN	-	-	-	-	-	-	-	-
1885825	0	4	M	NN	-	-	-	-	-	-	-	(198|(28
1885825	0	5	cell	NN	-	-	-	-	-	-	-	28)
1885825	0	6	differentiation	NN	-	-	-	-	-	-	-	198)
1885825	0	7	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	8	inducible	JJ	-	-	-	-	-	-	-	-
1885825	0	9	by	IN	-	-	-	-	-	-	-	-
1885825	0	10	microbial	JJ	-	-	-	-	-	-	-	-
1885825	0	11	challenge	NN	-	-	-	-	-	-	-	-
1885825	0	12	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	13	39	CD	-	-	-	-	-	-	-	-
1885825	0	14	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	15	,	,	-	-	-	-	-	-	-	-
1885825	0	16	it	PRP	-	-	-	-	-	-	-	(198)
1885825	0	17	may	MD	-	-	-	-	-	-	-	-
1885825	0	18	also	RB	-	-	-	-	-	-	-	-
1885825	0	19	be	VB	-	-	-	-	-	-	-	-
1885825	0	20	a	DT	-	-	-	-	-	-	-	-
1885825	0	21	consequence	NN	-	-	-	-	-	-	-	-
1885825	0	22	of	IN	-	-	-	-	-	-	-	-
1885825	0	23	bacterial	JJ	-	-	-	-	-	-	-	(43
1885825	0	24	translocations	NNS	-	-	-	-	-	-	-	43)|197)
1885825	0	25	and	CC	-	-	-	-	-	-	-	-
1885825	0	26	additional	JJ	-	-	-	-	-	-	-	-
1885825	0	27	experiments	NNS	-	-	-	-	-	-	-	-
1885825	0	28	are	VBP	-	-	-	-	-	-	-	-
1885825	0	29	required	VBN	-	-	-	-	-	-	-	-
1885825	0	30	to	TO	-	-	-	-	-	-	-	-
1885825	0	31	further	RB	-	-	-	-	-	-	-	-
1885825	0	32	dissect	VB	-	-	-	-	-	-	-	-
1885825	0	33	this	DT	-	-	-	-	-	-	-	(197
1885825	0	34	complex	JJ	-	-	-	-	-	-	-	-
1885825	0	35	relationship	NN	-	-	-	-	-	-	-	197)
1885825	0	36	.	.	-	-	-	-	-	-	-	-

1885825	0	1	It	PRP	-	-	-	-	-	-	-	-
1885825	0	2	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	3	also	RB	-	-	-	-	-	-	-	-
1885825	0	4	possible	JJ	-	-	-	-	-	-	-	-
1885825	0	5	to	TO	-	-	-	-	-	-	-	-
1885825	0	6	consider	VB	-	-	-	-	-	-	-	-
1885825	0	7	that	IN	-	-	-	-	-	-	-	-
1885825	0	8	CARD15	NN	-	-	-	-	-	-	-	(1
1885825	0	9	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	10	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	11	dysfunction	NN	-	-	-	-	-	-	-	-
1885825	0	12	facilitates	VBZ	-	-	-	-	-	-	-	-
1885825	0	13	bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	14	entry	NN	-	-	-	-	-	-	-	-
1885825	0	15	through	IN	-	-	-	-	-	-	-	-
1885825	0	16	defective	JJ	-	-	-	-	-	-	-	-
1885825	0	17	antibacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	18	peptide	NN	-	-	-	-	-	-	-	-
1885825	0	19	expression	NN	-	-	-	-	-	-	-	-
1885825	0	20	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	21	7	CD	-	-	-	-	-	-	-	(62)
1885825	0	22	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	23	,	,	-	-	-	-	-	-	-	-
1885825	0	24	impaired	VBN	-	-	-	-	-	-	-	-
1885825	0	25	intracellular	JJ	-	-	-	-	-	-	-	-
1885825	0	26	bactericidal	JJ	-	-	-	-	-	-	-	-
1885825	0	27	capacity	NN	-	-	-	-	-	-	-	-
1885825	0	28	or	CC	-	-	-	-	-	-	-	-
1885825	0	29	reduced	VBN	-	-	-	-	-	-	-	-
1885825	0	30	epithelial	JJ	-	-	-	-	-	-	-	-
1885825	0	31	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	32	defence	NN	-	-	-	-	-	-	-	-
1885825	0	33	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	bacterial	JJ	-	-	-	-	-	-	-	(43
1885825	0	4	translocation	NN	-	-	-	-	-	-	-	43)
1885825	0	5	may	MD	-	-	-	-	-	-	-	-
1885825	0	6	also	RB	-	-	-	-	-	-	-	-
1885825	0	7	be	VB	-	-	-	-	-	-	-	-
1885825	0	8	secondary	JJ	-	-	-	-	-	-	-	-
1885825	0	9	to	IN	-	-	-	-	-	-	-	-
1885825	0	10	primitive	JJ	-	-	-	-	-	-	-	-
1885825	0	11	local	JJ	-	-	-	-	-	-	-	-
1885825	0	12	cytokine	NN	-	-	-	-	-	-	-	-
1885825	0	13	changes	NNS	-	-	-	-	-	-	-	-
1885825	0	14	.	.	-	-	-	-	-	-	-	-

1885825	0	1	IFNγ	NN	-	-	-	-	-	-	-	(33)
1885825	0	2	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	3	known	VBN	-	-	-	-	-	-	-	-
1885825	0	4	to	TO	-	-	-	-	-	-	-	-
1885825	0	5	increase	VB	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	-
1885825	0	7	epithelial	JJ	-	-	-	-	-	-	-	-
1885825	0	8	adherence	NN	-	-	-	-	-	-	-	-
1885825	0	9	of	IN	-	-	-	-	-	-	-	-
1885825	0	10	selected	VBN	-	-	-	-	-	-	-	-
1885825	0	11	species	NNS	-	-	-	-	-	-	-	-
1885825	0	12	of	IN	-	-	-	-	-	-	-	-
1885825	0	13	enteric	JJ	-	-	-	-	-	-	-	-
1885825	0	14	bacteria	NNS	-	-	-	-	-	-	-	-
1885825	0	15	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	16	40	CD	-	-	-	-	-	-	-	-
1885825	0	17	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Ferrier	NNP	-	-	-	-	-	-	-	-
1885825	0	2	et	FW	-	-	-	-	-	-	-	-
1885825	0	3	al.	FW	-	-	-	-	-	-	-	-
1885825	0	4	have	VBP	-	-	-	-	-	-	-	-
1885825	0	5	shown	VBN	-	-	-	-	-	-	-	-
1885825	0	6	that	IN	-	-	-	-	-	-	-	-
1885825	0	7	a	DT	-	-	-	-	-	-	-	(199
1885825	0	8	chronic	JJ	-	-	-	-	-	-	-	-
1885825	0	9	stress	NN	-	-	-	-	-	-	-	-
1885825	0	10	in	IN	-	-	-	-	-	-	-	-
1885825	0	11	mice	NNS	-	-	-	-	-	-	-	(4)
1885825	0	12	drives	VBZ	-	-	-	-	-	-	-	-
1885825	0	13	an	DT	-	-	-	-	-	-	-	-
1885825	0	14	organ	NN	-	-	-	-	-	-	-	-
1885825	0	15	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	specific	JJ	-	-	-	-	-	-	-	-
1885825	0	17	cytokine	NN	-	-	-	-	-	-	-	-
1885825	0	18	expression	NN	-	-	-	-	-	-	-	-
1885825	0	19	pattern	NN	-	-	-	-	-	-	-	-
1885825	0	20	which	WDT	-	-	-	-	-	-	-	-
1885825	0	21	in	IN	-	-	-	-	-	-	-	-
1885825	0	22	turn	NN	-	-	-	-	-	-	-	-
1885825	0	23	,	,	-	-	-	-	-	-	-	-
1885825	0	24	alters	VBZ	-	-	-	-	-	-	-	-
1885825	0	25	the	DT	-	-	-	-	-	-	-	-
1885825	0	26	colonic	JJ	-	-	-	-	-	-	-	-
1885825	0	27	mucosal	JJ	-	-	-	-	-	-	-	-
1885825	0	28	barrier	NN	-	-	-	-	-	-	-	-
1885825	0	29	functions	NNS	-	-	-	-	-	-	-	-
1885825	0	30	and	CC	-	-	-	-	-	-	-	-
1885825	0	31	favours	VBZ	-	-	-	-	-	-	-	-
1885825	0	32	bacterial	JJ	-	-	-	-	-	-	-	(43
1885825	0	33	translocation	NN	-	-	-	-	-	-	-	43)|199)
1885825	0	34	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	35	31	CD	-	-	-	-	-	-	-	(193)
1885825	0	36	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	37	.	.	-	-	-	-	-	-	-	-

1885825	0	1	This	DT	-	-	-	-	-	-	-	(199
1885825	0	2	effect	NN	-	-	-	-	-	-	-	199)
1885825	0	3	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	4	dependent	JJ	-	-	-	-	-	-	-	-
1885825	0	5	on	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	-
1885825	0	7	presence	NN	-	-	-	-	-	-	-	-
1885825	0	8	of	IN	-	-	-	-	-	-	-	-
1885825	0	9	CD4	NN	-	-	-	-	-	-	-	(30
1885825	0	10	+	SYM	-	-	-	-	-	-	-	-
1885825	0	11	T	NN	-	-	-	-	-	-	-	-
1885825	0	12	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	13	cells	NNS	-	-	-	-	-	-	-	30)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	requires	VBZ	-	-	-	-	-	-	-	-
1885825	0	16	IFNγ	NN	-	-	-	-	-	-	-	(33)
1885825	0	17	production	NN	-	-	-	-	-	-	-	-
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	It	PRP	-	-	-	-	-	-	-	(200
1885825	0	2	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	3	thus	RB	-	-	-	-	-	-	-	-
1885825	0	4	possible	JJ	-	-	-	-	-	-	-	-
1885825	0	5	that	IN	-	-	-	-	-	-	-	-
1885825	0	6	bacterial	JJ	-	-	-	-	-	-	-	(43
1885825	0	7	translocation	NN	-	-	-	-	-	-	-	43)
1885825	0	8	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	9	a	DT	-	-	-	-	-	-	-	-
1885825	0	10	result	NN	-	-	-	-	-	-	-	-
1885825	0	11	of	IN	-	-	-	-	-	-	-	-
1885825	0	12	the	DT	-	-	-	-	-	-	-	(201
1885825	0	13	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	14	changes	NNS	-	-	-	-	-	-	-	201)
1885825	0	15	rather	RB	-	-	-	-	-	-	-	-
1885825	0	16	than	IN	-	-	-	-	-	-	-	-
1885825	0	17	its	PRP$	-	-	-	-	-	-	-	(201)
1885825	0	18	cause	NN	-	-	-	-	-	-	-	200)
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	additional	JJ	-	-	-	-	-	-	-	-
1885825	0	21	experiments	NNS	-	-	-	-	-	-	-	-
1885825	0	22	are	VBP	-	-	-	-	-	-	-	-
1885825	0	23	now	RB	-	-	-	-	-	-	-	-
1885825	0	24	required	VBN	-	-	-	-	-	-	-	-
1885825	0	25	to	TO	-	-	-	-	-	-	-	-
1885825	0	26	answer	VB	-	-	-	-	-	-	-	-
1885825	0	27	this	DT	-	-	-	-	-	-	-	(200
1885825	0	28	question	NN	-	-	-	-	-	-	-	200)
1885825	0	29	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	4	have	VBP	-	-	-	-	-	-	-	-
1885825	0	5	shown	VBN	-	-	-	-	-	-	-	-
1885825	0	6	that	IN	-	-	-	-	-	-	-	-
1885825	0	7	Card15	NN	-	-	-	-	-	-	-	(11|(202
1885825	0	8	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	10	invalidation	NN	-	-	-	-	-	-	-	202)
1885825	0	11	exacerbates	VBZ	-	-	-	-	-	-	-	-
1885825	0	12	the	DT	-	-	-	-	-	-	-	(203
1885825	0	13	severity	NN	-	-	-	-	-	-	-	-
1885825	0	14	of	IN	-	-	-	-	-	-	-	-
1885825	0	15	TNBS	NN	-	-	-	-	-	-	-	(44|(45)
1885825	0	16	induced	VBN	-	-	-	-	-	-	-	-
1885825	0	17	colitis	NN	-	-	-	-	-	-	-	44)|203)
1885825	0	18	,	,	-	-	-	-	-	-	-	-
1885825	0	19	as	IN	-	-	-	-	-	-	-	-
1885825	0	20	evidenced	VBN	-	-	-	-	-	-	-	-
1885825	0	21	by	IN	-	-	-	-	-	-	-	-
1885825	0	22	the	DT	-	-	-	-	-	-	-	-
1885825	0	23	increase	NN	-	-	-	-	-	-	-	-
1885825	0	24	in	IN	-	-	-	-	-	-	-	-
1885825	0	25	all	DT	-	-	-	-	-	-	-	-
1885825	0	26	parameters	NNS	-	-	-	-	-	-	-	-
1885825	0	27	characterising	VBG	-	-	-	-	-	-	-	-
1885825	0	28	colonic	JJ	-	-	-	-	-	-	-	-
1885825	0	29	inflammation	NN	-	-	-	-	-	-	-	-
1885825	0	30	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	31	damages	NNS	-	-	-	-	-	-	-	(164
1885825	0	32	scores	NNS	-	-	-	-	-	-	-	164)
1885825	0	33	and	CC	-	-	-	-	-	-	-	-
1885825	0	34	mucosal	JJ	-	-	-	-	-	-	-	(128b|(129a
1885825	0	35	levels	NNS	-	-	-	-	-	-	-	-
1885825	0	36	of	IN	-	-	-	-	-	-	-	129a)|128b)
1885825	0	37	IL	NN	-	-	-	-	-	-	-	(126
1885825	0	38	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	39	1β	NN	-	-	-	-	-	-	-	126)
1885825	0	40	,	,	-	-	-	-	-	-	-	-
1885825	0	41	TNFα	NN	-	-	-	-	-	-	-	(128b)|(31)
1885825	0	42	and	CC	-	-	-	-	-	-	-	-
1885825	0	43	IL	NN	-	-	-	-	-	-	-	(129a|(34
1885825	0	44	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	45	12	CD	-	-	-	-	-	-	-	34)|129a)
1885825	0	46	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	47	.	.	-	-	-	-	-	-	-	-

1885825	0	1	This	DT	-	-	-	-	-	-	-	(44
1885825	0	2	enhanced	VBN	-	-	-	-	-	-	-	-
1885825	0	3	colitis	NN	-	-	-	-	-	-	-	-
1885825	0	4	-	:	-	-	-	-	-	-	-	-
1885825	0	5	induced	VBN	-	-	-	-	-	-	-	-
1885825	0	6	by	IN	-	-	-	-	-	-	-	-
1885825	0	7	TNBS	NN	-	-	-	-	-	-	-	(45)|44)
1885825	0	8	might	MD	-	-	-	-	-	-	-	-
1885825	0	9	be	VB	-	-	-	-	-	-	-	-
1885825	0	10	explained	VBN	-	-	-	-	-	-	-	-
1885825	0	11	by	IN	-	-	-	-	-	-	-	-
1885825	0	12	different	JJ	-	-	-	-	-	-	-	-
1885825	0	13	mechanisms	NNS	-	-	-	-	-	-	-	-
1885825	0	14	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Firstly	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	since	IN	-	-	-	-	-	-	-	-
1885825	0	4	microflora	NN	-	-	-	-	-	-	-	-
1885825	0	5	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	6	required	VBN	-	-	-	-	-	-	-	-
1885825	0	7	for	IN	-	-	-	-	-	-	-	-
1885825	0	8	TNBS	NN	-	-	-	-	-	-	-	(45)
1885825	0	9	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	10	induced	VBN	-	-	-	-	-	-	-	-
1885825	0	11	colonic	JJ	-	-	-	-	-	-	-	-
1885825	0	12	mucosal	JJ	-	-	-	-	-	-	-	-
1885825	0	13	damages	NNS	-	-	-	-	-	-	-	-
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	since	IN	-	-	-	-	-	-	-	-
1885825	0	16	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	17	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	18	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	19	signaling	NN	-	-	-	-	-	-	-	-
1885825	0	20	has	VBZ	-	-	-	-	-	-	-	-
1885825	0	21	been	VBN	-	-	-	-	-	-	-	-
1885825	0	22	shown	VBN	-	-	-	-	-	-	-	-
1885825	0	23	to	TO	-	-	-	-	-	-	-	-
1885825	0	24	inhibit	VB	-	-	-	-	-	-	-	-
1885825	0	25	the	DT	-	-	-	-	-	-	-	-
1885825	0	26	TLR2	NN	-	-	-	-	-	-	-	(204)
1885825	0	27	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	28	driven	VBN	-	-	-	-	-	-	-	-
1885825	0	29	activation	NN	-	-	-	-	-	-	-	-
1885825	0	30	of	IN	-	-	-	-	-	-	-	-
1885825	0	31	Th1	NN	-	-	-	-	-	-	-	(205|(68)
1885825	0	32	response	NN	-	-	-	-	-	-	-	205)
1885825	0	33	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	34	8	CD	-	-	-	-	-	-	-	-
1885825	0	35	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	36	,	,	-	-	-	-	-	-	-	-
1885825	0	37	one	PRP	-	-	-	-	-	-	-	-
1885825	0	38	can	MD	-	-	-	-	-	-	-	-
1885825	0	39	hypothesize	VB	-	-	-	-	-	-	-	-
1885825	0	40	that	IN	-	-	-	-	-	-	-	-
1885825	0	41	the	DT	-	-	-	-	-	-	-	(205
1885825	0	42	Th1	NN	-	-	-	-	-	-	-	(68)
1885825	0	43	inflammatory	JJ	-	-	-	-	-	-	-	-
1885825	0	44	response	NN	-	-	-	-	-	-	-	205)
1885825	0	45	mediated	VBN	-	-	-	-	-	-	-	-
1885825	0	46	by	IN	-	-	-	-	-	-	-	-
1885825	0	47	TLR	NN	-	-	-	-	-	-	-	(204
1885825	0	48	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	49	2	CD	-	-	-	-	-	-	-	204)
1885825	0	50	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	51	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	52	in	IN	-	-	-	-	-	-	-	-
1885825	0	53	Card15	NN	-	-	-	-	-	-	-	(11|(170
1885825	0	54	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	55	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	56	deficient	JJ	-	-	-	-	-	-	-	-
1885825	0	57	mice	NNS	-	-	-	-	-	-	-	170)
1885825	0	58	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Secondly	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	since	IN	-	-	-	-	-	-	-	-
1885825	0	4	GALT	NN	-	-	-	-	-	-	-	(69)
1885825	0	5	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	6	reported	VBN	-	-	-	-	-	-	-	-
1885825	0	7	to	TO	-	-	-	-	-	-	-	-
1885825	0	8	modulate	VB	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	(203
1885825	0	10	severity	NN	-	-	-	-	-	-	-	-
1885825	0	11	of	IN	-	-	-	-	-	-	-	-
1885825	0	12	TNBS	NN	-	-	-	-	-	-	-	(44|(45)
1885825	0	13	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	14	induced	VBN	-	-	-	-	-	-	-	-
1885825	0	15	colitis	NN	-	-	-	-	-	-	-	44)|203)
1885825	0	16	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	17	41	CD	-	-	-	-	-	-	-	-
1885825	0	18	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	19	,	,	-	-	-	-	-	-	-	-
1885825	0	20	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	21	42	CD	-	-	-	-	-	-	-	-
1885825	0	22	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	23	it	PRP	-	-	-	-	-	-	-	-
1885825	0	24	can	MD	-	-	-	-	-	-	-	-
1885825	0	25	be	VB	-	-	-	-	-	-	-	-
1885825	0	26	hypothesised	VBN	-	-	-	-	-	-	-	-
1885825	0	27	that	IN	-	-	-	-	-	-	-	-
1885825	0	28	the	DT	-	-	-	-	-	-	-	(44
1885825	0	29	TNBS	NN	-	-	-	-	-	-	-	(45)
1885825	0	30	induced	VBN	-	-	-	-	-	-	-	-
1885825	0	31	colitis	NN	-	-	-	-	-	-	-	44)
1885825	0	32	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	33	exacerbated	VBN	-	-	-	-	-	-	-	-
1885825	0	34	in	IN	-	-	-	-	-	-	-	-
1885825	0	35	Card15	NN	-	-	-	-	-	-	-	(11|(12
1885825	0	36	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	37	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	38	KO	NN	-	-	-	-	-	-	-	-
1885825	0	39	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	40	because	IN	-	-	-	-	-	-	-	-
1885825	0	41	of	IN	-	-	-	-	-	-	-	-
1885825	0	42	GALT	NN	-	-	-	-	-	-	-	(69)
1885825	0	43	overdevelopment	NN	-	-	-	-	-	-	-	-
1885825	0	44	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Finally	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	an	DT	-	-	-	-	-	-	-	-
1885825	0	4	alternative	JJ	-	-	-	-	-	-	-	-
1885825	0	5	explanation	NN	-	-	-	-	-	-	-	-
1885825	0	6	could	MD	-	-	-	-	-	-	-	-
1885825	0	7	be	VB	-	-	-	-	-	-	-	-
1885825	0	8	that	IN	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	-
1885825	0	10	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	11	defect	NN	-	-	-	-	-	-	-	-
1885825	0	12	in	IN	-	-	-	-	-	-	-	-
1885825	0	13	terms	NNS	-	-	-	-	-	-	-	-
1885825	0	14	of	IN	-	-	-	-	-	-	-	-
1885825	0	15	intestinal	JJ	-	-	-	-	-	-	-	-
1885825	0	16	permeability	NN	-	-	-	-	-	-	-	-
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	bacterial	JJ	-	-	-	-	-	-	-	(43
1885825	0	19	translocation	NN	-	-	-	-	-	-	-	43)
1885825	0	20	makes	VBZ	-	-	-	-	-	-	-	-
1885825	0	21	the	DT	-	-	-	-	-	-	-	(173
1885825	0	22	intestine	NN	-	-	-	-	-	-	-	173)
1885825	0	23	more	RBR	-	-	-	-	-	-	-	-
1885825	0	24	susceptible	JJ	-	-	-	-	-	-	-	-
1885825	0	25	to	IN	-	-	-	-	-	-	-	-
1885825	0	26	TNBS	NN	-	-	-	-	-	-	-	(45)
1885825	0	27	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Altogether	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	-
1885825	0	4	present	JJ	-	-	-	-	-	-	-	-
1885825	0	5	data	NNS	-	-	-	-	-	-	-	-
1885825	0	6	demonstrate	VBP	-	-	-	-	-	-	-	-
1885825	0	7	that	IN	-	-	-	-	-	-	-	-
1885825	0	8	Card15	NN	-	-	-	-	-	-	-	(11|(206
1885825	0	9	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	10	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	11	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	12	required	VBN	-	-	-	-	-	-	-	-
1885825	0	13	to	TO	-	-	-	-	-	-	-	-
1885825	0	14	maintain	VB	-	-	-	-	-	-	-	-
1885825	0	15	the	DT	-	-	-	-	-	-	-	(3
1885825	0	16	homeostatis	NN	-	-	-	-	-	-	-	-
1885825	0	17	of	IN	-	-	-	-	-	-	-	-
1885825	0	18	the	DT	-	-	-	-	-	-	-	-
1885825	0	19	PPs	NNS	-	-	-	-	-	-	-	3)|206)
1885825	0	20	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Because	IN	-	-	-	-	-	-	-	-
1885825	0	2	CARD15	NN	-	-	-	-	-	-	-	(1
1885825	0	3	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	4	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	5	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	6	a	DT	-	-	-	-	-	-	-	-
1885825	0	7	well	RB	-	-	-	-	-	-	-	-
1885825	0	8	demonstrated	VBN	-	-	-	-	-	-	-	-
1885825	0	9	etiological	JJ	-	-	-	-	-	-	-	-
1885825	0	10	factor	NN	-	-	-	-	-	-	-	-
1885825	0	11	for	IN	-	-	-	-	-	-	-	-
1885825	0	12	CD	NN	-	-	-	-	-	-	-	(207|(6)
1885825	0	13	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	14	GVHD	NN	-	-	-	-	-	-	-	(8)|207)
1885825	0	15	,	,	-	-	-	-	-	-	-	-
1885825	0	16	this	DT	-	-	-	-	-	-	-	(206
1885825	0	17	conclusion	NN	-	-	-	-	-	-	-	206)
1885825	0	18	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	19	of	IN	-	-	-	-	-	-	-	-
1885825	0	20	particular	JJ	-	-	-	-	-	-	-	-
1885825	0	21	importance	NN	-	-	-	-	-	-	-	-
1885825	0	22	for	IN	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	-
1885825	0	24	understanding	NN	-	-	-	-	-	-	-	-
1885825	0	25	of	IN	-	-	-	-	-	-	-	-
1885825	0	26	disease	NN	-	-	-	-	-	-	-	(66
1885825	0	27	mechanisms	NNS	-	-	-	-	-	-	-	66)
1885825	0	28	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Indeed	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	it	PRP	-	-	-	-	-	-	-	(206)
1885825	0	4	further	RB	-	-	-	-	-	-	-	-
1885825	0	5	supports	VBZ	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	-
1885825	0	7	opinion	NN	-	-	-	-	-	-	-	-
1885825	0	8	that	IN	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	-
1885825	0	10	defect	NN	-	-	-	-	-	-	-	-
1885825	0	11	involved	VBN	-	-	-	-	-	-	-	-
1885825	0	12	in	IN	-	-	-	-	-	-	-	-
1885825	0	13	the	DT	-	-	-	-	-	-	-	-
1885825	0	14	development	NN	-	-	-	-	-	-	-	-
1885825	0	15	of	IN	-	-	-	-	-	-	-	-
1885825	0	16	the	DT	-	-	-	-	-	-	-	-
1885825	0	17	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	18	lesions	NNS	-	-	-	-	-	-	-	-
1885825	0	19	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	20	related	VBN	-	-	-	-	-	-	-	-
1885825	0	21	with	IN	-	-	-	-	-	-	-	-
1885825	0	22	PP	NNS	-	-	-	-	-	-	-	(2)|(48b)
1885825	0	23	and	CC	-	-	-	-	-	-	-	-
1885825	0	24	LF	NN	-	-	-	-	-	-	-	(20)
1885825	0	25	function	NN	-	-	-	-	-	-	-	(48b)
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	(208
1885825	0	2	GALT	NN	-	-	-	-	-	-	-	(69)
1885825	0	3	dysfunction	NN	-	-	-	-	-	-	-	-
1885825	0	4	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	5	in	IN	-	-	-	-	-	-	-	-
1885825	0	6	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	7	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	8	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	9	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	10	with	IN	-	-	-	-	-	-	-	-
1885825	0	11	an	DT	-	-	-	-	-	-	-	-
1885825	0	12	excessive	JJ	-	-	-	-	-	-	-	-
1885825	0	13	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	14	immune	JJ	-	-	-	-	-	-	-	-
1885825	0	15	response	NN	-	-	-	-	-	-	-	-
1885825	0	16	and	CC	-	-	-	-	-	-	-	-
1885825	0	17	an	DT	-	-	-	-	-	-	-	-
1885825	0	18	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	19	bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	20	translocation	NN	-	-	-	-	-	-	-	208)
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	These	DT	-	-	-	-	-	-	-	(208
1885825	0	2	findings	NNS	-	-	-	-	-	-	-	208)
1885825	0	3	are	VBP	-	-	-	-	-	-	-	-
1885825	0	4	consistent	JJ	-	-	-	-	-	-	-	-
1885825	0	5	with	IN	-	-	-	-	-	-	-	-
1885825	0	6	our	PRP$	-	-	-	-	-	-	-	(13)
1885825	0	7	knowledge	NN	-	-	-	-	-	-	-	-
1885825	0	8	on	IN	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	(7
1885825	0	10	Human	JJ	-	-	-	-	-	-	-	-
1885825	0	11	diseases	NNS	-	-	-	-	-	-	-	-
1885825	0	12	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	13	with	IN	-	-	-	-	-	-	-	-
1885825	0	14	CARD15	NN	-	-	-	-	-	-	-	(1|(5
1885825	0	15	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	NOD2	NN	-	-	-	-	-	-	-	1)
1885825	0	17	mutations	NNS	-	-	-	-	-	-	-	-
1885825	0	18	namely	RB	-	-	-	-	-	-	-	-
1885825	0	19	GVHD	NN	-	-	-	-	-	-	-	-
1885825	0	20	and	CC	-	-	-	-	-	-	-	-
1885825	0	21	CD	NN	-	-	-	-	-	-	-	(6)|7)|5)
1885825	0	22	and	CC	-	-	-	-	-	-	-	-
1885825	0	23	for	IN	-	-	-	-	-	-	-	-
1885825	0	24	which	WDT	-	-	-	-	-	-	-	-
1885825	0	25	similar	JJ	-	-	-	-	-	-	-	-
1885825	0	26	observations	NNS	-	-	-	-	-	-	-	-
1885825	0	27	have	VBP	-	-	-	-	-	-	-	-
1885825	0	28	been	VBN	-	-	-	-	-	-	-	-
1885825	0	29	reported	VBN	-	-	-	-	-	-	-	-
1885825	0	30	.	.	-	-	-	-	-	-	-	-

1885825	0	1	As	IN	-	-	-	-	-	-	-	-
1885825	0	2	a	DT	-	-	-	-	-	-	-	-
1885825	0	3	result	NN	-	-	-	-	-	-	-	-
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	the	DT	-	-	-	-	-	-	-	(12
1885825	0	6	phenotype	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	-
1885825	0	9	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	10	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	12	KO	NN	-	-	-	-	-	-	-	-
1885825	0	13	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	14	can	MD	-	-	-	-	-	-	-	-
1885825	0	15	be	VB	-	-	-	-	-	-	-	-
1885825	0	16	seen	VBN	-	-	-	-	-	-	-	-
1885825	0	17	as	IN	-	-	-	-	-	-	-	-
1885825	0	18	an	DT	-	-	-	-	-	-	-	-
1885825	0	19	attenuated	VBN	-	-	-	-	-	-	-	-
1885825	0	20	model	NN	-	-	-	-	-	-	-	-
1885825	0	21	of	IN	-	-	-	-	-	-	-	-
1885825	0	22	CD	NN	-	-	-	-	-	-	-	(207|(6)
1885825	0	23	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	24	GVHD	NN	-	-	-	-	-	-	-	(8)|207)
1885825	0	25	.	.	-	-	-	-	-	-	-	-

1885825	0	1	It	PRP	-	-	-	-	-	-	-	-
1885825	0	2	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	3	to	TO	-	-	-	-	-	-	-	-
1885825	0	4	note	VB	-	-	-	-	-	-	-	-
1885825	0	5	that	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	-
1885825	0	7	absence	NN	-	-	-	-	-	-	-	-
1885825	0	8	of	IN	-	-	-	-	-	-	-	-
1885825	0	9	a	DT	-	-	-	-	-	-	-	-
1885825	0	10	full	JJ	-	-	-	-	-	-	-	-
1885825	0	11	phenotype	NN	-	-	-	-	-	-	-	-
1885825	0	12	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	13	not	RB	-	-	-	-	-	-	-	-
1885825	0	14	unexpected	JJ	-	-	-	-	-	-	-	-
1885825	0	15	considering	VBG	-	-	-	-	-	-	-	-
1885825	0	16	the	DT	-	-	-	-	-	-	-	-
1885825	0	17	multifactorial	JJ	-	-	-	-	-	-	-	-
1885825	0	18	nature	NN	-	-	-	-	-	-	-	-
1885825	0	19	of	IN	-	-	-	-	-	-	-	-
1885825	0	20	the	DT	-	-	-	-	-	-	-	-
1885825	0	21	Human	JJ	-	-	-	-	-	-	-	-
1885825	0	22	diseases	NNS	-	-	-	-	-	-	-	-
1885825	0	23	where	WRB	-	-	-	-	-	-	-	-
1885825	0	24	exposure	NN	-	-	-	-	-	-	-	(209
1885825	0	25	to	IN	-	-	-	-	-	-	-	-
1885825	0	26	several	JJ	-	-	-	-	-	-	-	-
1885825	0	27	additional	JJ	-	-	-	-	-	-	-	-
1885825	0	28	unknown	JJ	-	-	-	-	-	-	-	-
1885825	0	29	genetic	JJ	-	-	-	-	-	-	-	-
1885825	0	30	and	CC	-	-	-	-	-	-	-	-
1885825	0	31	environmental	JJ	-	-	-	-	-	-	-	-
1885825	0	32	risk	NN	-	-	-	-	-	-	-	-
1885825	0	33	factors	NNS	-	-	-	-	-	-	-	209)
1885825	0	34	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	35	required	VBN	-	-	-	-	-	-	-	-
1885825	0	36	for	IN	-	-	-	-	-	-	-	-
1885825	0	37	disease	NN	-	-	-	-	-	-	-	(7)
1885825	0	38	expression	NN	-	-	-	-	-	-	-	-
1885825	0	39	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	the	DT	-	-	-	-	-	-	-	-
1885825	0	3	opposite	JJ	-	-	-	-	-	-	-	-
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	our	PRP$	-	-	-	-	-	-	-	(13)
1885825	0	6	work	NN	-	-	-	-	-	-	-	-
1885825	0	7	indicates	VBZ	-	-	-	-	-	-	-	-
1885825	0	8	that	IN	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	(12
1885825	0	10	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	11	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	12	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	13	KO	NN	-	-	-	-	-	-	-	-
1885825	0	14	mouse	NN	-	-	-	-	-	-	-	12)
1885825	0	15	is	VBZ	-	-	-	-	-	-	-	-
1885825	0	16	a	DT	-	-	-	-	-	-	-	-
1885825	0	17	relevant	JJ	-	-	-	-	-	-	-	-
1885825	0	18	model	NN	-	-	-	-	-	-	-	-
1885825	0	19	for	IN	-	-	-	-	-	-	-	-
1885825	0	20	investigating	VBG	-	-	-	-	-	-	-	-
1885825	0	21	these	DT	-	-	-	-	-	-	-	(209
1885825	0	22	other	JJ	-	-	-	-	-	-	-	-
1885825	0	23	risk	NN	-	-	-	-	-	-	-	-
1885825	0	24	factors	NNS	-	-	-	-	-	-	-	-
1885825	0	25	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	26	with	IN	-	-	-	-	-	-	-	-
1885825	0	27	CD	NN	-	-	-	-	-	-	-	(7|(6)
1885825	0	28	and	CC	-	-	-	-	-	-	-	-
1885825	0	29	GVHD	NN	-	-	-	-	-	-	-	(8)|7)|209)
1885825	0	30	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Material	NN	-	-	-	-	-	-	-	-
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	Methods	NNS	-	-	-	-	-	-	-	-

1885825	0	1	Animals	NNS	-	-	-	-	-	-	-	(210)

1885825	0	1	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	2	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	3	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	4	was	VBD	-	-	-	-	-	-	-	-
1885825	0	5	disrupted	VBN	-	-	-	-	-	-	-	-
1885825	0	6	in	IN	-	-	-	-	-	-	-	-
1885825	0	7	mice	NNS	-	-	-	-	-	-	-	(210)
1885825	0	8	by	IN	-	-	-	-	-	-	-	-
1885825	0	9	replacing	VBG	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	(211
1885825	0	11	first	JJ	-	-	-	-	-	-	-	-
1885825	0	12	coding	NN	-	-	-	-	-	-	-	-
1885825	0	13	exon	NN	-	-	-	-	-	-	-	-
1885825	0	14	carrying	VBG	-	-	-	-	-	-	-	-
1885825	0	15	the	DT	-	-	-	-	-	-	-	-
1885825	0	16	majority	NN	-	-	-	-	-	-	-	-
1885825	0	17	of	IN	-	-	-	-	-	-	-	-
1885825	0	18	the	DT	-	-	-	-	-	-	-	-
1885825	0	19	sequence	NN	-	-	-	-	-	-	-	-
1885825	0	20	encoding	VBG	-	-	-	-	-	-	-	-
1885825	0	21	the	DT	-	-	-	-	-	-	-	-
1885825	0	22	CARD	NN	-	-	-	-	-	-	-	-
1885825	0	23	domains	NNS	-	-	-	-	-	-	-	-
1885825	0	24	including	VBG	-	-	-	-	-	-	-	-
1885825	0	25	the	DT	-	-	-	-	-	-	-	-
1885825	0	26	start	NN	-	-	-	-	-	-	-	-
1885825	0	27	codon	NN	-	-	-	-	-	-	-	-
1885825	0	28	with	IN	-	-	-	-	-	-	-	-
1885825	0	29	a	DT	-	-	-	-	-	-	-	-
1885825	0	30	EGFP	NN	-	-	-	-	-	-	-	-
1885825	0	31	cassette	NN	-	-	-	-	-	-	-	211)
1885825	0	32	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	Fig.	NN	-	-	-	-	-	-	-	(212
1885825	0	3	7	CD	-	-	-	-	-	-	-	-
1885825	0	4	A	NN	-	-	-	-	-	-	-	212)
1885825	0	5	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	6	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	the	DT	-	-	-	-	-	-	-	(213
1885825	0	3	first	JJ	-	-	-	-	-	-	-	-
1885825	0	4	step	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(214
1885825	0	7	strategy	NN	-	-	-	-	-	-	-	214)|213)
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	(215
1885825	0	10	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	11	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	12	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	13	locus	NN	-	-	-	-	-	-	-	215)
1885825	0	14	was	VBD	-	-	-	-	-	-	-	-
1885825	0	15	targeted	VBN	-	-	-	-	-	-	-	-
1885825	0	16	with	IN	-	-	-	-	-	-	-	-
1885825	0	17	the	DT	-	-	-	-	-	-	-	(216
1885825	0	18	Card15	NN	-	-	-	-	-	-	-	-
1885825	0	19	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	20	Nod2	NN	-	-	-	-	-	-	-	-
1885825	0	21	KO	NN	-	-	-	-	-	-	-	-
1885825	0	22	targeting	NN	-	-	-	-	-	-	-	-
1885825	0	23	fragment	NN	-	-	-	-	-	-	-	216)
1885825	0	24	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	the	DT	-	-	-	-	-	-	-	(217
1885825	0	3	second	JJ	-	-	-	-	-	-	-	-
1885825	0	4	step	NN	-	-	-	-	-	-	-	217)
1885825	0	5	,	,	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(218
1885825	0	7	PGKHygromycin	NN	-	-	-	-	-	-	-	-
1885825	0	8	selection	NN	-	-	-	-	-	-	-	-
1885825	0	9	cassette	NN	-	-	-	-	-	-	-	218)
1885825	0	10	was	VBD	-	-	-	-	-	-	-	-
1885825	0	11	removed	VBN	-	-	-	-	-	-	-	-
1885825	0	12	by	IN	-	-	-	-	-	-	-	-
1885825	0	13	Cre	NN	-	-	-	-	-	-	-	(219
1885825	0	14	recombinase	NN	-	-	-	-	-	-	-	219)
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Targeted	VBN	-	-	-	-	-	-	-	-
1885825	0	2	disruption	NN	-	-	-	-	-	-	-	-
1885825	0	3	was	VBD	-	-	-	-	-	-	-	-
1885825	0	4	determined	VBN	-	-	-	-	-	-	-	-
1885825	0	5	by	IN	-	-	-	-	-	-	-	-
1885825	0	6	Southern	NNP	-	-	-	-	-	-	-	-
1885825	0	7	blot	NN	-	-	-	-	-	-	-	-
1885825	0	8	and	CC	-	-	-	-	-	-	-	-
1885825	0	9	long	JJ	-	-	-	-	-	-	-	-
1885825	0	10	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	range	NN	-	-	-	-	-	-	-	-
1885825	0	12	PCR	NN	-	-	-	-	-	-	-	(220)
1885825	0	13	analysis	NN	-	-	-	-	-	-	-	-
1885825	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	15	Fig.	NN	-	-	-	-	-	-	-	-
1885825	0	16	7	CD	-	-	-	-	-	-	-	-
1885825	0	17	B	NN	-	-	-	-	-	-	-	-
1885825	0	18	–	SYM	-	-	-	-	-	-	-	-
1885825	0	19	C	NN	-	-	-	-	-	-	-	-
1885825	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Genomic	JJ	-	-	-	-	-	-	-	(221
1885825	0	2	DNA	NN	-	-	-	-	-	-	-	-
1885825	0	3	from	IN	-	-	-	-	-	-	-	-
1885825	0	4	mice	NNS	-	-	-	-	-	-	-	(210)|221)
1885825	0	5	was	VBD	-	-	-	-	-	-	-	-
1885825	0	6	amplified	VBN	-	-	-	-	-	-	-	-
1885825	0	7	by	IN	-	-	-	-	-	-	-	-
1885825	0	8	PCR	NN	-	-	-	-	-	-	-	(220)
1885825	0	9	using	VBG	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	-
1885825	0	11	primers	NNS	-	-	-	-	-	-	-	-
1885825	0	12	:	:	-	-	-	-	-	-	-	-
1885825	0	13	5	CD	-	-	-	-	-	-	-	-
1885825	0	14	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	15	GTCATTTCCTGACCTCTGACC	NN	-	-	-	-	-	-	-	-
1885825	0	16	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	3	CD	-	-	-	-	-	-	-	-
1885825	0	18	and	CC	-	-	-	-	-	-	-	-
1885825	0	19	5	CD	-	-	-	-	-	-	-	(222
1885825	0	20	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	21	AACCGCATTATTCCATGGGGC	NN	-	-	-	-	-	-	-	-
1885825	0	22	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	23	3	CD	-	-	-	-	-	-	-	222)
1885825	0	24	to	TO	-	-	-	-	-	-	-	-
1885825	0	25	detect	VB	-	-	-	-	-	-	-	-
1885825	0	26	WT	NN	-	-	-	-	-	-	-	-
1885825	0	27	DNA	NN	-	-	-	-	-	-	-	-
1885825	0	28	and	CC	-	-	-	-	-	-	-	-
1885825	0	29	primers	NNS	-	-	-	-	-	-	-	-
1885825	0	30	5	CD	-	-	-	-	-	-	-	(222
1885825	0	31	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	32	AACCGCATTATTCCATGGGGC	NN	-	-	-	-	-	-	-	-
1885825	0	33	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	34	3	CD	-	-	-	-	-	-	-	222)
1885825	0	35	and	CC	-	-	-	-	-	-	-	-
1885825	0	36	5	CD	-	-	-	-	-	-	-	-
1885825	0	37	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	38	GCCTGCTCTTTACTGAAGGCTC	NN	-	-	-	-	-	-	-	-
1885825	0	39	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	40	3	CD	-	-	-	-	-	-	-	-
1885825	0	41	to	TO	-	-	-	-	-	-	-	-
1885825	0	42	detect	VB	-	-	-	-	-	-	-	-
1885825	0	43	the	DT	-	-	-	-	-	-	-	(223
1885825	0	44	disrupted	VBN	-	-	-	-	-	-	-	-
1885825	0	45	sequence	NN	-	-	-	-	-	-	-	223)
1885825	0	46	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	loss	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	mRNA	NN	-	-	-	-	-	-	-	(224
1885825	0	5	Nod2	NN	-	-	-	-	-	-	-	224)
1885825	0	6	expression	NN	-	-	-	-	-	-	-	-
1885825	0	7	was	VBD	-	-	-	-	-	-	-	-
1885825	0	8	demonstrated	VBN	-	-	-	-	-	-	-	-
1885825	0	9	in	IN	-	-	-	-	-	-	-	-
1885825	0	10	splenocytes	NNS	-	-	-	-	-	-	-	-
1885825	0	11	by	IN	-	-	-	-	-	-	-	-
1885825	0	12	RT	NN	-	-	-	-	-	-	-	(220
1885825	0	13	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	14	PCR	NN	-	-	-	-	-	-	-	220)
1885825	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	16	Fig.	NN	-	-	-	-	-	-	-	(225
1885825	0	17	7	CD	-	-	-	-	-	-	-	-
1885825	0	18	D	NN	-	-	-	-	-	-	-	225)
1885825	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	20	using	VBG	-	-	-	-	-	-	-	-
1885825	0	21	the	DT	-	-	-	-	-	-	-	-
1885825	0	22	following	VBG	-	-	-	-	-	-	-	-
1885825	0	23	primers	NNS	-	-	-	-	-	-	-	-
1885825	0	24	:	:	-	-	-	-	-	-	-	-
1885825	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	26	5	CD	-	-	-	-	-	-	-	-
1885825	0	27	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	28	CTTTGAACTGTATGGGTCC	NN	-	-	-	-	-	-	-	-
1885825	0	29	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	30	3	CD	-	-	-	-	-	-	-	-
1885825	0	31	and	CC	-	-	-	-	-	-	-	-
1885825	0	32	5	CD	-	-	-	-	-	-	-	-
1885825	0	33	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	34	CTCCACTGCCTCTGCCTTA	NN	-	-	-	-	-	-	-	-
1885825	0	35	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	36	3	CD	-	-	-	-	-	-	-	-
1885825	0	37	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	38	.	.	-	-	-	-	-	-	-	-

1885825	0	1	As	IN	-	-	-	-	-	-	-	-
1885825	0	2	expected	VBN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	no	DT	-	-	-	-	-	-	-	-
1885825	0	5	signal	NN	-	-	-	-	-	-	-	-
1885825	0	6	was	VBD	-	-	-	-	-	-	-	-
1885825	0	7	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	8	in	IN	-	-	-	-	-	-	-	-
1885825	0	9	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	10	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	11	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	(12
1885825	0	2	Card15	NN	-	-	-	-	-	-	-	-
1885825	0	3	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	4	Nod2	NN	-	-	-	-	-	-	-	-
1885825	0	5	−	SYM	-	-	-	-	-	-	-	-
1885825	0	6	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	7	−	SYM	-	-	-	-	-	-	-	-
1885825	0	8	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	9	KO	NN	-	-	-	-	-	-	-	-
1885825	0	10	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	11	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	12	used	VBN	-	-	-	-	-	-	-	-
1885825	0	13	for	IN	-	-	-	-	-	-	-	-
1885825	0	14	this	DT	-	-	-	-	-	-	-	(226
1885825	0	15	study	NN	-	-	-	-	-	-	-	226)|12)
1885825	0	16	were	VBD	-	-	-	-	-	-	-	-
1885825	0	17	back	RB	-	-	-	-	-	-	-	-
1885825	0	18	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	19	crossed	VBN	-	-	-	-	-	-	-	-
1885825	0	20	five	CD	-	-	-	-	-	-	-	-
1885825	0	21	times	NNS	-	-	-	-	-	-	-	-
1885825	0	22	with	IN	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	-
1885825	0	24	inbred	JJ	-	-	-	-	-	-	-	-
1885825	0	25	strains	NNS	-	-	-	-	-	-	-	-
1885825	0	26	C57BL	NN	-	-	-	-	-	-	-	-
1885825	0	27	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	28	6	CD	-	-	-	-	-	-	-	-
1885825	0	29	.	.	-	-	-	-	-	-	-	-

1885825	0	1	WT	NN	-	-	-	-	-	-	-	(86|(87f)
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	4	mice	NNS	-	-	-	-	-	-	-	(87f)|86)|12)
1885825	0	5	were	VBD	-	-	-	-	-	-	-	-
1885825	0	6	housed	VBN	-	-	-	-	-	-	-	-
1885825	0	7	and	CC	-	-	-	-	-	-	-	-
1885825	0	8	generated	VBN	-	-	-	-	-	-	-	-
1885825	0	9	in	IN	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	-
1885825	0	11	animal	NN	-	-	-	-	-	-	-	(76)
1885825	0	12	facility	NN	-	-	-	-	-	-	-	-
1885825	0	13	at	IN	-	-	-	-	-	-	-	-
1885825	0	14	Robert	NNP	-	-	-	-	-	-	-	-
1885825	0	15	Debré	NNP	-	-	-	-	-	-	-	-
1885825	0	16	Hospital	NNP	-	-	-	-	-	-	-	-
1885825	0	17	,	,	-	-	-	-	-	-	-	-
1885825	0	18	Paris	NNP	-	-	-	-	-	-	-	-
1885825	0	19	,	,	-	-	-	-	-	-	-	-
1885825	0	20	France	NNP	-	-	-	-	-	-	-	-
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	absence	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	enteropathogens	NNS	-	-	-	-	-	-	-	(72)
1885825	0	5	was	VBD	-	-	-	-	-	-	-	-
1885825	0	6	monitored	VBN	-	-	-	-	-	-	-	-
1885825	0	7	.	.	-	-	-	-	-	-	-	-

1885825	0	1	All	DT	-	-	-	-	-	-	-	-
1885825	0	2	experiments	NNS	-	-	-	-	-	-	-	-
1885825	0	3	were	VBD	-	-	-	-	-	-	-	-
1885825	0	4	approved	VBN	-	-	-	-	-	-	-	-
1885825	0	5	by	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	-
1885825	0	7	institutional	JJ	-	-	-	-	-	-	-	-
1885825	0	8	committee	NN	-	-	-	-	-	-	-	-
1885825	0	9	for	IN	-	-	-	-	-	-	-	-
1885825	0	10	animal	NN	-	-	-	-	-	-	-	(76)
1885825	0	11	use	NN	-	-	-	-	-	-	-	-
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Peyer	NNP	-	-	-	-	-	-	-	(19a|(2|(9
1885825	0	2	's	POS	-	-	-	-	-	-	-	-
1885825	0	3	patches	NNS	-	-	-	-	-	-	-	2)|19a)
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	isolated	VBN	-	-	-	-	-	-	-	(10|(90
1885825	0	6	lymphoid	JJ	-	-	-	-	-	-	-	-
1885825	0	7	follicle	NN	-	-	-	-	-	-	-	9)|10)
1885825	0	8	numbers	NNS	-	-	-	-	-	-	-	(19a)|90)

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	entire	JJ	-	-	-	-	-	-	-	-
1885825	0	3	small	JJ	-	-	-	-	-	-	-	-
1885825	0	4	intestines	NNS	-	-	-	-	-	-	-	-
1885825	0	5	were	VBD	-	-	-	-	-	-	-	-
1885825	0	6	removed	VBN	-	-	-	-	-	-	-	-
1885825	0	7	and	CC	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	(19
1885825	0	9	number	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	PPs	NNS	-	-	-	-	-	-	-	(2)|19)
1885825	0	12	was	VBD	-	-	-	-	-	-	-	-
1885825	0	13	determinated	VBN	-	-	-	-	-	-	-	-
1885825	0	14	by	IN	-	-	-	-	-	-	-	-
1885825	0	15	macroscopic	JJ	-	-	-	-	-	-	-	-
1885825	0	16	observation	NN	-	-	-	-	-	-	-	-
1885825	0	17	except	IN	-	-	-	-	-	-	-	-
1885825	0	18	at	IN	-	-	-	-	-	-	-	-
1885825	0	19	birth	NN	-	-	-	-	-	-	-	(21)
1885825	0	20	where	WRB	-	-	-	-	-	-	-	-
1885825	0	21	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	22	were	VBD	-	-	-	-	-	-	-	-
1885825	0	23	too	RB	-	-	-	-	-	-	-	-
1885825	0	24	small	JJ	-	-	-	-	-	-	-	-
1885825	0	25	to	TO	-	-	-	-	-	-	-	-
1885825	0	26	be	VB	-	-	-	-	-	-	-	-
1885825	0	27	seen	VBN	-	-	-	-	-	-	-	-
1885825	0	28	by	IN	-	-	-	-	-	-	-	-
1885825	0	29	the	DT	-	-	-	-	-	-	-	-
1885825	0	30	naked	JJ	-	-	-	-	-	-	-	-
1885825	0	31	eye	NN	-	-	-	-	-	-	-	-
1885825	0	32	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	birth	NN	-	-	-	-	-	-	-	(21)
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	small	JJ	-	-	-	-	-	-	-	(91
1885825	0	5	intestines	NNS	-	-	-	-	-	-	-	91)
1885825	0	6	were	VBD	-	-	-	-	-	-	-	-
1885825	0	7	fixed	VBN	-	-	-	-	-	-	-	-
1885825	0	8	in	IN	-	-	-	-	-	-	-	-
1885825	0	9	formalin	NN	-	-	-	-	-	-	-	(227)
1885825	0	10	,	,	-	-	-	-	-	-	-	-
1885825	0	11	stained	VBN	-	-	-	-	-	-	-	-
1885825	0	12	with	IN	-	-	-	-	-	-	-	-
1885825	0	13	0.5	CD	-	-	-	-	-	-	-	-
1885825	0	14	%	NN	-	-	-	-	-	-	-	-
1885825	0	15	methylene	NN	-	-	-	-	-	-	-	-
1885825	0	16	blue	JJ	-	-	-	-	-	-	-	-
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	decolorized	VBN	-	-	-	-	-	-	-	-
1885825	0	19	in	IN	-	-	-	-	-	-	-	-
1885825	0	20	fresh	JJ	-	-	-	-	-	-	-	-
1885825	0	21	2	CD	-	-	-	-	-	-	-	-
1885825	0	22	%	NN	-	-	-	-	-	-	-	-
1885825	0	23	acetic	JJ	-	-	-	-	-	-	-	-
1885825	0	24	acid	NN	-	-	-	-	-	-	-	-
1885825	0	25	.	.	-	-	-	-	-	-	-	-

1885825	0	1	For	IN	-	-	-	-	-	-	-	-
1885825	0	2	LF	NN	-	-	-	-	-	-	-	(20)
1885825	0	3	counts	NNS	-	-	-	-	-	-	-	-
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	small	JJ	-	-	-	-	-	-	-	(91
1885825	0	6	intestines	NNS	-	-	-	-	-	-	-	91)
1885825	0	7	were	VBD	-	-	-	-	-	-	-	-
1885825	0	8	fixed	VBN	-	-	-	-	-	-	-	-
1885825	0	9	in	IN	-	-	-	-	-	-	-	-
1885825	0	10	formalin	NN	-	-	-	-	-	-	-	(227)
1885825	0	11	and	CC	-	-	-	-	-	-	-	-
1885825	0	12	rolled	VBN	-	-	-	-	-	-	-	-
1885825	0	13	up	RP	-	-	-	-	-	-	-	-
1885825	0	14	into	IN	-	-	-	-	-	-	-	-
1885825	0	15	a	DT	-	-	-	-	-	-	-	-
1885825	0	16	‘	``	-	-	-	-	-	-	-	-
1885825	0	17	Swiss	NNP	-	-	-	-	-	-	-	-
1885825	0	18	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	19	roll	NN	-	-	-	-	-	-	-	-
1885825	0	20	’	''	-	-	-	-	-	-	-	-
1885825	0	21	,	,	-	-	-	-	-	-	-	-
1885825	0	22	embedded	VBN	-	-	-	-	-	-	-	-
1885825	0	23	in	IN	-	-	-	-	-	-	-	-
1885825	0	24	paraffin	NN	-	-	-	-	-	-	-	(228
1885825	0	25	blocks	NNS	-	-	-	-	-	-	-	228)
1885825	0	26	and	CC	-	-	-	-	-	-	-	-
1885825	0	27	cut	VBD	-	-	-	-	-	-	-	-
1885825	0	28	into	IN	-	-	-	-	-	-	-	-
1885825	0	29	5	CD	-	-	-	-	-	-	-	(229
1885825	0	30	µm	NN	-	-	-	-	-	-	-	229)
1885825	0	31	sections	NNS	-	-	-	-	-	-	-	-
1885825	0	32	.	.	-	-	-	-	-	-	-	-

1885825	0	1	LFs	NNS	-	-	-	-	-	-	-	(20)
1885825	0	2	were	VBD	-	-	-	-	-	-	-	-
1885825	0	3	counted	VBN	-	-	-	-	-	-	-	-
1885825	0	4	in	IN	-	-	-	-	-	-	-	-
1885825	0	5	a	DT	-	-	-	-	-	-	-	-
1885825	0	6	blind	JJ	-	-	-	-	-	-	-	-
1885825	0	7	fashion	NN	-	-	-	-	-	-	-	-
1885825	0	8	on	IN	-	-	-	-	-	-	-	-
1885825	0	9	two	CD	-	-	-	-	-	-	-	-
1885825	0	10	sections	NNS	-	-	-	-	-	-	-	-
1885825	0	11	per	IN	-	-	-	-	-	-	-	-
1885825	0	12	blocks	NNS	-	-	-	-	-	-	-	(228)
1885825	0	13	after	IN	-	-	-	-	-	-	-	-
1885825	0	14	haematoxylin	NN	-	-	-	-	-	-	-	-
1885825	0	15	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	eosin	NN	-	-	-	-	-	-	-	-
1885825	0	17	staining	NN	-	-	-	-	-	-	-	-
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Cell	NN	-	-	-	-	-	-	-	(24
1885825	0	2	composition	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	Peyer	NNP	-	-	-	-	-	-	-	(2
1885825	0	5	's	POS	-	-	-	-	-	-	-	-
1885825	0	6	Patches	NNS	-	-	-	-	-	-	-	24)|2)
1885825	0	7	and	CC	-	-	-	-	-	-	-	-
1885825	0	8	spleens	NNS	-	-	-	-	-	-	-	(107)

1885825	0	1	Cell	NN	-	-	-	-	-	-	-	(230
1885825	0	2	suspensions	NNS	-	-	-	-	-	-	-	-
1885825	0	3	from	IN	-	-	-	-	-	-	-	-
1885825	0	4	PPs	NNS	-	-	-	-	-	-	-	(2)|230)
1885825	0	5	were	VBD	-	-	-	-	-	-	-	-
1885825	0	6	prepared	VBN	-	-	-	-	-	-	-	-
1885825	0	7	by	IN	-	-	-	-	-	-	-	-
1885825	0	8	pressing	VBG	-	-	-	-	-	-	-	(231
1885825	0	9	the	DT	-	-	-	-	-	-	-	-
1885825	0	10	three	CD	-	-	-	-	-	-	-	-
1885825	0	11	largest	JJS	-	-	-	-	-	-	-	-
1885825	0	12	PPs	NNS	-	-	-	-	-	-	-	-
1885825	0	13	for	IN	-	-	-	-	-	-	-	-
1885825	0	14	each	DT	-	-	-	-	-	-	-	-
1885825	0	15	mouse	NN	-	-	-	-	-	-	-	-
1885825	0	16	with	IN	-	-	-	-	-	-	-	-
1885825	0	17	a	DT	-	-	-	-	-	-	-	-
1885825	0	18	5	CD	-	-	-	-	-	-	-	-
1885825	0	19	ml	NN	-	-	-	-	-	-	-	-
1885825	0	20	syringe	NN	-	-	-	-	-	-	-	-
1885825	0	21	piston	NN	-	-	-	-	-	-	-	-
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	preparation	NN	-	-	-	-	-	-	-	-
1885825	0	3	was	VBD	-	-	-	-	-	-	-	-
1885825	0	4	then	RB	-	-	-	-	-	-	-	-
1885825	0	5	incubated	VBN	-	-	-	-	-	-	-	-
1885825	0	6	with	IN	-	-	-	-	-	-	-	-
1885825	0	7	100	CD	-	-	-	-	-	-	-	-
1885825	0	8	U	NN	-	-	-	-	-	-	-	-
1885825	0	9	/	SYM	-	-	-	-	-	-	-	-
1885825	0	10	ml	NN	-	-	-	-	-	-	-	-
1885825	0	11	collagenase	NN	-	-	-	-	-	-	-	-
1885825	0	12	D	NN	-	-	-	-	-	-	-	-
1885825	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	14	Roche	NNP	-	-	-	-	-	-	-	-
1885825	0	15	,	,	-	-	-	-	-	-	-	-
1885825	0	16	Mannheim	NNP	-	-	-	-	-	-	-	-
1885825	0	17	,	,	-	-	-	-	-	-	-	-
1885825	0	18	Germany	NNP	-	-	-	-	-	-	-	-
1885825	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	20	for	IN	-	-	-	-	-	-	-	-
1885825	0	21	30	CD	-	-	-	-	-	-	-	(232
1885825	0	22	minutes	NNS	-	-	-	-	-	-	-	232)
1885825	0	23	at	IN	-	-	-	-	-	-	-	-
1885825	0	24	37	CD	-	-	-	-	-	-	-	(233
1885825	0	25	°C	NN	-	-	-	-	-	-	-	233)
1885825	0	26	in	IN	-	-	-	-	-	-	-	-
1885825	0	27	DMEM	NN	-	-	-	-	-	-	-	(234
1885825	0	28	media	NNS	-	-	-	-	-	-	-	234)|231)
1885825	0	29	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Cells	NNS	-	-	-	-	-	-	-	(235
1885825	0	2	from	IN	-	-	-	-	-	-	-	-
1885825	0	3	spleen	NN	-	-	-	-	-	-	-	(107)|235)
1885825	0	4	were	VBD	-	-	-	-	-	-	-	-
1885825	0	5	isolated	VBN	-	-	-	-	-	-	-	-
1885825	0	6	using	VBG	-	-	-	-	-	-	-	-
1885825	0	7	the	DT	-	-	-	-	-	-	-	(231
1885825	0	8	same	JJ	-	-	-	-	-	-	-	-
1885825	0	9	procedure	NN	-	-	-	-	-	-	-	231)
1885825	0	10	with	IN	-	-	-	-	-	-	-	-
1885825	0	11	an	DT	-	-	-	-	-	-	-	-
1885825	0	12	additional	JJ	-	-	-	-	-	-	-	-
1885825	0	13	step	NN	-	-	-	-	-	-	-	-
1885825	0	14	of	IN	-	-	-	-	-	-	-	-
1885825	0	15	erythrocytes	NNS	-	-	-	-	-	-	-	-
1885825	0	16	lysis	NN	-	-	-	-	-	-	-	-
1885825	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	18	Gey's	NN	-	-	-	-	-	-	-	-
1885825	0	19	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	20	solution	NN	-	-	-	-	-	-	-	-
1885825	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	After	IN	-	-	-	-	-	-	-	-
1885825	0	2	centrifugation	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	cells	NNS	-	-	-	-	-	-	-	(235)
1885825	0	5	were	VBD	-	-	-	-	-	-	-	-
1885825	0	6	re-suspended	VBN	-	-	-	-	-	-	-	-
1885825	0	7	in	IN	-	-	-	-	-	-	-	-
1885825	0	8	DMEM	NN	-	-	-	-	-	-	-	(234
1885825	0	9	media	NNS	-	-	-	-	-	-	-	234)
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	submitted	VBN	-	-	-	-	-	-	-	-
1885825	0	12	to	IN	-	-	-	-	-	-	-	-
1885825	0	13	flow	NN	-	-	-	-	-	-	-	(125|(25
1885825	0	14	cytometry	NN	-	-	-	-	-	-	-	25)
1885825	0	15	analyses	NNS	-	-	-	-	-	-	-	125)
1885825	0	16	on	IN	-	-	-	-	-	-	-	-
1885825	0	17	a	DT	-	-	-	-	-	-	-	-
1885825	0	18	FACScalibur	NN	-	-	-	-	-	-	-	-
1885825	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	20	Becton	NNP	-	-	-	-	-	-	-	(236
1885825	0	21	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	22	Dickinson	NNP	-	-	-	-	-	-	-	236)
1885825	0	23	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	24	,	,	-	-	-	-	-	-	-	-
1885825	0	25	and	CC	-	-	-	-	-	-	-	-
1885825	0	26	analyzed	VBN	-	-	-	-	-	-	-	-
1885825	0	27	by	IN	-	-	-	-	-	-	-	-
1885825	0	28	Cell	NN	-	-	-	-	-	-	-	-
1885825	0	29	Quest	NN	-	-	-	-	-	-	-	-
1885825	0	30	3.3	CD	-	-	-	-	-	-	-	-
1885825	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	32	Becton	NNP	-	-	-	-	-	-	-	(236
1885825	0	33	Dickinson	NNP	-	-	-	-	-	-	-	236)
1885825	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	35	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Monoclonal	JJ	-	-	-	-	-	-	-	-
1885825	0	2	antibodies	NNS	-	-	-	-	-	-	-	-
1885825	0	3	used	VBN	-	-	-	-	-	-	-	-
1885825	0	4	to	TO	-	-	-	-	-	-	-	-
1885825	0	5	stain	VB	-	-	-	-	-	-	-	-
1885825	0	6	cell	NN	-	-	-	-	-	-	-	(230
1885825	0	7	suspensions	NNS	-	-	-	-	-	-	-	230)
1885825	0	8	were	VBD	-	-	-	-	-	-	-	-
1885825	0	9	purchased	VBN	-	-	-	-	-	-	-	-
1885825	0	10	from	IN	-	-	-	-	-	-	-	-
1885825	0	11	BD	NN	-	-	-	-	-	-	-	(237
1885825	0	12	Biosciences	NNP	-	-	-	-	-	-	-	237)
1885825	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	14	Pharmingen	NNP	-	-	-	-	-	-	-	-
1885825	0	15	Heidelberg	NNP	-	-	-	-	-	-	-	-
1885825	0	16	,	,	-	-	-	-	-	-	-	-
1885825	0	17	Germany	NNP	-	-	-	-	-	-	-	-
1885825	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	19	:	:	-	-	-	-	-	-	-	-
1885825	0	20	PE	NN	-	-	-	-	-	-	-	-
1885825	0	21	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	22	Cy5	NN	-	-	-	-	-	-	-	-
1885825	0	23	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	24	anti-CD3	JJ	-	-	-	-	-	-	-	-
1885825	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	26	17A2	NN	-	-	-	-	-	-	-	-
1885825	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	28	,	,	-	-	-	-	-	-	-	-
1885825	0	29	PE	NN	-	-	-	-	-	-	-	-
1885825	0	30	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	31	Cy7	NN	-	-	-	-	-	-	-	-
1885825	0	32	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	33	anti-CD3	JJ	-	-	-	-	-	-	-	-
1885825	0	34	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	35	145	CD	-	-	-	-	-	-	-	-
1885825	0	36	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	37	2C11	NN	-	-	-	-	-	-	-	-
1885825	0	38	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	39	,	,	-	-	-	-	-	-	-	-
1885825	0	40	PE	NN	-	-	-	-	-	-	-	-
1885825	0	41	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	42	Cy5	NN	-	-	-	-	-	-	-	-
1885825	0	43	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	44	anti-CD4	JJ	-	-	-	-	-	-	-	-
1885825	0	45	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	46	H129.19	NN	-	-	-	-	-	-	-	-
1885825	0	47	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	48	,	,	-	-	-	-	-	-	-	-
1885825	0	49	PE	NN	-	-	-	-	-	-	-	-
1885825	0	50	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	51	anti-CD4	JJ	-	-	-	-	-	-	-	-
1885825	0	52	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	53	RM4	NN	-	-	-	-	-	-	-	-
1885825	0	54	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	55	,	,	-	-	-	-	-	-	-	-
1885825	0	56	FITC	NN	-	-	-	-	-	-	-	-
1885825	0	57	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	58	anti-CD8	JJ	-	-	-	-	-	-	-	-
1885825	0	59	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	60	53	CD	-	-	-	-	-	-	-	-
1885825	0	61	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	62	6.7	CD	-	-	-	-	-	-	-	-
1885825	0	63	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	64	,	,	-	-	-	-	-	-	-	-
1885825	0	65	PE	NN	-	-	-	-	-	-	-	-
1885825	0	66	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	67	anti-CD11c	JJ	-	-	-	-	-	-	-	-
1885825	0	68	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	69	HL3	NN	-	-	-	-	-	-	-	-
1885825	0	70	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	71	,	,	-	-	-	-	-	-	-	-
1885825	0	72	PE	NN	-	-	-	-	-	-	-	-
1885825	0	73	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	74	anti-CD25	JJ	-	-	-	-	-	-	-	-
1885825	0	75	,	,	-	-	-	-	-	-	-	-
1885825	0	76	PE	NN	-	-	-	-	-	-	-	-
1885825	0	77	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	78	anti-CD45R	NN	-	-	-	-	-	-	-	-
1885825	0	79	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	80	B220	NN	-	-	-	-	-	-	-	-
1885825	0	81	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	82	RA3	NN	-	-	-	-	-	-	-	-
1885825	0	83	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	84	6B2	NN	-	-	-	-	-	-	-	-
1885825	0	85	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	86	,	,	-	-	-	-	-	-	-	-
1885825	0	87	FITC	NN	-	-	-	-	-	-	-	-
1885825	0	88	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	89	anti-CD45RB	JJ	-	-	-	-	-	-	-	-
1885825	0	90	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	91	16A	NN	-	-	-	-	-	-	-	-
1885825	0	92	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	93	,	,	-	-	-	-	-	-	-	-
1885825	0	94	APC	NN	-	-	-	-	-	-	-	-
1885825	0	95	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	96	anti-annexin	NN	-	-	-	-	-	-	-	-
1885825	0	97	V	NN	-	-	-	-	-	-	-	-
1885825	0	98	and	CC	-	-	-	-	-	-	-	-
1885825	0	99	eBioscience	NN	-	-	-	-	-	-	-	-
1885825	0	100	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	101	San	NNP	-	-	-	-	-	-	-	(238
1885825	0	102	Diego	NNP	-	-	-	-	-	-	-	-
1885825	0	103	,	,	-	-	-	-	-	-	-	-
1885825	0	104	CA	NNP	-	-	-	-	-	-	-	238)
1885825	0	105	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	106	:	:	-	-	-	-	-	-	-	-
1885825	0	107	APC	NN	-	-	-	-	-	-	-	-
1885825	0	108	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	109	anti-Ly	NN	-	-	-	-	-	-	-	-
1885825	0	110	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	111	6G	NN	-	-	-	-	-	-	-	-
1885825	0	112	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	113	RB6	NN	-	-	-	-	-	-	-	-
1885825	0	114	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	115	8C5	NN	-	-	-	-	-	-	-	-
1885825	0	116	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	117	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Immunohistochemistry	NN	-	-	-	-	-	-	-	(26)

1885825	0	1	M	NN	-	-	-	-	-	-	-	(28
1885825	0	2	cells	NNS	-	-	-	-	-	-	-	28)
1885825	0	3	were	VBD	-	-	-	-	-	-	-	-
1885825	0	4	counted	VBN	-	-	-	-	-	-	-	-
1885825	0	5	in	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(111
1885825	0	7	FAE	NN	-	-	-	-	-	-	-	111)
1885825	0	8	using	VBG	-	-	-	-	-	-	-	-
1885825	0	9	a	DT	-	-	-	-	-	-	-	-
1885825	0	10	fluorescence	NN	-	-	-	-	-	-	-	-
1885825	0	11	microscope	NN	-	-	-	-	-	-	-	-
1885825	0	12	after	IN	-	-	-	-	-	-	-	-
1885825	0	13	immunostaining	NN	-	-	-	-	-	-	-	-
1885825	0	14	of	IN	-	-	-	-	-	-	-	-
1885825	0	15	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	16	cryostat	NN	-	-	-	-	-	-	-	-
1885825	0	17	sections	NNS	-	-	-	-	-	-	-	-
1885825	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	19	5	CD	-	-	-	-	-	-	-	(229
1885825	0	20	µm	NN	-	-	-	-	-	-	-	229)
1885825	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	with	IN	-	-	-	-	-	-	-	-
1885825	0	23	anti-Ulex	JJ	-	-	-	-	-	-	-	-
1885825	0	24	Europeaeus	NNP	-	-	-	-	-	-	-	-
1885825	0	25	antibodies	NNS	-	-	-	-	-	-	-	-
1885825	0	26	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	27	1	CD	-	-	-	-	-	-	-	-
1885825	0	28	/	SYM	-	-	-	-	-	-	-	-
1885825	0	29	250	CD	-	-	-	-	-	-	-	-
1885825	0	30	,	,	-	-	-	-	-	-	-	-
1885825	0	31	2	CD	-	-	-	-	-	-	-	(239
1885825	0	32	h	NN	-	-	-	-	-	-	-	239)
1885825	0	33	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	34	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	35	Sigma	NNP	-	-	-	-	-	-	-	(240
1885825	0	36	,	,	-	-	-	-	-	-	-	-
1885825	0	37	France	NNP	-	-	-	-	-	-	-	240)
1885825	0	38	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	39	,	,	-	-	-	-	-	-	-	-
1885825	0	40	revealed	VBN	-	-	-	-	-	-	-	-
1885825	0	41	by	IN	-	-	-	-	-	-	-	-
1885825	0	42	anti-Ulex	JJ	-	-	-	-	-	-	-	-
1885825	0	43	Europeaus	NNP	-	-	-	-	-	-	-	-
1885825	0	44	agglutinin	NN	-	-	-	-	-	-	-	-
1885825	0	45	I	CD	-	-	-	-	-	-	-	-
1885825	0	46	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	47	1	CD	-	-	-	-	-	-	-	-
1885825	0	48	/	SYM	-	-	-	-	-	-	-	-
1885825	0	49	500	CD	-	-	-	-	-	-	-	-
1885825	0	50	,	,	-	-	-	-	-	-	-	-
1885825	0	51	30	CD	-	-	-	-	-	-	-	(232
1885825	0	52	min	NN	-	-	-	-	-	-	-	232)
1885825	0	53	.	.	-	-	-	-	-	-	-	-
1885825	0	54	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	55	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	56	Vector	NN	-	-	-	-	-	-	-	-
1885825	0	57	laboratories	NNS	-	-	-	-	-	-	-	-
1885825	0	58	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	59	and	CC	-	-	-	-	-	-	-	-
1885825	0	60	anti-rabbit	JJ	-	-	-	-	-	-	-	-
1885825	0	61	FITC	NN	-	-	-	-	-	-	-	-
1885825	0	62	conjugate	NN	-	-	-	-	-	-	-	-
1885825	0	63	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	64	1	CD	-	-	-	-	-	-	-	-
1885825	0	65	/	SYM	-	-	-	-	-	-	-	-
1885825	0	66	80	CD	-	-	-	-	-	-	-	-
1885825	0	67	,	,	-	-	-	-	-	-	-	-
1885825	0	68	30	CD	-	-	-	-	-	-	-	(232
1885825	0	69	min.	NN	-	-	-	-	-	-	-	232)
1885825	0	70	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	71	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	72	Sigma	NNP	-	-	-	-	-	-	-	(240
1885825	0	73	,	,	-	-	-	-	-	-	-	-
1885825	0	74	France	NNP	-	-	-	-	-	-	-	240)
1885825	0	75	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	76	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Caspase	NN	-	-	-	-	-	-	-	(241
1885825	0	2	3	CD	-	-	-	-	-	-	-	-
1885825	0	3	immunostaining	NN	-	-	-	-	-	-	-	241)
1885825	0	4	was	VBD	-	-	-	-	-	-	-	-
1885825	0	5	done	VBN	-	-	-	-	-	-	-	-
1885825	0	6	using	VBG	-	-	-	-	-	-	-	-
1885825	0	7	rabbit	NN	-	-	-	-	-	-	-	-
1885825	0	8	polyclonal	JJ	-	-	-	-	-	-	-	-
1885825	0	9	antibodies	NNS	-	-	-	-	-	-	-	-
1885825	0	10	to	IN	-	-	-	-	-	-	-	-
1885825	0	11	Cleaved	VBN	-	-	-	-	-	-	-	-
1885825	0	12	Caspase	NN	-	-	-	-	-	-	-	-
1885825	0	13	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	14	3	CD	-	-	-	-	-	-	-	-
1885825	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	16	Asp	NN	-	-	-	-	-	-	-	-
1885825	0	17	175	CD	-	-	-	-	-	-	-	-
1885825	0	18	,	,	-	-	-	-	-	-	-	-
1885825	0	19	dilution	NN	-	-	-	-	-	-	-	-
1885825	0	20	:	:	-	-	-	-	-	-	-	-
1885825	0	21	1	CD	-	-	-	-	-	-	-	-
1885825	0	22	/	SYM	-	-	-	-	-	-	-	-
1885825	0	23	100	CD	-	-	-	-	-	-	-	-
1885825	0	24	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	26	Cell	NN	-	-	-	-	-	-	-	-
1885825	0	27	Signaling	NN	-	-	-	-	-	-	-	-
1885825	0	28	Technology	NN	-	-	-	-	-	-	-	-
1885825	0	29	,	,	-	-	-	-	-	-	-	-
1885825	0	30	Inc	NN	-	-	-	-	-	-	-	-
1885825	0	31	Ozyme	NN	-	-	-	-	-	-	-	-
1885825	0	32	,	,	-	-	-	-	-	-	-	-
1885825	0	33	Beverly	NN	-	-	-	-	-	-	-	-
1885825	0	34	,	,	-	-	-	-	-	-	-	-
1885825	0	35	MA	NN	-	-	-	-	-	-	-	-
1885825	0	36	,	,	-	-	-	-	-	-	-	-
1885825	0	37	USA	NN	-	-	-	-	-	-	-	-
1885825	0	38	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	39	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Cytokine	NN	-	-	-	-	-	-	-	-
1885825	0	2	Enzyme	NN	-	-	-	-	-	-	-	-
1885825	0	3	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	4	Linked	VBN	-	-	-	-	-	-	-	-
1885825	0	5	Immunosorbent	JJ	-	-	-	-	-	-	-	-
1885825	0	6	Assay	NN	-	-	-	-	-	-	-	-
1885825	0	7	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	8	ELISA	NN	-	-	-	-	-	-	-	-
1885825	0	9	)	-RRB-	-	-	-	-	-	-	-	-

1885825	0	1	PPs	NNS	-	-	-	-	-	-	-	(242d)|(27a)
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	ileum	NN	-	-	-	-	-	-	-	(150a)
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	spleen	NN	-	-	-	-	-	-	-	(38c|(97
1885825	0	6	from	IN	-	-	-	-	-	-	-	(150a|(242d|(27a)|38c)
1885825	0	7	WT	NN	-	-	-	-	-	-	-	(86|(87j)
1885825	0	8	and	CC	-	-	-	-	-	-	-	-
1885825	0	9	KO	NN	-	-	-	-	-	-	-	(12|(27a|(38c
1885825	0	10	mice	NNS	-	-	-	-	-	-	-	(87j)|97)|86)|38c)|27a)|242d)|150a)|12)
1885825	0	11	were	VBD	-	-	-	-	-	-	-	-
1885825	0	12	removed	VBN	-	-	-	-	-	-	-	-
1885825	0	13	,	,	-	-	-	-	-	-	-	-
1885825	0	14	washed	VBN	-	-	-	-	-	-	-	-
1885825	0	15	with	IN	-	-	-	-	-	-	-	-
1885825	0	16	cold	JJ	-	-	-	-	-	-	-	-
1885825	0	17	PBS	NNS	-	-	-	-	-	-	-	-
1885825	0	18	and	CC	-	-	-	-	-	-	-	-
1885825	0	19	the	DT	-	-	-	-	-	-	-	-
1885825	0	20	concentration	NN	-	-	-	-	-	-	-	-
1885825	0	21	of	IN	-	-	-	-	-	-	-	-
1885825	0	22	protein	NN	-	-	-	-	-	-	-	-
1885825	0	23	was	VBD	-	-	-	-	-	-	-	-
1885825	0	24	determined	VBN	-	-	-	-	-	-	-	-
1885825	0	25	using	VBG	-	-	-	-	-	-	-	-
1885825	0	26	commercial	JJ	-	-	-	-	-	-	-	-
1885825	0	27	kit	NN	-	-	-	-	-	-	-	-
1885825	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	29	Biorad	NNP	-	-	-	-	-	-	-	(243)
1885825	0	30	,	,	-	-	-	-	-	-	-	-
1885825	0	31	Marnes	NNP	-	-	-	-	-	-	-	-
1885825	0	32	la	NNP	-	-	-	-	-	-	-	-
1885825	0	33	Coquette	NNP	-	-	-	-	-	-	-	-
1885825	0	34	,	,	-	-	-	-	-	-	-	-
1885825	0	35	France	NNP	-	-	-	-	-	-	-	-
1885825	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	37	.	.	-	-	-	-	-	-	-	-

1885825	0	1	TNFα	NN	-	-	-	-	-	-	-	(31)
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	IFNγ	NN	-	-	-	-	-	-	-	(33)
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	IL	NN	-	-	-	-	-	-	-	(35
1885825	0	6	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	7	4	CD	-	-	-	-	-	-	-	35)
1885825	0	8	and	CC	-	-	-	-	-	-	-	-
1885825	0	9	IL	NN	-	-	-	-	-	-	-	(126
1885825	0	10	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	1β	NN	-	-	-	-	-	-	-	126)
1885825	0	12	were	VBD	-	-	-	-	-	-	-	-
1885825	0	13	determined	VBN	-	-	-	-	-	-	-	-
1885825	0	14	by	IN	-	-	-	-	-	-	-	-
1885825	0	15	ELISA	NN	-	-	-	-	-	-	-	(36
1885825	0	16	assays	NNS	-	-	-	-	-	-	-	36)
1885825	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	18	BD	NN	-	-	-	-	-	-	-	(237
1885825	0	19	Biosciences	NNS	-	-	-	-	-	-	-	237)
1885825	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	21	according	VBG	-	-	-	-	-	-	-	-
1885825	0	22	to	IN	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	(237
1885825	0	24	manufacturer	NN	-	-	-	-	-	-	-	-
1885825	0	25	's	POS	-	-	-	-	-	-	-	237)
1885825	0	26	instructions	NNS	-	-	-	-	-	-	-	-
1885825	0	27	.	.	-	-	-	-	-	-	-	-

1885825	0	1	All	DT	-	-	-	-	-	-	-	-
1885825	0	2	experimental	JJ	-	-	-	-	-	-	-	-
1885825	0	3	groups	NNS	-	-	-	-	-	-	-	-
1885825	0	4	were	VBD	-	-	-	-	-	-	-	-
1885825	0	5	tested	VBN	-	-	-	-	-	-	-	-
1885825	0	6	in	IN	-	-	-	-	-	-	-	-
1885825	0	7	duplicates	NNS	-	-	-	-	-	-	-	-
1885825	0	8	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Ussing	NNP	-	-	-	-	-	-	-	(39|(40
1885825	0	2	chamber	NN	-	-	-	-	-	-	-	39)
1885825	0	3	experiments	NNS	-	-	-	-	-	-	-	40)

1885825	0	1	Biopsies	NNS	-	-	-	-	-	-	-	-
1885825	0	2	from	IN	-	-	-	-	-	-	-	-
1885825	0	3	ileum	NN	-	-	-	-	-	-	-	(37a)
1885825	0	4	with	IN	-	-	-	-	-	-	-	-
1885825	0	5	or	CC	-	-	-	-	-	-	-	-
1885825	0	6	without	IN	-	-	-	-	-	-	-	(37a
1885825	0	7	PPs	NNS	-	-	-	-	-	-	-	(2)|37a)
1885825	0	8	were	VBD	-	-	-	-	-	-	-	-
1885825	0	9	placed	VBN	-	-	-	-	-	-	-	-
1885825	0	10	in	IN	-	-	-	-	-	-	-	-
1885825	0	11	a	DT	-	-	-	-	-	-	-	-
1885825	0	12	chamber	NN	-	-	-	-	-	-	-	-
1885825	0	13	exposing	VBG	-	-	-	-	-	-	-	-
1885825	0	14	0.196	CD	-	-	-	-	-	-	-	-
1885825	0	15	cm2	NN	-	-	-	-	-	-	-	-
1885825	0	16	of	IN	-	-	-	-	-	-	-	-
1885825	0	17	tissue	NN	-	-	-	-	-	-	-	-
1885825	0	18	surface	NN	-	-	-	-	-	-	-	-
1885825	0	19	to	IN	-	-	-	-	-	-	-	-
1885825	0	20	1.5	CD	-	-	-	-	-	-	-	-
1885825	0	21	ml	NN	-	-	-	-	-	-	-	-
1885825	0	22	of	IN	-	-	-	-	-	-	-	-
1885825	0	23	circulating	VBG	-	-	-	-	-	-	-	-
1885825	0	24	oxygenated	VBN	-	-	-	-	-	-	-	-
1885825	0	25	Ringer	NN	-	-	-	-	-	-	-	-
1885825	0	26	solution	NN	-	-	-	-	-	-	-	-
1885825	0	27	at	IN	-	-	-	-	-	-	-	-
1885825	0	28	37	CD	-	-	-	-	-	-	-	(233
1885825	0	29	°C	NN	-	-	-	-	-	-	-	233)
1885825	0	30	.	.	-	-	-	-	-	-	-	-

1885825	0	1	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	ileum	NN	-	-	-	-	-	-	-	(149)
1885825	0	4	permeability	NN	-	-	-	-	-	-	-	-
1885825	0	5	were	VBD	-	-	-	-	-	-	-	-
1885825	0	6	assessed	VBN	-	-	-	-	-	-	-	-
1885825	0	7	by	IN	-	-	-	-	-	-	-	-
1885825	0	8	measuring	VBG	-	-	-	-	-	-	-	-
1885825	0	9	steady	JJ	-	-	-	-	-	-	-	-
1885825	0	10	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	state	NN	-	-	-	-	-	-	-	-
1885825	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	13	from	IN	-	-	-	-	-	-	-	-
1885825	0	14	1	CD	-	-	-	-	-	-	-	-
1885825	0	15	to	IN	-	-	-	-	-	-	-	-
1885825	0	16	2	CD	-	-	-	-	-	-	-	(239
1885825	0	17	h	NN	-	-	-	-	-	-	-	239)
1885825	0	18	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	19	mucosal	JJ	-	-	-	-	-	-	-	-
1885825	0	20	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	21	to	IN	-	-	-	-	-	-	-	-
1885825	0	22	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	23	serosal	JJ	-	-	-	-	-	-	-	-
1885825	0	24	flux	NN	-	-	-	-	-	-	-	-
1885825	0	25	of	IN	-	-	-	-	-	-	-	-
1885825	0	26	4	CD	-	-	-	-	-	-	-	-
1885825	0	27	kDa	NN	-	-	-	-	-	-	-	-
1885825	0	28	FITC	NN	-	-	-	-	-	-	-	-
1885825	0	29	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	30	dextran	NN	-	-	-	-	-	-	-	-
1885825	0	31	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	32	Sigma	NNP	-	-	-	-	-	-	-	-
1885825	0	33	,	,	-	-	-	-	-	-	-	-
1885825	0	34	St.	NNP	-	-	-	-	-	-	-	-
1885825	0	35	Quentin	NNP	-	-	-	-	-	-	-	-
1885825	0	36	Fallavier	NNP	-	-	-	-	-	-	-	-
1885825	0	37	,	,	-	-	-	-	-	-	-	-
1885825	0	38	France	NNP	-	-	-	-	-	-	-	-
1885825	0	39	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	40	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Bacterial	JJ	-	-	-	-	-	-	-	(43
1885825	0	2	translocation	NN	-	-	-	-	-	-	-	43)
1885825	0	3	was	VBD	-	-	-	-	-	-	-	-
1885825	0	4	studied	VBN	-	-	-	-	-	-	-	-
1885825	0	5	using	VBG	-	-	-	-	-	-	-	-
1885825	0	6	chemically	RB	-	-	-	-	-	-	-	(153|(158a
1885825	0	7	killed	VBN	-	-	-	-	-	-	-	-
1885825	0	8	fluorescein	NN	-	-	-	-	-	-	-	-
1885825	0	9	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	10	conjugated	VBN	-	-	-	-	-	-	-	158a)
1885825	0	11	Escherichia	NNP	-	-	-	-	-	-	-	-
1885825	0	12	coli	NNP	-	-	-	-	-	-	-	-
1885825	0	13	K	NN	-	-	-	-	-	-	-	-
1885825	0	14	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	15	12	CD	-	-	-	-	-	-	-	153)
1885825	0	16	or	CC	-	-	-	-	-	-	-	-
1885825	0	17	Staphylococcus	NNP	-	-	-	-	-	-	-	(158a
1885825	0	18	Aureus	NNP	-	-	-	-	-	-	-	158a)
1885825	0	19	BioParticles	NNPS	-	-	-	-	-	-	-	-
1885825	0	20	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	21	Molecular	NNP	-	-	-	-	-	-	-	(244
1885825	0	22	Probes	NNP	-	-	-	-	-	-	-	-
1885825	0	23	,	,	-	-	-	-	-	-	-	-
1885825	0	24	Leiden	NNP	-	-	-	-	-	-	-	-
1885825	0	25	,	,	-	-	-	-	-	-	-	-
1885825	0	26	the	DT	-	-	-	-	-	-	-	-
1885825	0	27	Netherlands	NNP	-	-	-	-	-	-	-	244)
1885825	0	28	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	29	or	CC	-	-	-	-	-	-	-	-
1885825	0	30	a	DT	-	-	-	-	-	-	-	-
1885825	0	31	viable	JJ	-	-	-	-	-	-	-	-
1885825	0	32	Escherichia	NNP	-	-	-	-	-	-	-	-
1885825	0	33	coli	NNP	-	-	-	-	-	-	-	-
1885825	0	34	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	35	the	DT	-	-	-	-	-	-	-	(155
1885825	0	36	J53	NN	-	-	-	-	-	-	-	-
1885825	0	37	strain	NN	-	-	-	-	-	-	-	-
1885825	0	38	resistant	JJ	-	-	-	-	-	-	-	-
1885825	0	39	to	IN	-	-	-	-	-	-	-	-
1885825	0	40	rifampicin	NN	-	-	-	-	-	-	-	155)
1885825	0	41	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	42	at	IN	-	-	-	-	-	-	-	-
1885825	0	43	a	DT	-	-	-	-	-	-	-	-
1885825	0	44	final	JJ	-	-	-	-	-	-	-	-
1885825	0	45	concentration	NN	-	-	-	-	-	-	-	-
1885825	0	46	of	IN	-	-	-	-	-	-	-	-
1885825	0	47	1.107	CD	-	-	-	-	-	-	-	-
1885825	0	48	CFU	NN	-	-	-	-	-	-	-	-
1885825	0	49	/	SYM	-	-	-	-	-	-	-	-
1885825	0	50	ml	NN	-	-	-	-	-	-	-	-
1885825	0	51	in	IN	-	-	-	-	-	-	-	-
1885825	0	52	the	DT	-	-	-	-	-	-	-	(245
1885825	0	53	mucosal	JJ	-	-	-	-	-	-	-	-
1885825	0	54	reservoir	NN	-	-	-	-	-	-	-	245)
1885825	0	55	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Saccharomyces	NNP	-	-	-	-	-	-	-	(159
1885825	0	2	cerevisiae	NNP	-	-	-	-	-	-	-	159)
1885825	0	3	translocation	NN	-	-	-	-	-	-	-	-
1885825	0	4	was	VBD	-	-	-	-	-	-	-	-
1885825	0	5	studied	VBN	-	-	-	-	-	-	-	-
1885825	0	6	using	VBG	-	-	-	-	-	-	-	-
1885825	0	7	chemically	RB	-	-	-	-	-	-	-	(246
1885825	0	8	killed	VBN	-	-	-	-	-	-	-	-
1885825	0	9	fluorescein	NN	-	-	-	-	-	-	-	-
1885825	0	10	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	conjugated	VBN	-	-	-	-	-	-	-	-
1885825	0	12	S.	NNP	-	-	-	-	-	-	-	-
1885825	0	13	cerevisiae	NNP	-	-	-	-	-	-	-	246)
1885825	0	14	BioParticles	NNP	-	-	-	-	-	-	-	-
1885825	0	15	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	16	Molecular	NNP	-	-	-	-	-	-	-	(244
1885825	0	17	Probes	NNP	-	-	-	-	-	-	-	-
1885825	0	18	,	,	-	-	-	-	-	-	-	-
1885825	0	19	Leiden	NNP	-	-	-	-	-	-	-	-
1885825	0	20	,	,	-	-	-	-	-	-	-	-
1885825	0	21	the	DT	-	-	-	-	-	-	-	-
1885825	0	22	Netherlands	NNP	-	-	-	-	-	-	-	244)
1885825	0	23	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	24	at	IN	-	-	-	-	-	-	-	-
1885825	0	25	a	DT	-	-	-	-	-	-	-	-
1885825	0	26	final	JJ	-	-	-	-	-	-	-	-
1885825	0	27	concentration	NN	-	-	-	-	-	-	-	-
1885825	0	28	of	IN	-	-	-	-	-	-	-	-
1885825	0	29	1.107	CD	-	-	-	-	-	-	-	-
1885825	0	30	CFU	NN	-	-	-	-	-	-	-	-
1885825	0	31	/	SYM	-	-	-	-	-	-	-	-
1885825	0	32	ml	NN	-	-	-	-	-	-	-	-
1885825	0	33	in	IN	-	-	-	-	-	-	-	-
1885825	0	34	the	DT	-	-	-	-	-	-	-	(245
1885825	0	35	mucosal	JJ	-	-	-	-	-	-	-	-
1885825	0	36	reservoir	NN	-	-	-	-	-	-	-	245)
1885825	0	37	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Real	JJ	-	-	-	-	-	-	-	(220
1885825	0	2	time	NN	-	-	-	-	-	-	-	-
1885825	0	3	reverse	JJ	-	-	-	-	-	-	-	-
1885825	0	4	transcription	NN	-	-	-	-	-	-	-	-
1885825	0	5	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	6	polymerase	NN	-	-	-	-	-	-	-	-
1885825	0	7	chain	NN	-	-	-	-	-	-	-	-
1885825	0	8	reaction	NN	-	-	-	-	-	-	-	220)
1885825	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	10	RT	NN	-	-	-	-	-	-	-	-
1885825	0	11	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	12	PCR	NN	-	-	-	-	-	-	-	-
1885825	0	13	)	-RRB-	-	-	-	-	-	-	-	-

1885825	0	1	After	IN	-	-	-	-	-	-	-	-
1885825	0	2	extraction	NN	-	-	-	-	-	-	-	-
1885825	0	3	from	IN	-	-	-	-	-	-	-	-
1885825	0	4	PP	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	ileum	NN	-	-	-	-	-	-	-	(149)
1885825	0	7	by	IN	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	-
1885825	0	9	NucleoSpin®	NNP	-	-	-	-	-	-	-	-
1885825	0	10	RNA	NN	-	-	-	-	-	-	-	-
1885825	0	11	II	CD	-	-	-	-	-	-	-	-
1885825	0	12	Kit	NN	-	-	-	-	-	-	-	-
1885825	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	14	Macherey	NNP	-	-	-	-	-	-	-	-
1885825	0	15	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	Nagel	NNP	-	-	-	-	-	-	-	-
1885825	0	17	,	,	-	-	-	-	-	-	-	-
1885825	0	18	Hoerdt	NNP	-	-	-	-	-	-	-	-
1885825	0	19	,	,	-	-	-	-	-	-	-	-
1885825	0	20	France	NNP	-	-	-	-	-	-	-	-
1885825	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	,	,	-	-	-	-	-	-	-	-
1885825	0	23	total	JJ	-	-	-	-	-	-	-	-
1885825	0	24	RNA	NN	-	-	-	-	-	-	-	-
1885825	0	25	was	VBD	-	-	-	-	-	-	-	-
1885825	0	26	converted	VBN	-	-	-	-	-	-	-	-
1885825	0	27	to	IN	-	-	-	-	-	-	-	-
1885825	0	28	cDNA	NN	-	-	-	-	-	-	-	-
1885825	0	29	using	VBG	-	-	-	-	-	-	-	-
1885825	0	30	random	JJ	-	-	-	-	-	-	-	-
1885825	0	31	hexonucleotides	NNS	-	-	-	-	-	-	-	-
1885825	0	32	and	CC	-	-	-	-	-	-	-	-
1885825	0	33	then	RB	-	-	-	-	-	-	-	-
1885825	0	34	used	VBN	-	-	-	-	-	-	-	-
1885825	0	35	for	IN	-	-	-	-	-	-	-	-
1885825	0	36	PCR	NN	-	-	-	-	-	-	-	(220)
1885825	0	37	.	.	-	-	-	-	-	-	-	-

1885825	0	1	We	PRP	-	-	-	-	-	-	-	(13)
1885825	0	2	conducted	VBD	-	-	-	-	-	-	-	-
1885825	0	3	PCR	NN	-	-	-	-	-	-	-	(220)
1885825	0	4	with	IN	-	-	-	-	-	-	-	-
1885825	0	5	QuantiTect	NNP	-	-	-	-	-	-	-	-
1885825	0	6	SYBR	NN	-	-	-	-	-	-	-	-
1885825	0	7	Green	JJ	-	-	-	-	-	-	-	-
1885825	0	8	PCR	NN	-	-	-	-	-	-	-	-
1885825	0	9	Kit	NN	-	-	-	-	-	-	-	-
1885825	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	11	Applied	NNP	-	-	-	-	-	-	-	-
1885825	0	12	,	,	-	-	-	-	-	-	-	-
1885825	0	13	Courtaboeuf	NNP	-	-	-	-	-	-	-	-
1885825	0	14	,	,	-	-	-	-	-	-	-	-
1885825	0	15	France	NNP	-	-	-	-	-	-	-	-
1885825	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	17	using	VBG	-	-	-	-	-	-	-	-
1885825	0	18	sense	NN	-	-	-	-	-	-	-	-
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	antisense	JJ	-	-	-	-	-	-	-	-
1885825	0	21	primers	NNS	-	-	-	-	-	-	-	-
1885825	0	22	specific	JJ	-	-	-	-	-	-	-	-
1885825	0	23	for	IN	-	-	-	-	-	-	-	-
1885825	0	24	:	:	-	-	-	-	-	-	-	-
1885825	0	25	G3PDH	NN	-	-	-	-	-	-	-	-
1885825	0	26	,	,	-	-	-	-	-	-	-	-
1885825	0	27	5	CD	-	-	-	-	-	-	-	-
1885825	0	28	′	SYM	-	-	-	-	-	-	-	-
1885825	0	29	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	30	CACCATCTTCCAGGAGCGAG	NN	-	-	-	-	-	-	-	-
1885825	0	31	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	32	3	CD	-	-	-	-	-	-	-	-
1885825	0	33	′	SYM	-	-	-	-	-	-	-	-
1885825	0	34	and	CC	-	-	-	-	-	-	-	-
1885825	0	35	5	CD	-	-	-	-	-	-	-	-
1885825	0	36	′	SYM	-	-	-	-	-	-	-	-
1885825	0	37	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	38	GCCTTCTCCATGGTGGTGAA	NN	-	-	-	-	-	-	-	-
1885825	0	39	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	40	3	CD	-	-	-	-	-	-	-	-
1885825	0	41	′	SYM	-	-	-	-	-	-	-	-
1885825	0	42	;	:	-	-	-	-	-	-	-	-
1885825	0	43	Occludin	NN	-	-	-	-	-	-	-	(145)
1885825	0	44	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	45	Occ	NN	-	-	-	-	-	-	-	-
1885825	0	46	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	47	,	,	-	-	-	-	-	-	-	-
1885825	0	48	5	CD	-	-	-	-	-	-	-	-
1885825	0	49	′	SYM	-	-	-	-	-	-	-	-
1885825	0	50	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	51	AGCCTTCTGCTTCATCGCTTC	NN	-	-	-	-	-	-	-	-
1885825	0	52	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	53	3	CD	-	-	-	-	-	-	-	-
1885825	0	54	′	SYM	-	-	-	-	-	-	-	-
1885825	0	55	and	CC	-	-	-	-	-	-	-	-
1885825	0	56	5	CD	-	-	-	-	-	-	-	-
1885825	0	57	′	SYM	-	-	-	-	-	-	-	-
1885825	0	58	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	59	GTGGCAATAAACACCATGATGC	NN	-	-	-	-	-	-	-	-
1885825	0	60	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	61	3	CD	-	-	-	-	-	-	-	-
1885825	0	62	′	SYM	-	-	-	-	-	-	-	-
1885825	0	63	;	:	-	-	-	-	-	-	-	-
1885825	0	64	Zonula	NN	-	-	-	-	-	-	-	(142
1885825	0	65	Occludens	NN	-	-	-	-	-	-	-	-
1885825	0	66	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	67	1	CD	-	-	-	-	-	-	-	142)
1885825	0	68	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	69	ZO	NN	-	-	-	-	-	-	-	-
1885825	0	70	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	71	1	CD	-	-	-	-	-	-	-	-
1885825	0	72	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	73	,	,	-	-	-	-	-	-	-	-
1885825	0	74	5	CD	-	-	-	-	-	-	-	-
1885825	0	75	′	SYM	-	-	-	-	-	-	-	-
1885825	0	76	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	77	GACTCCAGACAACATCCCGAA	NN	-	-	-	-	-	-	-	-
1885825	0	78	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	79	3	CD	-	-	-	-	-	-	-	-
1885825	0	80	′	SYM	-	-	-	-	-	-	-	-
1885825	0	81	and	CC	-	-	-	-	-	-	-	-
1885825	0	82	5	CD	-	-	-	-	-	-	-	-
1885825	0	83	′	SYM	-	-	-	-	-	-	-	-
1885825	0	84	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	85	AACGCTGGAAATAACCTCGTTC	NN	-	-	-	-	-	-	-	-
1885825	0	86	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	87	3	CD	-	-	-	-	-	-	-	-
1885825	0	88	′	SYM	-	-	-	-	-	-	-	-
1885825	0	89	;	:	-	-	-	-	-	-	-	-
1885825	0	90	Zonula	NN	-	-	-	-	-	-	-	(140
1885825	0	91	Occludens	NN	-	-	-	-	-	-	-	-
1885825	0	92	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	93	2	CD	-	-	-	-	-	-	-	140)
1885825	0	94	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	95	ZO	NN	-	-	-	-	-	-	-	-
1885825	0	96	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	97	2	CD	-	-	-	-	-	-	-	-
1885825	0	98	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	99	,	,	-	-	-	-	-	-	-	-
1885825	0	100	5	CD	-	-	-	-	-	-	-	-
1885825	0	101	′	SYM	-	-	-	-	-	-	-	-
1885825	0	102	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	103	CAGCCACAATCAACGTGAATTC	NN	-	-	-	-	-	-	-	-
1885825	0	104	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	105	3	CD	-	-	-	-	-	-	-	-
1885825	0	106	′	SYM	-	-	-	-	-	-	-	-
1885825	0	107	and	CC	-	-	-	-	-	-	-	-
1885825	0	108	5	CD	-	-	-	-	-	-	-	-
1885825	0	109	′	SYM	-	-	-	-	-	-	-	-
1885825	0	110	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	111	CTGTCCTTCAAGCTGCCAAAC	NN	-	-	-	-	-	-	-	-
1885825	0	112	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	113	3	CD	-	-	-	-	-	-	-	-
1885825	0	114	′	SYM	-	-	-	-	-	-	-	-
1885825	0	115	.	.	-	-	-	-	-	-	-	-

1885825	0	1	After	IN	-	-	-	-	-	-	-	-
1885825	0	2	amplification	NN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	5	determined	VBD	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	-
1885825	0	7	threshold	NN	-	-	-	-	-	-	-	-
1885825	0	8	cycle	NN	-	-	-	-	-	-	-	-
1885825	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	10	Ct	NN	-	-	-	-	-	-	-	-
1885825	0	11	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	12	to	TO	-	-	-	-	-	-	-	-
1885825	0	13	obtain	VB	-	-	-	-	-	-	-	-
1885825	0	14	expression	NN	-	-	-	-	-	-	-	-
1885825	0	15	values	NNS	-	-	-	-	-	-	-	-
1885825	0	16	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	2	content	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	ileum	NN	-	-	-	-	-	-	-	(149)

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	entire	JJ	-	-	-	-	-	-	-	-
1885825	0	3	ileum	NN	-	-	-	-	-	-	-	-
1885825	0	4	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	5	5	CD	-	-	-	-	-	-	-	-
1885825	0	6	cm	NN	-	-	-	-	-	-	-	-
1885825	0	7	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	8	was	VBD	-	-	-	-	-	-	-	-
1885825	0	9	removed	VBN	-	-	-	-	-	-	-	-
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	ileal	JJ	-	-	-	-	-	-	-	(247
1885825	0	12	content	NN	-	-	-	-	-	-	-	247)
1885825	0	13	was	VBD	-	-	-	-	-	-	-	-
1885825	0	14	collected	VBN	-	-	-	-	-	-	-	-
1885825	0	15	using	VBG	-	-	-	-	-	-	-	-
1885825	0	16	3	CD	-	-	-	-	-	-	-	-
1885825	0	17	mL	NN	-	-	-	-	-	-	-	-
1885825	0	18	of	IN	-	-	-	-	-	-	-	-
1885825	0	19	steril	JJ	-	-	-	-	-	-	-	-
1885825	0	20	water	NN	-	-	-	-	-	-	-	-
1885825	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	22	Biorad	NNP	-	-	-	-	-	-	-	(243)
1885825	0	23	,	,	-	-	-	-	-	-	-	-
1885825	0	24	France	NNP	-	-	-	-	-	-	-	-
1885825	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	26	administered	VBN	-	-	-	-	-	-	-	-
1885825	0	27	with	IN	-	-	-	-	-	-	-	-
1885825	0	28	a	DT	-	-	-	-	-	-	-	-
1885825	0	29	polypropylene	NN	-	-	-	-	-	-	-	-
1885825	0	30	syringe	NN	-	-	-	-	-	-	-	-
1885825	0	31	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Then	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	ileal	JJ	-	-	-	-	-	-	-	(247
1885825	0	4	content	NN	-	-	-	-	-	-	-	247)
1885825	0	5	was	VBD	-	-	-	-	-	-	-	-
1885825	0	6	homogenized	VBN	-	-	-	-	-	-	-	-
1885825	0	7	and	CC	-	-	-	-	-	-	-	-
1885825	0	8	serial	JJ	-	-	-	-	-	-	-	-
1885825	0	9	dilution	NN	-	-	-	-	-	-	-	-
1885825	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	11	50	CD	-	-	-	-	-	-	-	-
1885825	0	12	µL	NN	-	-	-	-	-	-	-	-
1885825	0	13	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	14	of	IN	-	-	-	-	-	-	-	-
1885825	0	15	each	DT	-	-	-	-	-	-	-	-
1885825	0	16	aliquot	NN	-	-	-	-	-	-	-	-
1885825	0	17	were	VBD	-	-	-	-	-	-	-	-
1885825	0	18	plated	VBN	-	-	-	-	-	-	-	-
1885825	0	19	onto	IN	-	-	-	-	-	-	-	-
1885825	0	20	5	CD	-	-	-	-	-	-	-	(248
1885825	0	21	selective	JJ	-	-	-	-	-	-	-	-
1885825	0	22	gelose	NN	-	-	-	-	-	-	-	248)
1885825	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	24	URI	NN	-	-	-	-	-	-	-	-
1885825	0	25	4	CD	-	-	-	-	-	-	-	-
1885825	0	26	,	,	-	-	-	-	-	-	-	-
1885825	0	27	Drigalski	NNP	-	-	-	-	-	-	-	-
1885825	0	28	,	,	-	-	-	-	-	-	-	-
1885825	0	29	Columbia	NNP	-	-	-	-	-	-	-	-
1885825	0	30	ANC	NN	-	-	-	-	-	-	-	-
1885825	0	31	+	SYM	-	-	-	-	-	-	-	-
1885825	0	32	5	CD	-	-	-	-	-	-	-	-
1885825	0	33	%	NN	-	-	-	-	-	-	-	-
1885825	0	34	of	IN	-	-	-	-	-	-	-	-
1885825	0	35	sheep	NN	-	-	-	-	-	-	-	-
1885825	0	36	blood	NN	-	-	-	-	-	-	-	-
1885825	0	37	,	,	-	-	-	-	-	-	-	-
1885825	0	38	Chapman	NNP	-	-	-	-	-	-	-	-
1885825	0	39	and	CC	-	-	-	-	-	-	-	-
1885825	0	40	Coccosel	NNP	-	-	-	-	-	-	-	-
1885825	0	41	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	42	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Plates	NNS	-	-	-	-	-	-	-	(248)
1885825	0	2	were	VBD	-	-	-	-	-	-	-	-
1885825	0	3	incubated	VBN	-	-	-	-	-	-	-	-
1885825	0	4	for	IN	-	-	-	-	-	-	-	-
1885825	0	5	24	CD	-	-	-	-	-	-	-	-
1885825	0	6	hours	NNS	-	-	-	-	-	-	-	-
1885825	0	7	at	IN	-	-	-	-	-	-	-	-
1885825	0	8	37	CD	-	-	-	-	-	-	-	(233
1885825	0	9	°C	NN	-	-	-	-	-	-	-	233)
1885825	0	10	under	IN	-	-	-	-	-	-	-	-
1885825	0	11	aerobic	JJ	-	-	-	-	-	-	-	-
1885825	0	12	condition	NN	-	-	-	-	-	-	-	-
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	the	DT	-	-	-	-	-	-	-	-
1885825	0	15	number	NN	-	-	-	-	-	-	-	-
1885825	0	16	of	IN	-	-	-	-	-	-	-	-
1885825	0	17	colony	NN	-	-	-	-	-	-	-	-
1885825	0	18	forming	VBG	-	-	-	-	-	-	-	-
1885825	0	19	units	NNS	-	-	-	-	-	-	-	-
1885825	0	20	was	VBD	-	-	-	-	-	-	-	-
1885825	0	21	counted	VBN	-	-	-	-	-	-	-	-
1885825	0	22	and	CC	-	-	-	-	-	-	-	-
1885825	0	23	expressed	VBN	-	-	-	-	-	-	-	-
1885825	0	24	as	IN	-	-	-	-	-	-	-	-
1885825	0	25	cfu	NN	-	-	-	-	-	-	-	-
1885825	0	26	/	SYM	-	-	-	-	-	-	-	-
1885825	0	27	mg	NN	-	-	-	-	-	-	-	-
1885825	0	28	of	IN	-	-	-	-	-	-	-	-
1885825	0	29	ileal	JJ	-	-	-	-	-	-	-	(247
1885825	0	30	content	NN	-	-	-	-	-	-	-	247)
1885825	0	31	.	.	-	-	-	-	-	-	-	-

1885825	0	1	TNBS	NN	-	-	-	-	-	-	-	(44|(45)
1885825	0	2	induced	VBN	-	-	-	-	-	-	-	-
1885825	0	3	colitis	NN	-	-	-	-	-	-	-	44)

1885825	0	1	Under	IN	-	-	-	-	-	-	-	-
1885825	0	2	anaesthesia	NN	-	-	-	-	-	-	-	-
1885825	0	3	colitis	NN	-	-	-	-	-	-	-	(82)
1885825	0	4	was	VBD	-	-	-	-	-	-	-	-
1885825	0	5	induced	VBN	-	-	-	-	-	-	-	-
1885825	0	6	in	IN	-	-	-	-	-	-	-	-
1885825	0	7	12	CD	-	-	-	-	-	-	-	(16|(249
1885825	0	8	week	NN	-	-	-	-	-	-	-	-
1885825	0	9	old	JJ	-	-	-	-	-	-	-	16)
1885825	0	10	mice	NNS	-	-	-	-	-	-	-	249)
1885825	0	11	by	IN	-	-	-	-	-	-	-	-
1885825	0	12	a	DT	-	-	-	-	-	-	-	(250
1885825	0	13	single	JJ	-	-	-	-	-	-	-	-
1885825	0	14	intracolonic	JJ	-	-	-	-	-	-	-	-
1885825	0	15	administration	NN	-	-	-	-	-	-	-	-
1885825	0	16	of	IN	-	-	-	-	-	-	-	-
1885825	0	17	120	CD	-	-	-	-	-	-	-	(251
1885825	0	18	mg	NN	-	-	-	-	-	-	-	-
1885825	0	19	/	SYM	-	-	-	-	-	-	-	-
1885825	0	20	kg	NN	-	-	-	-	-	-	-	-
1885825	0	21	TNBS	NN	-	-	-	-	-	-	-	250)
1885825	0	22	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	23	Sigma	NNP	-	-	-	-	-	-	-	(240
1885825	0	24	,	,	-	-	-	-	-	-	-	-
1885825	0	25	France	NNP	-	-	-	-	-	-	-	240)
1885825	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	27	dissolved	VBN	-	-	-	-	-	-	-	-
1885825	0	28	in	IN	-	-	-	-	-	-	-	-
1885825	0	29	50	CD	-	-	-	-	-	-	-	-
1885825	0	30	%	NN	-	-	-	-	-	-	-	-
1885825	0	31	ethanol	NN	-	-	-	-	-	-	-	251)
1885825	0	32	.	.	-	-	-	-	-	-	-	-

1885825	0	1	A	DT	-	-	-	-	-	-	-	-
1885825	0	2	50	CD	-	-	-	-	-	-	-	-
1885825	0	3	µl	NN	-	-	-	-	-	-	-	-
1885825	0	4	aliquot	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(251
1885825	0	7	freshly	RB	-	-	-	-	-	-	-	-
1885825	0	8	prepared	VBN	-	-	-	-	-	-	-	-
1885825	0	9	solution	NN	-	-	-	-	-	-	-	251)
1885825	0	10	was	VBD	-	-	-	-	-	-	-	-
1885825	0	11	injected	VBN	-	-	-	-	-	-	-	-
1885825	0	12	into	IN	-	-	-	-	-	-	-	-
1885825	0	13	the	DT	-	-	-	-	-	-	-	(70
1885825	0	14	colon	NN	-	-	-	-	-	-	-	70)
1885825	0	15	,	,	-	-	-	-	-	-	-	-
1885825	0	16	4	CD	-	-	-	-	-	-	-	-
1885825	0	17	cm	NN	-	-	-	-	-	-	-	-
1885825	0	18	from	IN	-	-	-	-	-	-	-	-
1885825	0	19	the	DT	-	-	-	-	-	-	-	-
1885825	0	20	anus	NN	-	-	-	-	-	-	-	-
1885825	0	21	,	,	-	-	-	-	-	-	-	-
1885825	0	22	using	VBG	-	-	-	-	-	-	-	-
1885825	0	23	a	DT	-	-	-	-	-	-	-	-
1885825	0	24	3.5	CD	-	-	-	-	-	-	-	-
1885825	0	25	F	NN	-	-	-	-	-	-	-	-
1885825	0	26	polyethylene	NN	-	-	-	-	-	-	-	-
1885825	0	27	catheter	NN	-	-	-	-	-	-	-	-
1885825	0	28	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	(210
1885825	0	2	mice	NNS	-	-	-	-	-	-	-	210)
1885825	0	3	were	VBD	-	-	-	-	-	-	-	-
1885825	0	4	weighed	VBN	-	-	-	-	-	-	-	-
1885825	0	5	and	CC	-	-	-	-	-	-	-	-
1885825	0	6	killed	VBN	-	-	-	-	-	-	-	-
1885825	0	7	72	CD	-	-	-	-	-	-	-	-
1885825	0	8	h	NN	-	-	-	-	-	-	-	-
1885825	0	9	after	IN	-	-	-	-	-	-	-	-
1885825	0	10	TNBS	NN	-	-	-	-	-	-	-	(250|(45)
1885825	0	11	administration	NN	-	-	-	-	-	-	-	250)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Then	RB	-	-	-	-	-	-	-	-
1885825	0	2	,	,	-	-	-	-	-	-	-	-
1885825	0	3	body	NN	-	-	-	-	-	-	-	(83
1885825	0	4	weight	NN	-	-	-	-	-	-	-	83)
1885825	0	5	,	,	-	-	-	-	-	-	-	-
1885825	0	6	macroscopic	JJ	-	-	-	-	-	-	-	(164
1885825	0	7	damage	NN	-	-	-	-	-	-	-	-
1885825	0	8	score	NN	-	-	-	-	-	-	-	-
1885825	0	9	according	VBG	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	-
1885825	0	11	Wallace	NNP	-	-	-	-	-	-	-	-
1885825	0	12	scores	NNS	-	-	-	-	-	-	-	164)
1885825	0	13	[	-LRB-	-	-	-	-	-	-	-	-
1885825	0	14	43	CD	-	-	-	-	-	-	-	-
1885825	0	15	]	-RRB-	-	-	-	-	-	-	-	-
1885825	0	16	,	,	-	-	-	-	-	-	-	-
1885825	0	17	and	CC	-	-	-	-	-	-	-	-
1885825	0	18	cytokines	NNS	-	-	-	-	-	-	-	(252
1885825	0	19	levels	NNS	-	-	-	-	-	-	-	252)
1885825	0	20	were	VBD	-	-	-	-	-	-	-	-
1885825	0	21	assessed	VBN	-	-	-	-	-	-	-	-
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Statistical	JJ	-	-	-	-	-	-	-	(253
1885825	0	2	Analyses	NNS	-	-	-	-	-	-	-	253)

1885825	0	1	Values	NNS	-	-	-	-	-	-	-	-
1885825	0	2	are	VBP	-	-	-	-	-	-	-	-
1885825	0	3	expressed	VBN	-	-	-	-	-	-	-	-
1885825	0	4	as	IN	-	-	-	-	-	-	-	-
1885825	0	5	mean	NN	-	-	-	-	-	-	-	-
1885825	0	6	±	SYM	-	-	-	-	-	-	-	-
1885825	0	7	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	8	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Statistical	JJ	-	-	-	-	-	-	-	(253
1885825	0	2	analysis	NN	-	-	-	-	-	-	-	253)
1885825	0	3	were	VBD	-	-	-	-	-	-	-	-
1885825	0	4	performed	VBN	-	-	-	-	-	-	-	-
1885825	0	5	using	VBG	-	-	-	-	-	-	-	-
1885825	0	6	GraphPad	NNP	-	-	-	-	-	-	-	-
1885825	0	7	Prism	NNP	-	-	-	-	-	-	-	-
1885825	0	8	4.00	CD	-	-	-	-	-	-	-	-
1885825	0	9	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	10	GraphPad	NNP	-	-	-	-	-	-	-	-
1885825	0	11	Software	NNP	-	-	-	-	-	-	-	-
1885825	0	12	,	,	-	-	-	-	-	-	-	-
1885825	0	13	San	NNP	-	-	-	-	-	-	-	(238
1885825	0	14	Diego	NNP	-	-	-	-	-	-	-	-
1885825	0	15	,	,	-	-	-	-	-	-	-	-
1885825	0	16	CA	NNP	-	-	-	-	-	-	-	-
1885825	0	17	,	,	-	-	-	-	-	-	-	-
1885825	0	18	USA	NNP	-	-	-	-	-	-	-	238)
1885825	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	20	software	NN	-	-	-	-	-	-	-	-
1885825	0	21	package	NN	-	-	-	-	-	-	-	-
1885825	0	22	for	IN	-	-	-	-	-	-	-	-
1885825	0	23	PC	NN	-	-	-	-	-	-	-	-
1885825	0	24	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Single	JJ	-	-	-	-	-	-	-	-
1885825	0	2	comparisons	NNS	-	-	-	-	-	-	-	-
1885825	0	3	were	VBD	-	-	-	-	-	-	-	-
1885825	0	4	performed	VBN	-	-	-	-	-	-	-	-
1885825	0	5	by	IN	-	-	-	-	-	-	-	-
1885825	0	6	unpaired	JJ	-	-	-	-	-	-	-	-
1885825	0	7	Student	NN	-	-	-	-	-	-	-	-
1885825	0	8	's	POS	-	-	-	-	-	-	-	-
1885825	0	9	t	NN	-	-	-	-	-	-	-	-
1885825	0	10	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	test	NN	-	-	-	-	-	-	-	-
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	A	DT	-	-	-	-	-	-	-	-
1885825	0	2	value	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	P	NN	-	-	-	-	-	-	-	(254|(92)
1885825	0	5	<	SYM	-	-	-	-	-	-	-	-
1885825	0	6	0.05	CD	-	-	-	-	-	-	-	254)
1885825	0	7	was	VBD	-	-	-	-	-	-	-	-
1885825	0	8	considered	VBN	-	-	-	-	-	-	-	-
1885825	0	9	as	IN	-	-	-	-	-	-	-	-
1885825	0	10	statistically	RB	-	-	-	-	-	-	-	-
1885825	0	11	significant	JJ	-	-	-	-	-	-	-	-
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	All	DT	-	-	-	-	-	-	-	-
1885825	0	2	P	NN	-	-	-	-	-	-	-	(92)
1885825	0	3	values	NNS	-	-	-	-	-	-	-	-
1885825	0	4	were	VBD	-	-	-	-	-	-	-	-
1885825	0	5	two	CD	-	-	-	-	-	-	-	-
1885825	0	6	sided	VBN	-	-	-	-	-	-	-	-
1885825	0	7	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Supporting	JJ	-	-	-	-	-	-	-	-
1885825	0	2	Information	NN	-	-	-	-	-	-	-	-

1885825	0	1	Table	NN	-	-	-	-	-	-	-	(88
1885825	0	2	S1	NN	-	-	-	-	-	-	-	88)

1885825	0	1	Impact	NN	-	-	-	-	-	-	-	-
1885825	0	2	of	IN	-	-	-	-	-	-	-	-
1885825	0	3	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	4	on	IN	-	-	-	-	-	-	-	-
1885825	0	5	body	NN	-	-	-	-	-	-	-	(83
1885825	0	6	weight	NN	-	-	-	-	-	-	-	83)
1885825	0	7	,	,	-	-	-	-	-	-	-	-
1885825	0	8	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	9	weight	NN	-	-	-	-	-	-	-	-
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	intestine	NN	-	-	-	-	-	-	-	(173)
1885825	0	12	length	NN	-	-	-	-	-	-	-	-
1885825	0	13	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	weeks	NNS	-	-	-	-	-	-	-	(15|(17|(16f)|(18g)
1885825	0	3	4	CD	-	-	-	-	-	-	-	15)
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	12	CD	-	-	-	-	-	-	-	(16f)
1885825	0	6	and	CC	-	-	-	-	-	-	-	-
1885825	0	7	52	CD	-	-	-	-	-	-	-	(18g)|17)
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	we	PRP	-	-	-	-	-	-	-	(13)
1885825	0	10	investigated	VBD	-	-	-	-	-	-	-	-
1885825	0	11	the	DT	-	-	-	-	-	-	-	-
1885825	0	12	body	NN	-	-	-	-	-	-	-	-
1885825	0	13	and	CC	-	-	-	-	-	-	-	-
1885825	0	14	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	15	weight	NN	-	-	-	-	-	-	-	-
1885825	0	16	and	CC	-	-	-	-	-	-	-	-
1885825	0	17	the	DT	-	-	-	-	-	-	-	-
1885825	0	18	intestine	NN	-	-	-	-	-	-	-	(173)
1885825	0	19	length	NN	-	-	-	-	-	-	-	-
1885825	0	20	of	IN	-	-	-	-	-	-	-	-
1885825	0	21	KO	NN	-	-	-	-	-	-	-	(86|(12e)
1885825	0	22	and	CC	-	-	-	-	-	-	-	-
1885825	0	23	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	24	mice	NNS	-	-	-	-	-	-	-	(12e)|87)|86)
1885825	0	25	.	.	-	-	-	-	-	-	-	-

1885825	0	1	No	DT	-	-	-	-	-	-	-	-
1885825	0	2	difference	NN	-	-	-	-	-	-	-	-
1885825	0	3	was	VBD	-	-	-	-	-	-	-	-
1885825	0	4	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	5	between	IN	-	-	-	-	-	-	-	-
1885825	0	6	KO	NN	-	-	-	-	-	-	-	(86|(12r)
1885825	0	7	and	CC	-	-	-	-	-	-	-	-
1885825	0	8	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	(12r)|87)|86)
1885825	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	11	P	NN	-	-	-	-	-	-	-	(93|(92)
1885825	0	12	>	SYM	-	-	-	-	-	-	-	-
1885825	0	13	0.05	CD	-	-	-	-	-	-	-	93)
1885825	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	-
1885825	0	2	represent	VBP	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(255
1885825	0	4	means	NN	-	-	-	-	-	-	-	-
1885825	0	5	±	SYM	-	-	-	-	-	-	-	-
1885825	0	6	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	8	CD	-	-	-	-	-	-	-	-
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	10	per	IN	-	-	-	-	-	-	-	-
1885825	0	11	group	NN	-	-	-	-	-	-	-	255)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	0.03	CD	-	-	-	-	-	-	-	-
1885825	0	3	MB	NN	-	-	-	-	-	-	-	-
1885825	0	4	TIF	NN	-	-	-	-	-	-	-	-
1885825	0	5	)	-RRB-	-	-	-	-	-	-	-	-

1885825	0	1	Click	VB	-	-	-	-	-	-	-	-
1885825	0	2	here	RB	-	-	-	-	-	-	-	-
1885825	0	3	for	IN	-	-	-	-	-	-	-	-
1885825	0	4	additional	JJ	-	-	-	-	-	-	-	-
1885825	0	5	data	NNS	-	-	-	-	-	-	-	-
1885825	0	6	file	NN	-	-	-	-	-	-	-	-
1885825	0	7	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Table	NN	-	-	-	-	-	-	-	(151
1885825	0	2	S2	NN	-	-	-	-	-	-	-	151)

1885825	0	1	Ileal	JJ	-	-	-	-	-	-	-	-
1885825	0	2	microflora	NN	-	-	-	-	-	-	-	-
1885825	0	3	under	IN	-	-	-	-	-	-	-	-
1885825	0	4	basal	JJ	-	-	-	-	-	-	-	(187
1885825	0	5	condition	NN	-	-	-	-	-	-	-	187)
1885825	0	6	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Under	IN	-	-	-	-	-	-	-	-
1885825	0	2	basal	JJ	-	-	-	-	-	-	-	(187
1885825	0	3	condition	NN	-	-	-	-	-	-	-	187)
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	no	DT	-	-	-	-	-	-	-	-
1885825	0	6	difference	NN	-	-	-	-	-	-	-	-
1885825	0	7	was	VBD	-	-	-	-	-	-	-	-
1885825	0	8	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	9	between	IN	-	-	-	-	-	-	-	-
1885825	0	10	KO	NN	-	-	-	-	-	-	-	(86|(12a)
1885825	0	11	and	CC	-	-	-	-	-	-	-	-
1885825	0	12	WT	NN	-	-	-	-	-	-	-	(87
1885825	0	13	mice	NNS	-	-	-	-	-	-	-	(12a)|87)|86)
1885825	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	15	P	NN	-	-	-	-	-	-	-	(93|(92)
1885825	0	16	>	SYM	-	-	-	-	-	-	-	-
1885825	0	17	0.05	CD	-	-	-	-	-	-	-	93)
1885825	0	18	for	IN	-	-	-	-	-	-	-	-
1885825	0	19	each	DT	-	-	-	-	-	-	-	-
1885825	0	20	bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	21	group	NN	-	-	-	-	-	-	-	-
1885825	0	22	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	23	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	-
1885825	0	2	represent	VBP	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	-
1885825	0	4	means	NN	-	-	-	-	-	-	-	-
1885825	0	5	±	SYM	-	-	-	-	-	-	-	-
1885825	0	6	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	10	CD	-	-	-	-	-	-	-	-
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	10	per	IN	-	-	-	-	-	-	-	-
1885825	0	11	group	NN	-	-	-	-	-	-	-	-
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	0.03	CD	-	-	-	-	-	-	-	-
1885825	0	3	MB	NN	-	-	-	-	-	-	-	-
1885825	0	4	TIF	NN	-	-	-	-	-	-	-	-
1885825	0	5	)	-RRB-	-	-	-	-	-	-	-	-

1885825	0	1	Click	VB	-	-	-	-	-	-	-	-
1885825	0	2	here	RB	-	-	-	-	-	-	-	-
1885825	0	3	for	IN	-	-	-	-	-	-	-	-
1885825	0	4	additional	JJ	-	-	-	-	-	-	-	-
1885825	0	5	data	NNS	-	-	-	-	-	-	-	-
1885825	0	6	file	NN	-	-	-	-	-	-	-	-
1885825	0	7	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Figure	NN	-	-	-	-	-	-	-	-
1885825	0	2	S1	NN	-	-	-	-	-	-	-	-

1885825	0	1	PPs	NNS	-	-	-	-	-	-	-	(115
1885825	0	2	from	IN	-	-	-	-	-	-	-	-
1885825	0	3	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	4	mice	NNS	-	-	-	-	-	-	-	12)|115)
1885825	0	5	exhibit	VBP	-	-	-	-	-	-	-	-
1885825	0	6	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	7	rates	NNS	-	-	-	-	-	-	-	-
1885825	0	8	of	IN	-	-	-	-	-	-	-	-
1885825	0	9	CD4	NN	-	-	-	-	-	-	-	(30a
1885825	0	10	+	SYM	-	-	-	-	-	-	-	30a)
1885825	0	11	and	CC	-	-	-	-	-	-	-	-
1885825	0	12	CD4	NN	-	-	-	-	-	-	-	(256
1885825	0	13	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	14	CD8	NN	-	-	-	-	-	-	-	-
1885825	0	15	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	T	NN	-	-	-	-	-	-	-	(30a
1885825	0	17	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	18	cells	NNS	-	-	-	-	-	-	-	30a)|256)
1885825	0	19	at	IN	-	-	-	-	-	-	-	-
1885825	0	20	week	NN	-	-	-	-	-	-	-	(15
1885825	0	21	4	CD	-	-	-	-	-	-	-	15)
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	week	NN	-	-	-	-	-	-	-	(15
1885825	0	3	4	CD	-	-	-	-	-	-	-	15)
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	CD3	NN	-	-	-	-	-	-	-	(106
1885825	0	6	+	SYM	-	-	-	-	-	-	-	-
1885825	0	7	T	NN	-	-	-	-	-	-	-	-
1885825	0	8	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	cells	NNS	-	-	-	-	-	-	-	106)
1885825	0	10	recovered	VBN	-	-	-	-	-	-	-	-
1885825	0	11	from	IN	-	-	-	-	-	-	-	-
1885825	0	12	PPs	NNS	-	-	-	-	-	-	-	(2)
1885825	0	13	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	14	A	NN	-	-	-	-	-	-	-	-
1885825	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	16	and	CC	-	-	-	-	-	-	-	-
1885825	0	17	spleen	NN	-	-	-	-	-	-	-	(107)
1885825	0	18	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	19	B	NN	-	-	-	-	-	-	-	-
1885825	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	21	were	VBD	-	-	-	-	-	-	-	-
1885825	0	22	stained	VBN	-	-	-	-	-	-	-	-
1885825	0	23	with	IN	-	-	-	-	-	-	-	-
1885825	0	24	antibodies	NNS	-	-	-	-	-	-	-	(104|(257b|(258a
1885825	0	25	to	IN	-	-	-	-	-	-	-	258a)|257b)
1885825	0	26	CD3	NN	-	-	-	-	-	-	-	(103)|104)
1885825	0	27	,	,	-	-	-	-	-	-	-	-
1885825	0	28	CD4	NN	-	-	-	-	-	-	-	(257b)
1885825	0	29	,	,	-	-	-	-	-	-	-	-
1885825	0	30	and	CC	-	-	-	-	-	-	-	-
1885825	0	31	CD8	NN	-	-	-	-	-	-	-	(258a)
1885825	0	32	from	IN	-	-	-	-	-	-	-	-
1885825	0	33	KO	NN	-	-	-	-	-	-	-	(86|(12c)
1885825	0	34	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	35	▪	SYM	-	-	-	-	-	-	-	-
1885825	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	37	and	CC	-	-	-	-	-	-	-	-
1885825	0	38	WT	NN	-	-	-	-	-	-	-	(87e)
1885825	0	39	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	40	□	SYM	-	-	-	-	-	-	-	-
1885825	0	41	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	42	mice	NNS	-	-	-	-	-	-	-	(12c)|(87e)|86)
1885825	0	43	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	(259)
1885825	0	2	were	VBD	-	-	-	-	-	-	-	-
1885825	0	3	gated	VBN	-	-	-	-	-	-	-	-
1885825	0	4	for	IN	-	-	-	-	-	-	-	-
1885825	0	5	CD3	NN	-	-	-	-	-	-	-	(106
1885825	0	6	+	SYM	-	-	-	-	-	-	-	-
1885825	0	7	T	NN	-	-	-	-	-	-	-	-
1885825	0	8	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	cells	NNS	-	-	-	-	-	-	-	106)
1885825	0	10	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Relative	JJ	-	-	-	-	-	-	-	-
1885825	0	2	proportions	NNS	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	both	CC	-	-	-	-	-	-	-	-
1885825	0	5	CD3	NN	-	-	-	-	-	-	-	(260a
1885825	0	6	+	SYM	-	-	-	-	-	-	-	-
1885825	0	7	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	8	+	SYM	-	-	-	-	-	-	-	260a)
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	11	+	SYM	-	-	-	-	-	-	-	-
1885825	0	12	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	13	-	SYM	-	-	-	-	-	-	-	-
1885825	0	14	CD8	NN	-	-	-	-	-	-	-	-
1885825	0	15	-	SYM	-	-	-	-	-	-	-	-
1885825	0	16	T	NN	-	-	-	-	-	-	-	(260a
1885825	0	17	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	18	cells	NNS	-	-	-	-	-	-	-	260a)
1885825	0	19	were	VBD	-	-	-	-	-	-	-	-
1885825	0	20	significantly	RB	-	-	-	-	-	-	-	-
1885825	0	21	higher	JJR	-	-	-	-	-	-	-	-
1885825	0	22	in	IN	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	(2
1885825	0	24	PPs	NNS	-	-	-	-	-	-	-	2)
1885825	0	25	but	CC	-	-	-	-	-	-	-	-
1885825	0	26	not	RB	-	-	-	-	-	-	-	-
1885825	0	27	in	IN	-	-	-	-	-	-	-	-
1885825	0	28	the	DT	-	-	-	-	-	-	-	(38
1885825	0	29	spleen	NN	-	-	-	-	-	-	-	-
1885825	0	30	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	31	P	NN	-	-	-	-	-	-	-	(93|(92)
1885825	0	32	>	SYM	-	-	-	-	-	-	-	-
1885825	0	33	0.05	CD	-	-	-	-	-	-	-	93)
1885825	0	34	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	35	of	IN	-	-	-	-	-	-	-	-
1885825	0	36	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	37	mice	NNS	-	-	-	-	-	-	-	38)|12)
1885825	0	38	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	(259)
1885825	0	2	represent	VBP	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(255
1885825	0	4	means	NN	-	-	-	-	-	-	-	-
1885825	0	5	±	SYM	-	-	-	-	-	-	-	-
1885825	0	6	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	8	CD	-	-	-	-	-	-	-	-
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	10	per	IN	-	-	-	-	-	-	-	-
1885825	0	11	group	NN	-	-	-	-	-	-	-	255)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	*P	NN	-	-	-	-	-	-	-	(254|(92)
1885825	0	2	<	SYM	-	-	-	-	-	-	-	-
1885825	0	3	0.05	CD	-	-	-	-	-	-	-	254)
1885825	0	4	;	:	-	-	-	-	-	-	-	-
1885825	0	5	**P	NN	-	-	-	-	-	-	-	(143|(92)
1885825	0	6	<	SYM	-	-	-	-	-	-	-	-
1885825	0	7	0.01	CD	-	-	-	-	-	-	-	143)
1885825	0	8	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	0.08	CD	-	-	-	-	-	-	-	-
1885825	0	3	MB	NN	-	-	-	-	-	-	-	-
1885825	0	4	TIF	NN	-	-	-	-	-	-	-	-
1885825	0	5	)	-RRB-	-	-	-	-	-	-	-	-

1885825	0	1	Click	VB	-	-	-	-	-	-	-	-
1885825	0	2	here	RB	-	-	-	-	-	-	-	-
1885825	0	3	for	IN	-	-	-	-	-	-	-	-
1885825	0	4	additional	JJ	-	-	-	-	-	-	-	-
1885825	0	5	data	NNS	-	-	-	-	-	-	-	-
1885825	0	6	file	NN	-	-	-	-	-	-	-	-
1885825	0	7	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Figure	NN	-	-	-	-	-	-	-	-
1885825	0	2	S2	NN	-	-	-	-	-	-	-	-

1885825	0	1	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	4	+	SYM	-	-	-	-	-	-	-	-
1885825	0	5	T	NN	-	-	-	-	-	-	-	-
1885825	0	6	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	7	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	8	in	IN	-	-	-	-	-	-	-	-
1885825	0	9	Peyer	NNP	-	-	-	-	-	-	-	(2
1885825	0	10	's	POS	-	-	-	-	-	-	-	-
1885825	0	11	Patches	NNP	-	-	-	-	-	-	-	2)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	A	LS	-	-	-	-	-	-	-	-
1885825	0	3	and	CC	-	-	-	-	-	-	-	-
1885825	0	4	B	LS	-	-	-	-	-	-	-	-
1885825	0	5	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	6	Relative	JJ	-	-	-	-	-	-	-	-
1885825	0	7	proportions	NNS	-	-	-	-	-	-	-	-
1885825	0	8	of	IN	-	-	-	-	-	-	-	-
1885825	0	9	naïve	NN	-	-	-	-	-	-	-	(121|(118)|(122b)
1885825	0	10	,	,	-	-	-	-	-	-	-	-
1885825	0	11	regulatory	JJ	-	-	-	-	-	-	-	(119)|(123a)
1885825	0	12	and	CC	-	-	-	-	-	-	-	-
1885825	0	13	memory	NN	-	-	-	-	-	-	-	(120|(124
1885825	0	14	T	NNS	-	-	-	-	-	-	-	(122b|(123a
1885825	0	15	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	cells	NNS	-	-	-	-	-	-	-	120)
1885825	0	17	in	IN	-	-	-	-	-	-	-	-
1885825	0	18	PPs	NNS	-	-	-	-	-	-	-	(2)|124)|123a)|122b)|121)
1885825	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	20	A	NN	-	-	-	-	-	-	-	-
1885825	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	and	CC	-	-	-	-	-	-	-	-
1885825	0	23	spleens	NNS	-	-	-	-	-	-	-	(97|(107)
1885825	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	25	B	NN	-	-	-	-	-	-	-	-
1885825	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	27	of	IN	-	-	-	-	-	-	-	-
1885825	0	28	KO	NN	-	-	-	-	-	-	-	(12b)
1885825	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	30	▪	SYM	-	-	-	-	-	-	-	-
1885825	0	31	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	32	and	CC	-	-	-	-	-	-	-	-
1885825	0	33	WT	NN	-	-	-	-	-	-	-	(87i)
1885825	0	34	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	35	□	SYM	-	-	-	-	-	-	-	-
1885825	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	37	mice	NNS	-	-	-	-	-	-	-	(12b)|(87i)|97)
1885825	0	38	at	IN	-	-	-	-	-	-	-	-
1885825	0	39	week	NN	-	-	-	-	-	-	-	(16
1885825	0	40	12	CD	-	-	-	-	-	-	-	16)
1885825	0	41	.	.	-	-	-	-	-	-	-	-

1885825	0	1	CD4	NN	-	-	-	-	-	-	-	(30
1885825	0	2	+	SYM	-	-	-	-	-	-	-	-
1885825	0	3	T	NN	-	-	-	-	-	-	-	-
1885825	0	4	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	5	cells	NNS	-	-	-	-	-	-	-	30)
1885825	0	6	were	VBD	-	-	-	-	-	-	-	-
1885825	0	7	stained	VBN	-	-	-	-	-	-	-	-
1885825	0	8	with	IN	-	-	-	-	-	-	-	-
1885825	0	9	antibodies	NNS	-	-	-	-	-	-	-	-
1885825	0	10	to	IN	-	-	-	-	-	-	-	-
1885825	0	11	CD25	NN	-	-	-	-	-	-	-	-
1885825	0	12	and	CC	-	-	-	-	-	-	-	-
1885825	0	13	CD45RB	NN	-	-	-	-	-	-	-	-
1885825	0	14	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	C	LS	-	-	-	-	-	-	-	-
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Relative	JJ	-	-	-	-	-	-	-	-
1885825	0	5	proportions	NNS	-	-	-	-	-	-	-	-
1885825	0	6	of	IN	-	-	-	-	-	-	-	-
1885825	0	7	apoptotic	JJ	-	-	-	-	-	-	-	-
1885825	0	8	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	9	+	SYM	-	-	-	-	-	-	-	-
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	12	+	SYM	-	-	-	-	-	-	-	-
1885825	0	13	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	14	+	SYM	-	-	-	-	-	-	-	-
1885825	0	15	T	NN	-	-	-	-	-	-	-	-
1885825	0	16	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Apoptotic	JJ	-	-	-	-	-	-	-	-
1885825	0	2	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	3	+	SYM	-	-	-	-	-	-	-	-
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	CD3	NN	-	-	-	-	-	-	-	-
1885825	0	6	+	SYM	-	-	-	-	-	-	-	-
1885825	0	7	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	8	+	SYM	-	-	-	-	-	-	-	-
1885825	0	9	T	NN	-	-	-	-	-	-	-	-
1885825	0	10	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	12	were	VBD	-	-	-	-	-	-	-	-
1885825	0	13	investigated	VBN	-	-	-	-	-	-	-	-
1885825	0	14	by	IN	-	-	-	-	-	-	-	-
1885825	0	15	flow	NN	-	-	-	-	-	-	-	(25
1885825	0	16	cytometry	NN	-	-	-	-	-	-	-	25)
1885825	0	17	using	VBG	-	-	-	-	-	-	-	-
1885825	0	18	antibodies	NNS	-	-	-	-	-	-	-	(104|(257c
1885825	0	19	to	IN	-	-	-	-	-	-	-	257c)
1885825	0	20	CD3	NN	-	-	-	-	-	-	-	(103)|104)
1885825	0	21	,	,	-	-	-	-	-	-	-	-
1885825	0	22	CD4	NN	-	-	-	-	-	-	-	(257c)
1885825	0	23	and	CC	-	-	-	-	-	-	-	-
1885825	0	24	annexin	NN	-	-	-	-	-	-	-	-
1885825	0	25	V	CD	-	-	-	-	-	-	-	-
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	-
1885825	0	2	were	VBD	-	-	-	-	-	-	-	-
1885825	0	3	gated	VBN	-	-	-	-	-	-	-	-
1885825	0	4	for	IN	-	-	-	-	-	-	-	-
1885825	0	5	CD3	NN	-	-	-	-	-	-	-	(260
1885825	0	6	+	SYM	-	-	-	-	-	-	-	-
1885825	0	7	CD4	NN	-	-	-	-	-	-	-	-
1885825	0	8	+	SYM	-	-	-	-	-	-	-	-
1885825	0	9	T	NN	-	-	-	-	-	-	-	-
1885825	0	10	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	cells	NNS	-	-	-	-	-	-	-	260)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	-
1885825	0	2	represent	VBP	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(255
1885825	0	4	means	NNS	-	-	-	-	-	-	-	-
1885825	0	5	±	SYM	-	-	-	-	-	-	-	-
1885825	0	6	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	8	CD	-	-	-	-	-	-	-	-
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	10	per	IN	-	-	-	-	-	-	-	-
1885825	0	11	group	NN	-	-	-	-	-	-	-	255)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	0.04	CD	-	-	-	-	-	-	-	-
1885825	0	3	MB	NN	-	-	-	-	-	-	-	-
1885825	0	4	TIF	NN	-	-	-	-	-	-	-	-
1885825	0	5	)	-RRB-	-	-	-	-	-	-	-	-

1885825	0	1	Click	VB	-	-	-	-	-	-	-	-
1885825	0	2	here	RB	-	-	-	-	-	-	-	-
1885825	0	3	for	IN	-	-	-	-	-	-	-	-
1885825	0	4	additional	JJ	-	-	-	-	-	-	-	-
1885825	0	5	data	NNS	-	-	-	-	-	-	-	-
1885825	0	6	file	NN	-	-	-	-	-	-	-	-
1885825	0	7	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Acknowledgements	NNS	-	-	-	-	-	-	-	-

1885825	0	1	We	PRP	-	-	-	-	-	-	-	-
1885825	0	2	acknowledge	VBP	-	-	-	-	-	-	-	-
1885825	0	3	Veronique	NNP	-	-	-	-	-	-	-	(261
1885825	0	4	Mégras	NNP	-	-	-	-	-	-	-	-
1885825	0	5	,	,	-	-	-	-	-	-	-	-
1885825	0	6	Catherine	NNP	-	-	-	-	-	-	-	-
1885825	0	7	Martinet	NNP	-	-	-	-	-	-	-	-
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	Michel	NNP	-	-	-	-	-	-	-	-
1885825	0	10	Peuchmaur	NNP	-	-	-	-	-	-	-	-
1885825	0	11	,	,	-	-	-	-	-	-	-	-
1885825	0	12	Régine	NNP	-	-	-	-	-	-	-	-
1885825	0	13	Paris	NNP	-	-	-	-	-	-	-	-
1885825	0	14	,	,	-	-	-	-	-	-	-	-
1885825	0	15	Pascal	NNP	-	-	-	-	-	-	-	-
1885825	0	16	Blain	NNP	-	-	-	-	-	-	-	-
1885825	0	17	,	,	-	-	-	-	-	-	-	-
1885825	0	18	Jean	NNP	-	-	-	-	-	-	-	-
1885825	0	19	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	20	Baptiste	NNP	-	-	-	-	-	-	-	-
1885825	0	21	Huguet	NNP	-	-	-	-	-	-	-	-
1885825	0	22	,	,	-	-	-	-	-	-	-	-
1885825	0	23	Latifa	NNP	-	-	-	-	-	-	-	-
1885825	0	24	Ferkdadji	NNP	-	-	-	-	-	-	-	-
1885825	0	25	,	,	-	-	-	-	-	-	-	-
1885825	0	26	Françoise	NNP	-	-	-	-	-	-	-	-
1885825	0	27	Merlin	NNP	-	-	-	-	-	-	-	-
1885825	0	28	,	,	-	-	-	-	-	-	-	-
1885825	0	29	Robert	NNP	-	-	-	-	-	-	-	-
1885825	0	30	Ducroc	NNP	-	-	-	-	-	-	-	-
1885825	0	31	,	,	-	-	-	-	-	-	-	-
1885825	0	32	Christèle	NNP	-	-	-	-	-	-	-	-
1885825	0	33	Madre	NNP	-	-	-	-	-	-	-	-
1885825	0	34	,	,	-	-	-	-	-	-	-	-
1885825	0	35	Sarah	NNP	-	-	-	-	-	-	-	-
1885825	0	36	Cheriet	NNP	-	-	-	-	-	-	-	-
1885825	0	37	and	CC	-	-	-	-	-	-	-	-
1885825	0	38	Pauline	NNP	-	-	-	-	-	-	-	-
1885825	0	39	Thabuteau	NNP	-	-	-	-	-	-	-	261)
1885825	0	40	for	IN	-	-	-	-	-	-	-	-
1885825	0	41	their	PRP$	-	-	-	-	-	-	-	(261)
1885825	0	42	excellent	JJ	-	-	-	-	-	-	-	-
1885825	0	43	assistance	NN	-	-	-	-	-	-	-	-
1885825	0	44	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Figures	NNS	-	-	-	-	-	-	-	-
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	Tables	NNS	-	-	-	-	-	-	-	-

1885825	0	1	Figure	NN	-	-	-	-	-	-	-	-
1885825	0	2	1	CD	-	-	-	-	-	-	-	-

1885825	0	1	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	postnatal	JJ	-	-	-	-	-	-	-	-
1885825	0	4	development	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	gut	NN	-	-	-	-	-	-	-	(61)
1885825	0	7	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	8	lymphoid	JJ	-	-	-	-	-	-	-	-
1885825	0	9	formations	NNS	-	-	-	-	-	-	-	-
1885825	0	10	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	A	LS	-	-	-	-	-	-	-	(89)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	5	count	NN	-	-	-	-	-	-	-	-
1885825	0	6	on	IN	-	-	-	-	-	-	-	-
1885825	0	7	the	DT	-	-	-	-	-	-	-	-
1885825	0	8	whole	JJ	-	-	-	-	-	-	-	-
1885825	0	9	intestines	NNS	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	KO	NN	-	-	-	-	-	-	-	(86|(12w)
1885825	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	13	▪	SYM	-	-	-	-	-	-	-	-
1885825	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	15	and	CC	-	-	-	-	-	-	-	-
1885825	0	16	WT	NN	-	-	-	-	-	-	-	(87a)
1885825	0	17	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	18	□	SYM	-	-	-	-	-	-	-	-
1885825	0	19	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	20	mice	NNS	-	-	-	-	-	-	-	(12w)|(87a)|86)
1885825	0	21	at	IN	-	-	-	-	-	-	-	-
1885825	0	22	birth	NN	-	-	-	-	-	-	-	(21)
1885825	0	23	and	CC	-	-	-	-	-	-	-	-
1885825	0	24	at	IN	-	-	-	-	-	-	-	-
1885825	0	25	weeks	NNS	-	-	-	-	-	-	-	(15|(17|(16i)|(18h)
1885825	0	26	4	CD	-	-	-	-	-	-	-	15)
1885825	0	27	,	,	-	-	-	-	-	-	-	-
1885825	0	28	12	CD	-	-	-	-	-	-	-	(16i)
1885825	0	29	and	CC	-	-	-	-	-	-	-	-
1885825	0	30	52	CD	-	-	-	-	-	-	-	(18h)|17)
1885825	0	31	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	B	LS	-	-	-	-	-	-	-	-
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Number	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	isolated	VBN	-	-	-	-	-	-	-	(10
1885825	0	7	LFs	NNS	-	-	-	-	-	-	-	10)
1885825	0	8	identified	VBN	-	-	-	-	-	-	-	-
1885825	0	9	on	IN	-	-	-	-	-	-	-	-
1885825	0	10	microscopic	JJ	-	-	-	-	-	-	-	-
1885825	0	11	examination	NN	-	-	-	-	-	-	-	-
1885825	0	12	of	IN	-	-	-	-	-	-	-	-
1885825	0	13	the	DT	-	-	-	-	-	-	-	(91
1885825	0	14	small	JJ	-	-	-	-	-	-	-	-
1885825	0	15	intestine	NN	-	-	-	-	-	-	-	91)
1885825	0	16	at	IN	-	-	-	-	-	-	-	-
1885825	0	17	weeks	NNS	-	-	-	-	-	-	-	(16|(18a)
1885825	0	18	12	CD	-	-	-	-	-	-	-	16)
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	52	CD	-	-	-	-	-	-	-	(18a)
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	C	LS	-	-	-	-	-	-	-	-
1885825	0	3	and	CC	-	-	-	-	-	-	-	-
1885825	0	4	D	LS	-	-	-	-	-	-	-	-
1885825	0	5	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	6	Number	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	9	per	IN	-	-	-	-	-	-	-	-
1885825	0	10	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	11	and	CC	-	-	-	-	-	-	-	-
1885825	0	12	spleen	NN	-	-	-	-	-	-	-	(107)
1885825	0	13	at	IN	-	-	-	-	-	-	-	-
1885825	0	14	weeks	NNS	-	-	-	-	-	-	-	(15|(17|(16d)|(18d)
1885825	0	15	4	CD	-	-	-	-	-	-	-	15)
1885825	0	16	,	,	-	-	-	-	-	-	-	-
1885825	0	17	12	CD	-	-	-	-	-	-	-	(16d)
1885825	0	18	and	CC	-	-	-	-	-	-	-	-
1885825	0	19	52	CD	-	-	-	-	-	-	-	(18d)|17)
1885825	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	E	LS	-	-	-	-	-	-	-	(98)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Number	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	apoptotic	JJ	-	-	-	-	-	-	-	-
1885825	0	7	cells	NNS	-	-	-	-	-	-	-	-
1885825	0	8	identified	VBN	-	-	-	-	-	-	-	-
1885825	0	9	by	IN	-	-	-	-	-	-	-	-
1885825	0	10	caspase	NN	-	-	-	-	-	-	-	(241
1885825	0	11	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	12	3	CD	-	-	-	-	-	-	-	-
1885825	0	13	immunostaining	NN	-	-	-	-	-	-	-	241)
1885825	0	14	at	IN	-	-	-	-	-	-	-	-
1885825	0	15	week	NN	-	-	-	-	-	-	-	(16
1885825	0	16	12	CD	-	-	-	-	-	-	-	16)
1885825	0	17	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	-
1885825	0	2	represent	VBP	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(255
1885825	0	4	means	NN	-	-	-	-	-	-	-	-
1885825	0	5	±	SYM	-	-	-	-	-	-	-	-
1885825	0	6	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	8	CD	-	-	-	-	-	-	-	-
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	10	per	IN	-	-	-	-	-	-	-	-
1885825	0	11	group	NN	-	-	-	-	-	-	-	255)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	*P	NN	-	-	-	-	-	-	-	(254|(92)
1885825	0	2	<	SYM	-	-	-	-	-	-	-	-
1885825	0	3	0.05	CD	-	-	-	-	-	-	-	254)
1885825	0	4	;	:	-	-	-	-	-	-	-	-
1885825	0	5	**P	NN	-	-	-	-	-	-	-	(143|(92)
1885825	0	6	<	SYM	-	-	-	-	-	-	-	-
1885825	0	7	0.01	CD	-	-	-	-	-	-	-	143)
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	***P	NN	-	-	-	-	-	-	-	(92)
1885825	0	10	<	SYM	-	-	-	-	-	-	-	-
1885825	0	11	0.001	CD	-	-	-	-	-	-	-	-
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Figure	NN	-	-	-	-	-	-	-	-
1885825	0	2	2	CD	-	-	-	-	-	-	-	-

1885825	0	1	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	Peyer	NNP	-	-	-	-	-	-	-	(24
1885825	0	4	's	POS	-	-	-	-	-	-	-	-
1885825	0	5	patch	NN	-	-	-	-	-	-	-	-
1885825	0	6	cellular	JJ	-	-	-	-	-	-	-	-
1885825	0	7	composition	NN	-	-	-	-	-	-	-	24)
1885825	0	8	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	A	LS	-	-	-	-	-	-	-	(108
1885825	0	3	and	CC	-	-	-	-	-	-	-	-
1885825	0	4	B	LS	-	-	-	-	-	-	-	108)
1885825	0	5	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	6	Relative	JJ	-	-	-	-	-	-	-	-
1885825	0	7	proportions	NNS	-	-	-	-	-	-	-	-
1885825	0	8	of	IN	-	-	-	-	-	-	-	-
1885825	0	9	T	NN	-	-	-	-	-	-	-	(114a|(185
1885825	0	10	-	HYPH	-	-	-	-	-	-	-	114a)
1885825	0	11	,	,	-	-	-	-	-	-	-	-
1885825	0	12	B	NN	-	-	-	-	-	-	-	(183b
1885825	0	13	-	HYPH	-	-	-	-	-	-	-	183b)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	dendritic	JJ	-	-	-	-	-	-	-	(186
1885825	0	16	cells	NNS	-	-	-	-	-	-	-	(114a)|(183b)|186)|185)
1885825	0	17	from	IN	-	-	-	-	-	-	-	-
1885825	0	18	PPs	NNS	-	-	-	-	-	-	-	(2)|(242b)|(27d)
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	spleens	NNS	-	-	-	-	-	-	-	(97|(107)
1885825	0	21	of	IN	-	-	-	-	-	-	-	(27d
1885825	0	22	KO	NN	-	-	-	-	-	-	-	(242b|(86|(12f)|27d)
1885825	0	23	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	24	▪	SYM	-	-	-	-	-	-	-	-
1885825	0	25	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	26	and	CC	-	-	-	-	-	-	-	-
1885825	0	27	WT	NN	-	-	-	-	-	-	-	(87c)
1885825	0	28	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	29	□	SYM	-	-	-	-	-	-	-	-
1885825	0	30	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	31	mice	NNS	-	-	-	-	-	-	-	(12f)|(27d)|(87c)|97)|86)|242b)
1885825	0	32	at	IN	-	-	-	-	-	-	-	-
1885825	0	33	week	NN	-	-	-	-	-	-	-	(16
1885825	0	34	12	CD	-	-	-	-	-	-	-	16)
1885825	0	35	.	.	-	-	-	-	-	-	-	-

1885825	0	1	T	NN	-	-	-	-	-	-	-	(114b|(185
1885825	0	2	-	HYPH	-	-	-	-	-	-	-	114b)
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	B	NN	-	-	-	-	-	-	-	(183a
1885825	0	5	-	HYPH	-	-	-	-	-	-	-	183a)
1885825	0	6	and	CC	-	-	-	-	-	-	-	-
1885825	0	7	dendritic	JJ	-	-	-	-	-	-	-	(186
1885825	0	8	cells	NNS	-	-	-	-	-	-	-	(114b)|(183a)|186)|185)
1885825	0	9	were	VBD	-	-	-	-	-	-	-	-
1885825	0	10	investigated	VBN	-	-	-	-	-	-	-	-
1885825	0	11	by	IN	-	-	-	-	-	-	-	-
1885825	0	12	flow	NN	-	-	-	-	-	-	-	(25
1885825	0	13	cytometry	NN	-	-	-	-	-	-	-	25)
1885825	0	14	using	VBG	-	-	-	-	-	-	-	-
1885825	0	15	antibodies	NNS	-	-	-	-	-	-	-	(101a|(102|(104|(105a
1885825	0	16	to	IN	-	-	-	-	-	-	-	105a)|101a)
1885825	0	17	CD3	NN	-	-	-	-	-	-	-	(103)|104)
1885825	0	18	,	,	-	-	-	-	-	-	-	-
1885825	0	19	B220	NN	-	-	-	-	-	-	-	(100)|(101a)
1885825	0	20	and	CC	-	-	-	-	-	-	-	-
1885825	0	21	CD11c	NN	-	-	-	-	-	-	-	(105a)|102)
1885825	0	22	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	C	LS	-	-	-	-	-	-	-	(110)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Relative	JJ	-	-	-	-	-	-	-	-
1885825	0	5	proportion	NN	-	-	-	-	-	-	-	-
1885825	0	6	of	IN	-	-	-	-	-	-	-	-
1885825	0	7	polymorphonuclear	JJ	-	-	-	-	-	-	-	(109
1885825	0	8	neutrophils	NNS	-	-	-	-	-	-	-	109)
1885825	0	9	was	VBD	-	-	-	-	-	-	-	-
1885825	0	10	analyzed	VBN	-	-	-	-	-	-	-	-
1885825	0	11	using	VBG	-	-	-	-	-	-	-	-
1885825	0	12	Ly	NN	-	-	-	-	-	-	-	-
1885825	0	13	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	14	6G	NN	-	-	-	-	-	-	-	-
1885825	0	15	antibody	NN	-	-	-	-	-	-	-	-
1885825	0	16	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	D	LS	-	-	-	-	-	-	-	(112)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	M	NN	-	-	-	-	-	-	-	(28
1885825	0	5	cells	NNS	-	-	-	-	-	-	-	28)
1885825	0	6	number	NN	-	-	-	-	-	-	-	-
1885825	0	7	inside	IN	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	(111
1885825	0	9	follicle	NN	-	-	-	-	-	-	-	-
1885825	0	10	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	11	with	IN	-	-	-	-	-	-	-	-
1885825	0	12	epithelium	NN	-	-	-	-	-	-	-	111)
1885825	0	13	was	VBD	-	-	-	-	-	-	-	-
1885825	0	14	investigated	VBN	-	-	-	-	-	-	-	-
1885825	0	15	by	IN	-	-	-	-	-	-	-	-
1885825	0	16	immuno	NN	-	-	-	-	-	-	-	-
1885825	0	17	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	18	histochemistry	NN	-	-	-	-	-	-	-	-
1885825	0	19	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Arrows	NNS	-	-	-	-	-	-	-	-
1885825	0	2	indicated	VBD	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	-
1885825	0	4	presence	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	M	NN	-	-	-	-	-	-	-	(28
1885825	0	7	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	8	cell	NN	-	-	-	-	-	-	-	28)
1885825	0	9	inside	IN	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	(111
1885825	0	11	follicle	NN	-	-	-	-	-	-	-	-
1885825	0	12	associated	VBN	-	-	-	-	-	-	-	-
1885825	0	13	with	IN	-	-	-	-	-	-	-	-
1885825	0	14	epithelium	NN	-	-	-	-	-	-	-	111)
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	-
1885825	0	2	represent	VBP	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(255
1885825	0	4	means	NN	-	-	-	-	-	-	-	-
1885825	0	5	±	SYM	-	-	-	-	-	-	-	-
1885825	0	6	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	8	CD	-	-	-	-	-	-	-	-
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	10	per	IN	-	-	-	-	-	-	-	-
1885825	0	11	group	NN	-	-	-	-	-	-	-	255)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	**P	NN	-	-	-	-	-	-	-	(143|(92)
1885825	0	2	<	SYM	-	-	-	-	-	-	-	-
1885825	0	3	0.01	CD	-	-	-	-	-	-	-	143)
1885825	0	4	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Figure	NN	-	-	-	-	-	-	-	-
1885825	0	2	3	CD	-	-	-	-	-	-	-	-

1885825	0	1	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	2	and	CC	-	-	-	-	-	-	-	-
1885825	0	3	T	NNS	-	-	-	-	-	-	-	(114
1885825	0	4	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	5	cells	NNS	-	-	-	-	-	-	-	114)
1885825	0	6	subset	NN	-	-	-	-	-	-	-	-
1885825	0	7	in	IN	-	-	-	-	-	-	-	-
1885825	0	8	PP	NNS	-	-	-	-	-	-	-	(2)
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	spleen	NN	-	-	-	-	-	-	-	(107)
1885825	0	11	from	IN	-	-	-	-	-	-	-	-
1885825	0	12	mice	NNS	-	-	-	-	-	-	-	(249
1885825	0	13	at	IN	-	-	-	-	-	-	-	-
1885825	0	14	12	CD	-	-	-	-	-	-	-	(16
1885825	0	15	weeks	NNS	-	-	-	-	-	-	-	-
1885825	0	16	of	IN	-	-	-	-	-	-	-	-
1885825	0	17	age	NN	-	-	-	-	-	-	-	249)|16)
1885825	0	18	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Relative	JJ	-	-	-	-	-	-	-	-
1885825	0	2	proportion	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	CD4	NN	-	-	-	-	-	-	-	(30b
1885825	0	5	+	SYM	-	-	-	-	-	-	-	30b)
1885825	0	6	,	,	-	-	-	-	-	-	-	-
1885825	0	7	CD8	NN	-	-	-	-	-	-	-	(116a
1885825	0	8	+	SYM	-	-	-	-	-	-	-	116a)
1885825	0	9	and	CC	-	-	-	-	-	-	-	-
1885825	0	10	CD4	NN	-	-	-	-	-	-	-	(256
1885825	0	11	−	SYM	-	-	-	-	-	-	-	-
1885825	0	12	CD8	NN	-	-	-	-	-	-	-	-
1885825	0	13	−	SYM	-	-	-	-	-	-	-	-
1885825	0	14	T	NN	-	-	-	-	-	-	-	(116a|(30b
1885825	0	15	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	16	cells	NNS	-	-	-	-	-	-	-	30b)|256)|116a)
1885825	0	17	from	IN	-	-	-	-	-	-	-	-
1885825	0	18	PPs	NNS	-	-	-	-	-	-	-	(2)|(242c)|(27b)
1885825	0	19	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	20	A	NN	-	-	-	-	-	-	-	-
1885825	0	21	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	22	and	CC	-	-	-	-	-	-	-	-
1885825	0	23	spleen	NN	-	-	-	-	-	-	-	(38e|(97|(107)
1885825	0	24	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	25	B	NN	-	-	-	-	-	-	-	-
1885825	0	26	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	27	of	IN	-	-	-	-	-	-	-	(242c|(27b
1885825	0	28	KO	NN	-	-	-	-	-	-	-	(86|(12s)|38e)|27b)
1885825	0	29	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	30	▪	SYM	-	-	-	-	-	-	-	-
1885825	0	31	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	32	and	CC	-	-	-	-	-	-	-	-
1885825	0	33	WT	NN	-	-	-	-	-	-	-	(87g)
1885825	0	34	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	35	□	SYM	-	-	-	-	-	-	-	-
1885825	0	36	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	37	mice	NNS	-	-	-	-	-	-	-	(12s)|(27b)|(38e)|(87g)|97)|86)|242c)
1885825	0	38	.	.	-	-	-	-	-	-	-	-

1885825	0	1	At	IN	-	-	-	-	-	-	-	-
1885825	0	2	week	NN	-	-	-	-	-	-	-	(16
1885825	0	3	12	CD	-	-	-	-	-	-	-	16)
1885825	0	4	,	,	-	-	-	-	-	-	-	-
1885825	0	5	CD3	NN	-	-	-	-	-	-	-	(106
1885825	0	6	+	SYM	-	-	-	-	-	-	-	-
1885825	0	7	T	NN	-	-	-	-	-	-	-	-
1885825	0	8	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	cells	NNS	-	-	-	-	-	-	-	106)
1885825	0	10	were	VBD	-	-	-	-	-	-	-	-
1885825	0	11	stained	VBN	-	-	-	-	-	-	-	-
1885825	0	12	with	IN	-	-	-	-	-	-	-	-
1885825	0	13	antibodies	NNS	-	-	-	-	-	-	-	(104|(257a|(258b
1885825	0	14	to	IN	-	-	-	-	-	-	-	258b)|257a)
1885825	0	15	CD3	NN	-	-	-	-	-	-	-	(103)|104)
1885825	0	16	,	,	-	-	-	-	-	-	-	-
1885825	0	17	CD4	NN	-	-	-	-	-	-	-	(257a)
1885825	0	18	,	,	-	-	-	-	-	-	-	-
1885825	0	19	and	CC	-	-	-	-	-	-	-	-
1885825	0	20	CD8	NN	-	-	-	-	-	-	-	(258b)
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	-
1885825	0	2	were	VBD	-	-	-	-	-	-	-	-
1885825	0	3	gated	VBN	-	-	-	-	-	-	-	-
1885825	0	4	for	IN	-	-	-	-	-	-	-	-
1885825	0	5	CD3	NN	-	-	-	-	-	-	-	(106
1885825	0	6	+	SYM	-	-	-	-	-	-	-	-
1885825	0	7	T	NN	-	-	-	-	-	-	-	-
1885825	0	8	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	cells	NNS	-	-	-	-	-	-	-	106)
1885825	0	10	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	-
1885825	0	2	represent	VBP	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(255
1885825	0	4	means	NNS	-	-	-	-	-	-	-	-
1885825	0	5	±	SYM	-	-	-	-	-	-	-	-
1885825	0	6	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	8	CD	-	-	-	-	-	-	-	-
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	10	per	IN	-	-	-	-	-	-	-	-
1885825	0	11	group	NN	-	-	-	-	-	-	-	255)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	*P	NN	-	-	-	-	-	-	-	(254|(92)
1885825	0	2	<	SYM	-	-	-	-	-	-	-	-
1885825	0	3	0.05	CD	-	-	-	-	-	-	-	254)
1885825	0	4	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Figure	NN	-	-	-	-	-	-	-	-
1885825	0	2	4	CD	-	-	-	-	-	-	-	-

1885825	0	1	Nod2	NN	-	-	-	-	-	-	-	(202|(11)
1885825	0	2	invalidation	NN	-	-	-	-	-	-	-	202)
1885825	0	3	increases	VBZ	-	-	-	-	-	-	-	-
1885825	0	4	cytokine	NN	-	-	-	-	-	-	-	(80
1885825	0	5	expression	NN	-	-	-	-	-	-	-	-
1885825	0	6	in	IN	-	-	-	-	-	-	-	-
1885825	0	7	PP	NNS	-	-	-	-	-	-	-	(2)|80)
1885825	0	8	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Expressions	NNS	-	-	-	-	-	-	-	-
1885825	0	2	of	IN	-	-	-	-	-	-	-	-
1885825	0	3	Il	NN	-	-	-	-	-	-	-	(126|(127
1885825	0	4	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	5	1β	NN	-	-	-	-	-	-	-	126)
1885825	0	6	,	,	-	-	-	-	-	-	-	-
1885825	0	7	IFNγ	NN	-	-	-	-	-	-	-	(33)
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	TNFα	NN	-	-	-	-	-	-	-	(31)
1885825	0	10	,	,	-	-	-	-	-	-	-	-
1885825	0	11	IL	NN	-	-	-	-	-	-	-	(34
1885825	0	12	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	13	12	CD	-	-	-	-	-	-	-	34)
1885825	0	14	,	,	-	-	-	-	-	-	-	-
1885825	0	15	IL	NN	-	-	-	-	-	-	-	(35
1885825	0	16	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	4	CD	-	-	-	-	-	-	-	35)|127)
1885825	0	18	were	VBD	-	-	-	-	-	-	-	-
1885825	0	19	determined	VBN	-	-	-	-	-	-	-	-
1885825	0	20	by	IN	-	-	-	-	-	-	-	-
1885825	0	21	ELISA	NN	-	-	-	-	-	-	-	(36)
1885825	0	22	in	IN	-	-	-	-	-	-	-	-
1885825	0	23	PPs	NNS	-	-	-	-	-	-	-	(2)|(242a)
1885825	0	24	,	,	-	-	-	-	-	-	-	-
1885825	0	25	Ileum	NN	-	-	-	-	-	-	-	(149)|(150b)
1885825	0	26	and	CC	-	-	-	-	-	-	-	-
1885825	0	27	spleens	NNS	-	-	-	-	-	-	-	(97|(107)
1885825	0	28	from	IN	-	-	-	-	-	-	-	(150b|(242a
1885825	0	29	KO	NN	-	-	-	-	-	-	-	(86|(12i)
1885825	0	30	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	31	▪	SYM	-	-	-	-	-	-	-	-
1885825	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	33	and	CC	-	-	-	-	-	-	-	-
1885825	0	34	WT	NN	-	-	-	-	-	-	-	(87k)
1885825	0	35	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	36	□	SYM	-	-	-	-	-	-	-	-
1885825	0	37	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	38	mice	NNS	-	-	-	-	-	-	-	(12i)|(87k)|97)|86)|242a)|150b)
1885825	0	39	at	IN	-	-	-	-	-	-	-	-
1885825	0	40	weeks	NNS	-	-	-	-	-	-	-	(15|(16g)
1885825	0	41	4	CD	-	-	-	-	-	-	-	15)
1885825	0	42	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	43	left	JJ	-	-	-	-	-	-	-	-
1885825	0	44	panel	NN	-	-	-	-	-	-	-	-
1885825	0	45	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	46	and	CC	-	-	-	-	-	-	-	-
1885825	0	47	12	CD	-	-	-	-	-	-	-	(16g)
1885825	0	48	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	49	right	JJ	-	-	-	-	-	-	-	-
1885825	0	50	panel	NN	-	-	-	-	-	-	-	-
1885825	0	51	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	52	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	-
1885825	0	2	represent	VBP	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(255
1885825	0	4	means	NNS	-	-	-	-	-	-	-	-
1885825	0	5	±	SYM	-	-	-	-	-	-	-	-
1885825	0	6	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	8	CD	-	-	-	-	-	-	-	-
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	10	per	IN	-	-	-	-	-	-	-	-
1885825	0	11	group	NN	-	-	-	-	-	-	-	255)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	*P	NN	-	-	-	-	-	-	-	(254|(92)
1885825	0	2	<	SYM	-	-	-	-	-	-	-	-
1885825	0	3	0.05	CD	-	-	-	-	-	-	-	254)
1885825	0	4	;	:	-	-	-	-	-	-	-	-
1885825	0	5	**P	NN	-	-	-	-	-	-	-	(143|(92)
1885825	0	6	<	SYM	-	-	-	-	-	-	-	-
1885825	0	7	0.01	CD	-	-	-	-	-	-	-	143)
1885825	0	8	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Figure	NN	-	-	-	-	-	-	-	-
1885825	0	2	5	CD	-	-	-	-	-	-	-	-

1885825	0	1	Paracellular	JJ	-	-	-	-	-	-	-	(41
1885825	0	2	permeability	NN	-	-	-	-	-	-	-	41)
1885825	0	3	and	CC	-	-	-	-	-	-	-	-
1885825	0	4	bacterial	JJ	-	-	-	-	-	-	-	(43
1885825	0	5	translocation	NN	-	-	-	-	-	-	-	43)
1885825	0	6	are	VBP	-	-	-	-	-	-	-	-
1885825	0	7	increased	VBN	-	-	-	-	-	-	-	-
1885825	0	8	in	IN	-	-	-	-	-	-	-	-
1885825	0	9	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	10	invalidated	VBN	-	-	-	-	-	-	-	-
1885825	0	11	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Ussing	NNP	-	-	-	-	-	-	-	(39|(40a
1885825	0	2	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	3	chamber	NN	-	-	-	-	-	-	-	40a)|39)
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	Real	JJ	-	-	-	-	-	-	-	(220
1885825	0	6	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	7	time	NN	-	-	-	-	-	-	-	-
1885825	0	8	PCR	NN	-	-	-	-	-	-	-	220)
1885825	0	9	experiments	NNS	-	-	-	-	-	-	-	(40a)
1885825	0	10	were	VBD	-	-	-	-	-	-	-	-
1885825	0	11	performed	VBN	-	-	-	-	-	-	-	-
1885825	0	12	on	IN	-	-	-	-	-	-	-	-
1885825	0	13	PP	NNS	-	-	-	-	-	-	-	(135|(2)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	PP	NNS	-	-	-	-	-	-	-	(37|(2)
1885825	0	16	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	free	JJ	-	-	-	-	-	-	-	-
1885825	0	18	ileum	NN	-	-	-	-	-	-	-	37)|135)
1885825	0	19	from	IN	-	-	-	-	-	-	-	-
1885825	0	20	WT	NN	-	-	-	-	-	-	-	(86|(87)
1885825	0	21	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	22	□	SYM	-	-	-	-	-	-	-	-
1885825	0	23	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	24	and	CC	-	-	-	-	-	-	-	-
1885825	0	25	KO	NN	-	-	-	-	-	-	-	(12)|86)
1885825	0	26	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	27	▪	SYM	-	-	-	-	-	-	-	-
1885825	0	28	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	29	at	IN	-	-	-	-	-	-	-	-
1885825	0	30	week	NN	-	-	-	-	-	-	-	(16
1885825	0	31	12	CD	-	-	-	-	-	-	-	16)
1885825	0	32	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	A	LS	-	-	-	-	-	-	-	(137)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Paracellular	JJ	-	-	-	-	-	-	-	(41
1885825	0	5	permeability	NN	-	-	-	-	-	-	-	41)
1885825	0	6	was	VBD	-	-	-	-	-	-	-	-
1885825	0	7	analysed	VBN	-	-	-	-	-	-	-	-
1885825	0	8	by	IN	-	-	-	-	-	-	-	-
1885825	0	9	FITC	NN	-	-	-	-	-	-	-	-
1885825	0	10	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	11	dextran	NN	-	-	-	-	-	-	-	-
1885825	0	12	flux	NN	-	-	-	-	-	-	-	-
1885825	0	13	from	IN	-	-	-	-	-	-	-	-
1885825	0	14	PP	NNS	-	-	-	-	-	-	-	(135|(2)
1885825	0	15	and	CC	-	-	-	-	-	-	-	-
1885825	0	16	PP	NNS	-	-	-	-	-	-	-	(37|(2)
1885825	0	17	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	18	free	JJ	-	-	-	-	-	-	-	-
1885825	0	19	ileum	NN	-	-	-	-	-	-	-	37)|135)
1885825	0	20	under	IN	-	-	-	-	-	-	-	-
1885825	0	21	basal	JJ	-	-	-	-	-	-	-	(187
1885825	0	22	condition	NN	-	-	-	-	-	-	-	187)
1885825	0	23	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	B	LS	-	-	-	-	-	-	-	(144)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	mRNA	NN	-	-	-	-	-	-	-	(138
1885825	0	5	expression	NN	-	-	-	-	-	-	-	-
1885825	0	6	levels	NNS	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	TJ	NN	-	-	-	-	-	-	-	-
1885825	0	9	proteins	NN	-	-	-	-	-	-	-	138)
1885825	0	10	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	11	ZO	NN	-	-	-	-	-	-	-	(142
1885825	0	12	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	13	1	CD	-	-	-	-	-	-	-	142)
1885825	0	14	,	,	-	-	-	-	-	-	-	-
1885825	0	15	ZO	NN	-	-	-	-	-	-	-	(140
1885825	0	16	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	2	CD	-	-	-	-	-	-	-	140)
1885825	0	18	and	CC	-	-	-	-	-	-	-	-
1885825	0	19	Occ	NN	-	-	-	-	-	-	-	(145)
1885825	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	21	from	IN	-	-	-	-	-	-	-	-
1885825	0	22	PP	NN	-	-	-	-	-	-	-	(2)
1885825	0	23	were	VBD	-	-	-	-	-	-	-	-
1885825	0	24	analysed	VBN	-	-	-	-	-	-	-	-
1885825	0	25	by	IN	-	-	-	-	-	-	-	-
1885825	0	26	real	NN	-	-	-	-	-	-	-	(220
1885825	0	27	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	28	Time	NN	-	-	-	-	-	-	-	-
1885825	0	29	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	30	PCR	NN	-	-	-	-	-	-	-	220)
1885825	0	31	under	IN	-	-	-	-	-	-	-	-
1885825	0	32	basal	JJ	-	-	-	-	-	-	-	(187
1885825	0	33	condition	NN	-	-	-	-	-	-	-	187)
1885825	0	34	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	C	LS	-	-	-	-	-	-	-	(154)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Bacterial	JJ	-	-	-	-	-	-	-	-
1885825	0	5	translocation	NN	-	-	-	-	-	-	-	-
1885825	0	6	of	IN	-	-	-	-	-	-	-	-
1885825	0	7	chemically	RB	-	-	-	-	-	-	-	(153
1885825	0	8	killed	VBN	-	-	-	-	-	-	-	-
1885825	0	9	fluorescent	JJ	-	-	-	-	-	-	-	-
1885825	0	10	Escherichia	NNP	-	-	-	-	-	-	-	-
1885825	0	11	Coli	NNP	-	-	-	-	-	-	-	-
1885825	0	12	K	NN	-	-	-	-	-	-	-	-
1885825	0	13	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	14	12	CD	-	-	-	-	-	-	-	153)
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	D	LS	-	-	-	-	-	-	-	(157)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Translocation	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(155
1885825	0	7	viable	JJ	-	-	-	-	-	-	-	-
1885825	0	8	non	AFX	-	-	-	-	-	-	-	-
1885825	0	9	enteropathogen	NN	-	-	-	-	-	-	-	-
1885825	0	10	Escherichia	NNP	-	-	-	-	-	-	-	(156
1885825	0	11	Coli	NNP	-	-	-	-	-	-	-	156)
1885825	0	12	strain	NN	-	-	-	-	-	-	-	-
1885825	0	13	J53	NN	-	-	-	-	-	-	-	155)
1885825	0	14	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	E	LS	-	-	-	-	-	-	-	-
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Translocation	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	a	DT	-	-	-	-	-	-	-	-
1885825	0	7	chemically	RB	-	-	-	-	-	-	-	-
1885825	0	8	killed	VBN	-	-	-	-	-	-	-	-
1885825	0	9	fluorescent	JJ	-	-	-	-	-	-	-	-
1885825	0	10	Staphylococcus	NNP	-	-	-	-	-	-	-	-
1885825	0	11	Aureus	NNP	-	-	-	-	-	-	-	-
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	F	LS	-	-	-	-	-	-	-	-
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Translocation	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	chemically	RB	-	-	-	-	-	-	-	(246
1885825	0	7	killed	VBN	-	-	-	-	-	-	-	-
1885825	0	8	fluorescein	NN	-	-	-	-	-	-	-	-
1885825	0	9	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	10	conjugated	VBN	-	-	-	-	-	-	-	-
1885825	0	11	Saccharomyces	NNP	-	-	-	-	-	-	-	-
1885825	0	12	cerevisiae	NNP	-	-	-	-	-	-	-	246)
1885825	0	13	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Data	NNS	-	-	-	-	-	-	-	-
1885825	0	2	represent	VBP	-	-	-	-	-	-	-	-
1885825	0	3	the	DT	-	-	-	-	-	-	-	(255
1885825	0	4	means	NN	-	-	-	-	-	-	-	-
1885825	0	5	±	SYM	-	-	-	-	-	-	-	-
1885825	0	6	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	8	CD	-	-	-	-	-	-	-	-
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	10	per	IN	-	-	-	-	-	-	-	-
1885825	0	11	group	NN	-	-	-	-	-	-	-	255)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	*P	NN	-	-	-	-	-	-	-	(254|(92)
1885825	0	2	<	SYM	-	-	-	-	-	-	-	-
1885825	0	3	0.05	CD	-	-	-	-	-	-	-	254)
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	**P	NN	-	-	-	-	-	-	-	(143|(92)
1885825	0	6	<	SYM	-	-	-	-	-	-	-	-
1885825	0	7	0.01	CD	-	-	-	-	-	-	-	143)
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	significantly	RB	-	-	-	-	-	-	-	-
1885825	0	10	different	JJ	-	-	-	-	-	-	-	-
1885825	0	11	from	IN	-	-	-	-	-	-	-	-
1885825	0	12	WT	NN	-	-	-	-	-	-	-	(87)
1885825	0	13	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Figure	NN	-	-	-	-	-	-	-	-
1885825	0	2	6	CD	-	-	-	-	-	-	-	-

1885825	0	1	Nod2	NN	-	-	-	-	-	-	-	(202|(11)
1885825	0	2	invalidation	NN	-	-	-	-	-	-	-	202)
1885825	0	3	increased	VBD	-	-	-	-	-	-	-	-
1885825	0	4	the	DT	-	-	-	-	-	-	-	-
1885825	0	5	suceptibility	NN	-	-	-	-	-	-	-	-
1885825	0	6	of	IN	-	-	-	-	-	-	-	-
1885825	0	7	TNBS	NN	-	-	-	-	-	-	-	(44|(45)
1885825	0	8	induced	VBN	-	-	-	-	-	-	-	-
1885825	0	9	colitis	NN	-	-	-	-	-	-	-	44)
1885825	0	10	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	A	LS	-	-	-	-	-	-	-	(163)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Body	NN	-	-	-	-	-	-	-	(262|(83
1885825	0	5	weight	NN	-	-	-	-	-	-	-	83)
1885825	0	6	,	,	-	-	-	-	-	-	-	-
1885825	0	7	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	8	B	LS	-	-	-	-	-	-	-	(165)
1885825	0	9	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	10	Macroscopic	JJ	-	-	-	-	-	-	-	(164
1885825	0	11	damage	NN	-	-	-	-	-	-	-	-
1885825	0	12	score	NN	-	-	-	-	-	-	-	164)
1885825	0	13	,	,	-	-	-	-	-	-	-	-
1885825	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	15	C	LS	-	-	-	-	-	-	-	(166)
1885825	0	16	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	17	cytokines	NNS	-	-	-	-	-	-	-	(252
1885825	0	18	levels	NNS	-	-	-	-	-	-	-	262)|252)
1885825	0	19	were	VBD	-	-	-	-	-	-	-	-
1885825	0	20	assessed	VBN	-	-	-	-	-	-	-	-
1885825	0	21	in	IN	-	-	-	-	-	-	-	-
1885825	0	22	12	CD	-	-	-	-	-	-	-	(16|(249
1885825	0	23	week	NN	-	-	-	-	-	-	-	-
1885825	0	24	old	JJ	-	-	-	-	-	-	-	16)
1885825	0	25	mice	NNS	-	-	-	-	-	-	-	249)
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	These	DT	-	-	-	-	-	-	-	(262
1885825	0	2	parameters	NNS	-	-	-	-	-	-	-	262)
1885825	0	3	were	VBD	-	-	-	-	-	-	-	-
1885825	0	4	determined	VBN	-	-	-	-	-	-	-	-
1885825	0	5	three	CD	-	-	-	-	-	-	-	-
1885825	0	6	days	NNS	-	-	-	-	-	-	-	-
1885825	0	7	after	IN	-	-	-	-	-	-	-	-
1885825	0	8	intracolonic	JJ	-	-	-	-	-	-	-	(250
1885825	0	9	administration	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	TNBS	NN	-	-	-	-	-	-	-	(45)|250)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Values	NNS	-	-	-	-	-	-	-	-
1885825	0	2	are	VBP	-	-	-	-	-	-	-	-
1885825	0	3	mean	NN	-	-	-	-	-	-	-	-
1885825	0	4	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	5	SEM	NN	-	-	-	-	-	-	-	-
1885825	0	6	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	7	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	8	n 	NN	-	-	-	-	-	-	-	-
1885825	0	9	= 	SYM	-	-	-	-	-	-	-	-
1885825	0	10	8	CD	-	-	-	-	-	-	-	-
1885825	0	11	in	IN	-	-	-	-	-	-	-	-
1885825	0	12	each	DT	-	-	-	-	-	-	-	-
1885825	0	13	group	NN	-	-	-	-	-	-	-	-
1885825	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	*P	NN	-	-	-	-	-	-	-	(254|(92)
1885825	0	2	<	SYM	-	-	-	-	-	-	-	-
1885825	0	3	0.05	CD	-	-	-	-	-	-	-	254)
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	**P	NN	-	-	-	-	-	-	-	(143|(92)
1885825	0	6	<	SYM	-	-	-	-	-	-	-	-
1885825	0	7	0.01	CD	-	-	-	-	-	-	-	143)
1885825	0	8	between	IN	-	-	-	-	-	-	-	-
1885825	0	9	WT	NN	-	-	-	-	-	-	-	(86|(87b)
1885825	0	10	and	CC	-	-	-	-	-	-	-	-
1885825	0	11	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	12	mice	NNS	-	-	-	-	-	-	-	(87b)|86)|12)
1885825	0	13	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Figure	NN	-	-	-	-	-	-	-	-
1885825	0	2	7	CD	-	-	-	-	-	-	-	-

1885825	0	1	Targeting	NN	-	-	-	-	-	-	-	-
1885825	0	2	disruption	NN	-	-	-	-	-	-	-	-
1885825	0	3	of	IN	-	-	-	-	-	-	-	-
1885825	0	4	the	DT	-	-	-	-	-	-	-	-
1885825	0	5	murine	JJ	-	-	-	-	-	-	-	-
1885825	0	6	Nod2	NN	-	-	-	-	-	-	-	(11)
1885825	0	7	gene	NN	-	-	-	-	-	-	-	-
1885825	0	8	by	IN	-	-	-	-	-	-	-	-
1885825	0	9	homologous	JJ	-	-	-	-	-	-	-	(263
1885825	0	10	recombination	NN	-	-	-	-	-	-	-	263)
1885825	0	11	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	A	LS	-	-	-	-	-	-	-	(212)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Generation	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	-
1885825	0	7	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	8	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	9	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	10	KO	NN	-	-	-	-	-	-	-	-
1885825	0	11	allele	NN	-	-	-	-	-	-	-	-
1885825	0	12	:	:	-	-	-	-	-	-	-	-
1885825	0	13	targeting	NN	-	-	-	-	-	-	-	(214
1885825	0	14	strategy	NN	-	-	-	-	-	-	-	214)
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	restriction	NN	-	-	-	-	-	-	-	-
1885825	0	3	maps	NNS	-	-	-	-	-	-	-	-
1885825	0	4	of	IN	-	-	-	-	-	-	-	-
1885825	0	5	the	DT	-	-	-	-	-	-	-	-
1885825	0	6	Card15	NN	-	-	-	-	-	-	-	-
1885825	0	7	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	8	Nod2	NN	-	-	-	-	-	-	-	-
1885825	0	9	+	SYM	-	-	-	-	-	-	-	-
1885825	0	10	allele	NN	-	-	-	-	-	-	-	-
1885825	0	11	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	12	5	CD	-	-	-	-	-	-	-	-
1885825	0	13	′	SYM	-	-	-	-	-	-	-	-
1885825	0	14	portion	NN	-	-	-	-	-	-	-	-
1885825	0	15	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	16	,	,	-	-	-	-	-	-	-	-
1885825	0	17	the	DT	-	-	-	-	-	-	-	(216
1885825	0	18	Card15	NN	-	-	-	-	-	-	-	-
1885825	0	19	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	20	Nod2	NN	-	-	-	-	-	-	-	-
1885825	0	21	KO	NN	-	-	-	-	-	-	-	-
1885825	0	22	targeting	VBG	-	-	-	-	-	-	-	-
1885825	0	23	fragment	NN	-	-	-	-	-	-	-	216)
1885825	0	24	,	,	-	-	-	-	-	-	-	-
1885825	0	25	and	CC	-	-	-	-	-	-	-	-
1885825	0	26	the	DT	-	-	-	-	-	-	-	-
1885825	0	27	modified	VBN	-	-	-	-	-	-	-	-
1885825	0	28	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	29	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	30	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	31	allele	NN	-	-	-	-	-	-	-	-
1885825	0	32	after	IN	-	-	-	-	-	-	-	-
1885825	0	33	homologous	JJ	-	-	-	-	-	-	-	(263
1885825	0	34	recombination	NN	-	-	-	-	-	-	-	263)
1885825	0	35	and	CC	-	-	-	-	-	-	-	-
1885825	0	36	Cre	NN	-	-	-	-	-	-	-	-
1885825	0	37	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	38	mediated	VBN	-	-	-	-	-	-	-	-
1885825	0	39	recombination	NN	-	-	-	-	-	-	-	-
1885825	0	40	of	IN	-	-	-	-	-	-	-	-
1885825	0	41	an	DT	-	-	-	-	-	-	-	-
1885825	0	42	Hygromycin	NN	-	-	-	-	-	-	-	-
1885825	0	43	selection	NN	-	-	-	-	-	-	-	-
1885825	0	44	cassette	NN	-	-	-	-	-	-	-	-
1885825	0	45	are	VBP	-	-	-	-	-	-	-	-
1885825	0	46	shown	VBN	-	-	-	-	-	-	-	-
1885825	0	47	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Exons	NNS	-	-	-	-	-	-	-	(211
1885825	0	2	1	CD	-	-	-	-	-	-	-	211)
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	2	CD	-	-	-	-	-	-	-	-
1885825	0	5	,	,	-	-	-	-	-	-	-	-
1885825	0	6	and	CC	-	-	-	-	-	-	-	-
1885825	0	7	3	CD	-	-	-	-	-	-	-	-
1885825	0	8	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	9	black	JJ	-	-	-	-	-	-	-	-
1885825	0	10	boxes	NNS	-	-	-	-	-	-	-	-
1885825	0	11	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	12	and	CC	-	-	-	-	-	-	-	-
1885825	0	13	restriction	NN	-	-	-	-	-	-	-	-
1885825	0	14	sites	NNS	-	-	-	-	-	-	-	-
1885825	0	15	used	VBN	-	-	-	-	-	-	-	-
1885825	0	16	for	IN	-	-	-	-	-	-	-	-
1885825	0	17	cloning	VBG	-	-	-	-	-	-	-	-
1885825	0	18	and	CC	-	-	-	-	-	-	-	-
1885825	0	19	screening	VBG	-	-	-	-	-	-	-	-
1885825	0	20	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	21	X	NN	-	-	-	-	-	-	-	(264)
1885825	0	22	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	23	XbaI	NN	-	-	-	-	-	-	-	-
1885825	0	24	,	,	-	-	-	-	-	-	-	-
1885825	0	25	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	26	A	NN	-	-	-	-	-	-	-	(265)
1885825	0	27	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	28	AgeI	NN	-	-	-	-	-	-	-	-
1885825	0	29	,	,	-	-	-	-	-	-	-	-
1885825	0	30	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	31	P	NN	-	-	-	-	-	-	-	-
1885825	0	32	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	33	PmlI	NN	-	-	-	-	-	-	-	-
1885825	0	34	,	,	-	-	-	-	-	-	-	-
1885825	0	35	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	36	S	NN	-	-	-	-	-	-	-	(266)
1885825	0	37	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	38	SalI	NN	-	-	-	-	-	-	-	-
1885825	0	39	,	,	-	-	-	-	-	-	-	-
1885825	0	40	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	41	N	NN	-	-	-	-	-	-	-	-
1885825	0	42	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	43	NotI	NN	-	-	-	-	-	-	-	-
1885825	0	44	are	VBP	-	-	-	-	-	-	-	-
1885825	0	45	indicated	VBN	-	-	-	-	-	-	-	-
1885825	0	46	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	(216
1885825	0	2	Card15	NN	-	-	-	-	-	-	-	-
1885825	0	3	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	4	Nod2	NN	-	-	-	-	-	-	-	-
1885825	0	5	KO	NN	-	-	-	-	-	-	-	-
1885825	0	6	targeting	NN	-	-	-	-	-	-	-	-
1885825	0	7	fragment	NN	-	-	-	-	-	-	-	216)
1885825	0	8	comprises	VBZ	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	-
1885825	0	10	EGFP	NN	-	-	-	-	-	-	-	-
1885825	0	11	gene	NN	-	-	-	-	-	-	-	-
1885825	0	12	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	13	Clontech	NNP	-	-	-	-	-	-	-	(267)
1885825	0	14	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	15	in	IN	-	-	-	-	-	-	-	-
1885825	0	16	frame	NN	-	-	-	-	-	-	-	-
1885825	0	17	with	IN	-	-	-	-	-	-	-	-
1885825	0	18	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	19	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	20	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	21	ATG	NN	-	-	-	-	-	-	-	-
1885825	0	22	and	CC	-	-	-	-	-	-	-	-
1885825	0	23	the	DT	-	-	-	-	-	-	-	(218
1885825	0	24	floxed	VBN	-	-	-	-	-	-	-	-
1885825	0	25	PGKHygromycin	NN	-	-	-	-	-	-	-	-
1885825	0	26	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	27	Clontech	NNP	-	-	-	-	-	-	-	(267)
1885825	0	28	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	29	selection	NN	-	-	-	-	-	-	-	-
1885825	0	30	cassette	NN	-	-	-	-	-	-	-	218)
1885825	0	31	,	,	-	-	-	-	-	-	-	-
1885825	0	32	introduced	VBN	-	-	-	-	-	-	-	-
1885825	0	33	between	IN	-	-	-	-	-	-	-	-
1885825	0	34	the	DT	-	-	-	-	-	-	-	-
1885825	0	35	AgeI	NN	-	-	-	-	-	-	-	(265)
1885825	0	36	site	NN	-	-	-	-	-	-	-	-
1885825	0	37	downstream	RB	-	-	-	-	-	-	-	-
1885825	0	38	of	IN	-	-	-	-	-	-	-	-
1885825	0	39	Card15	NN	-	-	-	-	-	-	-	(11|(211
1885825	0	40	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	41	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	42	exon	NN	-	-	-	-	-	-	-	-
1885825	0	43	1	CD	-	-	-	-	-	-	-	211)
1885825	0	44	and	CC	-	-	-	-	-	-	-	-
1885825	0	45	the	DT	-	-	-	-	-	-	-	-
1885825	0	46	SalI	NN	-	-	-	-	-	-	-	(266)
1885825	0	47	site	NN	-	-	-	-	-	-	-	-
1885825	0	48	upstream	RB	-	-	-	-	-	-	-	-
1885825	0	49	of	IN	-	-	-	-	-	-	-	-
1885825	0	50	exon	NN	-	-	-	-	-	-	-	(211
1885825	0	51	1	CD	-	-	-	-	-	-	-	211)
1885825	0	52	in	IN	-	-	-	-	-	-	-	-
1885825	0	53	the	DT	-	-	-	-	-	-	-	-
1885825	0	54	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	55	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	56	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	57	orientation	NN	-	-	-	-	-	-	-	-
1885825	0	58	.	.	-	-	-	-	-	-	-	-

1885825	0	1	All	DT	-	-	-	-	-	-	-	-
1885825	0	2	loxP	NN	-	-	-	-	-	-	-	-
1885825	0	3	sites	NNS	-	-	-	-	-	-	-	-
1885825	0	4	are	VBP	-	-	-	-	-	-	-	-
1885825	0	5	represented	VBN	-	-	-	-	-	-	-	-
1885825	0	6	by	IN	-	-	-	-	-	-	-	-
1885825	0	7	open	JJ	-	-	-	-	-	-	-	-
1885825	0	8	triangles	NNS	-	-	-	-	-	-	-	-
1885825	0	9	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Recombination	NN	-	-	-	-	-	-	-	-
1885825	0	2	of	IN	-	-	-	-	-	-	-	-
1885825	0	3	loxP1	NN	-	-	-	-	-	-	-	(268
1885825	0	4	and	CC	-	-	-	-	-	-	-	-
1885825	0	5	loxP2	NN	-	-	-	-	-	-	-	268)
1885825	0	6	results	VBZ	-	-	-	-	-	-	-	-
1885825	0	7	in	IN	-	-	-	-	-	-	-	-
1885825	0	8	the	DT	-	-	-	-	-	-	-	-
1885825	0	9	loxP1	NN	-	-	-	-	-	-	-	(268
1885825	0	10	+	SYM	-	-	-	-	-	-	-	-
1885825	0	11	2	CD	-	-	-	-	-	-	-	268)
1885825	0	12	site	NN	-	-	-	-	-	-	-	-
1885825	0	13	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	the	DT	-	-	-	-	-	-	-	(213
1885825	0	3	first	JJ	-	-	-	-	-	-	-	-
1885825	0	4	step	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(214
1885825	0	7	strategy	NN	-	-	-	-	-	-	-	214)|213)
1885825	0	8	,	,	-	-	-	-	-	-	-	-
1885825	0	9	the	DT	-	-	-	-	-	-	-	(215
1885825	0	10	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	11	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	12	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	13	locus	NN	-	-	-	-	-	-	-	215)
1885825	0	14	was	VBD	-	-	-	-	-	-	-	-
1885825	0	15	targeted	VBN	-	-	-	-	-	-	-	-
1885825	0	16	with	IN	-	-	-	-	-	-	-	-
1885825	0	17	the	DT	-	-	-	-	-	-	-	(216
1885825	0	18	Card15	NN	-	-	-	-	-	-	-	-
1885825	0	19	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	20	Nod2	NN	-	-	-	-	-	-	-	-
1885825	0	21	KO	NN	-	-	-	-	-	-	-	-
1885825	0	22	targeting	VBG	-	-	-	-	-	-	-	-
1885825	0	23	fragment	NN	-	-	-	-	-	-	-	216)
1885825	0	24	.	.	-	-	-	-	-	-	-	-

1885825	0	1	In	IN	-	-	-	-	-	-	-	-
1885825	0	2	the	DT	-	-	-	-	-	-	-	(217
1885825	0	3	second	JJ	-	-	-	-	-	-	-	-
1885825	0	4	step	NN	-	-	-	-	-	-	-	217)
1885825	0	5	,	,	-	-	-	-	-	-	-	-
1885825	0	6	the	DT	-	-	-	-	-	-	-	(218
1885825	0	7	PGKHygromycin	NN	-	-	-	-	-	-	-	-
1885825	0	8	selection	NN	-	-	-	-	-	-	-	-
1885825	0	9	cassette	NN	-	-	-	-	-	-	-	218)
1885825	0	10	was	VBD	-	-	-	-	-	-	-	-
1885825	0	11	removed	VBN	-	-	-	-	-	-	-	-
1885825	0	12	by	IN	-	-	-	-	-	-	-	-
1885825	0	13	Cre	NN	-	-	-	-	-	-	-	(219
1885825	0	14	recombinase	NN	-	-	-	-	-	-	-	219)
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	The	DT	-	-	-	-	-	-	-	-
1885825	0	2	double	JJ	-	-	-	-	-	-	-	-
1885825	0	3	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	4	headed	VBN	-	-	-	-	-	-	-	-
1885825	0	5	arrows	NNS	-	-	-	-	-	-	-	-
1885825	0	6	indicate	VBP	-	-	-	-	-	-	-	-
1885825	0	7	the	DT	-	-	-	-	-	-	-	-
1885825	0	8	DNA	NN	-	-	-	-	-	-	-	-
1885825	0	9	fragments	NNS	-	-	-	-	-	-	-	-
1885825	0	10	resulting	VBG	-	-	-	-	-	-	-	-
1885825	0	11	from	IN	-	-	-	-	-	-	-	-
1885825	0	12	digestions	NNS	-	-	-	-	-	-	-	-
1885825	0	13	with	IN	-	-	-	-	-	-	-	-
1885825	0	14	different	JJ	-	-	-	-	-	-	-	-
1885825	0	15	enzymes	NNS	-	-	-	-	-	-	-	-
1885825	0	16	expected	VBN	-	-	-	-	-	-	-	-
1885825	0	17	to	TO	-	-	-	-	-	-	-	-
1885825	0	18	hybridize	VB	-	-	-	-	-	-	-	-
1885825	0	19	with	IN	-	-	-	-	-	-	-	-
1885825	0	20	probes	NNS	-	-	-	-	-	-	-	(269|(270b)|(271a)
1885825	0	21	A	NN	-	-	-	-	-	-	-	269)
1885825	0	22	,	,	-	-	-	-	-	-	-	-
1885825	0	23	B	NN	-	-	-	-	-	-	-	(270b)
1885825	0	24	or	CC	-	-	-	-	-	-	-	-
1885825	0	25	Hyg	NN	-	-	-	-	-	-	-	(271a)
1885825	0	26	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Also	RB	-	-	-	-	-	-	-	-
1885825	0	2	depicted	VBN	-	-	-	-	-	-	-	-
1885825	0	3	are	VBP	-	-	-	-	-	-	-	-
1885825	0	4	combinations	NNS	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	PCR	NN	-	-	-	-	-	-	-	(220)
1885825	0	7	primers	NNS	-	-	-	-	-	-	-	-
1885825	0	8	P1	NN	-	-	-	-	-	-	-	-
1885825	0	9	-	SYM	-	-	-	-	-	-	-	-
1885825	0	10	4	CD	-	-	-	-	-	-	-	-
1885825	0	11	that	WDT	-	-	-	-	-	-	-	-
1885825	0	12	detect	VBP	-	-	-	-	-	-	-	-
1885825	0	13	the	DT	-	-	-	-	-	-	-	-
1885825	0	14	different	JJ	-	-	-	-	-	-	-	-
1885825	0	15	Card15	NN	-	-	-	-	-	-	-	(11
1885825	0	16	/	HYPH	-	-	-	-	-	-	-	-
1885825	0	17	Nod2	NN	-	-	-	-	-	-	-	11)
1885825	0	18	alleles	NNS	-	-	-	-	-	-	-	-
1885825	0	19	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	B	LS	-	-	-	-	-	-	-	-
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Southern	NNP	-	-	-	-	-	-	-	-
1885825	0	5	blot	NN	-	-	-	-	-	-	-	-
1885825	0	6	analysis	NN	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	restricted	VBN	-	-	-	-	-	-	-	-
1885825	0	9	DNA	NN	-	-	-	-	-	-	-	-
1885825	0	10	resulting	VBG	-	-	-	-	-	-	-	-
1885825	0	11	from	IN	-	-	-	-	-	-	-	-
1885825	0	12	digestion	NN	-	-	-	-	-	-	-	-
1885825	0	13	with	IN	-	-	-	-	-	-	-	-
1885825	0	14	XbaI	NN	-	-	-	-	-	-	-	(264)
1885825	0	15	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Hybridation	NN	-	-	-	-	-	-	-	-
1885825	0	2	with	IN	-	-	-	-	-	-	-	-
1885825	0	3	Probe	NN	-	-	-	-	-	-	-	(269|(270a)
1885825	0	4	A	NN	-	-	-	-	-	-	-	269)
1885825	0	5	and	CC	-	-	-	-	-	-	-	-
1885825	0	6	B	NN	-	-	-	-	-	-	-	(270a)
1885825	0	7	show	VBP	-	-	-	-	-	-	-	-
1885825	0	8	complete	JJ	-	-	-	-	-	-	-	-
1885825	0	9	integration	NN	-	-	-	-	-	-	-	-
1885825	0	10	of	IN	-	-	-	-	-	-	-	-
1885825	0	11	the	DT	-	-	-	-	-	-	-	-
1885825	0	12	targetting	VBG	-	-	-	-	-	-	-	-
1885825	0	13	fragment	NN	-	-	-	-	-	-	-	-
1885825	0	14	after	IN	-	-	-	-	-	-	-	-
1885825	0	15	homologous	JJ	-	-	-	-	-	-	-	(263
1885825	0	16	recombination	NN	-	-	-	-	-	-	-	263)
1885825	0	17	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Probe	NN	-	-	-	-	-	-	-	(271
1885825	0	2	Hyg	NN	-	-	-	-	-	-	-	271)
1885825	0	3	show	VBP	-	-	-	-	-	-	-	-
1885825	0	4	the	DT	-	-	-	-	-	-	-	-
1885825	0	5	differents	NNS	-	-	-	-	-	-	-	-
1885825	0	6	integrations	NNS	-	-	-	-	-	-	-	-
1885825	0	7	of	IN	-	-	-	-	-	-	-	-
1885825	0	8	targetting	VBG	-	-	-	-	-	-	-	-
1885825	0	9	fragments	NNS	-	-	-	-	-	-	-	-
1885825	0	10	after	IN	-	-	-	-	-	-	-	-
1885825	0	11	homologous	JJ	-	-	-	-	-	-	-	(263
1885825	0	12	recombination	NN	-	-	-	-	-	-	-	263)
1885825	0	13	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	C	LS	-	-	-	-	-	-	-	-
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Genotyping	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	Nod2	NN	-	-	-	-	-	-	-	-
1885825	0	7	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	8	deficient	JJ	-	-	-	-	-	-	-	-
1885825	0	9	mice	NNS	-	-	-	-	-	-	-	-
1885825	0	10	by	IN	-	-	-	-	-	-	-	-
1885825	0	11	PCR	NN	-	-	-	-	-	-	-	(220)
1885825	0	12	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Genomic	JJ	-	-	-	-	-	-	-	(221
1885825	0	2	DNA	NN	-	-	-	-	-	-	-	-
1885825	0	3	from	IN	-	-	-	-	-	-	-	-
1885825	0	4	mice	NNS	-	-	-	-	-	-	-	(210)|221)
1885825	0	5	was	VBD	-	-	-	-	-	-	-	-
1885825	0	6	amplified	VBN	-	-	-	-	-	-	-	-
1885825	0	7	by	IN	-	-	-	-	-	-	-	-
1885825	0	8	PCR	NN	-	-	-	-	-	-	-	-
1885825	0	9	to	TO	-	-	-	-	-	-	-	-
1885825	0	10	detect	VB	-	-	-	-	-	-	-	-
1885825	0	11	the	DT	-	-	-	-	-	-	-	(223
1885825	0	12	disrupted	VBN	-	-	-	-	-	-	-	-
1885825	0	13	sequence	NN	-	-	-	-	-	-	-	223)
1885825	0	14	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	15	PCR	NN	-	-	-	-	-	-	-	-
1885825	0	16	product	NN	-	-	-	-	-	-	-	-
1885825	0	17	of	IN	-	-	-	-	-	-	-	-
1885825	0	18	459	CD	-	-	-	-	-	-	-	-
1885825	0	19	bp	NN	-	-	-	-	-	-	-	-
1885825	0	20	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	21	.	.	-	-	-	-	-	-	-	-

1885825	0	1	(	-LRB-	-	-	-	-	-	-	-	-
1885825	0	2	D	LS	-	-	-	-	-	-	-	(225)
1885825	0	3	)	-RRB-	-	-	-	-	-	-	-	-
1885825	0	4	Expression	NN	-	-	-	-	-	-	-	-
1885825	0	5	of	IN	-	-	-	-	-	-	-	-
1885825	0	6	Nod2	NN	-	-	-	-	-	-	-	(224|(11)
1885825	0	7	mRNA	NN	-	-	-	-	-	-	-	224)
1885825	0	8	in	IN	-	-	-	-	-	-	-	-
1885825	0	9	spleen	NN	-	-	-	-	-	-	-	(107)
1885825	0	10	.	.	-	-	-	-	-	-	-	-

1885825	0	1	RT	NN	-	-	-	-	-	-	-	-
1885825	0	2	-	HYPH	-	-	-	-	-	-	-	-
1885825	0	3	PCR	NN	-	-	-	-	-	-	-	-
1885825	0	4	was	VBD	-	-	-	-	-	-	-	-
1885825	0	5	performed	VBN	-	-	-	-	-	-	-	-
1885825	0	6	on	IN	-	-	-	-	-	-	-	-
1885825	0	7	purified	VBN	-	-	-	-	-	-	-	-
1885825	0	8	mRNA	NN	-	-	-	-	-	-	-	-
1885825	0	9	from	IN	-	-	-	-	-	-	-	-
1885825	0	10	the	DT	-	-	-	-	-	-	-	(38d|(97
1885825	0	11	spleen	NN	-	-	-	-	-	-	-	-
1885825	0	12	of	IN	-	-	-	-	-	-	-	38d)
1885825	0	13	WT	NN	-	-	-	-	-	-	-	(86|(87d)
1885825	0	14	and	CC	-	-	-	-	-	-	-	-
1885825	0	15	KO	NN	-	-	-	-	-	-	-	(12|(38d
1885825	0	16	mice	NNS	-	-	-	-	-	-	-	(87d)|97)|86)|38d)|12)
1885825	0	17	.	.	-	-	-	-	-	-	-	-

1885825	0	1	As	IN	-	-	-	-	-	-	-	-
1885825	0	2	expected	VBN	-	-	-	-	-	-	-	-
1885825	0	3	,	,	-	-	-	-	-	-	-	-
1885825	0	4	no	DT	-	-	-	-	-	-	-	-
1885825	0	5	signal	NN	-	-	-	-	-	-	-	-
1885825	0	6	was	VBD	-	-	-	-	-	-	-	-
1885825	0	7	observed	VBN	-	-	-	-	-	-	-	-
1885825	0	8	in	IN	-	-	-	-	-	-	-	-
1885825	0	9	KO	NN	-	-	-	-	-	-	-	(12
1885825	0	10	mice	NNS	-	-	-	-	-	-	-	12)
1885825	0	11	.	.	-	-	-	-	-	-	-	-

1885825	0	1	GAPDH	NN	-	-	-	-	-	-	-	-
1885825	0	2	expression	NN	-	-	-	-	-	-	-	-
1885825	0	3	was	VBD	-	-	-	-	-	-	-	-
1885825	0	4	used	VBN	-	-	-	-	-	-	-	-
1885825	0	5	as	IN	-	-	-	-	-	-	-	-
1885825	0	6	positive	JJ	-	-	-	-	-	-	-	-
1885825	0	7	control	NN	-	-	-	-	-	-	-	-
1885825	0	8	of	IN	-	-	-	-	-	-	-	-
1885825	0	9	expression	NN	-	-	-	-	-	-	-	-
1885825	0	10	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Footnotes	NNS	-	-	-	-	-	-	-	-

1885825	0	1	Competing	VBG	-	-	-	-	-	-	-	(272
1885825	0	2	Interests	NNS	-	-	-	-	-	-	-	272)
1885825	0	3	:	:	-	-	-	-	-	-	-	-
1885825	0	4	The	DT	-	-	-	-	-	-	-	(13
1885825	0	5	authors	NNS	-	-	-	-	-	-	-	13)
1885825	0	6	have	VBP	-	-	-	-	-	-	-	-
1885825	0	7	declared	VBN	-	-	-	-	-	-	-	-
1885825	0	8	that	IN	-	-	-	-	-	-	-	-
1885825	0	9	no	DT	-	-	-	-	-	-	-	-
1885825	0	10	competing	VBG	-	-	-	-	-	-	-	(272
1885825	0	11	interests	NNS	-	-	-	-	-	-	-	272)
1885825	0	12	exist	VBP	-	-	-	-	-	-	-	-
1885825	0	13	.	.	-	-	-	-	-	-	-	-

1885825	0	1	Funding	NN	-	-	-	-	-	-	-	-
1885825	0	2	:	:	-	-	-	-	-	-	-	-
1885825	0	3	This	DT	-	-	-	-	-	-	-	(226
1885825	0	4	work	NN	-	-	-	-	-	-	-	226)
1885825	0	5	was	VBD	-	-	-	-	-	-	-	-
1885825	0	6	supported	VBN	-	-	-	-	-	-	-	-
1885825	0	7	by	IN	-	-	-	-	-	-	-	-
1885825	0	8	the	NNP	-	-	-	-	-	-	-	-
1885825	0	9	Institut	NNP	-	-	-	-	-	-	-	-
1885825	0	10	National	NNP	-	-	-	-	-	-	-	-
1885825	0	11	de	NNP	-	-	-	-	-	-	-	-
1885825	0	12	la	NNP	-	-	-	-	-	-	-	-
1885825	0	13	Santé	NNP	-	-	-	-	-	-	-	-
1885825	0	14	et	NNP	-	-	-	-	-	-	-	-
1885825	0	15	de	NNP	-	-	-	-	-	-	-	-
1885825	0	16	la	NNP	-	-	-	-	-	-	-	-
1885825	0	17	Recherche	NNP	-	-	-	-	-	-	-	-
1885825	0	18	Médicale	NNP	-	-	-	-	-	-	-	-
1885825	0	19	,	,	-	-	-	-	-	-	-	-
1885825	0	20	the	NNP	-	-	-	-	-	-	-	-
1885825	0	21	Broad	NNP	-	-	-	-	-	-	-	-
1885825	0	22	Medical	NNP	-	-	-	-	-	-	-	-
1885825	0	23	Research	NNP	-	-	-	-	-	-	-	-
1885825	0	24	Program	NNP	-	-	-	-	-	-	-	-
1885825	0	25	,	,	-	-	-	-	-	-	-	-
1885825	0	26	la	NNP	-	-	-	-	-	-	-	-
1885825	0	27	Mairie	NNP	-	-	-	-	-	-	-	-
1885825	0	28	de	NNP	-	-	-	-	-	-	-	-
1885825	0	29	Paris	NNP	-	-	-	-	-	-	-	-
1885825	0	30	,	,	-	-	-	-	-	-	-	-
1885825	0	31	la	NNP	-	-	-	-	-	-	-	-
1885825	0	32	Fondation	NNP	-	-	-	-	-	-	-	-
1885825	0	33	pour	NNP	-	-	-	-	-	-	-	-
1885825	0	34	la	NNP	-	-	-	-	-	-	-	-
1885825	0	35	Recherche	NNP	-	-	-	-	-	-	-	-
1885825	0	36	Médicale	NNP	-	-	-	-	-	-	-	-
1885825	0	37	,	,	-	-	-	-	-	-	-	-
1885825	0	38	BREMICI	NNP	-	-	-	-	-	-	-	-
1885825	0	39	,	,	-	-	-	-	-	-	-	-
1885825	0	40	l'association	NN	-	-	-	-	-	-	-	-
1885825	0	41	François	NNP	-	-	-	-	-	-	-	-
1885825	0	42	Aupetit	NNP	-	-	-	-	-	-	-	-
1885825	0	43	and	CC	-	-	-	-	-	-	-	-
1885825	0	44	la	NNP	-	-	-	-	-	-	-	-
1885825	0	45	région	NNP	-	-	-	-	-	-	-	-
1885825	0	46	Ile	NNP	-	-	-	-	-	-	-	-
1885825	0	47	de	NNP	-	-	-	-	-	-	-	-
1885825	0	48	France	NNP	-	-	-	-	-	-	-	-
1885825	0	49	.	.	-	-	-	-	-	-	-	-

